<SEC-DOCUMENT>0001213900-23-036462.txt : 20230504
<SEC-HEADER>0001213900-23-036462.hdr.sgml : 20230504
<ACCEPTANCE-DATETIME>20230504170922
ACCESSION NUMBER:		0001213900-23-036462
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		20
CONFORMED PERIOD OF REPORT:	20230501
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230504
DATE AS OF CHANGE:		20230504

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			GD Culture Group Ltd
		CENTRAL INDEX KEY:			0001641398
		STANDARD INDUSTRIAL CLASSIFICATION:	WHOLESALE-METALS, MINERALS (NO PETROLEUM) [5050]
		IRS NUMBER:				473709051
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37513
		FILM NUMBER:		23889910

	BUSINESS ADDRESS:	
		STREET 1:		FLAT 1512, 15F, LUCKY CENTRE
		STREET 2:		NO.165-171 WAN CHAI ROA
		CITY:			WAN CHAI
		STATE:			K3
		ZIP:			000000
		BUSINESS PHONE:		852-95791074

	MAIL ADDRESS:	
		STREET 1:		FLAT 1512, 15F, LUCKY CENTRE
		STREET 2:		NO.165-171 WAN CHAI ROA
		CITY:			WAN CHAI
		STATE:			K3
		ZIP:			000000

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Code Chain New Continent Ltd
		DATE OF NAME CHANGE:	20200518

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TMSR HOLDING Co Ltd
		DATE OF NAME CHANGE:	20180207

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	JM Global Holding Co
		DATE OF NAME CHANGE:	20150505
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ea177982-8k_gdculture.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:us-roles="http://fasb.org/us-roles/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:GDC="http://ccnctech.com/20230501">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02C_US%2DGAAP%2D2023 -->
<!-- Field: Set; Name: xdx; ID: xdx_035_GDC_ccnctech.com_20230501 -->
<!-- Field: Set; Name: xdx; ID: xdx_04D_20230501_20230501 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DEntityCentralIndexKey_0001641398 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_051_edei%2D%2DEntityAddressPostalZipCode_00000 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2023-05-01to2023-05-01" name="dei:EntityCentralIndexKey">0001641398</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-05-01to2023-05-01" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-05-01to2023-05-01" name="dei:EntityAddressPostalZipCode">00000</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="gdc-20230501.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2023-05-01to2023-05-01">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001641398</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-05-01</xbrli:startDate>
        <xbrli:endDate>2023-05-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>WASHINGTON, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <span id="xdx_906_edei--DocumentType_c20230501__20230501_zZyMeiejlRgl"><ix:nonNumeric contextRef="From2023-05-01to2023-05-01" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Pursuant to Section 13 or 15(d) of the</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Securities Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of report (Date of earliest event reported):&#160;<span id="xdx_90B_edei--DocumentPeriodEndDate_c20230501__20230501_zoLHSmkDvNW8"><ix:nonNumeric contextRef="From2023-05-01to2023-05-01" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">May
1, 2023</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_905_edei--EntityRegistrantName_c20230501__20230501_zx0Bbjc59HY6"><ix:nonNumeric contextRef="From2023-05-01to2023-05-01" name="dei:EntityRegistrantName">GD Culture Group Limited</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Exact name of Company as specified in charter)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><b><span id="xdx_90A_edei--EntityIncorporationStateCountryCode_c20230501__20230501_zLcaDMGmsEa3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="From2023-05-01to2023-05-01" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Nevada</ix:nonNumeric></span></b></td>
    <td style="width: 2%; text-align: center"><b>&#160;</b></td>
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><b><span id="xdx_90E_edei--EntityFileNumber_c20230501__20230501_zIcyCs6jahej" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="From2023-05-01to2023-05-01" name="dei:EntityFileNumber">001-37513</ix:nonNumeric></span></b></td>
    <td style="width: 2%; text-align: center"><b>&#160;</b></td>
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><b><span id="xdx_902_edei--EntityTaxIdentificationNumber_c20230501__20230501_zwgUfqtdeXO2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="From2023-05-01to2023-05-01" name="dei:EntityTaxIdentificationNumber">47-3709051</ix:nonNumeric></span></b></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(State or other jurisdiction&#160;<br />
    of incorporation)</b></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Commission File No.)</b></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(IRS Employer</b><br />
    <b>Identification No.)</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_904_edei--EntityAddressAddressLine1_c20230501__20230501_zO8nIwb34IF8"><ix:nonNumeric contextRef="From2023-05-01to2023-05-01" name="dei:EntityAddressAddressLine1">c/o GD Culture Group Limited</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_901_edei--EntityAddressAddressLine2_c20230501__20230501_zsigHgPUIxpd"><ix:nonNumeric contextRef="From2023-05-01to2023-05-01" name="dei:EntityAddressAddressLine2">Flat 1512, 15F, Lucky Centre,</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_90A_edei--EntityAddressAddressLine3_c20230501__20230501_zwF6FcEZMELl"><ix:nonNumeric contextRef="From2023-05-01to2023-05-01" name="dei:EntityAddressAddressLine3">No.165-171 Wan Chai Road</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_90E_edei--EntityAddressCityOrTown_c20230501__20230501_z8pSIvbbsdye"><ix:nonNumeric contextRef="From2023-05-01to2023-05-01" name="dei:EntityAddressCityOrTown">Wan Chai</ix:nonNumeric></span>, <span id="xdx_901_edei--EntityAddressCountry_c20230501__20230501_z5JABWEH2hF3"><ix:nonNumeric contextRef="From2023-05-01to2023-05-01" format="ixt-sec:countrynameen" name="dei:EntityAddressCountry">Hong Kong</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Address of Principal Executive Offices) (Zip code)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_902_edei--CityAreaCode_c20230501__20230501_zrGojsaGJH9k"><ix:nonNumeric contextRef="From2023-05-01to2023-05-01" name="dei:CityAreaCode">+852</ix:nonNumeric></span>-<span id="xdx_905_edei--LocalPhoneNumber_c20230501__20230501_zHqtYzitPzDi"><ix:nonNumeric contextRef="From2023-05-01to2023-05-01" name="dei:LocalPhoneNumber">95791074</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Company&#8217;s Telephone number, including
area code)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the Company under any of the following provisions (see General
Instruction A.2. below):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.25in"><span id="xdx_903_edei--WrittenCommunications_c20230501__20230501_zpjyxh7gRjNb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="From2023-05-01to2023-05-01" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written communications pursuant to Rule 425 under the
    Securities Act (17 CFR 230.425)</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span id="xdx_907_edei--SolicitingMaterial_c20230501__20230501_zFGSTI6P6Yh3" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="From2023-05-01to2023-05-01" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting material pursuant to Rule 14a-12 under the
    Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span id="xdx_901_edei--PreCommencementTenderOffer_c20230501__20230501_za2lekR5YeOj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="From2023-05-01to2023-05-01" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement communications pursuant to Rule 14d-2(b)
    under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span id="xdx_903_edei--PreCommencementIssuerTenderOffer_c20230501__20230501_zNpDUDddEzA" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="From2023-05-01to2023-05-01" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement communications pursuant to Rule 13e-4(c)
    under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Emerging growth company&#160;<span id="xdx_90A_edei--EntityEmergingGrowthCompany_c20230501__20230501_zr1HBFtkto7k"><ix:nonNumeric contextRef="From2023-05-01to2023-05-01" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Securities registered pursuant to Section 12(b)
of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title
    of each class</b></span></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trading
    Symbol(s)</b></span></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name
    of each exchange on which registered</b></span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td style="text-align: center"><span id="xdx_902_edei--Security12bTitle_c20230501__20230501_zhpMTUUyNjZ7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="From2023-05-01to2023-05-01" name="dei:Security12bTitle">Common Stock, par value $0.0001</ix:nonNumeric></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span id="xdx_90E_edei--TradingSymbol_c20230501__20230501_zIV5Rkz9nb3e" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="From2023-05-01to2023-05-01" name="dei:TradingSymbol">GDC</ix:nonNumeric></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span id="xdx_902_edei--SecurityExchangeName_c20230501__20230501_zCLLI3EMybsi" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="From2023-05-01to2023-05-01" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital Market</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Item 1.01 Entry into a Material Definitive
Agreement.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On May 1, 2023, GD Culture Group Limited (the
&#8220;Company&#8221;, &#8220;we&#8221;, &#8220;us&#8221; or &#8220;our&#8221;) entered into a placement agency agreement (the &#8220;Placement
Agency Agreement&#8221;), with Univest Securities, LLC (the &#8220;Placement Agent&#8221; or &#8220;Univest&#8221;). Pursuant to the Placement
Agency Agreement, the Placement Agent agrees to use its reasonable best efforts to sell the Company&#8217;s common stock (the &#8220;Common
Stock&#8221;) in a registered direct offering (the &#8220;RD Offering&#8221;), and a concurrent private placement (the &#8220;PIPE Offering&#8221;,
together with the RD Offering, collectively the &#8220;Offering&#8221;). The Placement Agent has no obligation to buy any of the securities
from us or to arrange for the purchase or sale of any specific number or dollar amount of securities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the RD Offering, an aggregate of 310,168
shares of common stock (the &#8220;Common Shares&#8221;) of the Company, par value $0.0001 per share, and pre-funded warrants to
purchase up to an aggregate of 844,351 shares of common stock (the &#8220;Pre-Funded Warrants&#8221;, and the common stock
underlying such warrants, the &#8220;Pre-Funded Warrant Shares&#8221;) are sold to certain purchasers (the
&#8220;Purchasers&#8221;), pursuant to a securities purchase agreement, dated May 1, 2023 (the &#8220;RD Securities Purchase
Agreement&#8221;). The purchase price of each Common Share is $8.27. The purchase price of each Pre-funded Warrant is $8.269, which
equals the price per Common Share being sold to the public in this offering, minus $0.001. The RD Offering is being made pursuant to
a shelf registration statement (No.&#160;333-254366)&#160;on Form&#160;S-3,&#160;which was declared effective by the U.S. Securities
and Exchange Commission (the &#8220;SEC&#8221;) on March 26, 2021, and related prospectus supplement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the concurrent PIPE Offering, warrants to purchase
up to 1,154,519 shares of common stock (the &#8220;Unregistered Warrants&#8221;, and the common stock underlying such warrants, the &#8220;Unregistered
Warrant Shares&#8221;) are also sold to the Purchasers, pursuant to a private warrant securities purchase agreement, dated May 1, 2023
(the &#8220;PIPE Securities Purchase Agreement&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The net proceeds from the Offering, after deducting
placement agent discounts and commissions and estimated offering expenses payable by the Company, are approximately $8.53 million (assuming
the Unregistered Warrants are not exercised). The Company intends to use the net proceeds from the Offering for working capital and general
corporate purposes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the Placement Agency Agreement, the Company has agreed
to pay the Placement Agent a total cash fee equal to 7.0% of the aggregate gross proceeds received in the Offering and the Company has
also agreed to pay the Placement Agent a non-accountable expense allowance equal to 1% of the aggregate gross proceeds. The Placement
Agent will also be reimbursed for certain out-of-pocket accountable expenses incurred in this offering up to $150,000.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Pre-funded Warrants</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#8220;Pre-funded&#8221; refers to the fact that
the purchase price of the warrants in the offering includes almost the entire exercise price that will be paid under the Pre-funded Warrants,
except for a nominal remaining exercise price of $0.001. The purpose of the Pre-funded Warrants is to enable Purchasers that may have
restrictions on their ability to beneficially own more than 4.99% (or, upon election of the holder, 9.99%) of the Company&#8217;s outstanding
Common Stock following the consummation of the offering the opportunity to make an investment in the Company without triggering their
ownership restrictions, by receiving Pre-funded Warrants in lieu of the Company&#8217;s common stock which would result in such ownership
of more than 4.99% (or 9.99%), and receive the ability to exercise their option to purchase the shares underlying the Pre-funded Warrants
at such nominal price at a later date. In the RD Offering, each Pre-funded Warrant is exercisable for one share of our Common Stock,
with an exercise price equal to $0.001 per share, at any time that the Pre-funded Warrant is outstanding. The Pre-funded Warrants will
be exercisable immediately after issuance and will expire five (5) years from the date of issuance. The holder of a Pre-funded Warrant
will not be deemed a holder of our underlying common stock until the Pre-funded Warrant is exercised.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Unregistered Warrants</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In a concurrent private placement, the Company has agreed to sell to
such Purchasers warrants to purchase up to 1,154,519 Unregistered Warrants. The Unregistered Warrants and the Unregistered Warrant Shares
are not being registered under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;). The Unregistered Warrants and
the Unregistered Warrant Shares are being offered pursuant to an exemption from the registration requirements of the Securities Act provided
in Section 4(a)(2) of the Securities Act and/or Regulation D promulgated thereunder.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Unregistered Warrants will be exercisable
immediately after issuance and will expire five (5) years from the date of issuance. The Exercise Price of the Unregistered Warrants
is $8.27, subject to adjustment as provided in the form of Unregistered&#160;Warrants.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Placement Agent Warrants</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the Placement Agency Agreement, the
Company has agreed to issue the Placement Agent Warrants&#160;to the Placement Agent to purchase up to 115,452 shares of Common
Stock (equal to 5.0% of the aggregate number of Common Shares, Pre-Funded Warrant Shares, and the Unregistered Warrant Shares) at an exercise
price of $9.924 per share, which represents 120% of the offering price of each share. The Placement Agent&#8217;s Warrants will have substantially
the same terms as the Unregistered Warrants, which is not covered by the shelf registration statement (No.&#160;333-254366)&#160;on Form&#160;S-3,&#160;which
was declared effective by the SEC on March 26, 2021, and related prospectus supplement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Placement Agency Agreement is filed as
Exhibit 10.1 to this Current Report on Form 8-K and is incorporated herein by reference. The form of RD Securities Purchase
Agreement is filed as Exhibit 10.2 to this Current Report on Form 8-K and is incorporated herein by reference. The form of PIPE
Securities Purchase Agreement is filed as Exhibit 10.3 to this Current Report on Form 8-K and is incorporated herein by reference.
The form of&#160;Pre-funded&#160;Warrants is filed as Exhibit 4.1 to this Current Report on Form&#160;8-K&#160;and is incorporated
herein by reference. The form of&#160;Unregistered&#160;Warrants is filed as Exhibit 4.2 to this Current Report on
Form&#160;8-K&#160;and is incorporated herein by reference. The foregoing descriptions of the terms of the Purchase Agreements and
form of&#160;Pre-funded&#160;Warrant and Unregistered Warrants do not purport to be complete descriptions of the rights and
obligations thereunder and are qualified in their entirety by reference to such exhibits. A copy of the opinion of the
Company&#8217;s counsel, relating to the validity of the Common Shares and&#160;Pre-funded Warrants in connection with the RD
Offering, is filed as Exhibit 5.1 to this Current Report on Form&#160;8-K.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 8.01 Other Events.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On May 4, 2023, the Company issued a press release
announcing the closing of the Offering, a copy of which is attached hereto as Exhibit 99.1.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 9.01. Financial Statements and Exhibits</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; width: 9%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit<br />
    Number</b></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: black 1.5pt solid; width: 90%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description
    of Exhibit</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</span></td>
    <td style="text-align: center">&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ea177982ex4-1_gdculture.htm">Form of&#160;Pre-funded&#160;Warrants</a></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</span></td>
    <td style="text-align: center">&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ea177982ex4-2_gdculture.htm">Form of&#160;Unregistered&#160;Warrants</a></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1</span></td>
    <td style="text-align: center">&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ea177982ex5-1_gdculture.htm">Opinion of Ortoli
    Rosenstadt LLP</a></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</span></td>
    <td style="text-align: center">&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ea177982ex10-1_gdculture.htm">Placement Agency
    Agreement, dated May 1, 2023</a></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</span></td>
    <td style="text-align: center">&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ea177982ex10-2_gdculture.htm">Form of RD
    Securities Purchase Agreement between the Company and certain Purchasers, dated May 1, 2023</a></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</span></td>
    <td style="text-align: center">&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ea177982ex10-3_gdculture.htm">Form of PIPE
    Securities Purchase Agreement between the Company and certain Purchasers, dated May 1, 2023</a></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.1</span></td>
    <td style="text-align: center">&#160;</td>
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ea177982ex5-1_gdculture.htm">Consent of Ortoli
    Rosenstadt LLP (included in Exhibit 5.1)</a></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</span></td>
    <td style="text-align: center">&#160;</td>
    <td><a href="ea177982ex99-1_gdculture.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Closing Press Release dated May 4, 2023</span></a></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td>104</td>
    <td style="text-align: center">&#160;</td>
    <td>Cover Page Interactive Data File (embedded within the Inline XBRL document)</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td colspan="2" style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>GD CULTURE
    GROUP LIMITED</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="width: 60%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: May 4,
    2023</span></td>
    <td style="width: 5%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1.5pt solid; width: 35%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Xiaojian Wang</i></span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Xiaojian Wang</span></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer,
    President and<br />
    Chairman of the Board</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">4</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjdEKgkAQRb/Afxj2OWq1hPCtpCKyCJHodckplnRHZjerT+ovW5VoGBiGe8+9QozEhta6QobzMs+gwLqplEPI8YqM5oLekW53Cfib401bx8q4/v2BKXkGPROPw7nyQm9ttcUyARlP5GwSTSGUyTSCxV4EnZ6SueoSjdOqAmVKODI1rNEpfg8JhXqRofrdV52QrSaTQDiWg/yBSIYRHKhVT+K7hSxLRTDqJxAbpkfT1TysoxpWFda+yw7of4MvD+hJOg== -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>2
<FILENAME>ea177982ex4-1_gdculture.htm
<DESCRIPTION>FORM OF PRE-FUNDED WARRANTS
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><B>Exhibit 4.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>PRE-FUNDED WARRANT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>TO PURCHASE COMMON STOCK</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>GD CULTURE GROUP LIMITED</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 76%; font-size: 10pt; text-align: left">Warrant Shares: [number of shares of common stock]</TD>
    <TD STYLE="width: 24%; font-size: 10pt; text-align: right">Issue Date: May [_], 2023</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">THIS PRE-FUNDED WARRANT
TO PURCHASE COMMON STOCK (the &ldquo;Warrant&rdquo;) certifies that, for value received, [ ] or its assigns (the &ldquo;Holder&rdquo;)
is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after
the Issue Date (the &ldquo;Initial Exercise Date&rdquo;) until this Warrant is exercised in full (the &ldquo;Termination Date&rdquo;),
but not thereafter, to subscribe for and purchase from GD Culture Group Limited, a Nevada corporation (the &ldquo;Company&rdquo;), up
to [ ] shares of Common Stock (as defined below) of the Company (the shares of Common Stock issuable hereunder, the &ldquo;Warrant Shares&rdquo;).
The purchase price of a Warrant under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Section 1</U>.
<U>Definitions</U>. In addition to the terms defined elsewhere in this Warrant, the following terms have the meanings indicated in this
Section 1:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Business
Day</U>&rdquo; means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States or any day
on which the Federal Reserve Bank of New York are authorized or required by law or other governmental action to close.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common Stock</U>&rdquo;
means the common stock of the Company, par value $0.0001, and any other class of securities into which such securities may hereafter be
reclassified or changed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Commission</U>&rdquo; means the United States Securities
and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Exchange Act</U>&rdquo; means
the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Liens</U>&rdquo; means a lien,
charge pledge, security interest, encumbrance, right of first refusal, preemptive right or other restriction</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common Stock
Equivalents</U>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire at any
time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is at any
time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company,
joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>&ldquo;Proceeding&rdquo;</U>
means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding,
such as a deposition), whether commenced or threatened</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading Day</U>&rdquo; means a day on which the
principal Trading Market is open for Trading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the Common Stock are listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock
Exchange (or any successors to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><U>Section 2</U>. <U>Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">a)&nbsp;<U>Exercise
of Warrant</U>. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time or times on
or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company (or such other office or agency of
the Company as it may designate by notice in writing to the registered Holder at the address of the Holder appearing on the books of the
Company) of a duly executed facsimile copy or PDF copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form
annexed hereto, delivered in accordance with Section 5(i) (the &ldquo;<U>Notice of Exercise</U>&rdquo;). Within the earlier of (i) two
(2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined in Section 2(d)(i) herein)
following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the Warrant Shares specified in
the applicable Notice of Exercise by wire transfer or cashier&rsquo;s check drawn on a United States bank, unless the cashless exercise
procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise. No ink-original Notice of Exercise shall
be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise be required. Notwithstanding
anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company until the Holder
has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full, in which case the Holder shall
surrender this Warrant to the Company for cancellation within three (3) Trading Days of the date on which the final Notice of Exercise
is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the total number of Warrant Shares
available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder in an amount equal
to the applicable number of Warrant Shares purchased in connection with such partial exercise. The Holder and the Company shall maintain
records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection to any
Notice of Exercise within one (1) Trading Day of receipt of such notice. <B>The Holder and any assignee, by acceptance of this Warrant,
acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder,
the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">For the avoidance of doubt, there is no
circumstance that would require the Company to net cash settle the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">For the avoidance of doubt, at any time
during which there is no effective registration statement for the resale of the Warrant Shares, the Company may settle the exercise of
the Warrant with unregistered Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">b)&nbsp;<U>Exercise
Price</U>. The aggregate exercise price of this Warrant, except for a nominal exercise price of $0.0001 per Warrant, was pre-funded to
the Company on or prior to the Initial Exercise Date and, consequently, no additional consideration (other than the nominal exercise price
of $0.0001 per Warrant) shall be required to be paid by the Holder to any Person to effect any exercise of this Warrant. The Holder shall
not be entitled to the return or refund of all, or any portion, of such pre-paid aggregate exercise price under any circumstance or for
any reason whatsoever, including in the event this Warrant shall not have been exercised prior to the Termination Date. The remaining
unpaid exercise price per Warrant under this Warrant shall be $0.0001, subject to adjustment hereunder (the &ldquo;<U>Exercise Price</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">c)&nbsp;<U>Cashless
Exercise</U>. This Warrant may also be exercised, in whole or in part, at such time by means of a &ldquo;cashless exercise&rdquo; in which
the Holder shall be entitled to receive a number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(A) = as applicable: (i) the VWAP on
the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of Exercise is (1) both executed and
delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed and delivered pursuant to Section 2(a)
hereof on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo; (as defined in Rule 600(b) of Regulation NMS promulgated
under the federal securities laws) on such Trading Day, (ii) at the option of the Holder, either (y) the VWAP on the Trading Day immediately
preceding the date of the applicable Notice of Exercise or (z) the Bid Price of the Common Stock on the principal Trading Market as reported
by Bloomberg L.P. (&ldquo;<U>Bloomberg</U>&rdquo;) as of the time of the Holder&rsquo;s execution of the applicable Notice of Exercise
if such Notice of Exercise is executed during &ldquo;regular trading hours&rdquo; on a Trading Day and is delivered within two (2) hours
thereafter (including until two (2) hours after the close of &ldquo;regular trading hours&rdquo; on a Trading Day) pursuant to Section
2(a) hereof, or (iii) the VWAP on the date of the applicable Notice of Exercise if the date of such Notice of Exercise is a Trading Day
and such Notice of Exercise is both executed and delivered pursuant to Section 2(a) hereof after the close of &ldquo;regular trading hours&rdquo;
on such Trading Day;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(B) = the Exercise Price of this Warrant,
as adjusted hereunder; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(X) = the number of Warrant Shares that
would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise were by means of a cash
exercise rather than a cashless exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If Warrant Shares
are issued in such a cashless exercise, the parties acknowledge and agree that, in accordance with Section 3(a)(9) of the Securities Act,
the Warrant Shares shall take on the registered characteristics of the Warrants being exercised. The Company agrees not to take any position
contrary to this Section 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>Bid Price</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or
quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest preceding date) on the Trading
Market on which the Common Stock are then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30 a.m. (New York City
time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average price of the Common
Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not then listed or quoted
for trading on OTCQB or OTCQX and if prices for the Common Stock is then reported on The Pink Open Market (or a similar organization or
agency succeeding to its functions of reporting prices), the most recent bid price per share of Common Stock so reported, or (d) in all
other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith by the
Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company, the fees and expenses
of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or
quoted on a Trading Market, the daily volume weighted average price of a share of Common Stock for such date (or the nearest preceding
date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg (based on a Trading Day from 9:30
a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average
price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the common Stock is not
then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock is then reported on The Pink Open Market (or a
similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of Common Stock so
reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected
in good faith by the Purchasers of a majority in interest of the Securities then outstanding and reasonably acceptable to the Company,
the fees and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Notwithstanding anything herein to the
contrary, on the Termination Date, this Warrant shall be automatically exercised via cashless exercise pursuant to this Section 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-indent: 0in; text-align: justify">d) <U>Mechanics
of Exercise</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in">i. <U>Delivery
of Warrant Upon Exercise</U>. The Company shall cause the Warrant purchased hereunder to be transmitted by the transfer agent to the Holder
by crediting the account of the Holder&rsquo;s or its designee&rsquo;s balance account with DTC through its Deposit or Withdrawal at Custodian
system (&ldquo;<U>DWAC</U>&rdquo;) if the Company is then a participant in such system and either (A) there is an effective registration
statement permitting the issuance of the Warrant to or resale of the Warrant by the Holder or (B) this Warrant is being exercised via
cashless exercise, and otherwise by physical delivery of the Warrant Shares, registered in the Company&rsquo;s stock register in the name
of the Holder or its designee, for the number of Warrant Shares to which the Holder is entitled pursuant to such exercise to the address
specified by the Holder in the Notice of Exercise by the date that is the earliest of (i) two (2) Trading Days after the delivery to the
Company of the Notice of Exercise, (ii) one (1) Trading Day after delivery of the aggregate Exercise Price to the Company, and (iii) the
number of Trading Days comprising the Standard Settlement Period after the delivery to the Company of the Notice of Exercise (such date,
the &ldquo;<U>Warrant Delivery Date</U>&rdquo;). Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate
purposes to have become the holder of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective
of the date of delivery of the Warrant Shares, provided that payment of the aggregate Exercise Price (other than in the case of a cashless
exercise) is received within the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement
Period following delivery of the Notice of Exercise. If the Company fails for any reason to deliver to the Holder the Warrant Shares subject
to a Notice of Exercise by the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not
as a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Stock on the date of the applicable
Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the third Trading Day after the Warrant Share Delivery
Date) for each Trading Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or Holder rescinds such exercise.
The Company agrees to maintain a transfer agent that is a participant in the FAST program so long as this Warrant remains outstanding
and exercisable. As used herein, &ldquo;<U>Standard Settlement Period</U>&rdquo; means the standard settlement period, expressed in a
number of Trading Days, on the Company&rsquo;s primary Trading Market with respect to the Common Stock as in effect on the date of delivery
of the Notice of Exercise. Notwithstanding the foregoing, with respect to any Notice(s) of Exercise delivered on or prior to 9:00 a.m.
(New York City time) on the Initial Exercise Date, the Company agrees to deliver, or cause to be delivered, the Warrant Shares subject
to such notice(s) by 4:00 p.m. (New York City time) on the Initial Exercise Date and the Initial Exercise Date shall be the Warrant Share
Delivery Date for purposes hereunder, provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise)
is received by such Warrant Shares Delivery Date. The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that,
by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant
Shares available for purchase hereunder at any given time will be less than the amount stated on the face hereof.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">ii.&nbsp;<U>Delivery
of New Warrants Upon Exercise</U>. If this Warrant shall have been exercised in part, the Company shall, at the request of a Holder and
upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant evidencing
the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in all other respects
be identical with this Warrant.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">iii.&nbsp;<U>Rescission
Rights</U>. If the Company fails to cause the transfer agent to transmit to the Holder the Warrant Shares pursuant to Section 2(d)(i)
by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 41pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">iv.&nbsp;<U>Compensation
for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise</U>. In addition to any other rights available to the Holder, if
the Company fails to cause the transfer agent to transmit to the Holder the Warrant Shares in accordance with the provisions of Section
2(d)(i) above pursuant to an exercise on or before the Warrant Shares Delivery Date, and if after such date the Holder is required by
its broker to purchase (in an open market transaction or otherwise) or the Holder&rsquo;s brokerage firm otherwise purchases, Common Stock
to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated receiving upon such exercise (a
&ldquo;<U>Buy-In</U>&rdquo;), then the Company shall (A) pay in cash to the Holder the amount, if any, by which (x) the Holder&rsquo;s
total purchase price (including brokerage commissions, if any) for the Common Stock so purchased exceeds (y) the amount obtained by multiplying(1)
the number of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise at issue times (2)
the price at which the sell order giving rise to such purchase obligation was executed, and (B) at the option of the Holder, either reinstate
the portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in which case such exercise
shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock that would have been issued had the Company timely
complied with its exercise and delivery obligations hereunder. For example, if the Holder purchases Common Stock having a total purchase
price of $11,000 to cover a Buy-In with respect to an attempted exercise of Warrants with an aggregate sale price giving rise to such
purchase obligation of $10,000, under clause (A) of the immediately preceding sentence the Company shall be required to pay the Holder
$1,000. The Holder shall provide the Company written notice indicating the amounts payable to the Holder in respect of the Buy-In and,
upon request of the Company, evidence of the amount of such loss. Nothing herein shall limit a Holder&rsquo;s right to pursue any other
remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific performance and/or injunctive
relief with respect to the Company&rsquo;s failure to timely deliver Common Stock upon exercise of the Warrant as required pursuant to
the terms hereof.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">v.&nbsp;<U>No
Fractional Shares of Common Stock or Scrip</U>. No fractional shares of Common Stock or scrip representing fractional shares of Common
Stock shall be issued upon the exercise of this Warrant. As to any fraction of a share of Common Stock which the Holder would otherwise
be entitled to purchase upon such exercise, the Company shall, at its election, either pay a cash adjustment in respect of such final
fraction in an amount equal to such fraction multiplied by the Exercise Price or round up to the next whole share of Common Stock.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">vi.&nbsp;<U>Charges,
Taxes and Expenses</U>. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax or other incidental
expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company, and such Warrant
Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; <U>provided</U>, <U>however</U>,
that in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when surrendered for
exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may require, as a condition
thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto, and this Warrant shall be surrendered
to the Company and, if any portion of this Warrant remains unexercised, a new Warrant in the form hereof shall be delivered to the assignee.
The Company shall pay all transfer agent fees required for same- day processing of any Notice of Exercise and all fees to DTC (or another
established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">vii.&nbsp;<U>Closing
of Books</U>. The Company will not close its stockholder books or records in any manner which prevents the timely exercise of this Warrant,
pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 41pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">viii.&nbsp;
<U>Holder&rsquo;s Exercise Limitations</U>. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the
right to exercise all or any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such
issuance upon exercise as set forth on the applicable Notice of Exercise, the Holder (together with (i) the Holder&rsquo;s Affiliates,
(ii) any other Persons acting as a group together with the Holder or any of the Holder&rsquo;s Affiliates and (iii) any other Persons
whose beneficial ownership of the Common Stock would or could be aggregated with the Holder&rsquo;s for purposes of Section 13(d) (such
Persons, &ldquo;<U>Attribution Parties</U>&rdquo;)), would beneficially own in excess of the Beneficial Ownership Limitation (as defined
below). For purposes of the foregoing sentence, the number of shares of Common Stock beneficially owned by the Holder and its Affiliates
and Attribution Parties shall include the number of shares of Common Stock underlying such Warrant issuable upon exercise of this Warrant
with respect to which such determination is being made, but shall exclude the shares of Common Stock underlying the Warrant which would
be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant beneficially owned by the Holder or any of its Affiliates
or Attribution Parties and (ii) exercise or conversion of the unexercised or nonconverted portion of any other securities of the Company
(including, without limitation, any other Common Stock Equivalents) subject to a limitation on conversion or exercise analogous to the
limitation contained herein beneficially owned by the Holder or any of its Affiliates or Attribution Parties. Except as set forth in the
preceding sentence, for purposes of this Section 2(e), beneficial ownership shall be calculated in accordance with Section 13(d) of the
Exchange Act and the rules and regulations promulgated thereunder, it being acknowledged by the Holder that the Company is not representing
to the Holder that such calculation is in compliance with Section 13(d) of the Exchange Act and the Holder is solely responsible for any
schedules required to be filed in accordance therewith. To the extent that the limitation contained in this Section 2(e) applies, the
determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any Affiliates
and Attribution Parties) and of which portion of this Warrant is exercisable shall be in the sole discretion of the Holder, and the submission
of a Notice of Exercise shall be deemed to be the Holder&rsquo;s determination of whether this Warrant is exercisable (in relation to
other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable,
in each case subject to the Beneficial Ownership Limitation, and the Company shall have no obligation to verify or confirm the accuracy
of such determination. In addition, a determination as to any group status as contemplated above shall be determined in accordance with
Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes of this Section 2(e), in determining
the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding shares of Common Stock as reflected in
(A) the Company&rsquo;s most recent periodic or annual report filed with the Commission, as the case may be, (B) a more recent public
announcement by the Company or (C) a more recent written notice by the Company or the transfer agent setting forth the number of shares
of Common Stock outstanding. Upon the written or oral request of a Holder, the Company shall within one Trading Day confirm orally and
in writing to the Holder the number of shares of Common Stock then outstanding. In any case, the number of outstanding shares of Common
Stock shall be determined after giving effect to the conversion or exercise of securities of the Company, including this Warrant, by the
Holder or its Affiliates or Attribution Parties since the date as of which such number of outstanding shares of Common Stock was reported.
The &ldquo;<U>Beneficial Ownership Limitation</U>&rdquo; shall be 4.99% of the number of shares of Common Stock outstanding immediately
after giving effect to the issuance of Common Stock underlying the Warrant issuable upon exercise of this Warrant. The Holder, upon notice
to the Company, may increase or decrease the Beneficial Ownership Limitation provisions of this Section 2(e), provided that the Beneficial
Ownership Limitation in no event exceeds 4.99% of the number of shares of Common Stock outstanding immediately after giving effect to
the issuance of Common Stock upon exercise of this Warrant held by the Holder and the provisions of this Section 2(e) shall continue to
apply. Any increase in the Beneficial Ownership Limitation will not be effective until the 61st day after such notice is delivered to
the Company. The provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with
the terms of this Section 2(e) to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended
Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable to properly give effect to such
limitation. The limitations contained in this paragraph shall apply to a successor holder of this Warrant. If the Warrant is unexercisable
as a result of the Holder&rsquo;s Beneficial Ownership Limitation, no alternate consideration is owing to the Holder. So long as this
Warrant is outstanding, in no event shall the Holder or the Attribution Parties hold more than 4.99% of the voting power of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><U>Section 3</U>. <U>Certain Adjustments</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">a)&nbsp;<U>Stock
Dividends and Splits</U>. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise makes
a distribution or distributions on its Common Stock or any other equity or equity equivalent securities payable in Common Stock (which,
for avoidance of doubt, shall not include any Common Stock upon exercise of this Warrant), as applicable, (ii) subdivides outstanding
shares of Common Stock into a larger number of shares of Common Stock, as applicable, (iii) combines (including by way of reverse stock
split) outstanding shares of Common Stock into a smaller number of shares of Common Stock, as applicable, or (iv) issues by reclassification
of shares of Common Stock or any stock capital of the Company, as applicable, then in each case the Exercise Price shall be multiplied
by a fraction of which the numerator shall be the number of shares of Common Stock (excluding treasury stock, if any) outstanding immediately
before such event and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event,
and the number of shares of Common Stock issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate
Exercise Price of this Warrant shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately
after the record date for the determination of stockholders entitled to receive such dividend or distribution and shall become effective
immediately after the effective date in the case of a subdivision, combination or re-classification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">b)&nbsp;
<I><U>[Intentionally Omitted]</U></I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in">c)&nbsp;<U>Pro
Rata Distributions</U>. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or other distribution
of its assets (or rights to acquire its assets) to holders of Common Stock, by way of return of capital or otherwise (including, without
limitation, any distribution of cash, common stock or other securities, property or options by way of a dividend, spin off, reclassification,
corporate rearrangement, scheme of arrangement or other similar transaction) (a &ldquo;<U>Distribution</U>&rdquo;), at any time after
the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution to the same extent
that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable upon complete exercise
of this Warrant (without regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation)
immediately before the date of which a record is taken for such Distribution, or, if no such record is taken, the date as of which the
record holders of Common Stock are to be determined for the participation in such Distribution (provided, however, to the extent that
the Holder&rsquo;s right to participate in any such Distribution would result in the Holder exceeding the Beneficial Ownership Limitation,
then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial ownership of any Common
Stock as a result of such Distribution to such extent) and the portion of such Distribution shall be held in abeyance for the benefit
of the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Beneficial Ownership Limitation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">d)&nbsp;<I><U>[Intentionally
Omitted]</U></I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in">e)&nbsp;<U>Calculations</U>.
All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share of Common Stock, as the case
may be. For purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall
be the sum of the number of shares of the Common stock (excluding treasury stocks, if any) issued and outstanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-indent: 0in; text-align: justify">f) <U>Notice
to Holder</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">i.&nbsp;<U>Adjustment
to Exercise Price</U>. Whenever the Exercise Price, the number of shares of Common Stock, the subject of each Warrant, or the number of
Warrants is adjusted pursuant to any provision of this Section 3, the Company shall promptly deliver to the Holder by facsimile or email
a notice setting forth the Exercise Price after such adjustment and any resulting adjustment to the number of Warrants or the number of
shares of Common Stock, the subject of each Warrant and setting forth a brief statement of the facts requiring such adjustment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">ii.&nbsp;<U>Notice
to Allow Exercise by Holder</U>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common
Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the Company shall
authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any capital stock of any class
or of any rights, , or (D) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs
of the Company, then, in each case, the Company shall cause to be delivered by facsimile or email to the Holder at its last facsimile
number or email address as it shall appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable
record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such
dividend, distribution, redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common
Stock of record to be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on
which such reclassification, consolidation, merger, sale, transfer or stock exchange is expected to become effective or close, and the
date as of which it is expected that holders of the Common Stock of record shall be entitled to exchange their Common Stock for securities,
cash or other property deliverable upon such reclassification, consolidation, merger, sale, transfer or stock exchange; provided that
the failure to deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action
required to be specified in such notice. To the extent that any notice provided in this Warrant constitutes, or contains, material, non-public
information regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant
to a Current Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of
such notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">g)&nbsp;<U>Voluntary
Adjustment by Company</U>. Subject to the rules and regulations of the Trading Market and requirements of any applicable law, the Company
may at any time during the term of this Warrant, subject to the prior written consent of the Holder, reduce the then current Exercise
Price to any amount and for any period of time deemed appropriate by the board of directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><U>Section 4</U>. <U>Transfer of Warrant</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">a)&nbsp;<U>Transferability</U>.
If this Warrant is to be transferred, the Holder shall surrender this Warrant to the Company, whereupon the Company will forthwith issue
and deliver upon the order of the Holder a new Warrant (in accordance with Section 4(d)), registered as the Holder may request, representing
the right to purchase the number of Warrant Shares being transferred by the Holder and, if less than the total number of Warrant Shares
then underlying this Warrant is being transferred, a new Warrant (in accordance with Section 4(d)) to the Holder representing the right
to purchase the number of Warrant Shares not being transferred.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">b)&nbsp;<U>Lost,
Stolen or Mutilated Warrant</U>. Upon receipt by the Company of evidence reasonably satisfactory to the Company of the loss, theft, destruction
or mutilation of this Warrant (as to which a written certification and the indemnification contemplated below shall suffice as such evidence),
and, in the case of loss, theft or destruction, of any indemnification undertaking by the Holder to the Company in customary and reasonable
form and, in the case of mutilation, upon surrender and cancellation of this Warrant, the Company shall execute and deliver to the Holder
a new Warrant (in accordance with Section 4(d)) representing the right to purchase the Warrant Shares then underlying this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">c)&nbsp;<U>Exchangeable
for Multiple Warrants</U>. This Warrant is exchangeable, upon the surrender hereof by the Holder at the principal office of the Company,
for a new Warrant or Warrants (in accordance with Section 4(d)) representing in the aggregate the right to purchase the number of Warrant
Shares then underlying this Warrant, and each such new Warrant will represent the right to purchase such portion of such Warrant Shares
as is designated by the Holder at the time of such surrender; provided, however, no warrants for fractional shares of Common Stock shall
be given.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">d)&nbsp;<U>Issuance
of New Warrants</U>. Whenever the Company is required to issue a new Warrant pursuant to the terms of this Warrant, such new Warrant (i)
shall be of like tenor with this Warrant, (ii) shall represent, as indicated on the face of such new Warrant, the right to purchase the
Warrant Shares then underlying this Warrant (or in the case of a new Warrant being issued pursuant to Section 4(a) or Section 4(c), the
Warrant Shares designated by the Holder which, when added to the number of shares of Common Stock underlying the other new Warrants issued
in connection with such issuance, does not exceed the number of Warrant Shares then underlying this Warrant), (iii) shall have an issuance
date, as indicated on the face of such new Warrant which is the same as the Issuance Date, and (iv) shall have the same rights and conditions
as this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><U>Section 5</U>. <U>Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">a)&nbsp;<U>Currency</U>.
Unless otherwise indicated, all dollar amounts referred to in this Warrant are in United States Dollars (&ldquo;<U>U.S. Dollars</U>&rdquo;).
All amounts owing under this Warrant shall be paid in U.S. Dollars.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">b)&nbsp;<U>No
Rights as Stockholder Until Exercise; No Settlement in Cash</U>. This Warrant does not entitle the Holder to any voting rights, dividends
or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except as expressly set
forth in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a &ldquo;cashless exercise&rdquo; pursuant to
Section 2(c) or to receive cash payments pursuant to Section 2(d)(i) and Section 2(d)(iv) herein, in no event shall the Company be required
to net cash settle an exercise of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">c)&nbsp;<U>Loss,
Theft, Destruction or Mutilation of Warrant</U>. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory
to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and in case
of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant, shall not include
the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the Company will make
and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant or stock certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">d)&nbsp;<U>Saturdays,
Sundays, Holidays, etc</U>. If the last or appointed day for the taking of any action or the expiration of any right required or granted
herein shall not be a Business Day, then, such action may be taken or such right may be exercised on the next succeeding Business Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0.5in; text-indent: 0in; text-align: justify">e)
<U>Authorized Shares</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Company covenants
that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common Stock a sufficient number
of shares of Common Stock to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights under this Warrant.
The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers who are charged with the
duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company will take all such
reasonable action as may be necessary to assure that such Warrant Shares may be issued, and the Warrant Shares delivered, as provided
herein without violation of any applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock
may be listed. The Company covenants that all Warrant Shares which may be issued upon the exercise of the purchase rights represented
by this Warrant will, upon exercise of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance
herewith, be duly authorized, validly issued, fully paid and nonassessable and free from all taxes, Liens and charges created by the Company
in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Except and to the
extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation, amending its certificate
of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or
any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at all
times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate
to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the foregoing, the
Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such exercise immediately prior
to such increase in par value, (ii) take all such action as may be necessary or appropriate in order that the Company may validly and
legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant and (iii) use commercially reasonable efforts
to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof, as may be, necessary
to enable the Company to perform its obligations under this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Before taking any
action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise Price,
the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any public regulatory
body or bodies having jurisdiction thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">f)&nbsp;<U>Jurisdiction</U>.
All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be governed by and construed
and enforced in accordance with the laws of the State of New York, without giving effect to conflict of laws principles thereof. Each
party hereby agrees that any action, proceeding or claim against it arising out of, or relating in any way to this Warrant shall be brought
and enforced in the New York Supreme Court, County of New York, or in the United States District Court for the Southern District of New
York, and irrevocably submits to such jurisdiction, which jurisdiction shall be exclusive. Each party hereby waives any objection to such
exclusive jurisdiction and that such courts represent an inconvenient forum. Any such process or summons to be served upon each party
may be served by transmitting a copy thereof by registered or certified mail, return receipt requested, postage prepaid, addressed to
it at the address set forth in Section 5(i) hereof. Such mailing shall be deemed personal service and shall be legal and binding upon
the receiving party in any action, proceeding or claim. Each of the Company and the Holder agrees that the prevailing party(ies) in any
such action shall be entitled to recover from the other party(ies) all of its reasonable attorneys&rsquo; fees and expenses relating to
such action or proceeding and/or incurred in connection with the preparation therefor. Each party (on its behalf and, to the extent permitted
by applicable law, on behalf of its stockholders and affiliates) hereby irrevocably waives, to the fullest extent permitted by applicable
law, any and all right to trial by jury in any legal proceeding arising out of or relating to this Warrant or the transactions contemplated
here by respective affiliates, directors, officers, Stockholders, partners, members, employees or agents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in">g)&nbsp;<U>Restrictions</U>.
The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered and the Holder does not
utilize cashless exercise, will have restrictions upon resale imposed by state and federal or foreign securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in">h)&nbsp;<U>Nonwaiver
and Expenses</U>. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall operate as
a waiver of such right or otherwise prejudice the Holder&rsquo;s rights, powers or remedies. Without limiting any other provision of this
Warrant, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material damages
to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but
not limited to, reasonable attorneys&rsquo; fees, including those of appellate Proceedings, incurred by the Holder in collecting any amounts
due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">i) <U>Notices</U>. Whenever notice is required to be given under this Warrant, unless otherwise provided herein, such notice shall be given in accordance with Section 5.4 of the Securities Purchase Agreement, dated as of May 1, 2023, by and between the Company and the Holder (the &ldquo;Securities Purchase Agreement&rdquo;). The Company shall provide the Holder with prompt written notice of all actions taken pursuant to this Warrant, including in reasonable detail a description of such action and the reason therefor. Without limiting the generality of the foregoing, the Company will give written notice to the Holder (i) as soon as practicable upon each adjustment of the Exercise Price and the number of Warrant Shares, setting forth in reasonable detail, and certifying, the calculation of such adjustment(s) and (ii) at least fifteen (15) days prior to the date on which the Company closes its books or takes a record (A) with respect to any dividend or distribution upon the Common Stock, (B) with respect to any grants, issuances or sales of any options, convertible securities or rights to purchase stock, warrants, securities, indebtedness, or other property pro rata to holders of Common Stock or (C) for determining rights to vote with respect to any dissolution or liquidation, provided in each case that such information (to the extent it constitutes, or contains, material, non-public information regarding the Company shall be made known to the public prior to or in conjunction with such notice being provided to the Holder. It is expressly understood and agreed that the time of execution specified by the Holder in each Exercise Notice shall be definitive and may not be disputed or challenged by the Company.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">j)&nbsp;<U>Limitation
of Liability</U>. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant to purchase Warrant
Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of the Holder for the purchase
price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company or by creditors of the
Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in">k)&nbsp;<U>Remedies</U>.
The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will be entitled to specific
performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate compensation for any loss
incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to assert the defense in any
action for specific performance that a remedy at law would be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 41pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in">l)&nbsp;<U>Successors
and Assigns</U>. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall inure to the
benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns of Holder.
The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall be enforceable
by the Holder or holder of Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">m)&nbsp;<U>Amendment</U>.
This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company and the Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in">n)&nbsp;<U>Severability</U>.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable law,
but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective to the
extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in">o)&nbsp;<U>Expense
Reimbursement</U>. The Holder shall be reimbursed by the Company for any fees charged to the Holder by the transfer agent in connection
with the issuance or holding or sale of the Common Stock, and/or Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in">p)&nbsp;<U>Headings</U>.
The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">********************</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">[<I>Signature Page Follows</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><I>&nbsp;</I></P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.05pt; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: 1in">IN WITNESS WHEREOF, the Company has caused
this Warrant to be executed by its officer thereunto duly authorized as of the date first above indicated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.05pt; text-indent: 1in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 40%; font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>GD Culture Group Limited</B></FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.05pt; text-indent: 1in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 0; width: 60%">&nbsp;</TD>
    <TD STYLE="padding-bottom: 0; width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; padding-bottom: 0; width: 36%"></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 0">&nbsp;</TD>
    <TD STYLE="padding-bottom: 0">&nbsp;</TD>
    <TD STYLE="padding-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 0">&nbsp;</TD>
    <TD STYLE="padding-bottom: 0">&nbsp;</TD>
    <TD STYLE="padding-bottom: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    </TR>
  </TABLE>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><I>[Signature Page to Pre-Funded
Warrant]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>EXHIBIT A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>NOTICE OF EXERCISE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5pt">TO: [&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(1)&#9;The undersigned hereby elects to purchase
<U>&#9;</U> Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised in full), and tenders herewith
payment of the exercise price in full, together with all applicable transfer taxes, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(2)
Payment shall take the form of (check applicable box):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;
</FONT>in lawful money of the United States; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0 0pt 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;&#9;</FONT>if
permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection 2(c),
to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure
set forth in subsection 2(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(3)
Company Wire Instructions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in">Account name:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in">Account Number:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in">SWIFT Code:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in">Bank name:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in">Bank address: BSB:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">(4)
Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 40%"></TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in">The Warrant Shares shall be delivered to the following DWAC
Account Number:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 40%"></TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 40%"></TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 40%"></TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify">[SIGNATURE OF HOLDER]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Investing Entity: <U STYLE="text-decoration: none">___________</U><I>Signature of Authorized
Signatory of Investing Entity</I>: <U STYLE="text-decoration: none">________________</U>Name of Authorized Signatory: <U>&#9;</U>____________ Title of Authorized
Signatory: <U>&#9;</U>____________ Date:_____________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.2
<SEQUENCE>3
<FILENAME>ea177982ex4-2_gdculture.htm
<DESCRIPTION>FORM OF UNREGISTERED WARRANTS
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: normal 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: none; text-align: right"><B>Exhibit 4.2</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: justify">NEITHER THIS SECURITY
NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE u.s. SECURITIES AND EXCHANGE COMMISSION OR THE
SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;SECURITIES
ACT&rdquo;), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES
ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT
AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY
BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">FORM OF COMMON
STOCK PURCHASE WARRANT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Date of Issuance: May [&#9679;]. 2023 (&ldquo;<B>Issuance Date</B>&rdquo;)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">GD Culture Group Limited,
a Nevada corporation (the &ldquo;<B>Company</B>&rdquo;), hereby certifies that, for good and valuable consideration, the receipt and sufficiency
of which are hereby acknowledged, [&#9679;], the registered holder hereof or its permitted assigns (the &ldquo;<B>Holder</B>&rdquo;),
is entitled, subject to the terms set forth below, to purchase from the Company, at the Exercise Price (as defined below) then in effect,
upon exercise of this Common Stock Purchase Warrant (including any Common Stock Purchase Warrants issued in exchange, transfer or replacement
hereof, the &ldquo;<B>Warrant</B>&rdquo;), at any time or times on or after the Issuance Date, but not after 11:59 p.m., New York time,
on the Expiration Date (as defined below), up to [&#9679;] (subject to adjustment as provided herein) shares of common stock of the Company,
par value $0.0001 (the &ldquo;<B>Common Stock</B>&rdquo;) (as subject to adjustment hereunder, the &ldquo;<B>Warrant Shares</B>&rdquo;).
Except as otherwise defined herein, capitalized terms in this Warrant shall have the meanings set forth in Section 17. This Warrant is
issued to Holder pursuant to that certain Securities Purchase Agreement, effective as of May [&#9679;], 2023, by and between the Company
and the Holder (the &ldquo;<B>Securities Purchase Agreement</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">1.&nbsp;<U>EXERCISE
OF WARRANT</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;<U>Mechanics of
Exercise</U>. Subject to the terms and conditions hereof (including, without limitation, the limitations set forth in Section 1(f)),
this Warrant may be exercised by the Holder on any day on or after the Issuance Date in whole or in part, by delivery (whether via facsimile
or otherwise) of a written notice, in the form attached hereto as <B><U>Exhibit A</U></B> (the &ldquo;<B>Exercise Notice</B>&rdquo;),
of the Holder&rsquo;s election to exercise this Warrant. Within one (1) Trading Day following an exercise of this Warrant as aforesaid,
the Holder shall deliver payment to the Company of an amount equal to the Exercise Price in effect on the date of such exercise multiplied
by the number of Warrant Shares as to which this Warrant was so exercised (in respect of such specific exercise, the &ldquo;<B>Aggregate
Exercise Price</B>&rdquo;) in cash or via wire transfer of immediately available funds if the Holder did not notify the Company in such
Exercise Notice that such exercise was made pursuant to a Cashless Exercise (as defined in Section 1(d)).</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Holder shall not be required
to deliver the original of this Warrant in order to effect an exercise hereunder. Execution and delivery of an Exercise Notice with respect
to less than all of the Warrant Shares shall have the same effect as cancellation of the original of this Warrant certificate and issuance
of a new Warrant certificate evidencing the right to purchase the remaining number of Warrant Shares. Execution and delivery of an Exercise
Notice for all of the then-remaining Warrant Shares shall have the same effect as cancellation of the original of this Warrant certificate
after delivery of the Warrant Shares in accordance with the terms hereof. On or before the first (1st) Trading Day following the date
on which the Company has received an Exercise Notice, the Company shall transmit by facsimile or e-mail an acknowledgment of confirmation
of receipt of such Exercise Notice, in the form attached hereto as <B><U>Exhibit B</U></B>, to the Holder and the Company&rsquo;s transfer
agent (the &ldquo;<B>Transfer Agent</B>&rdquo;). On or before the second (2nd) Trading Day following the date on which the Company has
received such Exercise Notice (the &ldquo;<B>Required Delivery Date</B>&rdquo;), the Company shall (i) provided that the Transfer Agent
is participating in The Depository Trust Company (&ldquo;<B>DTC</B>&rdquo;) Fast Automated Securities Transfer Program (which the Company
shall cause the Transfer Agent to do at Holder&rsquo;s request), upon the request of the Holder, credit such aggregate number of shares
of Common Stock to which the Holder is entitled pursuant to such exercise to the Holder&rsquo;s or its designee&rsquo;s balance account
with DTC through its Deposit or Withdrawal at Custodian system, or (ii) if the Transfer Agent is not participating in the DTC Fast Automated
Securities Transfer Program, issue and deliver to the Holder or, at the Holder&rsquo;s instruction pursuant to the Exercise Notice, the
Holder&rsquo;s agent or designee, in each case, sent by reputable overnight courier to the address as specified in the applicable Exercise
Notice, a certificate, registered in the Company&rsquo;s registrar in the name of the Holder or its designee (as indicated in the applicable
Exercise Notice), for the number of shares of the Common Stock to which the Holder is entitled pursuant to such exercise. Upon delivery
of an Exercise Notice, the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares
with respect to which this Warrant has been exercised, irrespective of the date such Warrant Shares are credited to the Holder&rsquo;s
DTC account or the date of delivery of the certificates evidencing such Warrant Shares (as the case may be). If this Warrant is submitted
in connection with any exercise pursuant to this Section 1(a) and the number of Warrant Shares represented by this Warrant is greater
than the number of Warrant Shares being acquired upon an exercise, then, at the request of the Holder and upon surrender hereof by the
Holder at the principal office of the Company, the Company shall as soon as practicable and in no event later than three (3) Business
Days after any exercise and at its own expense, issue and deliver to the Holder (or its designee) a new Warrant (in accordance with Section
7(d)) representing the right to purchase the number of Warrant Shares purchasable immediately prior to such exercise under this Warrant,
less the number of Warrant Shares with respect to which this Warrant is exercised. No fractional shares of Common Stock or scrip representing
fractional shares of Common Stock shall be issued upon the exercise of this Warrant, but rather the number of shares of Common Stock to
be issued shall be rounded up to the nearest whole number. The Company shall pay any and all taxes and fees which may be payable with
respect to the issuance and delivery of Warrant Shares upon exercise of this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;<U>Exercise
Price</U>. For purposes of this Warrant, &ldquo;<B>Exercise Price</B>&rdquo; means $8.27, subject to adjustment as provided herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&nbsp;<U>Company&rsquo;s
Failure to Timely Deliver Securities</U>. If the Company fails to issue and deliver (or cause to be delivered) to the Holder by the Required
Delivery Date a certificate representing the Warrant Shares or credit the balance account of Holder or Holder&rsquo;s nominee with DTC
for such number of Warrant Shares so delivered to the Company, then, in addition to all other remedies available to Holder, at the sole
discretion of Holder, the Company shall:</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i)&nbsp;pay
in cash to Holder on each Trading Day after the Required Delivery Date that the issuance or credit of such Warrant Shares is not timely
effected an amount equal to 1% of the product of (A) the number of shares of Common Stock not so delivered or credited (as the case may
be) to Holder or Holder&rsquo;s nominee multiplied by (B) the Closing Sale Price of the Common Stock on the Trading Day immediately preceding
the Required Delivery Date; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">(A)&nbsp;
if on or after the Required Delivery Date, Holder (or any other Person in respect, or on behalf, of Holder) purchases (in an open market
transaction or otherwise) Common Stock (&ldquo;<B>Replacement Common Stock</B>&rdquo;) to deliver in satisfaction of a sale by Holder
of all or any portion of the number of shares of Common Stock, or a sale of a number of shares of Common Stock equal to all or any portion
of the number of shares of Common Stock, that Holder so anticipated receiving from the Company without any restrictive legend, then, within
five (5) Trading Days after Holder&rsquo;s request and in Holder&rsquo;s sole discretion, either (A) pay cash to Holder in an amount equal
to Holder&rsquo;s total purchase price (including brokerage commissions and other out-of-pocket expenses, if any) for the Replacement
Common Stock (the &ldquo;Buy-In Price&rdquo;), at which point the Company&rsquo;s obligation to so deliver such certificate or credit
Holder&rsquo;s balance account shall terminate and such Common Stock shall be cancelled, or (B) promptly honor its obligation to so deliver
to Holder a certificate or certificates or credit Holder&rsquo;s DTC account representing such number of shares of Common Stock that would
have been so delivered if the Company timely complied with its obligations hereunder and pay cash to Holder in an amount equal to the
excess (if any) of the Buy-In Price over the product of (1) such number of shares of Common Stock that the Company was required to deliver
to Holder by the Required Delivery Date multiplied by (2) the lowest Closing Sale Price of the Common Stock on any Trading Day during
the period commencing on the date Holder purchased Replacement Common Stock and ending on the date of such delivery and payment under
this clause (ii).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To the extent permitted by law, the Company&rsquo;s
obligations to issue and deliver the shares of Common Stock upon exercise of the Warrant in accordance with the terms hereof are absolute
and unconditional, irrespective of any action or inaction by the Holder to enforce the same, any waiver or consent with respect to any
provision hereof, the recovery of any judgment against any person or any action to enforce the same, or any setoff, counterclaim, recoupment,
limitation or termination, or any breach or alleged breach by the Holder or any other person of any obligation to the Company or any violation
or alleged violation of law by the Holder or any other person, and irrespective of any other circumstance that might otherwise limit such
obligation of the Company to the Holder in connection with the issuance of the shares of Common Stock. Nothing herein shall limit the
Holder&rsquo;s right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree
of specific performance and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver the shares of Common Stock
issuable upon exercise of this Warrant as required pursuant to the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)&nbsp;<U>Cashless
Exercise</U>. The Holder may in its sole discretion (and without limiting the Holder&rsquo;s rights and remedies contained herein or in
any of the other Transaction Documents (as defined in the Securities Purchase Agreement)), exercise this Warrant in whole or in part and,
in lieu of making the cash payment otherwise contemplated to be made to the Company upon such exercise in payment of the Aggregate Exercise
Price, elect instead to receive upon such exercise the &ldquo;Net Number&rdquo; of shares of Common Stock determined according to the
following formula (a &ldquo;<B>Cashless Exercise</B>&rdquo;):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">Net Number = (A x B) / C</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">For purposes of the foregoing formulas:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.35in">A =</TD><TD STYLE="text-align: justify">The total number of shares of Common Stock with respect to which this Warrant is then being exercised.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.35in">B =</TD><TD>The Black Scholes Value (as defined in Section 17 herein).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.35in">C =</TD><TD STYLE="text-align: justify">The Closing Bid Price of the Common Stock as of two (2) Trading Days prior to the time of such exercise (as such Closing Bid Price
is defined in Section 17 herein), but in any event not less than $0.01 (as may be adjusted for stock dividends, subdivisions, or combinations
in the manner described in Section 2(a) herein).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If Warrant Shares are issued in such a cashless
exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the Securities Act, the Warrant Shares shall take
on the characteristics of the Warrant being exercised, and the holding period of the Warrant Shares being issued may be tacked on to the
holding period of this Warrant. Assuming (i) the Holder is not an Affiliate of the Company, and (ii) all of the applicable conditions
of Rule 144 promulgated under the Securities Act with respect to Holder and the Warrant Shares are met in the case of such a cashless
exercise, the Company agrees that the Company will use its best efforts to cause the removal of the legend from such Warrant Shares (including
by delivering an opinion of the Company&rsquo;s counsel to the Company&rsquo;s transfer agent at its own expense to ensure the foregoing),
and the Company agrees that the Holder is under no obligation to sell the Warrant Shares issuable upon the exercise of the Warrant prior
to removing the legend. The Company agrees not to take any position contrary to this Section 1(d).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)&nbsp;<U>Disputes</U>.
In the case of a dispute as to the determination of the Exercise Price or the arithmetic calculation of the number of Warrant Shares to
be issued pursuant to the terms hereof (including, without limitation, the Net Number), the Company shall promptly issue to the Holder
the number of Warrant Shares that are not disputed, provided that following such issuance to Holder such dispute shall be resolved in
accordance with Section 14.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f)&nbsp;<U>Limitations
on Exercises and Exchanges</U>. Notwithstanding anything to the contrary contained in this Warrant, this Warrant shall not be exercisable
or exchangeable by the Holder hereof to the extent (but only to the extent) that the Holder or any of its affiliates would beneficially
own in excess of 4.99% (or, upon election by a Holder prior to the issuance of any Warrants, 9.99%) of the number of shares of Common
Stock outstanding after giving effect to the issuance of shares of Common Stock underlying the Warrant issuable upon exercise of the Warrants
calculated in accordance with Section 13(d) of the 1934 Act (as defined in the Securities Purchase Agreement) (the &ldquo;<B>Maximum Percentage</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">To the extent the above limitation applies, the determination of whether this Warrant shall be exercisable or exchangeable (vis-&agrave;-vis
other convertible, exercisable or exchangeable securities owned by the Holder or any of its affiliates) and of which such securities shall
be exercisable or exchangeable (as among all such securities owned by the Holder) shall, subject to such Maximum Percentage limitation,
be determined on the basis of the first submission to the Company for conversion, exercise or exchange (as the case may be). No prior
inability to exercise or exchange this Warrant pursuant to this paragraph shall have any effect on the applicability of the provisions
of this paragraph with respect to any subsequent determination of exercisability or exchangeability. For the purposes of this paragraph,
beneficial ownership and all determinations and calculations (including, without limitation, with respect to calculations of percentage
ownership) shall be determined in accordance with Section 13(d) of the 1934 Act and the rules and regulations promulgated thereunder.
The provisions of this paragraph shall be implemented in a manner otherwise than in strict conformity with the terms of this paragraph
to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Maximum Percentage beneficial
ownership limitation herein contained or to make changes or supplements necessary or desirable to properly give effect to such Maximum
Percentage limitation. The limitations contained in this paragraph shall apply to a successor Holder of this Warrant. The holders of Common
Stock shall be third party beneficiaries of this paragraph and the Company may not waive this paragraph without the consent of holders
of a majority of its Common Stock. For any reason at any time, upon the written or oral request of the Holder, the Company shall within
two (2) Business Days confirm orally and in writing to the Holder the number of Common Stock then outstanding, including by virtue of
any prior conversion or exercise or exchange of convertible or exercisable or exchangeable securities into Common Stock, including, without
limitation, pursuant to this Warrant or securities issued pursuant to the Securities Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g)&nbsp;<U>Reservation
of shares of Common Stock; Insufficient Authorized share of Common Stock</U>. The Company shall initially reserve out of its authorized
and unissued shares of Common Stock a number of shares of Common Stock equal to 200% of the maximum number of shares of Common Stock underlying
the Warrant issuable to satisfy the Company&rsquo;s obligations to issue shares of Common Stock hereunder, and the Company shall at all
times keep reserved for issuance under this Warrant a number of shares of Common Stock equal to 200% of the maximum number of shares of
Common Stock underlying the Warrant issuable to satisfy the Company&rsquo;s obligation to issue shares of Common Stock hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h)&nbsp;<U>[Reserved]</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">2.&nbsp;<U>ADJUSTMENT
OF EXERCISE PRICE AND NUMBER OF WARRANT SHARES</U>. The Exercise Price and number of Warrant Shares issuable upon exercise of this Warrant
are subject to adjustment from time to time as set forth in this Section 2.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;<U>Stock
Dividends and Splits</U>. Without limiting any provision of Section 4, if the Company, at any time on or after the date of the Securities
Purchase Agreement, (i) pays a stock dividend on one or more classes of its then outstanding Common Stock or otherwise makes a distribution
on any class of capital stock that is payable in shares of Common Stock, (ii) subdivides (by any share split, stock dividend, recapitalization
or otherwise) one or more classes of its then outstanding Common Stock into a larger number of shares of Common Stock or (iii) combines
(by combination, reverse stock split or otherwise) one or more classes of its then outstanding Common Stock into a smaller number of shares
of Common Stock, then in each such case the Exercise Price shall be multiplied by a fraction of which the numerator shall be the number
of share of Common Stock outstanding immediately before such event and of which the denominator shall be the number of shares of Common
Stock outstanding immediately after such event. Any adjustment made pursuant to clause (i) of this paragraph shall become effective immediately
after the record date for the determination of stockholders entitled to receive such dividend or distribution, and any adjustment pursuant
to clause (ii) or (iii) of this paragraph shall become effective immediately after the effective date of such subdivision or combination.
If any event requiring an adjustment under this paragraph occurs during the period that an Exercise Price is calculated hereunder, then
the calculation of such Exercise Price shall be adjusted appropriately to reflect such event.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;<U>Adjustment
Upon Issuance of Common Stock</U>. If, during the Restricted Period (as defined in the Securities Purchase Agreement), the Company effects
an Subsequent Financing (as defined in the Securities Purchase Agreement), or in accordance with this Section 2 is deemed to have effected
an Subsequent Financing, any shares of Common Stock (including the issuance or sale of Common Stock owned or held by or for the account
of the Company) issued or sold or deemed to have been issued or sold) for a consideration per share of Common Stock (the &ldquo;<B>New
Issuance Price</B>&rdquo;) less than a price equal to the Exercise Price in effect immediately prior to such issue or sale or deemed issuance
or sale (such Exercise Price then in effect is referred to as the &ldquo;<B>Applicable Price</B>&rdquo;) (the foregoing a &ldquo;<B>Dilutive
Issuance</B>&rdquo;), then immediately after such Dilutive Issuance, the Exercise Price then in effect shall be reduced (and in no event
increased) to the price per share of Common Stock as determined in accordance with the following formula:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">EP2 = EP1 x (A + B) / (A + C)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">For purposes of the foregoing formula:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.35in">A =</TD><TD STYLE="text-align: justify">The total number of Warrant Shares with respect to which this Warrant may be exercised.</TD></TR></TABLE>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 1.5in"></TD><TD STYLE="text-align: justify; width: 0.35in">B =</TD><TD STYLE="text-align: justify">The total number of shares of Common Stock that would be issued or issuable under the Dilutive Issuance if issued at a per share of
Common Stock equal to EP1.</TD></TR></TABLE>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 1.5in"></TD><TD STYLE="text-align: justify; width: 0.35in">C =</TD><TD STYLE="text-align: justify">The total number of shares of Common Stock actually issued or issuable under the Dilutive Issuance.</TD></TR></TABLE>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 1.5in"></TD><TD STYLE="text-align: justify; width: 0.35in">EP1 =</TD><TD STYLE="text-align: justify">The Exercise Price in effect immediately prior to a Dilutive Issuance.</TD></TR></TABLE>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 1.5in"></TD><TD STYLE="text-align: justify; width: 0.35in">EP2 =</TD><TD STYLE="text-align: justify">The Exercise Price immediately after such Dilutive Issuance; provided, however, that such price shall in no event be less than $0.01
per share of Common Stock (as may be adjusted for stock dividends, subdivisions, or combinations in the manner described in Section 2(a)
herein, the &ldquo;Floor Price&rdquo;);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">provided, that if such issuance or sale
(or deemed issuance or sale) was without consideration, then the Company shall be deemed to have received the Floor Price for each such
share of Common Stock so issued or deemed to be issued. For all purposes of the foregoing (including, without limitation, determining
the adjusted Exercise Price and consideration per share under this Section 2(c)), the following shall be applicable:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i)&nbsp;<U>Issuance
of Options</U>. If, during the Restricted Period, the Company in any manner grants or sells any Options and the lowest price per share
of Common Stock for which one share of Common Stock is issuable upon the exercise of any such Option or upon conversion, exercise or exchange
of any Convertible Securities issuable upon exercise of any such Option is less than the Applicable Price, then such shares of Common
Stock shall be deemed to be outstanding and to have been issued and sold by the Company at the time of the granting or sale of such Option
for such price per share of Common Stock. For purposes of this Section 2(c)(i), the &ldquo;lowest price per share of Common Stock for
which one share of Common Stock is issuable upon the exercise of any such Options or upon conversion, exercise or exchange of any Convertible
Securities issuable upon exercise of any such Option&rdquo; shall be equal to (A) the sum of the lowest amounts of consideration (if any)
received or receivable by the Company with respect to any one share of Common Stock upon the granting or sale of such Option, upon exercise
of such Option and upon conversion, exercise or exchange of any Convertible Security issuable upon exercise of such Option minus (B) the
sum of all amounts paid or payable to the holder of such Option (or any other Person) upon the granting or sale of such Option, upon exercise
of such Option and upon conversion, exercise or exchange of any Convertible Security issuable upon exercise of such Option plus the value
of any other consideration received or receivable by, or benefit conferred on, the holder of such Option (or any other Person). Except
as contemplated below, no further adjustment of the Exercise Price shall be made upon the actual issuance of such shares of Common Stock
or of such Convertible Securities upon the exercise of such Options or upon the actual issuance of such shares of Common Stock upon conversion,
exercise or exchange of such Convertible Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ii)&nbsp;<U>Issuance
of Convertible Securities</U>. If, during the Restricted Period, the Company in any manner issues or sells any Convertible Securities
and the lowest price per share of Common Stock for which one share of Common Stock is issuable upon the conversion, exercise or exchange
thereof is less than the Applicable Price, then such shares of Common Stock shall be deemed to be outstanding and to have been issued
and sold by the Company at the time of the issuance or sale of such Convertible Securities for such price per share. For the purposes
of this Section 2(c)(ii), the &ldquo;lowest price per share of Common Stock for which one share of Common Stock is issuable upon the conversion,
exercise or exchange thereof&rdquo; shall be equal to (A) the sum of the lowest amounts of consideration (if any) received or receivable
by the Company with respect to one share of Common Stock upon the issuance or sale of the Convertible Security and upon conversion, exercise
or exchange of such Convertible Security minus (B) the sum of all amounts paid or payable to the holder of such Convertible Security (or
any other Person) upon the issuance or sale of such Convertible Security plus the value of any other consideration received or receivable
by, or benefit conferred on, the holder of such Convertible Security (or any other Person). Except as contemplated below, no further adjustment
of the Exercise Price shall be made upon the actual issuance of such shares of Common Stock upon conversion, exercise or exchange of such
Convertible Securities, and if any such issue or sale of such Convertible Securities is made upon exercise of any Options for which adjustment
of this Warrant has been or is to be made pursuant to other provisions of this Section 2(c), except as contemplated below, no further
adjustment of the Exercise Price shall be made by reason of such issue or sale.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(iii)&nbsp;<U>Change
in Option Price or Rate of Conversion</U>. If, during the Restricted Period, the purchase or exercise price provided for in any Options,
the additional consideration, if any, payable upon the issue, conversion, exercise or exchange of any Convertible Securities, or the rate
at which any Convertible Securities are convertible into or exercisable or exchangeable for shares of Common Stock increases or decreases
at any time, the Exercise Price in effect at the time of such increase or decrease shall be adjusted to the Exercise Price which would
have been in effect at such time had such Options or Convertible Securities provided for such increased or decreased purchase price, additional
consideration or increased or decreased conversion rate, as the case may be, at the time initially granted, issued or sold. For purposes
of this Section 2(c)(iii), if the terms of any Option or Convertible Security that was outstanding as of the date of issuance of this
Warrant are increased or decreased in the manner described in the immediately preceding sentence, then such Option or Convertible Security
and shares of Common Stock deemed issuable upon exercise, conversion or exchange thereof shall be deemed to have been issued as of the
date of such increase or decrease. No adjustment pursuant to this Section 2(c) shall be made if such adjustment would result in an increase
of the Exercise Price then in effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(iv)&nbsp;<U>Calculation
of Consideration Received</U>. If, during the Restricted Period, any Option or Convertible Security is issued in connection with the issuance
or sale or deemed issuance or sale of any other securities of the Company, together comprising one integrated transaction, (A) such Option
or Convertible Security (as applicable) will be deemed to have been issued for consideration equal to the Black Scholes Value &ndash;
Consideration thereof and the other securities issued shares of Common Stock, Options or Convertible Securities are issued or sold or
deemed to have been issued or sold for cash, the consideration received therefor will be deemed to be the net amount of consideration
received by the Company therefor. If any Common Stock, Options or Convertible Securities are issued or sold for a consideration other
than cash, the amount of such consideration received by the Company will be the fair value of such consideration, except where such consideration
consists of publicly traded securities, in which case the amount of consideration received by the Company for such securities will be
the arithmetic average of the VWAPs of such security for each of the five (5) Trading Days immediately preceding the date of receipt.
If any Common Stock, Options or Convertible Securities are issued to the owners of the non-surviving entity in connection with any merger
in which the Company is the surviving entity, the amount of consideration therefor will be deemed to be the fair value of such portion
of the net assets and business of the non-surviving entity as is attributable to such Common Stock, Options or Convertible Securities,
as the case may be. The fair value of any consideration other than cash or publicly traded securities will be determined jointly by the
Company and the Holder. If such parties are unable to reach agreement within ten (10) days after the occurrence of an event requiring
valuation (the &ldquo;<B>Valuation Event</B>&rdquo;), the fair value of such consideration will be determined within five (5) Trading
Days after the tenth (10th) day following such Valuation Event by an independent, reputable appraiser jointly selected by the Company
and the Holder. The determination of such appraiser shall be final and binding upon all parties absent manifest error and the fees and
expenses of such appraiser shall be borne by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(v)&nbsp;<U>Record
Date</U>. If, during the Restricted Period, the Company takes a record of the holders of Common Stock for the purpose of entitling them
(A) to receive a dividend or other distribution payable in shares of Common Stock, Options or in Convertible Securities or (B) to subscribe
for or purchase shares of Common Stock, Options or Convertible Securities, then such record date will be deemed to be the date of the
issue or sale of Common Stock deemed to have been issued or sold upon the declaration of such dividend or the making of such other distribution
or the date of the granting of such right of subscription or purchase (as the case may be).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&nbsp;<U>Number
of Warrant Shares</U>. Simultaneously with any adjustment to the Exercise Price pursuant to paragraph (a) or (b) of this Section 2, the
number of Warrant Shares that may be purchased upon exercise of this Warrant shall be increased or decreased proportionately, so that
after such adjustment the aggregate Exercise Price payable hereunder for the adjusted number of Warrant Shares shall be the same as the
aggregate Exercise Price in effect immediately prior to such adjustment (without regard to any limitations on exercise contained herein).
In addition, and notwithstanding anything to the contrary contained herein, upon a Cashless Exercise as set forth in Section 1(d) hereof,
the number of Warrant Shares for which this Warrant is exercisable immediately following such Cashless Exercise shall be equal to (i)
the number of Warrant Shares for which this Warrant was exercisable immediately prior to such Cashless Exercise <U>less</U> (ii) the number
of Warrant Shares as to which such Cashless Exercise was exercised (such number of Warrant Shares in this clause (ii) in respect of such
Cashless Exercise being equal to &ldquo;A&rdquo; in such Cashless Exercise formula in respect of such Cashless Exercise) and the number
of such Warrant Shares issuable hereunder shall automatically be adjusted, as necessary, to enable to the Company to comply with its obligations
to issue the Net Number of shares of Common Stock under Section 1(d)(i) hereof upon any Cashless Exercise thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)&nbsp;<U>Calculations</U>.
All calculations under this Section 2 shall be made by rounding to the nearest 1/10000<SUP>th</SUP> of cent and the nearest 1/100<SUP>th</SUP>
of a share of Common Stock, as applicable. The number of shares of Common Stock outstanding at any given time shall not include Common
Stock owned or held by or for the account of the Company, and the disposition of any such Common Stock shall be considered an issue or
sale of shares of Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)&nbsp;<U>Other
Events</U>. In the event that the Company shall take any action to which the provisions hereof are not strictly applicable, or, if applicable,
would not operate to protect the Holder from dilution or if any event occurs of the type contemplated by the provisions of this Section
2 but not expressly provided for by such provisions (including, without limitation, the granting of stock appreciation rights, phantom
stock rights or other rights with equity features), then the Company&rsquo;s board of directors shall in good faith determine and implement
an appropriate adjustment in the Exercise Price and the number of Warrant Shares (if applicable) so as to protect the rights of the Holder,
provided that no such adjustment pursuant to this Section 2(e) will increase the Exercise Price or decrease the number of Warrant Shares
as otherwise determined pursuant to this Section 2, provided further that if the Holder does not accept such adjustments as appropriately
protecting its interests hereunder against such dilution, then the Company&rsquo;s board of directors and the Holder shall agree, in good
faith, upon an independent investment bank of nationally recognized standing to make such appropriate adjustments, whose determination
shall be final and binding and whose fees and expenses shall be borne by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">3.&nbsp;<U>RIGHTS
UPON DISTRIBUTION OF ASSETS</U>. In addition to any adjustments pursuant to Section 2 above, if the Company shall declare or make any
dividend or other distribution of its assets (or rights to acquire its assets) to holders of Common Stock, by way of return of capital
or otherwise (including, without limitation, any distribution of cash, stock or other securities, indebtedness, property or options by
way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction, other than
a distribution of Common Stock covered by Section 2(b)) (a &ldquo;<B>Distribution</B>&rdquo;), at any time after the issuance of this
Warrant, then, in each such case, provision shall be made so that upon exercise of this Warrant, the Holder shall be entitled to participate
in such Distribution to the same extent that the Holder would have participated therein if the Holder had held the number of shares of
Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise hereof, including without
limitation, the Maximum Percentage) immediately before the date on which a record is taken for such Distribution, or, if no such record
is taken, the date as of which the record holders of Common Stock are to be determined for the participation in such Distribution (provided,
however, to the extent that the Holder&rsquo;s right to participate in any such Distributions would result in the Holder exceeding the
Maximum Percentage, then the Holder shall not be entitled to participate in such Distribution to such extent (or the beneficial ownership
of any such Common Stock as a result of such Distribution to such extent) and such Distribution to such extent shall be held in abeyance
for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding the Maximum Percentage).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">4.&nbsp;<U>[INTENTIONALLY
OMITTED]</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">5.&nbsp;<U>NONCIRCUMVENTION</U>.
The Company hereby covenants and agrees that the Company will not, by amendment of its Bylaws or through any reorganization, transfer
of assets, consolidation, merger, scheme of arrangement, dissolution, issue or sale of securities, or any other voluntary action, avoid
or seek to avoid the observance or performance of any of the terms of this Warrant, and will at all times in good faith carry out all
the provisions of this Warrant and take all action as may be required to protect the rights of the Holder. Without limiting the generality
of the foregoing, the Company (i) shall not increase the par value of the Common Stock underlying the Warrant Shares receivable upon the
exercise of this Warrant above the Exercise Price then in effect, (ii) shall take all such actions as may be necessary or appropriate
in order that the Company may validly and legally issue fully paid and non-assessable Common Stock upon the exercise of this Warrant,
and (iii) shall, so long as the Warrant is outstanding, take all action necessary to reserve and keep available out of its authorized
and unissued Common Stock, solely for the purpose of effecting the exercise of the Warrant Shares, the maximum number of shares of Common
Stock as shall from time to time be necessary to effect the exercise of the Warrant then outstanding; provided, however, that such amount
of reserved shares of Common Stock shall be limited by the Maximum Percentage of Common Stock as set forth in Section 1(f).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">6.&nbsp;<U>WARRANT
HOLDER NOT DEEMED A STOCKHOLDER</U>. Except as otherwise specifically provided herein, the Holder, solely in its capacity as a holder
of this Warrant, shall not be entitled to vote or receive dividends or be deemed the holder of Common Stock of the Company for any purpose,
nor shall anything contained in this Warrant be construed to confer upon the Holder, solely in its capacity as the Holder of this Warrant,
any of the rights of a stockholder of the Company or any right to vote, give or withhold consent to any corporate action (whether any
reorganization, issue of stock, reclassification of stock, consolidation, merger, conveyance or otherwise), receive notice of meetings,
receive dividends or subscription rights, or otherwise, prior to the issuance to the Holder of the Warrant Shares which it is then entitled
to receive upon the due exercise of this Warrant. In addition, nothing contained in this Warrant shall be construed as imposing any liabilities
on the Holder to purchase any securities (upon exercise of this Warrant or otherwise) or as a stockholder of the Company, whether such
liabilities are asserted by the Company or by creditors of the Company. Notwithstanding this Section 6, the Company shall provide the
Holder with copies of the same notices and other information given to the stockholders of the Company generally, contemporaneously with
the giving thereof to the stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">7.&nbsp;<U>REISSUANCE
OF WARRANTS</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;<U>Transfer
of Warrant</U>. If this Warrant is to be transferred, the Holder shall surrender this Warrant to the Company, whereupon the Company will
forthwith issue and deliver upon the order of the Holder a new Warrant (in accordance with Section 7(d)), registered as the Holder may
request, representing the right to purchase the number of Warrant Shares being transferred by the Holder and, if less than the total number
of Warrant Shares then underlying this Warrant is being transferred, a new Warrant (in accordance with Section 7(d)) to the Holder representing
the right to purchase the number of Warrant Shares not being transferred. If, at the time of the surrender of this Warrant in connection
with any transfer of this Warrant, the transfer of this Warrant shall not be either (i) registered pursuant to an effective registration
statement under the Securities Act and under applicable state securities or blue sky laws or (ii) eligible for resale without volume or
manner-of-sale restrictions or current public information requirements pursuant to Rule 144 promulgated under the Securities Act, the
Company may require, as a condition of allowing such transfer, that the Holder or transferee of this Warrant, as the case may be, provide
to the Company an opinion of counsel selected by the Holder and reasonably acceptable to the Company, the form and substance of which
opinion shall be reasonably satisfactory to the Company, to the effect that such transfer does not require registration of such transferred
securities under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;<U>Lost,
Stolen or Mutilated Warrant</U>. Upon receipt by the Company of evidence reasonably satisfactory to the Company of the loss, theft, destruction
or mutilation of this Warrant (as to which a written certification and the indemnification contemplated below shall suffice as such evidence),
and, in the case of loss, theft or destruction, of any indemnification undertaking by the Holder to the Company in customary and reasonable
form and, in the case of mutilation, upon surrender and cancellation of this Warrant, the Company shall execute and deliver to the Holder
a new Warrant (in accordance with Section 7(d)) representing the right to purchase the Warrant Shares then underlying this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&nbsp;<U>Exchangeable
for Multiple Warrants</U>. This Warrant is exchangeable, upon the surrender hereof by the Holder at the principal office of the Company,
for a new Warrant or Warrants (in accordance with Section 7(d)) representing in the aggregate the right to purchase the number of Warrant
Shares then underlying this Warrant, and each such new Warrant will represent the right to purchase such portion of such Warrant Shares
as is designated by the Holder at the time of such surrender; provided, however, no warrants for fractional shares of Common Stock shall
be given.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)&nbsp;<U>Issuance
of New Warrants</U>. Whenever the Company is required to issue a new Warrant pursuant to the terms of this Warrant, such new Warrant (i)
shall be of like tenor with this Warrant, (ii) shall represent, as indicated on the face of such new Warrant, the right to purchase the
Warrant Shares then underlying this Warrant (or in the case of a new Warrant being issued pursuant to Section 7(a) or Section 7(c), the
Warrant Shares designated by the Holder which, when added to the number of shares of Common Stock underlying the other new Warrants issued
in connection with such issuance, does not exceed the number of Warrant Shares then underlying this Warrant), (iii) shall have an issuance
date, as indicated on the face of such new Warrant which is the same as the Issuance Date, and (iv) shall have the same rights and conditions
as this Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">8.&nbsp;<U>REGISTRATION
RIGHTS.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;<U>Demand
Registration. </U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><U>(i) Grant of Right.</U> Unless
all of the Registrable Securities (as defined below) are included in an effective registration statement with a current prospectus or
a qualified offering statement with a current registration statement, the Company, upon written demand (a &ldquo;<B>Demand Notice</B>&rdquo;)
of the Holder(s) of at least fifty-one percent (51%) of the Warrants and/or the underlying Common Stock (&ldquo;<B>Majority Holders</B>&rdquo;),
agrees to register, on one occasion, all or any portion of the Common Stock underlying this Warrant that are permitted to be registered
under the Act (collectively, the &ldquo;<B>Registrable Securities</B>&rdquo;). On such occasion, the Company will file a registration
statement with the Commission (a &ldquo;<B>Demand Registration Statement</B>&rdquo;) covering the Registrable Securities within sixty
(60) days after receipt of a Demand Notice and use its best efforts to have the registration statement declared effective promptly thereafter,
subject to compliance with review by the Commission; provided, however, that the Company shall not be required to comply with a Demand
Notice if the Company has filed a registration statement with respect to which the Holder is entitled to piggyback pursuant to Section
8(b) hereof and either: (i) the Holder has elected to participate in the offering covered by such registration statement; or (ii) if such
registration statement relates to an underwritten primary offering of securities of the Company, until the offering covered by such registration
statement has been withdrawn or until thirty days after such offering is consummated. The demand for registration may be made at any time
during a period of five years beginning on the date of commencement of sales of the offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ii) <U>Terms</U>. The Company
shall bear all fees and expenses attendant to the Demand Registration Statement pursuant to Section 8(a)(i), but the Holder(s) shall pay
any and all underwriting commissions and the expenses of any legal counsel selected by the Holder(s) to represent the Holder(s) in connection
with the sale of the Registrable Securities. The Company agrees to use its best efforts to cause the filing of a Demand Registration Statement
required herein to become effective promptly and to qualify or register the Registrable Securities in such states as are reasonably requested
by the Holder(s); provided, however, that in no event shall the Company be required to register the Registrable Securities in a state
in which such registration would cause: (i) the Company to be obligated to register or license to do business in such State or submit
to general service of process in such State, or (ii) the principal stockholders of the Company to be obligated to escrow their Common
Stock of the Company. The Company shall cause any registration statement filed pursuant to the demand right granted under Section 8(a)(i)
to remain effective for a period of at least 12 consecutive months after the date that the Holders of the Registrable Securities covered
by such registration statement are first given the opportunity to sell all of such securities. The Holder(s) shall only use the prospectuses
provided by the Company to sell the shares of Common Stock covered by such registration statement, and will immediately cease to use any
prospectus furnished by the Company if the Company advises the Holder(s) that such prospectus may no longer be used due to a material
misstatement or omission. Notwithstanding the provisions of this Section 8(a)(ii), the Holder(s) shall be entitled to a Demand Registration
Statement under this Section 8(a)(ii) on only one occasion and such demand registration right shall terminate on the fifth anniversary
of the commencement of sales of the offering in accordance with FINRA Rule 5110(g)(8)(C).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;<U>&ldquo;Piggy-Back&rdquo;
Registration.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i) <U>Grant of Right</U>. Unless
all of the Registrable Securities are included in an effective registration statement with a current prospectus or a qualified offering
statement with a current offering circular, the Holder shall have the right, for a period of five years commencing on the commencement
of sales of the offering, to include the remaining Registrable Securities as part of any other registration of securities filed by the
Company (other than in connection with a transaction contemplated by Rule 145 promulgated under the Act or pursuant to Form S-3 or any
equivalent form).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ii) <U>Terms</U>. The Company
shall bear all fees and expenses attendant to registering the Registrable Securities pursuant to Section 8(b)(i) hereof, but the Holder(s)
shall pay any and all underwriting commissions and the expenses of any legal counsel selected by the Holder(s) to represent them in connection
with the sale of the Registrable Securities. In the event of such a proposed registration, the Company shall furnish the then Holders
of outstanding Registrable Securities with not less than 30 days written notice prior to the proposed date of filing of such registration
statement. Such notice to the Holder(s) shall continue to be given for each registration statement filed by the Company until such time
as all of the Registrable Securities have been registered under an effective registration statement. The holders of the Registrable Securities
shall exercise the &ldquo;piggy-back&rdquo; rights provided for herein by giving written notice, within ten days of the receipt of the
Company&rsquo;s notice of its intention to file a registration statement. Except as otherwise provided in this Warrant, there shall be
no limit on the number of times the Holder may request registration under this Section 8(b)(ii). Notwithstanding the provisions of this
Section 8(b)(ii), such piggyback registration rights shall terminate on the fifth anniversary of the commencement of sales of the offering
in accordance with FINRA Rule 5110(g)(8)(D).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">9.&nbsp;<U>NOTICES</U>.
Whenever notice is required to be given under this Warrant, unless otherwise provided herein, such notice shall be given in accordance
with Section 5.4 of the Securities Purchase Agreement. The Company shall provide the Holder with prompt written notice of all actions
taken pursuant to this Warrant, including in reasonable detail a description of such action and the reason therefor. Without limiting
the generality of the foregoing, the Company will give written notice to the Holder (i) as soon as practicable upon each adjustment of
the Exercise Price and the number of Warrant Shares, setting forth in reasonable detail, and certifying, the calculation of such adjustment(s)
and (ii) at least fifteen (15) days prior to the date on which the Company closes its books or takes a record (A) with respect to any
dividend or distribution upon the Common Stock, (B) with respect to any grants, issuances or sales of any Options, Convertible Securities
or rights to purchase stock, warrants, securities, indebtedness, or other property pro rata to holders of Common Stock or (C) for determining
rights to vote with respect to any Fundamental Transaction, dissolution or liquidation, provided in each case that such information (to
the extent it constitutes, or contains, material, non-public information regarding the Company shall be made known to the public prior
to or in conjunction with such notice being provided to the Holder and (iii) at least ten (10) Trading Days prior to the consummation
of any Fundamental Transaction. It is expressly understood and agreed that the time of execution specified by the Holder in each Exercise
Notice shall be definitive and may not be disputed or challenged by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">10.&nbsp;<U>AMENDMENT
AND WAIVER</U>. Except as otherwise provided herein, the provisions of this Warrant (other than Section 1(f)) may be amended and the Company
may take any action herein prohibited, or omit to perform any act herein required to be performed by it, only if the Company has obtained
the written consent of the Holder. The Holder shall be entitled, at its option, to the benefit of any amendment of any other similar warrant
issued under the Securities Purchase Agreement. No waiver shall be effective unless it is in writing and signed by an authorized representative
of the waiving party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">11.&nbsp;<U>SEVERABILITY</U>.
If any provision of this Warrant is prohibited by law or otherwise determined to be invalid or unenforceable by a court of competent jurisdiction,
the provision that would otherwise be prohibited, invalid or unenforceable shall be deemed amended to apply to the broadest extent that
it would be valid and enforceable, and the invalidity or unenforceability of such provision shall not affect the validity of the remaining
provisions of this Warrant so long as this Warrant as so modified continues to express, without material change, the original intentions
of the parties as to the subject matter hereof and the prohibited nature, invalidity or unenforceability of the provision(s) in question
does not substantially impair the respective expectations or reciprocal obligations of the parties or the practical realization of the
benefits that would otherwise be conferred upon the parties. The parties will endeavor in good faith negotiations to replace the prohibited,
invalid or unenforceable provision(s) with a valid provision(s), the effect of which comes as close as possible to that of the prohibited,
invalid or unenforceable provision(s).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">12.&nbsp;<U>GOVERNING
LAW</U>. This Warrant shall be governed by and construed and enforced in accordance with, and all questions concerning the construction,
validity, interpretation and performance of this Warrant shall be governed by, the internal laws of the State of New York, without giving
effect to any choice of law or conflict of law provision or rule (whether of the State of New York or any other jurisdictions) that would
cause the application of the laws of any jurisdictions other than the State of New York. The Company hereby irrevocably submits to the
exclusive jurisdiction of the state and federal courts sitting in The City of New York, Borough of Manhattan, for the adjudication of
any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably
waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of
any such court, that such suit, action or proceeding is brought in an inconvenient forum or that the venue of such suit, action or proceeding
is improper. Nothing contained herein shall be deemed to limit in any way any right to serve process in any manner permitted by law. Nothing
contained herein shall be deemed or operate to preclude the Holder from bringing suit or taking other legal action against the Company
in any other jurisdiction to collect on the Company&rsquo;s obligations to the Holder or to enforce a judgment or other court ruling in
favor of the Holder. <B>THE COMPANY HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE TO, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE
ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION WITH OR ARISING OUT OF THIS WARRANT OR ANY TRANSACTION CONTEMPLATED HEREBY.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">13.&nbsp;<U>CONSTRUCTION;
HEADINGS</U>. This Warrant shall be deemed to be jointly drafted by the Company and the Holder and shall not be construed against any
Person as the drafter hereof. The headings of this Warrant are for convenience of reference and shall not form part of, or affect the
interpretation of, this Warrant. Terms used in this Warrant but defined in the other Transaction Documents shall have the meanings ascribed
to such terms on the Closing Date (as defined in the Securities Purchase Agreement) in such other Transaction Documents unless otherwise
consented to in writing by the Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">14.&nbsp;<U>DISPUTE
RESOLUTION</U>. In the case of a dispute as to the determination of the Exercise Price, the Closing Sale Price, the Closing Bid Price,
the Bid Price or fair market value or the arithmetic calculation of the Warrant Shares (as the case may be), the Company or the Holder
(as the case may be) shall submit the disputed determinations or arithmetic calculations (as the case may be) via facsimile (i) within
two (2) Business Days after receipt of the applicable notice giving rise to such dispute to the Company or the Holder (as the case may
be) or (ii) if no notice gave rise to such dispute, at any time after the Holder or the Company (as the case may be) learned of the circumstances
giving rise to such dispute. If the Holder and the Company are unable to agree upon such determination or calculation (as the case may
be) of the Exercise Price, the Closing Sale Price, the Closing Bid Price, the Bid Price or fair market value or the number of Warrant
Shares (as the case may be) within three (3) Business Days of such disputed determination or arithmetic calculation being submitted to
the Company or the Holder (as the case may be), then the Company shall, within two (2) Business Days submit via facsimile (a) the disputed
arithmetic calculation of the Warrant Shares, the disputed determination of the Exercise Price, the Closing Sale Price, the Closing Bid
Price, the Bid Price or fair market value (as the case may be) to an independent, reputable investment bank selected by the Holder, with
the consent of the Company (which may not be unreasonably withheld, conditioned or delayed), or (b) if acceptable to the Holder, the disputed
arithmetic calculation of the Warrant Shares to the Company&rsquo;s independent, outside accountant. The Company shall cause at its expense
the investment bank or the accountant (as the case may be) to perform the determinations or calculations (as the case may be) and notify
the Company and the Holder of the results no later than ten (10) Business Days from the time it receives such disputed determinations
or calculations (as the case may be). Such investment bank&rsquo;s or accountant&rsquo;s determination or calculation (as the case may
be) shall be binding upon all parties absent demonstrable error. The fees and expenses of such investment bank or accountant shall be
borne by the parties in the same proportion as the respective amounts by which the investment bank&rsquo;s or accountant&rsquo;s determination
differs from such party&rsquo;s calculation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">15.&nbsp;<U>REMEDIES,
CHARACTERIZATION, OTHER OBLIGATIONS, BREACHES AND INJUNCTIVE RELIEF</U>. The remedies provided in this Warrant shall be cumulative and
in addition to all other remedies available under this Warrant and the other Transaction Documents, at law or in equity (including a decree
of specific performance and/or other injunctive relief), and nothing herein shall limit the right of the Holder to pursue actual damages
for any failure by the Company to comply with the terms of this Warrant. The Company covenants to the Holder that there shall be no characterization
concerning this instrument other than as expressly provided herein. Amounts set forth or provided for herein with respect to payments,
exercises and the like (and the computation thereof) shall be the amounts to be received by the Holder and shall not, except as expressly
provided herein, be subject to any other obligation of the Company (or the performance thereof). The Company acknowledges that a breach
by it of its obligations hereunder will cause irreparable harm to the Holder and that the remedy at law for any such breach may be inadequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company therefore agrees that, in the event
of any such breach or threatened breach, the holder of this Warrant shall be entitled, in addition to all other available remedies, to
an injunction restraining any breach, without the necessity of showing economic loss and without any bond or other security being required.
The Company shall provide all information and documentation to the Holder that is requested by the Holder to enable the Holder to confirm
the Company&rsquo;s compliance with the terms and conditions of this Warrant (including, without limitation, compliance with Section 2
hereof). The issuance of Common Stock and certificates for Common Stock as contemplated hereby upon the exercise of this Warrant shall
be made without charge to the Holder or such shares of Common Stock for any issuance tax or other costs in respect thereof, provided that
the Company shall not be required to pay any tax which may be payable in respect of any transfer involved in the issuance and delivery
of any certificate in a name other than the Holder or its agent on its behalf.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">16.&nbsp;<U>TRANSFER</U>.
This Warrant may be offered for sale, sold, transferred or assigned without the consent of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">17.&nbsp;<U>CERTAIN
DEFINITIONS</U>. For purposes of this Warrant, the following terms shall have the following meanings:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;&ldquo;<B>Bid
Price</B>&rdquo; means, for any security as of the particular time of determination, the bid price of such security on the principal securities
exchange or trading market where such security is listed or traded as reported by Bloomberg as of such time of determination, or if the
foregoing does not apply, the bid price of such security in the over-the-counter market on the electronic bulletin board for such security
as reported by Bloomberg as of such time of determination, or, if no bid price is reported for such security by Bloomberg as of such time
of determination, the average of the bid prices of all of the market makers for such security as reported in the &ldquo;pink sheets&rdquo;
by OTC Markets Group Inc. (formerly Pink Sheets LLC) as of such time of determination. If the Bid Price cannot be calculated for a security
as of the particular time of determination on any of the foregoing bases, the Bid Price of such security as of such time of determination
shall be the fair market value as mutually determined by the Company and the Holder. If the Company and the Holder are unable to agree
upon the fair market value of such security, then such dispute shall be resolved in accordance with the procedures in Section 14. All
such determinations shall be appropriately adjusted for any stock dividend, stock split, stock combination or other similar transaction
during such period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;&ldquo;<B>Black
Scholes Value</B>&rdquo; means the Black Scholes value of an option for one share of Common Stock at the date of the applicable Cashless
Exercise, as such Black Scholes value is determined, calculated using the Black Scholes Option Pricing Model obtained from the &ldquo;OV&rdquo;
function on Bloomberg utilizing (i) an underlying price per share of Common Stock equal to the Exercise Price, as adjusted, (ii) a risk-free
interest rate corresponding to the U.S. Treasury rate, (iii) a strike price equal to the Exercise Price in effect at the time of the applicable
Cashless Exercise, (iv) an expected volatility equal to 135%, and (v) a deemed remaining term of the Warrant of five (5) years (regardless
of the actual remaining term of the Warrant).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&nbsp;&ldquo;<B>Black
Scholes Value &ndash; Consideration</B>&rdquo; means the value of the applicable Option or Convertible Security (as the case may be) as
of the date of issuance thereof calculated using the Black Scholes Option Pricing Model obtained from the &ldquo;OV&rdquo; function on
Bloomberg utilizing (i) an underlying price per share equal to the Closing Sale Price of the Common Stock on the Trading Day immediately
preceding the public announcement of the execution of definitive documents with respect to the issuance of such Option or Convertible
Security (as the case may be), (ii) a risk-free interest rate corresponding to the U.S. Treasury rate for a period equal to the remaining
term of such Option or Convertible Security (as the case may be) as of the date of issuance of such Option or Convertible Security (as
the case may be) and (iii) an expected volatility equal to the greater of 100% and the 100 day volatility obtained from the HVT function
on Bloomberg (determined utilizing a 365 day annualization factor) as of the Trading Day immediately following the date of issuance of
such Option or Convertible Security (as the case may be).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)&nbsp;&ldquo;<B>Black
Scholes Value &ndash; FT</B>&rdquo; means the value of the unexercised portion of this Warrant remaining on the date of the Holder&rsquo;s
request pursuant to Section 4(c), which value is calculated using the Black Scholes Option Pricing Model obtained from the &ldquo;OV&rdquo;
function on Bloomberg utilizing (i) an underlying price per share of Common Stock equal to the greater of (A) the highest Closing Sale
Price of the Common Stock during the period beginning on the Trading Day immediately preceding the earliest to occur of (1) the public
disclosure of the applicable Fundamental Transaction, (2) the consummation of the applicable Fundamental Transaction and (3) the date
on which the Holder first became aware of the applicable Fundamental Transaction and ending on the Trading Day of the Holder&rsquo;s request
pursuant to Section 4(c) and (B) the sum of the price per share of Common Stock being offered in cash in the applicable Fundamental Transaction
(if any) plus the value of the non-cash consideration being offered in the applicable Fundamental Transaction (if any), (ii) a strike
price equal to the Exercise Price in effect on the date of the Holder&rsquo;s request pursuant to Section 4(c), (iii) a risk-free interest
rate corresponding to the U.S. Treasury rate for a period equal to the greater of (A) the remaining term of this Warrant as of the date
of the Holder&rsquo;s request pursuant to Section 4(c) and (B) the remaining term of this Warrant as of the date of consummation of the
applicable Fundamental Transaction or as of the date of the Holder&rsquo;s request pursuant to Section 4(c) if such request is prior to
the date of the consummation of the applicable Fundamental Transaction and (iv) an expected volatility equal to the greater of 135% and
the 100 day volatility obtained from the HVT function on Bloomberg (determined utilizing a 365 day annualization factor) as of the Trading
Day immediately following the earliest to occur of (A) the public disclosure of the applicable Fundamental Transaction, (B) the consummation
of the applicable Fundamental Transaction and (C) the date on which the Holder first became aware of the applicable Fundamental Transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)&nbsp;&ldquo;<B>Bloomberg</B>&rdquo;
means Bloomberg, L.P.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f)&nbsp;&ldquo;<B>Business
Day</B>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in New York, New York are authorized or
required by law to remain closed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g)&nbsp;&ldquo;<B>Closing
Bid Price</B>&rdquo; and &ldquo;<B>Closing Sale Price</B>&rdquo; means, for any security as of any date, the last closing bid price and
the last closing trade price, respectively, for such security on the principal securities exchange or trading market where such security
is listed or traded as reported by Bloomberg, or if the foregoing do not apply, the average of the bid prices, or the ask prices, respectively,
of all of the market makers for such security as reported in the &ldquo;pink sheets&rdquo; by OTC Markets Group Inc. (formerly Pink Sheets
LLC). If the Closing Bid Price or the Closing Sale Price cannot be calculated for a security on a particular date on any of the foregoing
bases, the Closing Bid Price or the Closing Sale Price (as the case may be) of such security on such date shall be the fair market value
as mutually determined by the Company and the Holder. If the Company and the Holder are unable to agree upon the fair market value of
such security, then such dispute shall be resolved in accordance with the procedures in Section 14. All such determinations shall be appropriately
adjusted for any stock dividend, stock split, stock combination or other similar transaction during such period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h)&nbsp;&ldquo;<B>Convertible
Securities</B>&rdquo; means any capital stock or other security of the Company that is at any time and under any circumstances directly
or indirectly convertible into, exercisable or exchangeable for, or which otherwise entitles the holder thereof to acquire, any capital
stock or other security of the Company (including, without limitation, the Common Stock).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i)&nbsp;&ldquo;<B>Transfer
Agent</B>&rdquo; means Continental Stock Transfer &amp; Trust Company, with a mailing address of 1 State Street, 30th Floor, New York,
NY 10004, and any successor transfer agent of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(j)&nbsp;
&ldquo;<B>Trading Market</B>&rdquo; means the New York Stock Exchange, the NYSE Amex, the Nasdaq Global Select Market, the Nasdaq Global
Market or the Nasdaq Capital Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(k)&nbsp;&ldquo;<B>Expiration
Date</B>&rdquo; means [&#9679;], 202[&#9679;] or, if such date falls on a day other than a Business Day or on which trading does not take
place on the principal securities exchange or trading market where the Common Stock is listed (a &ldquo;<B>Holiday</B>&rdquo;), the next
date that is not a Holiday.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(l)&nbsp;&ldquo;<B>Fundamental
Transaction</B>&rdquo; means that (i) the Company shall, directly or indirectly, in one or more related transactions, (1) consolidate
or merge with or into (whether or not the Company is the surviving entity) any other Person unless the stockholders of the Company immediately
prior to such consolidation or merger continue to hold more than 50% of the outstanding shares of Voting Stock after such consolidation
or merger, or (2) sell, lease, license, assign, transfer, convey or otherwise dispose of all or substantially all of its properties or
assets to any other Person, in connection with which the Company is dissolved, or (3) allow any other Person to make a purchase, tender
or exchange offer that is accepted by the holders of more than 50% of the outstanding shares of Voting Stock of the Company (not including
any shares of Voting Stock of the Company held by the Person or Persons making or party to, or associated or affiliated with the Persons
making or party to, such purchase, tender or exchange offer), or (4) consummate a stock or share purchase agreement or other business
combination (including, without limitation, a reorganization, recapitalization, spin-off or scheme of arrangement) with any other Person
whereby such other Person acquires more than 50% of the outstanding shares of Voting Stock of the Company (not including any shares of
Voting Stock of the Company held by the other Person or other Persons making or party to, or associated or affiliated with the other Persons
making or party to, such stock or share purchase agreement or other business combination), or (ii) any &ldquo;person&rdquo; or &ldquo;group&rdquo;
(as these terms are used for purposes of Sections 13(d) and 14(d) of the 1934 Act and the rules and regulations promulgated thereunder)
is or shall become the &ldquo;beneficial owner&rdquo; (as defined in Rule 13d-3 under the 1934 Act), directly or indirectly, of 50% of
the aggregate ordinary voting power represented by issued and outstanding Voting Stock of the Company; provide however that a Fundamental
Transaction shall not include the Merger.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(m)&nbsp;&ldquo;<B>Options</B>&rdquo;
means any rights, warrants or options to subscribe for or purchase Common Stock or Convertible Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(n)&nbsp;&ldquo;<B>Parent
Entity</B>&rdquo; of a Person means an entity that, directly or indirectly, controls the applicable Person and whose common stock or equivalent
equity security is quoted or listed on a Trading Market, or, if there is more than one such Person or Parent Entity, the Person or Parent
Entity with the largest public market capitalization as of the date of consummation of the Fundamental Transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(o)&nbsp;&ldquo;<B>Person</B>&rdquo;
means an individual, a limited liability company, a partnership, a joint venture, a corporation, a trust, an unincorporated organization,
any other entity or a government or any department or agency thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(p)&nbsp;&ldquo;<B>Successor
Entity</B>&rdquo; means the Person (or, if so elected by the Holder, the Parent Entity) formed by, resulting from or surviving any Fundamental
Transaction or the Person (or, if so elected by the Holder, the Parent Entity) with which such Fundamental Transaction shall have been
entered into.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(q)&nbsp;&ldquo;<B>Trading
Day</B>&rdquo; means, as applicable, (x) with respect to all price determinations relating to the Common Stock, any day on which the Common
Stock is traded on the principal securities exchange or securities market on which the Common Stock is then traded, provided that &ldquo;Trading
Day&rdquo; shall not include any day on which the Common Stock is scheduled to trade on such exchange or market for less than 4.5 hours
or any day that the Common Stock is suspended from trading during the final hour of trading on such exchange or market (or if such exchange
or market does not designate in advance the closing time of trading on such exchange or market, then during the hour ending at 4:00:00
p.m., New York time) unless such day is otherwise designated as a Trading Day in writing by the Holder or (y) with respect to all determinations
other than price determinations relating to the Common Stock, any day on which The New York Stock Exchange (or any successor thereto)
is open for trading of securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(r)&nbsp;&ldquo;<B>Voting
Stock</B>&rdquo; of a Person means capital stock of such Person of the class or classes pursuant to which the holders thereof have the
general voting power to elect, or the general power to appoint, at least a majority of the board of directors, managers or trustees of
such Person (irrespective of whether or not at the time capital stock of any other class or classes shall have or might have voting power
by reason of the happening of any contingency).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(s)&nbsp;&ldquo;<B>VWAP</B>&rdquo;
means, for any security as of any date, the dollar volume-weighted average price for such security on the principal securities exchange
or securities market on which such security is then traded during the period beginning at 9:30:01 a.m., New York time, and ending at 4:00:00
p.m., New York time, as reported by Bloomberg through its &ldquo;Volume at Price&rdquo; function or, if the foregoing does not apply,
the dollar volume-weighted average price of such security in the over-the-counter market on the electronic bulletin board for such security
during the period beginning at 9:30:01 a.m., New York time, and ending at 4:00:00 p.m., New York time, as reported by Bloomberg, or, if
no dollar volume-weighted average price is reported for such security by Bloomberg for such hours, the average of the three highest closing
bid prices and the three lowest closing ask prices of all of the market makers for such security as reported in the &ldquo;pink sheets&rdquo;
by OTC Markets Group Inc. (formerly Pink Sheets LLC). If VWAP cannot be calculated for such security on such date on any of the foregoing
bases, the VWAP of such security on such date shall be the fair market value as mutually determined by the Company and the Holder. If
the Company and the Holder are unable to agree upon the fair market value of such security, then such dispute shall be resolved in accordance
with the procedures in Section 14. All such determinations shall be appropriately adjusted for any stock dividend, stock split, stock
combination or other similar transaction during such period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>Signature Page Follows</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 40.5pt"><B>IN WITNESS WHEREOF, </B>the
Company has caused this Common Stock Purchase Warrant to be duly executed as of the Issuance Date set out above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 3in"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2"><B>GD CULTURE GROUP LIMITED</B> </TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 35%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt">By:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Name:</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Title:</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 3in"></P>


<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">EXHIBIT A</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">EXERCISE NOTICE</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">TO BE EXECUTED
BY THE REGISTERED HOLDER TO EXERCISE THIS COMMON STOCK PURCHASE WARRANT</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">GD CULTURE GROUP
LIMITED</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The undersigned holder hereby
exercises the right to purchase <U STYLE="text-decoration: none">____</U> shares of Common Stock (&ldquo;<B>Warrant Shares</B>&rdquo;), par value $0.0001 per share,
of GD Culture Group Limited, a Nevada company (the &ldquo;<B>Company</B>&rdquo;), evidenced by Common Stock Purchase Warrant No. ___ (the
&ldquo;<B>Warrant</B>&rdquo;). Capitalized terms used herein and not otherwise defined shall have the respective meanings set forth in
the Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.&nbsp;<U>Form
of Exercise Price</U>. The Holder intends that payment of the Exercise Price shall be made as:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-indent: -1.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 1.5in">____________</TD><TD>a &ldquo;<U>Cash Exercise</U>&rdquo; with respect to _________ Warrant Shares; and/or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-indent: -1.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 1.5in">____________</TD><TD>a &ldquo;<U>Cashless Exercise</U>&rdquo; with respect to <U STYLE="text-decoration: none">___________</U> Warrant Shares.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the event that the Holder
has elected a Cashless Exercise with respect to some or all of the Warrant Shares, the Holder represents and warrants that the shares
of Common Stock are to be delivered pursuant to such Cashless Exercise, as further specified in Annex A to this Exercise Notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2. <U>Payment of
Exercise Price</U>. In the event that the Holder has elected a Cash Exercise with respect to some or all of the Warrant Shares, the
Holder shall pay the Aggregate Exercise Price in the sum of $<U STYLE="text-decoration: none">__</U> to the Company in accordance with the terms of the
Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3. <U>Delivery of Warrant
Shares and Net Number of Shares of Common Stock</U>. The Company shall deliver to Holder, or its designee or agent as specified below,
<U STYLE="text-decoration: none">_____</U>shares of Common Stock in respect of the exercise contemplated hereby. Delivery shall be made to Holder, or for its benefit,
to the following address:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Date:_________________,____</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 40%">Name of Registered Holder</TD>
    <TD STYLE="width: 60%">&nbsp;</TD>
    </TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; width: 4%"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 36%">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 60%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Account Number:_____________________ (if electronic book entry transfer)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Transaction Code Number:<U STYLE="text-decoration: none">_____________</U> (if electronic
book entry transfer)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">ANNEX A TO EXERCISE
NOTICE CASHLESS EXERCISE EXCHANGE CALCULATION</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">TO BE FILLED IN
BY THE REGISTERED HOLDER TO EXCHANGE THE COMMON STOCK PURCHASE WARRANT TO IN A CASHLESS EXERCISE PURSUANT TO SECTION 1(d) OF THE WARRANT</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Capitalized terms used herein
and not otherwise defined shall have the respective meanings set forth in the Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&#9744; Net Number = (A x B)/C = shares of Common Stock</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-indent: 0.5in">OR</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: 0.5in">&#9744;
Net Number = (C - D) x A / C</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">For purposes of the foregoing formula:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.35in">A =</TD><TD STYLE="text-align: justify">the total number of shares of Common Stock with respect to which the Warrant is then being exercised = <U STYLE="text-decoration: none">_____________</U>.</TD></TR></TABLE>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 1.5in"></TD><TD STYLE="text-align: justify; width: 0.35in">B =</TD><TD STYLE="text-align: justify">Black Scholes Value(as defined in Section 17 of the Warrant) =<BR>
____________.</TD></TR></TABLE>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="text-align: justify; width: 1.5in"></TD><TD STYLE="text-align: justify; width: 0.35in">C =</TD><TD STYLE="text-align: justify">the Closing Bid Price of the Common Stock as of two (2) Trading Days prior to the time of such exercise (as such Closing Bid Price
is defined in Section 17 of the Warrant) = <U STYLE="text-decoration: none">________</U>.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Date:_______________,<U STYLE="text-decoration: none">___</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD>
    <TD STYLE="width: 60%">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>Name of Registered Holder<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    </TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt; width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By: </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 36%">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 60%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD>
    <TD>Name:</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD></TD>
    <TD>Title:</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 2.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 2.5in"></P>

<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 2.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">EXHIBIT B</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">ACKNOWLEDGMENT</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company hereby acknowledges
this Exercise Notice and hereby directs <U STYLE="text-decoration: none">______</U> to issue the above indicated number of share of Common Stock in accordance with
the Transfer Agent Instructions dated <U STYLE="text-decoration: none">____</U>__, 20______, from the Company and acknowledged and agreed to by <U STYLE="text-decoration: none">__________</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>GD CULTURE GROUP LIMITED</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 36%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD>
    <TD>Name:</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD></TD>
    <TD>Title:</TD></TR>
  </TABLE>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>4
<FILENAME>ea177982ex5-1_gdculture.htm
<DESCRIPTION>OPINION OF ORTOLI ROSENSTADT LLP
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"><B>Exhibit 5.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="ex5-1_001.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt">May 4, 2023</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">GD Culture Group Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Flat 1512, 15F, Lucky Centre,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">No.165-171 Wan Chai Road</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Wan Chai, Hong Kong&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have acted as special counsel to GD Culture
Group Limited, a Nevada corporation (the &ldquo;<U>Company</U>&rdquo;), in connection with a prospectus supplement, dated May 4, 2023
(the &ldquo;<U>Prospectus Supplement</U>&rdquo;) to the prospectus which forms a part of a Registration Statement (as amended from time-to-time,
referred to as the &ldquo;<U>Registration Statement</U>&rdquo;) on Form S-3 filed by the Company on March 16, 2021 (Registration No. 333-254366,
under the Securities Act of 1933, as amended (the &ldquo;<U>Act</U>&rdquo;), with the U.S. Securities and Exchange Commission (the &ldquo;<U>Commission</U>&rdquo;)
and declared effective on March 26, 2021, relating to the public offering of (i) 310,168 shares (the &ldquo;<U>Shares</U>&rdquo;) of the
Company&rsquo;s common stock, par value $0.0001 per share (the &ldquo;<U>Common Stock</U>&rdquo;) and (ii) pre-funded warrants (the &ldquo;<U>Pre-Funded
Warrants</U>&rdquo;) to purchase an aggregate of 844,351 shares of the Company&rsquo;s Common Stock (the &ldquo;<U>Pre-Funded Warrant
Shares</U>&rdquo;). The Shares, the Pre-funded Warrants and the Pre-Funded Warrant Shares are collectively referred to as the &ldquo;Securities&rdquo;.
The Shares and the Pre-Funded Warrants are to be sold pursuant to that certain securities purchase agreement, dated as of May 1, 2023
by and between the Company and the purchasers identified on the signature pages thereto (the &ldquo;<U>Purchase Agreement</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with this matter, we have examined
the originals or copies certified or otherwise identified to our satisfaction of the following: (a) Articles of Incorporation of the Company,
as amended to date, (b) By-laws of the Company, as amended to date, (c) the Registration Statement, all documents incorporated therein
by reference and all exhibits thereto, (d) the Prospectus Supplement, (e) the Purchase Agreement and all the schedules and exhibits thereto
and (f) the placement agency agreement, dated May 1, 2023, by and between the Company and Univest Securities LLC (the &ldquo;<U>Placement
Agency Agreement</U>&rdquo;). In addition to the foregoing, we have relied as to matters of fact upon the representations made by the
Company and their representatives, and we have assumed the genuineness of all signatures, the authenticity of all documents submitted
to us as originals, and the conformity to original documents of all documents submitted to us certified or photostatic copies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are members of the Bar of the State of New
York. We do not hold ourselves out as being conversant with, or expressing any opinion with respect to, the laws of any jurisdiction other
than the federal laws of the United States of America, the laws of the State of New York, and Chapter 78 of the Nevada Revised Statutes.
Accordingly, the opinions expressed herein are expressly limited to the federal laws of the United States of America, the laws of the
State of New York, and Chapter 78 of the Nevada Revised Statutes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Based upon the foregoing and in reliance thereon,
and subject to the qualifications, limitations, exceptions and assumptions set forth herein, we are of the opinion that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify">the Securities have been duly authorized for issuance by all necessary corporate action by the Company;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify">the Shares, when issued and sold as described in the Registration Statement, the Prospectus Supplement,
the Purchase Agreement and the Placement Agency Agreement, were validly issued, fully paid and non-assessable;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="ex5-1_001.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">(iii)</FONT></TD><TD STYLE="text-align: justify">provided that the Pre-Funded Warrants have been duly executed and delivered by the Company and duly delivered
to the purchasers thereof against payment therefor, such Pre-Funded Warrants, when sold and issued as contemplated in the Registration
Statement, the Prospectus Supplement, the Purchase Agreement and the Placement Agency Agreement, are valid and binding obligations of
the Company;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt">(iv)</FONT></TD><TD STYLE="text-align: justify">the Pre-Funded Warrant Shares upon payment to the Company of the required consideration, and when issued
and sold by the Company and paid for in accordance with the terms of the Pre-Funded Warrants, as applicable, and as described in the Registration
Statement, the Prospectus Supplement, the Purchase Agreement and the Placement Agency Agreement, will be validly issued, fully paid and
non-assessable.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This opinion letter speaks only as of the date
hereof, and we assume no obligation to update or supplement this opinion letter if any applicable laws change after the date of this opinion
letter or if we become aware after the date of this opinion letter of any facts, whether existing before or arising after the date hereof,
that might change the opinions expressed above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This opinion letter is furnished in connection
with the Prospectus Supplement and may not be relied upon for any other purpose without our prior written consent in each instance. Further,
no portion of this letter may be quoted, circulated or referred to in any other document for any other purpose without our prior written
consent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We hereby consent to the filing of this opinion
with the Commission as Exhibit 5.1 to the Company&rsquo;s Current Report on Form 8-K filed on May 4, 2023, incorporated by reference into
the Registration Statement, and to the use of our name as it appears under the caption &ldquo;Legal Matters&rdquo; in the Prospectus Supplement.
In giving such consent, we do not thereby admit that we come within the category of persons whose consent is required under Section 7
of the Act or the rules and regulations of the Commission promulgated thereunder. This opinion is expressed as of the date hereof unless
otherwise expressly stated, and we disclaim any undertaking to advise you of any subsequent changes in the facts stated or assumed herein
or of any subsequent changes in applicable laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very truly yours,</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/ Ortoli Rosenstadt LLP</I></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ortoli Rosenstadt LLP</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">2</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>5
<FILENAME>ea177982ex10-1_gdculture.htm
<DESCRIPTION>PLACEMENT AGENCY AGREEMENT, DATED MAY 1, 2023
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: right"><FONT STYLE="text-transform: none">Exhibit
10.1</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">PLACEMENT AGENCY
AGREEMENT</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">May 1, 2023</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">GD Culture Group Limited</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Flat 1512, 15F, Lucky Centre,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">No.165-171 Wan Chai Road</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Wan Chai, Hong Kong</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dear Mr. Xiao Jian Wang:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This letter (the &ldquo;<B>Agreement</B>&rdquo;)
constitutes the agreement by and between Univest Securities, LLC (&ldquo;<B>Univest</B>&rdquo; or the &ldquo;<B>Placement Agent</B>&rdquo;)
and GD Culture Group Limited, a Nevada corporation (the &ldquo;<B>Company</B>&rdquo;), pursuant to which the Placement Agent shall serve
as the placement agent for the Company, on a &ldquo;reasonable best efforts&rdquo; basis, in connection with the proposed placements (the
&ldquo;<B>Placements</B>&rdquo;) of (i) via a registered direct offering of shares of common stock, par value $0.0001 (&ldquo;<B>Common
Stock</B>&rdquo;), of the Company (the &ldquo;<B>Offered Shares</B>&rdquo;) and pre-funded warrants to purchase shares of Common Stock
(the &ldquo;<B>Pre-Funded Warrants</B>&rdquo;, collectively with the Shares, the &ldquo;<B>Public Securities</B>&rdquo;) and (ii) warrants
to purchase shares of Common Stock (the &ldquo;<B>Warrants</B>&rdquo;) (collectively with the Public Securities, the &ldquo;<B>Securities</B>&rdquo;)
in a concurrent private placement. The terms of the Placements and the Securities shall be mutually agreed upon by the Company and the
purchasers (each, a &ldquo;<B>Purchaser</B>&rdquo; and collectively, the &ldquo;<B>Purchasers</B>&rdquo;) and nothing herein shall be
deemed to mean that the Placement Agent would have the power or authority to bind the Company or any Purchaser or an obligation for the
Company to issue any Securities or complete the Placements. This Agreement and the documents executed and delivered by the Company and
the Purchasers in connection with the Placements, including but not limited to the Purchase Agreement (as defined below) and the forms
of the Warrants and Pre-Funded Warrants, shall be collectively referred to herein as the &ldquo;<B>Transaction Documents</B>.&rdquo; The
date of the closing of the Placements shall be referred to herein as the &ldquo;<B>Closing Date</B>.&rdquo; The Company expressly acknowledges
and agrees that the obligations of the Placement Agent hereunder are on a reasonable best efforts basis only and that the execution of
this Agreement does not constitute a commitment by the Placement Agent to purchase the Securities and does not ensure the successful placement
of the Securities or any portion thereof or the success of the Placement Agent with respect to securing any other financing on behalf
of the Company. Following the prior written consent of the Company, the Placement Agent may retain other brokers or dealers to act as
sub-agents or selected-dealers on its behalf in connection with the Placements. The sale of the Securities to any Purchaser will be evidenced
by a securities purchase agreement (the &ldquo;<B>Purchase Agreement</B>&rdquo;) between the Company and such Purchaser in a form mutually
agreed upon by the Company and the Placement Agent. Capitalized terms that are not otherwise defined herein have the meanings given to
such terms in the Purchase Agreement. Prior to the signing of any Purchase Agreement, executive officers of the Company will be available
upon reasonable notice and during normal business hours to answer inquiries from prospective Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><U>SECTION 1. REPRESENTATIONS AND WARRANTIES
OF THE COMPANY; COVENANTS OF THE COMPANY</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">A. <U>Representations
of the Company</U>. Each of the representations and warranties (together with any related disclosure schedules thereto) and covenants
made by the Company to the Purchasers in the Purchase Agreement in connection with the Placements is hereby incorporated herein by reference
into this Agreement (as though fully restated herein) and is, as of the date of this Agreement and as of the Closing Date, hereby made
to, and in favor of, the Placement Agent. In addition to the foregoing, the Company represents and warrants that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">1. The
Company has prepared and filed with the U.S. Securities and Exchange Commission (the &ldquo;<B>Commission</B>&rdquo;) a registration statement
on Form S-3 (File No. 333-254366) for the registration under the Securities Act of 1933, as amended (the &ldquo;<B>Securities Act</B>&rdquo;),
of the Public Securities, which registration statement became effective on March 26, 2021. At the time of such filing, the Company met
the requirements of Form S-3 under the Securities Act. Such registration statement meets the requirements set forth in Rule 415(a)(1)(x)
under the Securities Act and complies with said Rule. The Company will file with the Commission pursuant to Rule 424(b) under the Securities
Act, and the rules and regulations (the &ldquo;<B>Rules and Regulations</B>&rdquo;) of the Commission promulgated thereunder, a supplement
to the form of prospectus included in such registration statement relating to the placement of the Public Securities and the plan of distribution
thereof and has advised the Placement Agent of all further information (financial and other) with respect to the Company required to be
set forth therein. Such registration statement, including the exhibits thereto, as amended at the date of this Agreement, is hereinafter
called the &ldquo;<B>Registration Statement</B>&rdquo;; such prospectus in the form in which it appears in the Registration Statement
is hereinafter called the &ldquo;<B>Base Prospectus</B>&rdquo;; and the supplemented form of prospectus, in the form in which it will
be filed with the Commission pursuant to Rule 424(b) (including the Base Prospectus as so supplemented) is hereinafter called the &ldquo;<B>Prospectus
Supplement</B>.&rdquo; Any reference in this Agreement to the Registration Statement, the Base Prospectus or the Prospectus Supplement
shall be deemed to refer to and include the documents incorporated by reference therein (the &ldquo;<B>Incorporated Documents</B>&rdquo;)
pursuant to Item 12 of Form S-3 which were filed under the Securities Exchange Act of 1934, as amended (the &ldquo;<B>Exchange Act</B>&rdquo;),
on or before the date of this Agreement, or the issue date of the Base Prospectus or the Prospectus Supplement, as the case may be; and
any reference in this Agreement to the terms &ldquo;amend,&rdquo; &ldquo;amendment&rdquo; or &ldquo;supplement&rdquo; with respect to
the Registration Statement, the Base Prospectus or the Prospectus Supplement shall be deemed to refer to and include the filing of any
document under the Exchange Act after the date of this Agreement, or the issue date of the Base Prospectus or the Prospectus Supplement,
as the case may be, deemed to be incorporated therein by reference. All references in this Agreement to financial statements and schedules
and other information which is &ldquo;contained,&rdquo; &ldquo;included,&rdquo; &ldquo;described,&rdquo; &ldquo;referenced,&rdquo; &ldquo;set
forth&rdquo; or &ldquo;stated&rdquo; in the Registration Statement, the Base Prospectus or the Prospectus Supplement (and all other references
of like import) shall be deemed to mean and include all such financial statements and schedules and other information which is or is deemed
to be incorporated by reference in the Registration Statement, the Base Prospectus or the Prospectus Supplement, as the case may be. No
stop order suspending the effectiveness of the Registration Statement or the use of the Base Prospectus or the Prospectus Supplement has
been issued, and no proceeding for any such purpose is pending or has been initiated or, to the Company&rsquo;s knowledge, is threatened
by the Commission. For purposes of this Agreement, &ldquo;<B>Free Writing Prospectus</B>&rdquo; has the meaning set forth in Rule 405
under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">2. The
Registration Statement (and any further documents to be filed with the Commission) contains all exhibits and schedules as required by
the Securities Act. Each of the Registration Statement and any post-effective amendment thereto, at the time it became effective, complied
in all material respects with the Securities Act and the Exchange Act and the applicable Rules and Regulations and did not and, as amended
or supplemented, if applicable, will not, contain any untrue statement of a material fact or omit to state a material fact required to
be stated therein or necessary to make the statements therein not misleading. The Base Prospectus and the Prospectus Supplement, each
as of its respective date, complied or will comply in all material respects with the Securities Act and the Exchange Act and the applicable
Rules and Regulations. Each of the Base Prospectus, and the Prospectus Supplement, as amended or supplemented, did not and will not contain
as of the date thereof any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements
therein, in the light of the circumstances under which they were made, not misleading. The Incorporated Documents, when they were filed
with the Commission, conformed in all material respects to the requirements of the Exchange Act and the applicable Rules and Regulations,
and none of such documents, when they were filed with the Commission, contained any untrue statement of a material fact or omitted to
state a material fact necessary to make the statements therein (with respect to Incorporated Documents incorporated by reference in the
Base Prospectus or Prospectus Supplement), in the light of the circumstances under which they were made not misleading; and any further
documents so filed and incorporated by reference in the Base Prospectus, or Prospectus Supplement, when such documents are filed with
the Commission, will conform in all material respects to the requirements of the Exchange Act and the applicable Rules and Regulations,
as applicable, and will not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements
therein, in the light of the circumstances under which they were made, not misleading. No post-effective amendment to the Registration
Statement reflecting any facts or events arising after the date thereof which represent, individually or in the aggregate, a fundamental
change in the information set forth therein is required to be filed with the Commission. Except for this Agreement and the Transaction
Documents, there are no documents required to be filed with the Commission in connection with the transaction contemplated hereby that
(x) have not been filed as required pursuant to the Securities Act or (y) will not be filed within the requisite time period. There are
no contracts or other documents required to be described in the Base Prospectus, or Prospectus Supplement, or to be filed as exhibits
or schedules to the Registration Statement, which (x) have not been described or filed as required or (y) will not be filed within the
requisite time period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">3. The
Company is eligible to use Free Writing Prospectuses in connection with the Placement pursuant to Rules 164 and 433 under the Securities
Act. Any Free Writing Prospectus that the Company is required to file pursuant to Rule 433(d) under the Securities Act has been, or will
be, filed with the Commission in accordance with the requirements of the Securities Act and the applicable rules and regulations of the
Commission thereunder. Each Free Writing Prospectus that the Company has filed, or is required to file, pursuant to Rule 433(d) under
the Securities Act or that was prepared by or behalf of or used by the Company complies or will comply in all material respects with the
requirements of the Securities Act and the applicable rules and regulations of the Commission thereunder. The Company will not, without
the prior consent of the Placement Agent, prepare, use or refer to, any Free Writing Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">4. The
Company has filed all reports, schedules, forms, statements or other documents required to be filed by the Company under the Securities
Act or Exchange Act, during the three years preceding the date hereof (the foregoing materials filed during such three-year period, including
the exhibits thereto and documents incorporated by reference therein, the &ldquo;<B>SEC Reports</B>&rdquo;). For the twelve months preceding
the date hereof, the Company has filed the SEC Reports on a timely basis (including any valid extension of such time of filing provided
under Rule 12b-5 or under coronavirus-related relief by the SEC) and has filed any such SEC Reports prior to the expiration of any such
extension. As of their respective filing or amendment dates, the SEC Reports complied in all material respects with the requirements of
the Exchange Act and the rules and regulations of the Commission promulgated thereunder; and as of their respective filing or amendment
dates, the SEC Reports did not contain any untrue statement of a material fact or omit to state any material fact necessary in order to
make the statements therein, in light of the circumstances under which they were made, not misleading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">5. There
are no affiliations with any Financial Industry Regulatory Authority, Inc. (&ldquo;<B>FINRA</B>&rdquo;) member firm among the Company&rsquo;s
officers, directors or, to the knowledge of the Company, any ten percent (10%) or greater shareholder of the Company, except as set forth
in the Registration Statement and the SEC Reports.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">B. <U>Covenants
of the Company</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">1. The
Company has delivered or made available, or will as promptly as practicable deliver or make available, to the Placement Agent complete
conformed copies of the Registration Statement and of each consent and certificate of experts, as applicable, filed as a part thereof,
and conformed copies of the Registration Statement (without exhibits), the Base Prospectus, and the Prospectus Supplement, as amended
or supplemented, in such quantities and at such places as the Placement Agent reasonably requests. Neither the Company nor any of its
directors and officers has distributed and none of them will distribute, prior to the Closing Date, any offering material in connection
with the offering and sale of the Securities pursuant to the Placements other than the Transaction Documents, the Base Prospectus, the
Prospectus Supplement, the Registration Statement, copies of the documents incorporated by reference therein and any other materials permitted
by the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">2. The
Company will advise the Placement Agent promptly after it receives notice thereof of the time when any amendment to the Registration Statement
has been filed or becomes effective or any supplement to the Base Prospectus or the Prospectus Supplement has been filed and will furnish
the Placement Agent with copies thereof, the parties acknowledging that such obligation is satisfied by filing such materials on the EDGAR
system of the SEC. The Company will file promptly all reports and any definitive proxy or information statements required to be filed
by the Company with the Commission pursuant to Section 13(a), 14 or 15(d) of the Exchange Act subsequent to the date of the Prospectus
Supplement and for so long as the delivery of a prospectus is required in connection with the Placement. The Company will advise the Placement
Agent, promptly after it receives notice thereof (i) of any request by the Commission to amend the Registration Statement or to amend
or supplement any Prospectus or for additional information, and (ii) of the issuance by the Commission of any stop order suspending the
effectiveness of the Registration Statement or any post-effective amendment thereto or any order directed at any Incorporated Document,
if any, or any amendment or supplement thereto or any order preventing or suspending the use of the Base Prospectus or the final Prospectus
or any prospectus supplement or any amendment or supplement thereto or any post-effective amendment to the Registration Statement, of
the suspension of the qualification of any of the Public Securities for offering or sale in any jurisdiction, of the institution or threatened
institution of any proceeding for any such purpose, or of any request by the Commission for the amending or supplementing of the Registration
Statement or a Prospectus or for additional information. The Company shall use its best efforts to prevent the issuance of any such stop
order or prevention or suspension of such use. If the Commission shall enter any such stop order or order or notice of prevention or suspension
at any time, the Company will use its best efforts to obtain the lifting of such order at the earliest possible moment, or will file a
new registration statement and use its best efforts to have such new registration statement declared effective as soon as practicable.
Additionally, the Company agrees that it shall comply with the provisions of Rules 424(b), 430A, 430B and 430C, as applicable, under the
Securities Act, including with respect to the timely filing of documents thereunder, and will use its best efforts to confirm that any
filings made by the Company under such Rule 424(b) are received in a timely manner by the Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">3. The
Company will cooperate with the Placement Agent and the Purchasers in endeavoring to qualify the Securities for sale under the securities
laws of such jurisdictions (United States and foreign) as the Placement Agent and the Purchasers may reasonably request and will make
such applications, file such documents, and furnish such information as may be reasonably required for that purpose, provided the Company
shall not be required to qualify as a foreign corporation or to file a general consent to service of process in any jurisdiction where
it is not now so qualified or required to file such a consent, and provided further that the Company shall not be required to produce
any new disclosure document. The Company will, from time to time, prepare and file such statements, reports and other documents as are
or may be required to continue such qualifications in effect for so long a period as the Placement Agent may reasonably request for distribution
of the Securities. The Company will advise the Placement Agent promptly of the suspension of the qualification or registration of (or
any such exemption relating to) the Securities for offering, sale or trading in any jurisdiction or any initiation or threat of any proceeding
for any such purpose, and in the event of the issuance of any order suspending such qualification, registration or exemption, the Company
shall use its best efforts to obtain the withdrawal thereof at the earliest possible moment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">4. The
Company will comply with the Securities Act and the Exchange Act, and the rules and regulations of the Commission thereunder, so as to
permit the completion of the distribution of the Securities as contemplated in this Agreement, the Incorporated Documents and any Prospectus.
If during the period in which a prospectus is required by law to be delivered in connection with the distribution of any Securities contemplated
by the Incorporated Documents or any Prospectus (the &ldquo;<B>Prospectus Delivery Period</B>&rdquo;), any event shall occur as a result
of which, in the judgment of the Company or in the opinion of the Placement Agent or counsel for the Placement Agent, it becomes necessary
to amend or supplement the Incorporated Documents or any Prospectus in order to make the statements therein, in the light of the circumstances
under which they were made, as the case may be, not misleading, or if it is necessary at any time to amend or supplement the Incorporated
Documents or any Prospectus or to file under the Exchange Act any Incorporated Document to comply with any law, the Company will promptly
prepare and file with the Commission, and furnish at its own expense to the Placement Agent and to dealers, an appropriate amendment to
the Registration Statement or supplement to the Registration Statement, the Incorporated Documents or any Prospectus that is necessary
in order to make the statements in the Incorporated Documents and any Prospectus as so amended or supplemented, in the light of the circumstances
under which they were made, as the case may be, not misleading, or so that the Registration Statement, the Incorporated Documents or any
Prospectus, as so amended or supplemented, will comply with law. Before amending the Registration Statement or supplementing the Incorporated
Documents or any Prospectus in connection with the Placement, the Company will furnish the Placement Agent with a copy of such proposed
amendment or supplement and will not file any such amendment or supplement to which the Placement Agent reasonably objects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">5. During
the Prospectus Delivery Period, the Company will duly file, on a timely basis, with the Commission and the Trading Market all reports
and documents required to be filed under the Exchange Act within the time periods and in the manner required by the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">6. The
Company will not take, directly or indirectly, any action designed to cause or result in, or that has constituted or might reasonably
be expected to constitute, the stabilization or manipulation of the price of any securities of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">7. [<I>Intentionally
Omitted</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">8. If
any of the conditions specified in this Section 1(B) shall not have been fulfilled when and as provided in this Agreement, or if any of
the opinions and certificates mentioned above or elsewhere in this Agreement shall not be reasonably satisfactory in form and substance
to the Placement Agent and its counsel, this Agreement and all obligations of the Placement Agent hereunder may be canceled at, or at
any time prior to, the Closing Date by the Placement Agent. Notice of such cancellation shall be given to the Company in writing or by
telephone or facsimile confirmed in writing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">C. <U>Subsequent
Equity Sales</U>. From the date hereof until forty-five (45) trading days (on which days the Nasdaq Global Market is open for trading)
after the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance
or proposed issuance of any shares of Common Stock or Common Stock Equivalents other than an through Exempt Issuance. From the date hereof
until one (1) year after the Closing Date, the Company shall be prohibited from effecting or entering into an agreement to effect any
issuance by the Company or any of its Subsidiaries of any shares of Common Stock or Common Stock Equivalents (or a combination of units
thereof) involving a Variable Rate Transaction. For purposes of this Agreement, &ldquo;<B>Variable Rate Transaction</B>&rdquo; shall mean
a transaction in which the Company (i) issues or sells any debt or equity securities that are convertible into, exchangeable or exercisable
for, or include the right to receive additional shares of Common Stok (A) at a conversion price, exercise price or exchange rate or other
price that is based upon and/or varies with the trading prices of or quotations for the Common Stock at any time after the initial issuance
of such debt or equity securities, or (B) with a conversion, exercise or exchange price that is subject to being reset at some future
date after the initial issuance of such debt or equity security or upon the occurrence of specified or contingent events directly or indirectly
related to the business of the Company or the market for the Common Stock or (ii) enters into, or effects a transaction under, any agreement,
including, but not limited to, an equity line of credit, whereby the Company may issue securities at a future determined price. The Placement
Agent shall be entitled to obtain injunctive relief against the Company to preclude any such issuance, which remedy shall be in addition
to any right to collect damages.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>SECTION 2. REPRESENTATIONS
OF THE PLACEMENT AGENT</U>. The Placement Agent represents and warrants that it (i) is a member in good standing of FINRA, (ii) is registered
as a broker/dealer under the Exchange Act, (iii) is licensed as a broker/dealer under the laws of the States applicable to the offers
and sales of the Securities by the Placement Agent, (iv) is and will be a corporate entity validly existing under the laws of its place
of formation, and (v) has full power and authority to enter into and perform its obligations under this Agreement. The Placement Agent
will immediately notify the Company in writing of any change in its status as such. The Placement Agent covenants that it will use its
reasonable best efforts to conduct the Placement hereunder in compliance with the provisions of this Agreement and the requirements of
applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>SECTION 3. COMPENSATION;
OTHER ARRANGEMENTS</U>. In consideration of the services to be provided for hereunder by the Placement Agent, the Company shall pay to
the Placement Agent the following compensation with respect to the Securities which the Placement Agent is placing:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">A. A
cash fee (the &ldquo;<B>Cash Fee</B>&rdquo;) equal to seven percent (7.0%) of the aggregate gross proceeds raised in the Placement. The
Cash Fee shall be paid at the closing of the Placements (the &ldquo;<B>Closing</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">B. In
addition to the Cash Fee, the Company shall issue the Placement Agent a warrant for the purchase of a number of shares of Common Stock
equal to five percent (5.0%) of the aggregate number of Offered Shares, Warrants and Pre-Funded Warrants issued in the Placements, at
an exercise price equal to one hundred twenty percent (120%) of the offering price in the Placement, for an aggregate purchase price of
one hundred U.S. dollars (US$100), which warrant shall be exercisable at any time during the period commencing six (6) months after commencement
of sales in the Offering through the fifth (5<FONT STYLE="font-size: 10pt"><SUP>th</SUP></FONT>) anniversary of issuance (the &ldquo;<B>Placement
Agent Warrant</B>&rdquo; and together with the shares of Common Stock underlying the Placement Agent Warrant, the &ldquo;<B>Placement
Agent Securities</B>&rdquo;) and in all respects in compliance with FINRA Rule 5110.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">C. Subject
to compliance with FINRA Rule 5110(g), the Company also agrees to reimburse the Placement Agent for all travel and other out-of-pocket
expenses, including the reasonable fees, costs and disbursements of its legal counsel, in an amount not to exceed an aggregate of one
hundred fifty thousand U.S. dollars (US$150,000). The Company will reimburse the Placement Agent at the Closing directly out of the gross
proceeds raised in the Placement. In the event this Agreement shall terminate prior to the consummation of the Placement, the Placement
Agent, shall be entitled to reimbursement for actual expenses upon providing reasonable documentation relating to the incurrence of such
expenses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">D. If
within twelve (12) months after the end of the Term (as defined below), the Company completes any financing of equity, equity-linked or
debt or other capital-raising activity of the Company for which any investors in the Placement were contacted by the Placement Agent in
connection therewith (other than the exercise by any person or entity of any options, warrants or other convertible securities), then
the Company shall pay to the Placement Agent a commission as described in Section 3(A)-(C) herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">E. The
Placement Agent reserves the right to reduce any item of its compensation or adjust (in the Company&rsquo;s favor) the terms thereof as
specified herein in the event that a determination shall be made by FINRA to the effect that the Placement Agent&rsquo;s aggregate compensation
is in excess of FINRA&rsquo;s rules and regulations or that the terms thereof require adjustment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>SECTION 4. INDEMNIFICATION</U>.
The Company agrees to the indemnification and other agreements set forth in the Indemnification Provisions (the &ldquo;<B>Indemnification</B>&rdquo;)
attached hereto as <U>Addendum A</U>, the provisions of which are incorporated herein by reference and shall survive the termination or
expiration of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>SECTION 5. ENGAGEMENT
TERM</U>. The Placement Agent&rsquo;s engagement hereunder shall be until the final Closing Date of the Placement; provided that, on or
after May 1, 2024, the engagement may be terminated by the Company or the Placement Agent upon 60 days&rsquo; written notice to the other
party, effective upon receipt of such written notice (such date, the &ldquo;<B>Termination Date</B>&rdquo; and the period of time during
which this Agreement remains in effect is referred to herein as the &ldquo;<B>Term</B>&rdquo;). Notwithstanding anything to the contrary
contained herein, the provisions concerning the Company&rsquo;s obligation to pay any fees actually earned pursuant to Section 3 hereof
and the provisions concerning confidentiality, indemnification and contribution contained herein and the Company&rsquo;s obligations contained
in the Indemnification Provisions attached hereto as <U>Addendum A</U> will survive any expiration or termination of this Agreement. If
this Agreement is terminated prior to the completion of the Placement, all fees and expense reimbursements due to the Placement Agent
shall be paid by the Company to the Placement Agent on or before the Termination Date (in the event such fees are earned or owed as of
the Termination Date). The Placement Agent agrees not to use any confidential information concerning the Company provided to the Placement
Agent by the Company for any purposes other than those contemplated under this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>SECTION 6. PLACEMENT
AGENT&rsquo;S INFORMATION</U>. The Company agrees that any information or advice rendered by the Placement Agent in connection with this
engagement is for the confidential use of the Company only in its evaluation of the Placement and, except as otherwise required by law,
the Company will not disclose or otherwise refer to the advice or information in any manner without the Placement Agent&rsquo;s prior
written consent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>SECTION 7. NO FIDUCIARY
RELATIONSHIP</U>. This Agreement does not create, and shall not be construed as creating rights enforceable by any person or entity not
a party hereto, except those entitled hereto by virtue of the Indemnification Provisions attached hereto as <U>Addendum A</U> hereof.
The Company acknowledges and agrees that the Placement Agent is not nor shall it be construed as a fiduciary of the Company and the Placement
Agent shall not have any duties or liabilities to the equity holders or the creditors of the Company or any other person by virtue of
this Agreement or the retention of the Placement Agent hereunder, all of which are hereby expressly waived.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>SECTION 8. CLOSING</U>.
The obligations of the Placement Agent, and the Closing of the sale of the Securities hereunder are subject to the accuracy, when made
and on the Closing Date, of the representations and warranties on the part of the Company contained herein and in the Purchase Agreement,
to the accuracy of the statements of the Company made in any certificates pursuant to the provisions hereof, to the performance by the
Company of their obligations hereunder, and to each of the following additional terms and conditions, except as otherwise disclosed to
and acknowledged and waived by the Placement Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">A. No
stop order suspending the effectiveness of the Registration Statement shall have been issued and no proceedings for that purpose shall
have been initiated or threatened by the Commission, and any request for additional information on the part of the Commission (to be included
in the Registration Statement, the Base Prospectus, the Prospectus Supplement or otherwise) shall have been complied with to the reasonable
satisfaction of the Placement Agent. Any filings required to be made by the Company in connection with the Placement shall have been timely
filed with the Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">B. The
Placement Agent shall not have discovered and disclosed to the Company on or prior to the Closing Date that the Registration Statement,
the Base Prospectus, the Prospectus Supplement or any amendment or supplement thereto contains an untrue statement of a fact which, in
the opinion of counsel for the Placement Agent, is material or omits to state any fact which, in the opinion of such counsel, is material
and is required to be stated therein or is necessary to make the statements therein not misleading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">C. All
corporate proceedings and other legal matters incident to the authorization, form, execution, delivery and validity of each of this Agreement,
the other Transaction Documents, the Securities, the Registration Statement, the Base Prospectus and the Prospectus Supplement and all
other legal matters relating to this Agreement and the transactions contemplated hereby and thereby shall be reasonably satisfactory in
all material respects to counsel for the Placement Agent and the Company shall have furnished to such counsel all documents and information
that they may reasonably request to enable them to pass upon such matters.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">D. The
Placement Agent shall have completed its due diligence investigation of the Company to the satisfaction of the Placement Agent and its
counsel.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">E. The
Placement Agent shall have received from outside counsels to the Company such counsels&rsquo; written opinions, including, without limitation,
a negative assurance letter from applicable counsel, addressed to the Placement Agent and the Purchasers and dated as of the Closing Date,
in form and substance reasonably satisfactory to the Placement Agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">F. On
the date of this Agreement and on the Closing Date, the Placement Agent shall have received a &ldquo;comfort&rdquo; letter from each of
the Company&rsquo;s independent registered public accounting firm, Enrome, LLP and WWC, P.C, and a certificate of the chief financial
officer of the Company, as of each such date, addressed to the Placement Agent and in form and substance satisfactory in all respects
to the Placement Agent and Placement Agent&rsquo;s counsel. Such officer shall also provide a customary certification as to such accounting
or financial matters that are included or incorporated by reference in the Registration Statement or the Prospectus that either Enrome,
LLP or WWC, P.C are unable to provide assurances on in the &ldquo;comfort&rdquo; letter contemplated by the immediately preceding sentence.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">G. On
the Closing Date, Placement Agent shall have received a certificate of signed by each of the co-chief executive officers of the Company,
dated, as applicable, as of the date of such Closing, to the effect that, as of the date of this Agreement and as of the Closing Date,
the representations and warranties of the Company contained herein and in the Purchase Agreement were and are accurate in all material
respects, except for such changes as are contemplated by this Agreement and except as to representations and warranties that were expressly
limited to a state of facts existing at a time prior to the applicable Closing Date, and that, as of the applicable date, the obligations
to be performed by the Company hereunder on or prior thereto have been fully performed in all material respects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">H. On
the Closing Date, Placement Agent shall have received from the Company a certificate of the corporate secretary of the Company, dated,
as applicable, as of the date of such Closing, certifying to the organizational documents of the Company, good standing in the jurisdiction
of formation of the Company and board resolutions authorizing the Placement of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">I. The
Company (i) shall not have sustained since the date of the latest audited financial statements included or incorporated by reference in
the Registration Statement, the Base Prospectus and the Prospectus Supplement, any loss or interference with its business as a result
of any fire, explosion, flood, terrorist act, epidemic or pandemic (including as a result of the coronavirus known as COVID-19), any change
in general economic, political or financial conditions in the United States or elsewhere, act of war or other calamity, whether or not
covered by insurance, or from any labor dispute or court or governmental action, order or decree, otherwise than as set forth in or contemplated
by the Registration Statement, the Base Prospectus and the Prospectus Supplement, and (ii) since such date there shall not have been any
change in the capital stock or long-term debt of the Company or any change, or any development involving a prospective change, in or affecting
the business, general affairs, management, financial position, shareholders&rsquo; equity, results of operations or prospects of the Company,
otherwise than as set forth in or contemplated by the Registration Statement, the Base Prospectus and the Prospectus Supplement, the effect
of which, in any such case described in clause (i) or (ii), is, in the judgment of the Placement Agent, so material and adverse as to
make it impracticable or inadvisable to proceed with the sale or delivery of the Securities on the terms and in the manner contemplated
by the Base Prospectus, the Prospectus Supplement and the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">J. The
Common Stock is registered under the Exchange Act and, as of the Closing Date, the Company has submitted the notification of listing of
additional Common Stock, including the Offered Shares, the Warrants and the Pre-Funded Warrants to the Trading Market or other U.S. applicable
national exchange, and the Offered Shares, the Warrants and the Pre-Funded Warrants shall be listed for trading on the Trading Market
or other applicable U.S. national exchange and reasonable evidence of such action, if available, shall have been provided to the Placement
Agent. The Company shall have taken no action designed to terminate, or likely to have the effect of, terminating the registration of
the Common Stock under the Exchange Act or delisting or suspending from trading the Common Stock from the Trading Market or other applicable
U.S. national exchange, nor has the Company received any information suggesting that the Commission or the Trading Market or other U.S.
applicable national exchange is contemplating terminating such registration or listing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">K. No
action shall have been taken and no statute, rule, regulation or order shall have been enacted, adopted or issued by any governmental
agency or body which would, as of the Closing Date, prevent the issuance or sale of the Securities or materially and adversely affect
or potentially and adversely affect the business or operations of the Company; and no injunction, restraining order or order of any other
nature by any federal or state court of competent jurisdiction shall have been issued as of the Closing Date which would prevent the issuance
or sale of the Securities or materially and adversely affect or potentially and adversely affect the business or operations of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">L. The
Company shall have prepared and filed with the Commission a Current Report on Form 8-K with respect to the Placement, including as an
exhibit thereto this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">M. The
Company shall have entered into a Purchase Agreement with each of the Purchasers and such agreements shall be in full force and effect
and shall contain representations, warranties and covenants of the Company as agreed between the Company and the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">N. FINRA
shall have raised no objection to the fairness and reasonableness of the terms and arrangements of this Agreement. In addition, the Company
shall, if requested by the Placement Agent, make or authorize Placement Agent&rsquo;s counsel to make on the Company&rsquo;s behalf, any
filing with the FINRA Corporate Financing Department pursuant to FINRA Rule 5110 with respect to the Placement and pay all filing fees
required in connection therewith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">O. The
Company shall apply the net proceeds from the Placement received by it in a manner consistent with the application thereof described under
the caption or heading &ldquo;Use of Proceeds&rdquo; in the Registration Statement, the Base Prospectus, the Prospectus Supplement and
the Purchase Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">P. Prior
to the Closing Date, the Company shall have furnished to the Placement Agent such further information, certificates and documents as the
Placement Agent may reasonably request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If any of the conditions specified in this Section
8 shall not have been fulfilled when and as required by this Agreement, or if any of the certificates, opinions, written statements or
letters furnished to the Placement Agent or to Placement Agent&rsquo;s counsel pursuant to this Section 8 shall not be reasonably satisfactory
in form and substance to the Placement Agent and to Placement Agent&rsquo;s counsel, all obligations of the Placement Agent hereunder
may be cancelled by the Placement Agent at, or at any time prior to, the consummation of the Closing. Notice of such cancellation shall
be given to the Company in writing or orally. Any such oral notice shall be confirmed promptly thereafter in writing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>SECTION 9. RIGHT OF
FIRST REFUSAL</U>. Subject to the Placement Agent&rsquo;s consummation of this Placement, beginning on the Closing Date of such Placement
until the eighteen (18)-month anniversary following the Closing Date (the &ldquo;<B>ROFR Period</B>&rdquo;), whether or not this Agreement
is terminated pursuant to Section 5, other than termination for Cause (as defined below), the Company grants the Placement Agent the right
to provide investment banking services to the Company on an exclusive basis in all matters for which the following investment banking
services are sought by the Company (such right, the &ldquo;<B>ROFR</B>&rdquo;), which right is exercisable in the Placement Agent&rsquo;s
sole discretion and which right shall not have a duration of more than three (3) years from the commencement of the sales of the Securities
in the Placement or the termination of the Placement Agent&rsquo;s engagement hereby in accordance with FINRA Rule 5110(g)(6)(A). For
these purposes, investment banking services shall mean (a) acting as lead manager for any underwritten public offering; (b) acting as
exclusive placement agent, initial purchaser or financial advisor in connection with any private offering of securities of the Company;
and (c) acting as financial advisor in connection with any sale or other transfer by the Company, directly or indirectly, of a majority
or controlling portion of its capital stock or assets to another entity, any purchase or other transfer by another entity, directly or
indirectly, of a majority or controlling portion of the capital stock or assets of the Company, and any merger or consolidation of the
Company with another entity. Within five (5) days after the Company&rsquo;s decision to enter into any such transaction, the Company shall
provide written notice to the Placement Agent, and the Placement Agent shall notify the Company of its intention to exercise the ROFR
within fifteen (15) business days following receipt of such written notice from the Company. Any decision by the Placement Agent to act
in any such capacity shall be contained in separate agreements, which agreements would contain, among other matters, provisions for customary
fees for transactions of similar size and nature, as may be mutually agreed upon by the parties thereto, and indemnification of the Placement
Agent which are appropriate to such transaction and shall be subject to general market conditions. If the Placement Agent declines to
exercise the ROFR or in the event the terms proposed by the Placement Agent are unsatisfactory to the Company, the Company shall have
the right to retain any other person or persons to provide such services on terms and conditions which are not more favorable to such
other person or persons than the terms declined by the Placement Agent in the first instance, or than the terms proposed by the Placement
Agent in the second instance. The ROFR granted hereunder may be terminated by the Company for &ldquo;Cause&rdquo;, which shall mean a
material breach by the Placement Agent of this Agreement or a material failure by the Placement Agent to provide the services as contemplated
by this Agreement. The services provided by the Placement Agent hereunder are solely for the benefit of the Company and are not intended
to confer any rights upon any persons or entities not a party hereto (including, without limitation, securityholders, employees or creditors
of the Company) as against the Placement Agent or its directors, officers, agents and employees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>SECTION 10. GOVERNING
LAW</U>. This Agreement will be governed by, and construed in accordance with, the laws of the State of New York applicable to agreements
made and to be performed entirely in such State. This Agreement may not be assigned by either party without the prior written consent
of the other party. This Agreement shall be binding upon and inure to the benefit of the parties hereto, and their respective successors
and permitted assigns. Any right to trial by jury with respect to any dispute arising under this Agreement or any transaction or conduct
in connection herewith is waived. Any dispute arising under this Agreement may be brought into the courts of the State of New York or
into the Federal Court located in New York, New York and, by execution and delivery of this Agreement, the Company hereby accepts for
itself and in respect of its property, generally and unconditionally, the jurisdiction of aforesaid courts. Each party hereto hereby irrevocably
waives personal service of process and consents to process being served in any such suit, action or proceeding by delivering a copy thereof
via overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Agreement and agrees
that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed
to limit in any way any right to serve process in any manner permitted by law. If either party shall commence an action or proceeding
to enforce any provisions of a Transaction Document, then the prevailing party in such action or proceeding shall be reimbursed by the
other party for its attorney&rsquo;s fees and other costs and expenses incurred with the investigation, preparation and prosecution of
such action or proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>SECTION 11. ENTIRE AGREEMENT/MISC</U>.
This Agreement (including the Indemnification Provisions attached hereto as <U>Addendum A</U>) embodies the entire agreement and understanding
between the parties hereto with respect to this Placement, and supersedes all prior agreements and understandings, relating to the subject
matter hereof. If any provision of this Agreement is determined to be invalid or unenforceable in any respect, such determination will
not affect such provision in any other respect or any other provision of this Agreement, which will remain in full force and effect. This
Agreement may not be amended or otherwise modified or waived except by an instrument in writing signed by both the Placement Agent and
the Company. The representations, warranties, agreements and covenants contained herein shall survive the Closing of the Placement and
delivery of the Securities. This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered
one and the same agreement and shall become effective when counterparts have been signed by each party hereto and delivered to the other
party hereto, it being understood that both parties hereto need not sign the same counterpart. In the event that any signature is delivered
by facsimile transmission or a .pdf format file, such signature shall create a valid and binding obligation of the party executing (or
on whose behalf such signature is executed) with the same force and effect as if such facsimile or .pdf signature page were an original
thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>SECTION 12.&nbsp;CONFIDENTIALITY</U>.
The Placement Agent (i) will keep the Confidential Information (as such term is defined below) confidential and will not (except as required
by applicable law or Trading Market or other stock exchange requirement, regulation or legal process (&ldquo;<B>Legal Requirement</B>&rdquo;)),
without the Company&rsquo;s prior written consent, disclose to any person any Confidential Information, and (ii) will not use any Confidential
Information other than in connection with the Placement. The Placement Agent further agrees to disclose the Confidential Information only
to its Representatives (as such term is defined below) who need to know the Confidential Information for the purpose of the Placement,
and who are informed by the Placement Agent of the confidential nature of the Confidential Information. The term &ldquo;<B>Confidential
Information</B>&rdquo; shall mean, all confidential, proprietary and non-public information (whether written, oral or electronic communications)
furnished by the Company to the Placement Agent or its Representatives in connection with such Placement Agent&rsquo;s evaluation of the
Placement. The term &ldquo;<B>Confidential Information</B>&rdquo; will not, however, include information which (i) is or becomes publicly
available other than as a result of a disclosure by the Placement Agent or its Representatives in violation of this Agreement, (ii) is
or becomes available to the Placement Agent or any of its Representatives on a non-confidential basis from a third-party, (iii) is known
to the Placement Agent or any of its Representatives prior to disclosure by the Company or any of its Representatives, or (iv) is or has
been independently developed by the Placement Agent and/or the Representatives without use of any Confidential Information furnished to
it by the Company. The term &ldquo;<B>Representatives</B>&rdquo; shall mean with respect to the Placement Agent, its directors, board
committees, officers, employees, financial advisors, attorneys and accountants. This provision shall be in full force until the earlier
of (a) the date on which the Confidential Information ceases to be confidential and (b) two years from the date hereof. Notwithstanding
any of the foregoing, in the event that the Placement Agent or any of its Representatives are required by Legal Requirement to disclose
any of the Confidential Information, the Placement Agent and its Representatives will furnish only that portion of the Confidential Information
which the Placement Agent or its Representative, as applicable, is required to disclose by Legal Requirement as advised by counsel, and
will use reasonable efforts to obtain reliable assurance that confidential treatment will be accorded the Confidential Information so
disclosed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>SECTION 13. NOTICES</U>.
Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing and shall
be deemed given and effective on the earliest of (a) the date of transmission, if such notice or communication is sent to the email address
specified on the signature pages attached hereto prior to 6:30 p.m. (New York City time) on a business day, (b) the next business day
after the date of transmission, if such notice or communication is sent to the email address on the signature pages attached hereto on
a day that is not a business day or later than 6:30 p.m. (New York City time) on any business day, (c) the third business day following
the date of mailing, if sent by U.S. internationally recognized air courier service, or (d) upon actual receipt by the party to whom such
notice is required to be given. The address for such notices and communications shall be as set forth on the signature pages hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><U>SECTION 14. <FONT STYLE="text-transform: uppercase">PRESS
ANNOUNCEMENTS</FONT></U>. The Company agrees that the Placement Agent shall, from and after any Closing, have the right to reference the
Placement and the Placement Agent&rsquo;s role in connection therewith in the Placement Agent&rsquo;s marketing materials and on its website
and to place advertisements in financial and other newspapers and journals, in each case at its own expense.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>[The remainder of this page has been intentionally
left blank.]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Please confirm that the foregoing
correctly sets forth our agreement by signing and returning to Univest the enclosed copy of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very truly yours,</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; width: 36%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>UNIVEST SECURITIES, LLC</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt"></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Edric Yi Guo</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: CEO and Head of Investment
    Banking</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Address for notice</U>:</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">75 Rockefeller Plaza #1838</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New York, New York 10019</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention: Edric Guo</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email: yguo@univest.us</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-bottom: 0pt; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accepted
    and Agreed to as of</FONT></TD>
    <TD STYLE="padding-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-bottom: 0pt; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    date first written above:</FONT></TD>
    <TD STYLE="padding-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-bottom: 0pt; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-bottom: 0pt; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>GD
    CULTURE GROUP LIMITED</B></FONT></TD>
    <TD STYLE="padding-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-bottom: 0pt; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 0pt; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="padding-bottom: 0pt; border-bottom: Black 1.5pt solid; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 0pt; font-size: 10pt; width: 4%"></TD>
    <TD STYLE="padding-bottom: 0pt; font-size: 10pt; width: 36%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
    Xiaojian Wang</FONT></TD>
    <TD STYLE="padding-bottom: 0pt; width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 0pt; font-size: 10pt"></TD>
    <TD STYLE="padding-bottom: 0pt; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
    Chief Executive Officer</FONT></TD>
    <TD STYLE="padding-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-bottom: 0pt; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-bottom: 0pt; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Address
    for notice</U>:</FONT></TD>
    <TD STYLE="padding-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-bottom: 0pt; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-bottom: 0pt; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">GD
    Culture Group Limited</FONT></TD>
    <TD STYLE="padding-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-bottom: 0pt; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Flat
    1512, 15F, Lucky Centre,</FONT></TD>
    <TD STYLE="padding-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-bottom: 0pt; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No.165-171
    Wan Chai Road</FONT></TD>
    <TD STYLE="padding-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-bottom: 0pt; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wan
    Chai, Hong Kong</FONT></TD>
    <TD STYLE="padding-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-bottom: 0pt; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
    Xiaojian Wang</FONT></TD>
    <TD STYLE="padding-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-bottom: 0pt; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
    xiaojian.gdc@gmail.com</FONT></TD>
    <TD STYLE="padding-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>[Signature Page to Placement Agency Agreement
Between GD Culture Group Limited and<BR>
 Univest Securities, LLC]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">ADDENDUM A</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><U>INDEMNIFICATION
PROVISIONS</U></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with the engagement
of Univest Securities, LLC (&ldquo;Univest&rdquo; or the &ldquo;Lead Manager&rdquo;) or together with other broker dealers registered
with FINRA and caused by Univest to also act as a manager in connection with the Placements of the Securities (the &ldquo;Lead Managers&rdquo;)
to be issued by GD Culture Group Limited (the &ldquo;Company&rdquo;) pursuant to the Placement Agency Agreement, dated May 1, 2023, by
and between the Company and the Lead Manager(s), as it may be amended from time to time in writing (the &ldquo;Agreement&rdquo;), the
Company hereby agrees as follows (capitalized terms used herein without definition shall have the meanings ascribed to such terms in the
Agreement):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">1. To
the extent permitted by law, the Company shall indemnify the Lead Manager(s) and each of their respective affiliates, directors, officers,
employees, agents and controlling persons (within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act) against
all joint or several losses, claims, damages, expenses and liabilities (or actions, including shareholder actions, in respect thereof),
as the same are incurred (including the reasonable fees and expenses of counsel), relating to or arising out of its activities hereunder
or pursuant to the Agreement, including, without limitation, those which arise out of or are based on (i) any untrue statement or alleged
untrue statement of a material fact contained in the Registration Statement (or any amendment thereto), including the information deemed
to be a part of the Registration Statement at the time of effectiveness and at any subsequent time pursuant to Rules 430A and 430B of
the Securities Act and the rules and regulations thereunder, as applicable, or the omission or alleged omission therefrom of a material
fact required to be stated therein or necessary to make the statements therein not misleading, (ii) any untrue statement or alleged untrue
statement of a material fact contained in any Prospectus or Prospectus Supplement (or any amendment or supplement to any of the foregoing)
or the omission or alleged omission therefrom of a material fact necessary in order to make the statements therein, in the light of the
circumstances under which they were made, not misleading, (iii) any untrue statement or alleged untrue statement of a material fact contained
in any materials or information provided to investors by, or with the approval of, the Company in connection with the marketing of the
offering of the Securities, including any roadshow or investor presentations made to investors by the Company (whether in person or electronically)
or the omission or alleged omission therefrom of a material fact necessary in order to make the statements therein, in the light of the
circumstances under which they were made, not misleading, or (iv) in whole or in part any inaccuracy in any material respect in the representations
and warranties of the Company contained herein or in the Purchase Agreement; provided however, with regard to the Lead Managers, the Company
shall not be obligated to indemnify the Lead Manager(s) or such other person or entities under this Section 1 to the extent that any losses,
claims, damages, expenses or liabilities (or actions in respect thereof) are found in a final judgment (not subject to appeal) by a court
of competent jurisdiction to have resulted primarily and directly from the willful misconduct or gross negligence of the Lead Manager(s)
in performing the services described herein, as the case may be. The Company also agrees that no Lead Manager shall have any liability
(whether direct or indirect, in contract or tort or otherwise) to the Company or its security holders or creditors related to or arising
out of the engagement of the Lead Manager(s) pursuant to, or the performance by the Lead Manager(s) of the services contemplated by, this
Agreement except to the extent that any loss, claim, damage or liability is found in a final, non-appealable judgment by a court of competent
jurisdiction to have resulted primarily from the willful misconduct or gross negligence of the Lead Manager(s).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">2. Promptly
after receipt by the Lead Manager(s) of notice of any claim or the commencement of any action or proceeding with respect to which the
Lead Manager(s) are entitled to indemnity hereunder, the Lead Manager(s) will notify the Company in writing of such claim or of the commencement
of such action or proceeding, and the Company will assume the defense of such action or proceeding and will employ counsel reasonably
satisfactory to the Lead Manager(s) and will pay the fees and expenses of such counsel. Notwithstanding the preceding sentence, the Lead
Manager(s) will be entitled to employ counsel separate from counsel for the Company and from any other party in such action if counsel
for the Lead Manager(s) reasonably determines that it would be inappropriate under the applicable rules of professional responsibility
for the same counsel to represent both the Company and the Lead Manager(s). In such event, the reasonable fees and disbursements of no
more than one such separate counsel will be paid by the Company. The Company will have the exclusive right to settle the claim or proceeding
provided that the Company will not settle any such claim, action or proceeding without the prior written consent of the Lead Manager(s),
which will not be unreasonably withheld.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">3. The
Company agrees to notify the Lead Manager(s) promptly of the assertion against it or any other person of any claim or the commencement
of any action or proceeding relating to a transaction contemplated by the Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">4. If
for any reason the foregoing indemnity is unavailable to the Lead Manager(s) or insufficient to hold such Lead Manager(s) harmless, then
the Company shall contribute to the amount paid or payable by the Lead Manager(s), as the case may be, as a result of such losses, claims,
damages or liabilities in such proportion as is appropriate to reflect not only the relative benefits received by the Company on the one
hand, and the Lead Manager(s) on the other, but also the relative fault of the Company on the one hand and the Lead Manager(s) on the
other that resulted in such losses, claims, damages or liabilities, as well as any relevant equitable considerations. The amounts paid
or payable by a party in respect of losses, claims, damages and liabilities referred to above shall be deemed to include any legal or
other fees and expenses incurred in defending any litigation, proceeding or other action or claim. Notwithstanding the provisions hereof,
the share of the liability of the Lead Manager(s) hereunder shall not be in excess of the amount of fees actually received, or to be received,
by the Lead Manager(s) under the Agreement (excluding any amounts received as reimbursement of expenses incurred by the Lead Manager(s)
t).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">5. These
Indemnification Provisions shall remain in full force and effect whether or not the transactions contemplated by the Agreement are completed
and shall survive the termination of the Agreement, and shall be in addition to any liability that the Company might otherwise have to
any indemnified party under the Agreement or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>[The remainder of this page has been intentionally
left blank.]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very truly yours,</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 4%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; width: 36%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>UNIVEST SECURITIES, LLC</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font-size: 10pt"></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Edric Yi Guo</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: CEO and Head of Investment
    Banking</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Address for notice</U>:</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">75 Rockefeller Plaza #1838</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New York, New York 10019</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention: Edric Guo</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email: yguo@univest.us</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-bottom: 0pt; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accepted
    and Agreed to as of</FONT></TD>
    <TD STYLE="padding-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-bottom: 0pt; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    date first written above:</FONT></TD>
    <TD STYLE="padding-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-bottom: 0pt; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-bottom: 0pt; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>GD
    CULTURE GROUP LIMITED</B></FONT></TD>
    <TD STYLE="padding-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-bottom: 0pt; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 0pt; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="padding-bottom: 0pt; border-bottom: Black 1.5pt solid; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 0pt; font-size: 10pt; width: 4%"></TD>
    <TD STYLE="padding-bottom: 0pt; font-size: 10pt; width: 36%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
    Xiaojian Wang</FONT></TD>
    <TD STYLE="padding-bottom: 0pt; width: 60%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-bottom: 0pt; font-size: 10pt"></TD>
    <TD STYLE="padding-bottom: 0pt; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
    Chief Executive Officer</FONT></TD>
    <TD STYLE="padding-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-bottom: 0pt; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-bottom: 0pt; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Address
    for notice</U>:</FONT></TD>
    <TD STYLE="padding-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-bottom: 0pt; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="padding-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-bottom: 0pt; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">GD
    Culture Group Limited</FONT></TD>
    <TD STYLE="padding-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-bottom: 0pt; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Flat
    1512, 15F, Lucky Centre,</FONT></TD>
    <TD STYLE="padding-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-bottom: 0pt; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No.165-171
    Wan Chai Road</FONT></TD>
    <TD STYLE="padding-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-bottom: 0pt; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wan
    Chai, Hong Kong</FONT></TD>
    <TD STYLE="padding-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-bottom: 0pt; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
    Xiaojian Wang</FONT></TD>
    <TD STYLE="padding-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-bottom: 0pt; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
    xiaojian.gdc@gmail.com</FONT></TD>
    <TD STYLE="padding-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>6
<FILENAME>ea177982ex10-2_gdculture.htm
<DESCRIPTION>FORM OF RD SECURITIES PURCHASE AGREEMENT BETWEEN THE COMPANY AND CERTAIN PURCHASERS, DATED MAY 1, 2023
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: right"><FONT STYLE="text-transform: none">Exhibit
10.2</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">SECURITIES PURCHASE
AGREEMENT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Securities Purchase Agreement
(this &ldquo;<U>Agreement</U>&rdquo;) is dated as of May 1, 2023, between GD Culture Group Limited, a Nevada corporation (the &ldquo;<U>Company</U>&rdquo;),
and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a &ldquo;<U>Purchaser</U>&rdquo;
and collectively the &ldquo;<U>Purchasers</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="background-color: white">WHEREAS,
subject to the terms and conditions set forth in this Agreement and pursuant to an effective registration statement under the Securities
Act of 1933, as amended (the &ldquo;</FONT><U>Securities Act</U><FONT STYLE="background-color: white">&rdquo;), the Company desires to
issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company, securities of the
Company as more fully described in this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NOW, THEREFORE, IN CONSIDERATION
of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt and adequacy of which are
hereby acknowledged, the Company and each Purchaser agree as follows:</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif">ARTICLE
I</FONT><BR>
DEFINITIONS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.1&nbsp;<U>Definitions</U>.
In addition to the terms defined elsewhere in this Agreement, for all purposes of this Agreement, the following terms have the meanings
set forth in this Section 1.1:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Acquiring
Person</U>&rdquo; shall have the meaning ascribed to such term in Section 4.4.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Action</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(j).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person as such terms are used in and construed under Rule 405 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Applicable
Laws</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1 (n).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Authorizations</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1 (n).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Board
of Directors</U>&rdquo; means the board of directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Business
Day</U>&rdquo; means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States or any day
on which the Federal Reserve Bank of New York are authorized or required by law or other governmental action to close; provided, however,
for clarification, commercial banks shall not be deemed to be authorized or required by law to remain closed due to &ldquo;stay at home&rdquo;,
&ldquo;shelter-in-place&rdquo;, &ldquo;non-essential employee&rdquo; or any other similar orders or restrictions or the closure of any
physical branch locations at the direction of any governmental authority so long as the electronic funds transfer systems (including for
wire transfers) of commercial banks in The City of New York are generally are open for use by customers on such day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Closing</U>&rdquo;
means the closing of the purchase and sale of the Securities pursuant to Section 2.1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Closing
Date</U>&rdquo; means the Trading Day on which all of the Transaction Documents have been executed and delivered by the applicable parties
thereto, and all conditions precedent to (i) the Purchasers&rsquo; obligations to pay the Subscription Amount and (ii) the Company&rsquo;s
obligations to deliver the Securities, in each case, have been satisfied or waived, but in no event later than the second (2<SUP>nd</SUP>)
Trading Day following the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common
Stock</U>&rdquo; means the shares of common stock, par value $0.0001, of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common
Stock Equivalents</U>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time shares of Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument
that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, shares of
Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Company
U.S. Counsel</U>&rdquo; means Ortoli Rosenstadt LLP, with offices at 366 Madison Avenue, 3<SUP>rd</SUP> Floor, New York, NY 10017.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Company
PRC Counsel</U>&rdquo; means [__], with offices located at [&#9679;].</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Disclosure
Schedules</U>&rdquo; means the Disclosure Schedules of the Company delivered concurrently herewith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Evaluation
Date</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(s).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Exempt
Issuance</U>&rdquo; means the issuance of (a) the issuance of Securities hereunder or any issuance of shares of Common Stock upon exercise
of the Warrants or the Pre-Funded Warrants issued hereunder (including the placement agent warrants to be issued as compensation to the
Placement Agent in connection with this Placement); provided that such securities have not been amended since the date of this Agreement
to increase the number of such securities or to decrease the exercise price, exchange price or conversion price of such securities (other
than in connection with stock splits or combinations) or to extend the term of such securities; (b) shares of Common Stock, options to
employees, officers or directors of the Company pursuant to the Company&rsquo;s previously authorized share incentive plans or pursuant
to the compensation agreements previously authorized by the Board of Directors; (c) securities upon the exercise or exchange of or conversion
of securities exercisable or exchangeable for or convertible into shares of Common Stock issued and outstanding on the date of this Agreement,
provided that such securities have not been amended since the date of this Agreement to increase the number of such securities or to decrease
the exercise price, exchange price or conversion price of such securities (other than in connection with stock splits or combinations)
or to extend the term of such securities, and (d) securities issued pursuant to acquisitions or strategic transactions and the payment
of contractor invoices in the ordinary course of business approved by a majority of the disinterested directors of the Company, provided
that such securities are issued as &ldquo;restricted securities&rdquo; (as defined in Rule 144) and carry no registration rights that
require or permit the filing of any registration statement in connection therewith during the prohibition period in Section 4.10(a) herein,
and provided that any such issuance shall only be to a Person (or to the equityholders of a Person) which is, itself or through its subsidiaries,
an operating company or an owner of an asset in a business synergistic with the business of the Company and shall provide to the Company
additional benefits in addition to the investment of funds, but shall not include a transaction in which the Company is issuing securities
primarily for the purpose of raising capital or to an entity whose primary business is investing in securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>FCPA</U>&rdquo;
means the Foreign Corrupt Practices Act of 1977, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>GAAP</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(h).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Indebtedness</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(aa).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Intellectual
Property Rights</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(p).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Liens</U>&rdquo;
means a lien, charge, pledge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Lock-Up
Agreement</U>&rdquo; shall have the meaning ascribed to such term in Section 4.17.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Material
Adverse Effect</U>&rdquo; shall have the meaning assigned to such term in Section 3.1(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Per Share
Purchase Price</U>&rdquo; equals $8.27, subject to adjustment for reverse and forward share splits, share dividends, share combinations
and other similar transactions with respect to the Common Stock that occur between the date hereof and the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Per Pre-Funded
Warrant Purchase Price</U>&rdquo; equals $8.269, subject to adjustment for reverse and forward share splits, share dividends, share combinations
and other similar transactions with respect to the Common Stock that occur after the date of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company,
joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Placement
Agent</U>&rdquo; means Univest Securities LLC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Placement
Agency Agreement</U>&rdquo; means the Placement Agency Agreement by and between the Company and the Placement Agent dated the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Proceeding</U>&rdquo;
means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding,
such as a deposition), whether commenced or threatened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Prospectus</U>&rdquo;
means the final prospectus filed for the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Prospectus
Supplement</U>&rdquo; means the supplement to the Prospectus complying with Rule 424(b) of the Securities Act that is filed with the Commission
and delivered by the Company to each Purchaser at the Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Purchaser
Party</U>&rdquo; shall have the meaning ascribed to such term in Section 4.8.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Offered
Shares</U>&rdquo; means the shares of Common Stock issued or issuable to each Purchaser pursuant to this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Pre-Funded
Warrants</U>&rdquo; means, the Pre-Funded Purchase Warrants delivered to the Purchasers at the Closing in accordance with Section 2.2(a)
hereof, which Pre-Funded Warrants shall be exercisable immediately and until the Pre-Funded Warrants are exercised in full, in the form
of <U>Exhibit A</U> attached hereto, and which are being registered pursuant to the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Registration
Statement</U>&rdquo; means the effective registration statement on Form S-3 (File No. 333-254366) filed with Commission and which registers
the Offered Shares, the Warrants and the Pre-Funded Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Required
Approvals</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(e).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Rule 144</U>&rdquo;
means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time,
or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Rule 424</U>&rdquo;
means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time,
or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>SEC Reports</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(h).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Securities</U><FONT STYLE="background-color: white">&rdquo;
means the Offered Shares, the Warrants and the Pre-Funded Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Short
Sales</U>&rdquo; means all &ldquo;short sales&rdquo; as defined in Rule 200 of Regulation SHO under the Exchange Act (but shall not be
deemed to include locating and/or borrowing shares of Common Stock).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Subscription
Amount</U>&rdquo; means, as to each Purchaser, the aggregate amount to be paid for the Offered Shares, the Pre-Funded Warrants and Warrants
purchased hereunder as specified below such Purchaser&rsquo;s name on the signature page of this Agreement and next to the heading &ldquo;Subscription
Amount,&rdquo; in United States dollars and in immediately available funds.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Subsidiary</U>&rdquo;
means any subsidiary of the Company as set forth on <U>Schedule 3.1(a)</U>, and shall, where applicable, also include any direct or indirect
subsidiary of the Company formed or acquired after the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the principal Trading Market is open for trading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the shares of Common Stock are listed or quoted for trading
on the date in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the
New York Stock Exchange (or any successors to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Transaction
Documents</U>&rdquo; means this Agreement and the Placement Agency Agreement, all exhibits and schedules hereto and thereto, the Warrants,
the Pre-Funded Warrants, the Lock-Up Agreements, and any other documents or agreements executed in connection with the transactions contemplated
hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or
quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30
a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average
price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not
then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Open Market (or a
similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of Common Stock so
reported, or (d) in all other cases, the fair market value of each share of Common Stock as determined by an independent appraiser selected
in good faith by the holders of a majority in interest of the Warrants then outstanding and reasonably acceptable to the Company, the
fees and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Warrant
Shares</U>&rdquo; means the shares of Common Stock issuable upon exercise of the Pre-Funded Warrants and which are being registered pursuant
to the Registration Statement.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif">ARTICLE
II</FONT><BR>
PURCHASE AND SALE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.1&nbsp;<U>Closing</U>.
On the Closing Date, upon the terms and subject to the conditions set forth herein, substantially concurrent with the execution and delivery
of this Agreement by the parties hereto, the Company agrees to sell, and the Purchasers, severally and not jointly, agree to purchase,
(i) the number of shares of Common Stock set forth under the heading &ldquo;Subscription Amount&rdquo; on the Purchaser&rsquo;s signature
page hereto, at the Per Share Purchase Price; provided, however, that, to the extent that a Purchaser determines, in its sole discretion,
that such Purchaser (together with such Purchaser&rsquo;s Affiliates, and any Person acting as a group together with such purchaser or
any of such Holder&rsquo;s Affiliates) would beneficially own in excess of the Beneficial Ownership Maximum (as defined below), or as
such Purchaser may otherwise choose, in lieu of purchasing shares of Common Stock such Purchaser may elect to purchase Pre-Funded Warrants
in lieu of shares of Common Stock in such manner to result in the full Subscription Amount being paid by such Purchaser to the Company.
Each Purchaser&rsquo;s Subscription Amount as set forth on the signature page hereto executed by such Purchaser shall be made available
for &ldquo;Delivery Versus Payment&rdquo; (&ldquo;<U>DVP</U>&rdquo;) settlement with the Company or its designee. The Company shall deliver
to each Purchaser its respective Offered Shares and Pre-Funded Warrants, as applicable, as determined pursuant to Section 2.2(a), and
the Company and each Purchaser shall deliver the other items set forth in Section 2.2 deliverable at the Closing. Upon satisfaction of
the covenants and conditions set forth in Sections 2.2 and 2.3, the Closing shall occur at the offices of Placement Agent&rsquo;s counsel
or at such other location as the parties shall mutually agree or virtually in accordance with the provisions of this Agreement. Unless
otherwise directed by the Placement Agent, settlement of the Offered Shares shall occur via DVP (i.e., on the Closing Date, the Company
shall issue the Offered Shares registered in the Purchasers&rsquo; names and addresses and released by the Depositary directly to the
account(s) at the Placement Agent identified by each Purchaser; upon receipt of such Offered Shares, the Placement Agent shall promptly
electronically deliver such Offered Shares to the applicable Purchaser, and payment therefor shall be made by the Placement Agent (or
its clearing firm) by wire transfer to the Company). Notwithstanding anything to the contrary hereunder, to the extent that a Purchaser
determines, in its sole discretion, that such Purchaser (together with such Purchaser&rsquo;s Affiliates, and any Person acting as a group
together with such purchaser or any of such Purchaser&rsquo;s Affiliates) would beneficially own in excess of 4.99% or 9.99%, as applicable,
of the number of shares of Common Stock outstanding immediately prior to giving effect to the issuance of the Offered Shares on the Closing
Date (&ldquo;<U>Beneficial Ownership Maximum</U>&rdquo;), such Purchaser may elect to receive only the Beneficial Ownership Maximum at
the Closing with the balance of any shares of Common Stock purchased hereunder, if any, held in abeyance for such Purchaser and issued
immediately following the Closing provided in no event shall such Purchaser&rsquo;s beneficial ownership ever exceed the Beneficial Ownership
Maximum. The determination pursuant to the provisions of the previous sentence of whether any Purchaser&rsquo;s beneficial ownership exceeds
the Beneficial Ownership Maximum shall be in the sole discretion of such Purchaser and the Company shall have no obligation to verify
or confirm the accuracy of such determination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.2&nbsp;<U>Deliveries</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;On
or prior to the Closing Date, the Company shall deliver or cause to be delivered to each Purchaser and the Placement Agent the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(i)&nbsp;this
Agreement duly executed by the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(ii)&nbsp;legal
opinions of Company U.S. Counsel and Company PRC Counsel, each in a form reasonably satisfactory to the Placement Agent and the Purchasers;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iii)&nbsp;a
cold comfort letter, addressed to the Placement Agent from each of Enrome, LLP and WWC, P.C, the registered independent accountants of
the Company, in a form and substance reasonably satisfactory in all material respects to the Placement Agent;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iv)&nbsp;the
Company shall have provided each Purchaser with the Company&rsquo;s wire instructions, on Company letterhead and executed by the Chief
Executive Officer or Chief Financial Officer;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(v)&nbsp;a
copy of the irrevocable instructions to the Depositary instructing the Depositary to deliver on an expedited basis via The Depository
Trust Company Deposit or Withdrawal at Custodian System (&ldquo;<U>DWAC</U>&rdquo;) shares of Common Stock equal to such Purchaser&rsquo;s
Subscription Amount divided by the Per Share Purchase Price, registered in the name of such Purchaser;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(vi)&nbsp;for
each Purchaser of Pre-Funded Warrants pursuant to Section 2.1, a Pre-Funded Warrant registered in the name of such Purchaser to purchase
up to a number of shares of Common Stock equal to the portion of such Purchaser&rsquo;s Subscription Amount applicable to Pre-Funded Warrants
divided by the Per Pre-Funded Warrant Purchase Price with an exercise price equal to $0.0001, subject to adjustment therein; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(vii)&nbsp;the
Prospectus and Prospectus Supplement (which may be delivered in accordance with Rule 172 under the Securities Act).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;On
or prior to the Closing Date, each Purchaser shall deliver or cause to be delivered to the Company, the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(i)&nbsp;this
Agreement duly executed by such Purchaser; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(ii)&nbsp;such
Purchaser&rsquo;s Subscription Amount, which shall be made available for &ldquo;Delivery Versus Payment&rdquo; settlement with the Company
or its designee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.3&nbsp;<U>Closing
Conditions</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;The
obligations of the Company hereunder in connection with the Closing are subject to the following conditions being met:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(i)&nbsp;the
accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect,
in all respects) on the Closing Date of the representations and warranties of the Purchasers contained herein (unless as of a specific
date therein in which case they shall be accurate as of such date);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(ii)&nbsp;all
obligations, covenants and agreements of each Purchaser required to be performed at or prior to the Closing Date shall have been performed;
and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iii)&nbsp;the
delivery by each Purchaser of the items set forth in Section 2.2(b) of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;The
respective obligations of the Purchasers hereunder in connection with the Closing are subject to the following conditions being met:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(i)&nbsp;the
accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect,
in all respects) when made and on the Closing Date of the representations and warranties of the Company contained herein (unless as of
a specific date therein in which case they shall be accurate as of such date);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(ii)&nbsp;all
obligations, covenants and agreements of the Company required to be performed at or prior to the Closing Date shall have been performed;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iii)&nbsp;the
delivery by the Company of the items set forth in Section 2.2(a) of this Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iv)&nbsp;there
shall have been no Material Adverse Effect with respect to the Company since the date hereof; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(v)&nbsp;from
the date hereof to the Closing Date, trading in the Common Stock and the Company&rsquo;s securities shall not have been suspended by the
Commission or any principal Trading Market, and, at any time prior to the Closing Date, trading in securities generally as reported by
Bloomberg L.P. shall not have been suspended or limited, or minimum prices shall not have been established on securities whose trades
are reported by such service, or on any Trading Market, nor shall a banking moratorium have been declared either by the United States
or New York State authorities nor shall there have occurred any material outbreak or escalation of hostilities or other national or international
calamity of such magnitude in its effect on, or any material adverse change in, any financial market which, in each case, in the reasonable
judgment of such Purchaser, makes it impracticable or inadvisable to purchase the Securities at the Closing.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif">ARTICLE
III</FONT><BR>
REPRESENTATIONS AND WARRANTIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.1&nbsp;<U>Representations
and Warranties of the Company</U>. Except as set forth in the Disclosure Schedules, which Disclosure Schedules shall be deemed a part
hereof and shall qualify any representation or otherwise made herein to the extent of the disclosure contained in the corresponding section
of the Disclosure Schedules, the Company hereby makes the following representations and warranties to each Purchaser:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;<U>Subsidiaries</U>.
All of the direct and indirect Subsidiaries of the Company are set forth on <U>Schedule 3.1(a)</U>. The Company owns or controls, directly
or indirectly, the percentage of the capital stock or other equity interests disclosed in <U>Schedule 3.1(a)</U> of each Subsidiary of
the Company free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly
issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;<U>Organization
and Qualification</U>. The Company and each of the Subsidiaries is an entity duly incorporated or otherwise organized, validly existing
and in good standing under the laws of the jurisdiction of its incorporation or organization, with the requisite power and authority to
own and use its properties and assets and to carry on its business as currently conducted. Neither the Company nor any Subsidiary is in
violation or default of any of the provisions of its respective certificate or articles of incorporation, bylaws or other organizational
or charter documents. Each of the Company and the Subsidiaries is duly qualified to conduct business and is in good standing as a foreign
corporation or other entity in each jurisdiction in which the nature of the business conducted or property owned by it makes such qualification
necessary, except where the failure to be so qualified or in good standing, as the case may be, could not have or reasonably be expected
to result in: (i) a material adverse effect on the legality, validity or enforceability of any Transaction Document, (ii) a material adverse
effect on the results of operations, assets, business, prospects or condition (financial or otherwise) of the Company and the Subsidiaries,
taken as a whole, or (iii) a material adverse effect on the Company&rsquo;s ability to perform in any material respect on a timely basis
its obligations under any Transaction Document (any of (i), (ii) or (iii), a &ldquo;<U>Material Adverse Effect</U>&rdquo;) and no Proceeding
has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking to revoke, limit or curtail such power and authority
or qualification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&nbsp;<U>Authorization;
Enforcement</U>. The Company has the requisite corporate power and authority to enter into and to consummate the transactions contemplated
by this Agreement and each of the other Transaction Documents and otherwise to carry out its obligations hereunder and thereunder. The
execution and delivery of this Agreement and each of the other Transaction Documents by the Company and the consummation by it of the
transactions contemplated hereby and thereby have been duly authorized by all necessary action on the part of the Company and no further
action is required by the Company, the Board of Directors, a committee of the Board of Directors or the Company&rsquo;s shareholders in
connection herewith or therewith other than in connection with the Required Approvals. This Agreement and each other Transaction Document
to which it is a party has been (or upon delivery will have been) duly executed by the Company and, when delivered in accordance with
the terms hereof and thereof, will constitute the valid and binding obligation of the Company enforceable against the Company in accordance
with its terms, except (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium
and other laws of general application affecting enforcement of creditors&rsquo; rights generally, (ii) as limited by laws relating to
the availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution
provisions may be limited by applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)&nbsp;<U>No
Conflicts</U>. The execution, delivery and performance by the Company of this Agreement and the other Transaction Documents to which it
is a party, the issuance and sale of the Securities and the consummation by it of the transactions contemplated hereby and thereby do
not and will not (i) conflict with or violate any provision of the Company&rsquo;s or any Subsidiary&rsquo;s certificate or articles of
incorporation, bylaws or other organizational or charter documents, or (ii) conflict with, or constitute a default (or an event that with
notice or lapse of time or both would become a default) under, result in the creation of any Lien upon any of the properties or assets
of the Company or any Subsidiary, or give to others any rights of termination, amendment, anti-dilution or similar adjustments, acceleration
or cancellation (with or without notice, lapse of time or both) of, any agreement, credit facility, Indebtedness or other instrument (evidencing
a Company or Subsidiary Indebtedness or otherwise) or other understanding to which the Company or any Subsidiary is a party or by which
any property or asset of the Company or any Subsidiary is bound or affected, or (iii) subject to the Required Approvals, conflict with
or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or governmental
authority to which the Company or a Subsidiary is subject (including federal and state securities laws and regulations), or by which any
property or asset of the Company or a Subsidiary is bound or affected; except in the case of each of clauses (ii) and (iii), such as could
not have or reasonably be expected to result in a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)&nbsp;<U>Filings,
Consents and Approvals</U>. The Company is not required to obtain any consent, waiver, authorization or order of, give any notice to,
or make any filing or registration with, any court or other federal, state, local or other governmental authority or other Person in connection
with the execution, delivery and performance by the Company of the Transaction Documents, other than: (i) the filings required pursuant
to Section 4.4 of this Agreement, (ii) the filing with the Commission of the Prospectus Supplement, (iii) the filing and approval of the
application(s) to each applicable Trading Market for the listing of the Offered Shares and Pre-Funded Warrants for trading thereon in
the time and manner required thereby and (iv) such filings as are required to be made under applicable state securities laws (collectively,
the &ldquo;<U>Required Approvals</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f)&nbsp;<U>Issuance
of the Securities; Registration</U>. The Securities are duly authorized and, when issued and paid for in accordance with the applicable
Transaction Documents, will be duly and validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company.
The Company has reserved from its duly authorized capital stock the maximum number of shares of Common Stock, including shares of Common
Stock issuable upon exercise of the Pre-Funded Warrants issuable pursuant to this Agreement. The shares of Common Stock issuable upon
exercise of the Pre-Funded Warrants, <FONT STYLE="background-color: white">when issued in accordance with the terms of </FONT>the Pre-Funded
Warrants, respectively<FONT STYLE="background-color: white">, will be validly issued, fully paid and nonassessable, free and clear of
all Liens imposed by the Company. </FONT>The Company has prepared and filed the Registration Statement in conformity with the requirements
of the Securities Act, which became effective on March 26, 2021 (the &ldquo;<U>Effective Date</U>&rdquo;), including the Prospectus, and
such amendments and supplements thereto as may have been required to the date of this Agreement. The Registration Statement is effective
under the Securities Act and no stop order preventing or suspending the effectiveness of the Registration Statement or suspending or preventing
the use of the Prospectus has been issued by the Commission and no proceedings for that purpose have been instituted or, to the knowledge
of the Company, are threatened by the Commission. The Company, if required by the rules and regulations of the Commission, shall file
the Prospectus with the Commission pursuant to Rule 424(b). At the time the Registration Statement and any amendments thereto became effective
as determined under the Securities Act, at the date of this Agreement and at the Closing Date, the Registration Statement and any amendments
thereto conformed and will conform in all material respects to the requirements of the Securities Act and did not and will not contain
any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements
therein not misleading; and the Prospectus and any amendments or supplements thereto, at the time the Prospectus or any amendment or supplement
thereto was issued and at the Closing Date, conformed and will conform in all material respects to the requirements of the Securities
Act and did not and will not contain an untrue statement of a material fact or omit to state a material fact necessary in order to make
the statements therein, in the light of the circumstances under which they were made, not misleading. The Company was at the time of the
filing of the Registration Statement eligible to use Form S-3. The Company is eligible to use Form S-3 under the Securities Act and it
meets the transaction requirements with respect to the aggregate market value of securities being sold pursuant to this offering and during
the twelve (12) months prior to this offering, as set forth in General Instruction I.B.1 of Form S-3. All corporate action required to
be taken for the authorization, issuance and sale of the Securities has been duly and validly taken. The Offered Securities conform in
all material respects to all statements with respect thereto contained in the Registration Statement, the Prospectus and the Prospectus
Supplement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g)&nbsp;<U>Capitalization</U>.
The capitalization of the Company as of the date hereof is as set forth on <U>Schedule 3.1(g)</U>, which <U>Schedule 3.1(g)</U> shall
also include the number of shares of Common Stock owned beneficially, and of record, by Affiliates of the Company as of the date hereof.
No Person has any right of first refusal, preemptive right, right of participation, or any similar right to participate in the transactions
contemplated by the Transaction Documents. None of the Securities will be subject to the preemptive rights of any holders of any security
of the Company or similar contractual rights granted by the Company. Except as disclosed in the Registration Statement, the Prospectus
and the Prospectus Supplement, there are no outstanding options, warrants, scrip rights to subscribe to, calls or commitments of any character
whatsoever relating to, or securities, rights or obligations convertible into or exercisable or exchangeable for, or giving any Person
any right to subscribe for or acquire, any shares of Common Stock or the capital stock of any Subsidiary, or contracts, commitments, understandings
or arrangements by which the Company or any Subsidiary is or may become bound to issue additional shares of Common Stock or Common Stock
Equivalents or capital stock of any Subsidiary. The issuance and sale of the Securities will not obligate the Company or any Subsidiary
to issue shares of Common Stock or other securities to any Person (other than the Purchasers). Except as disclosed on <U>Schedule 3.1(g),</U>
there are no outstanding securities or instruments of the Company or any Subsidiary with any provision that adjusts the exercise, conversion,
exchange or reset price of such security or instrument upon an issuance of securities by the Company or any Subsidiary. There are no outstanding
securities or instruments of the Company or any Subsidiary that contain any redemption or similar provisions, and there are no contracts,
commitments, understandings or arrangements by which the Company or any Subsidiary is or may become bound to redeem a security of the
Company or such Subsidiary. The Company does not have any stock appreciation rights or &ldquo;phantom stock&rdquo; plans or agreements
or any similar plan or agreement. All of the outstanding shares of capital stock of the Company are duly authorized, validly issued, fully
paid and nonassessable, have been issued in compliance with all federal and state securities laws, and none of such outstanding shares
was issued in violation of any preemptive rights or similar rights to subscribe for or purchase securities. No further approval or authorization
of any stockholder, the Board of Directors or others is required for the issuance and sale of the Securities. There are no shareholders
agreements, voting agreements or other similar agreements with respect to the Company&rsquo;s capital stock to which the Company is a
party or, to the knowledge of the Company, between or among any of the Company&rsquo;s shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h)&nbsp;<U>SEC
Reports; Financial Statements</U>. The Company has filed all reports, schedules, forms, statements and other documents required to be
filed by the Company under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, for the three
years preceding the date hereof (or such shorter period as the Company was required by law or regulation to file such material) (the foregoing
materials, including the exhibits thereto and documents incorporated by reference therein, together with the Registration Statement, Prospectus
and the Prospectus Supplement, being collectively referred to herein as the &ldquo;<U>SEC Reports</U>&rdquo;). For the twelve months preceding
the date hereof, the Company has filed the SEC Reports on a timely basis (including any valid extension of such time of filing provided
under Rule 12b-25 or under coronavirus-related relief by the SEC) and has filed any such SEC Reports prior to the expiration of any such
extension. As of their respective dates, the SEC Reports complied in all material respects with the requirements of the Securities Act
and the Exchange Act, as applicable, and none of the SEC Reports, when filed, contained any untrue statement of a material fact or omitted
to state a material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances
under which they were made, not misleading. The Company is not and has never been an issuer subject to Rule 144(i) under the Securities
Act. The financial statements of the Company included in the SEC Reports comply in all material respects with applicable accounting requirements
and the rules and regulations of the Commission with respect thereto as in effect at the time of filing. Such financial statements have
been prepared in accordance with United States generally accepted accounting principles applied on a consistent basis during the periods
involved (&ldquo;<U>GAAP</U>&rdquo;), except as may be otherwise specified in such financial statements or the notes thereto and except
that unaudited financial statements may not contain all footnotes required by GAAP, and fairly present in all material respects the financial
position of the Company and its consolidated Subsidiaries as of and for the dates thereof and the results of operations and cash flows
for the periods then ended, subject, in the case of unaudited statements, to normal, immaterial, year-end audit adjustments. The selected
financial data set forth under the caption &ldquo;Selected Financial Data&rdquo; in the SEC Reports fairly present, on the basis stated
in such SEC Reports, the information included therein. The agreements and documents described in the Registration Statement and the SEC
Reports conform in all material aspects to the descriptions thereof contained therein and there are no agreements or other documents required
by the Securities Act and the rules and regulations thereunder to be described in the Registration Statement, the Prospectus or the SEC
Reports or to be filed with the Commission as exhibits to the Registration Statement, that have not been so described or filed. Each agreement
or other instrument (however characterized or described) to which the Company is a party or by which it is or may be bound or affected
and (i) that is referred to in the Registration Statement or the SEC Reports, or (ii) is material to the Company&rsquo;s business, has
been duly authorized and validly executed by the Company, is in full force and effect in all material respects and is enforceable against
the Company and, to the Company&rsquo;s knowledge, the other parties thereto, in accordance with its terms, except (x) as such enforceability
may be limited by bankruptcy, insolvency, reorganization or similar laws affecting creditors&rsquo; rights generally, (y) as enforceability
of any indemnification or contribution provision may be limited under the federal and state securities laws, and (z) that the remedy of
specific performance and injunctive and other forms of equitable relief may be subject to the equitable defenses and to the discretion
of the court before which any proceeding therefore may be brought. None of such agreements or instruments has been assigned by the Company,
and neither the Company nor, to the best of the Company&rsquo;s knowledge, any other party is in default thereunder and, to the best of
the Company&rsquo;s knowledge, no event has occurred that, with the lapse of time or the giving of notice, or both, would constitute a
default thereunder. To the best of the Company&rsquo;s knowledge, performance by the Company of the material provisions of such agreements
or instruments will not result in a violation of any existing applicable law, rule, regulation, judgment, order or decree of any governmental
agency or court, domestic or foreign, having jurisdiction over the Company or any of its assets or businesses, including, without limitation,
those relating to environmental laws and regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i)&nbsp;<U>Material
Changes; Undisclosed Events, Liabilities or Developments</U>. Since the date of the latest audited financial statements included within
the SEC Reports, except as set forth on <U>Schedule 3.1(i)</U>, (i) there has been no event, occurrence or development that has had or
that could reasonably be expected to result in a Material Adverse Effect, (ii) the Company has not incurred any liabilities (contingent
or otherwise) other than (A) trade payables and accrued expenses incurred in the ordinary course of business consistent with past practice
and (B) liabilities not required to be reflected in the Company&rsquo;s financial statements pursuant to GAAP or disclosed in filings
made with the Commission, (iii) the Company has not altered its method of accounting, (iv) the Company has not declared or made any dividend
or distribution of cash or other property to its shareholders or purchased, redeemed or made any agreements to purchase or redeem any
shares of its capital stock and (v) the Company has not issued any equity securities to any officer, director or Affiliate, except pursuant
to existing stock incentive plans, the issuance of Common Stock Equivalents as disclosed in the SEC Reports. The Company does not have
pending before the Commission any request for confidential treatment of information. Except for the issuance of the Securities contemplated
by this Agreement or as set forth on <U>Schedule 3.1(i)</U>, no event, liability, fact, circumstance, occurrence or development has occurred
or exists or is reasonably expected to occur or exist with respect to the Company or its Subsidiaries or their respective businesses,
prospects, properties, operations, assets or financial condition that would be required to be disclosed by the Company under applicable
securities laws at the time this representation is made or deemed made that has not been publicly disclosed at least one (1) Trading Day
prior to the date that this representation is made. Unless otherwise disclosed in an SEC Report filed prior to the date hereof, the Company
has not: (i) issued any securities or incurred any liability or obligation, direct or contingent, for borrowed money; or (ii) declared
or paid any dividend or made any other distribution on or in respect to its capital stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(j)&nbsp;<U>Litigation</U>.
Except as set forth on <U>Schedule 3.1(j)</U>, there is no action, suit, inquiry, notice of violation, proceeding or investigation pending
or, to the knowledge of the Company, threatened against or affecting the Company, any Subsidiary or any of their respective properties
before or by any court, arbitrator, governmental or administrative agency or regulatory authority (federal, state, county, local or foreign)
(collectively, an &ldquo;<U>Action</U>&rdquo;). None of the Actions set forth on <U>Schedule 3.1(j)</U>, (i) adversely affects or challenges
the legality, validity or enforceability of any of the Transaction Documents or the Securities or (ii) could, if there were an unfavorable
decision, have or reasonably be expected to result in a Material Adverse Effect. Neither the Company nor any Subsidiary, nor any director
or officer thereof, is or has been the subject of any Action involving a claim of violation of or liability under federal or state securities
laws or a claim of breach of fiduciary duty. There has not been, and to the knowledge of the Company, there is not pending or threatened,
any investigation by the Commission involving the Company or any current or former director or officer of the Company. There are no Actions
required to be disclosed in the SEC Reports that have not been disclosed. The Commission has not issued any stop order or other order
suspending the effectiveness of any registration statement filed by the Company or any Subsidiary under the Exchange Act or the Securities
Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(k)&nbsp;<U>Labor
Relations</U>. No labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees of the Company,
which could reasonably be expected to result in a Material Adverse Effect. None of the Company&rsquo;s or its Subsidiaries&rsquo; employees
is a member of a union that relates to such employee&rsquo;s relationship with the Company or such Subsidiary, and neither the Company
nor any of its Subsidiaries is a party to a collective bargaining agreement, and the Company and its Subsidiaries believe that their relationships
with their employees are good. To the knowledge of the Company, no executive officer of the Company or any Subsidiary, is, or is now expected
to be, in violation of any material term of any employment contract, confidentiality, disclosure or proprietary information agreement
or non-competition agreement, or any other contract or agreement or any restrictive covenant in favor of any third party, and the continued
employment of each such executive officer does not subject the Company or any of its Subsidiaries to any liability with respect to any
of the foregoing matters. The Company and its Subsidiaries are in compliance with all U.S. federal, state, local and foreign laws and
regulations relating to employment and employment practices, terms and conditions of employment and wages and hours, except where the
failure to be in compliance could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(l)&nbsp;<U>Compliance</U>.
Neither the Company nor any Subsidiary: (i) is in default under or in violation of (and no event has occurred that has not been waived
that, with notice or lapse of time or both, would result in a default by the Company or any Subsidiary under), nor has the Company or
any Subsidiary received notice of a claim that it is in default under or that it is in violation of, any indenture, loan or credit agreement
or any other agreement or instrument to which it is a party or by which it or any of its properties is bound (whether or not such default
or violation has been waived), (ii) is in violation of any judgment, decree or order of any court, arbitrator or other governmental authority
or (iii) is or has been in violation of any statute, rule, ordinance or regulation of any governmental authority, including without limitation
all foreign, federal, state and local laws relating to taxes, environmental protection, occupational health and safety, product quality
and safety and employment and labor matters, except in each case as could not have or reasonably be expected to result in a Material Adverse
Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(m)&nbsp;<U>Environmental
Laws</U>. The Company and its Subsidiaries (i) are in compliance with all federal, state, local and foreign laws relating to pollution
or protection of human health or the environment (including ambient air, surface water, groundwater, land surface or subsurface strata),
including laws relating to emissions, discharges, releases or threatened releases of chemicals, pollutants, contaminants, or toxic or
hazardous substances or wastes (collectively, &ldquo;<U>Hazardous Materials</U>&rdquo;) into the environment, or otherwise relating to
the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials, as well as
all authorizations, codes, decrees, demands, or demand letters, injunctions, judgments, licenses, notices or notice letters, orders, permits,
plans or regulations, issued, entered, promulgated or approved thereunder (&ldquo;<U>Environmental Laws</U>&rdquo;); (ii) have received
all permits licenses or other approvals required of them under applicable Environmental Laws to conduct their respective businesses; and
(iii) are in compliance with all terms and conditions of any such permit, license or approval where in each clause (i), (ii) and (iii),
the failure to so comply could be reasonably expected to have, individually or in the aggregate, a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(n)&nbsp;<U>Regulatory
Permits</U>. The Company and the Subsidiaries possess all certificates, licenses, authorizations approvals, clearances, consents, registration
and permits issued by the appropriate federal, state, local or foreign regulatory authorities applicable to the Company (&ldquo;<U>Applicable
Laws</U>&rdquo;) necessary to conduct their respective businesses as described in the SEC Reports, except where the failure to possess
such permits could not reasonably be expected to result in a Material Adverse Effect (each, an &ldquo;<U>Authorization</U>&rdquo;), and
neither the Company nor any Subsidiary has received any notice of proceedings relating to the revocation or modification of any Authorization
or the noncompliance with any ordinance, law, rule or regulation applicable to the Company. The disclosures in the Registration Statement
concerning the effects of federal, state, local and all foreign regulation on the Company&rsquo;s business as currently contemplated are
correct in all material respects. The Company is and has been in material compliance with any term of any such Authorizations, except
for any violations which would not reasonably be expected to have a Material Adverse Effect. The Company has not received notice of any
claim, action, suit, proceeding, hearing, enforcement, investigation, arbitration or other action from any governmental authority or body
or third party alleging that any product, operation or activity is in violation of any Applicable Laws or Authorizations or has any knowledge
that any such entity or third party is considering any such claim, litigation, arbitration, action, suit, investigation or proceeding,
nor, to the Company&rsquo;s knowledge, has there been any material noncompliance with or violation of any Applicable Laws by the Company
that could reasonably be expected to require the issuance of any such communication or result in an investigation, corrective action,
or enforcement action by any governmental body or entity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(o)&nbsp;<U>Title
to Assets</U>. The Company and the Subsidiaries have good and marketable title in fee simple to all real property owned by them and good
and marketable title in all personal property owned by them that is material to the business of the Company and the Subsidiaries, in each
case free and clear of all Liens, except for (i) Liens as do not materially affect the value of such property and do not materially interfere
with the use made and proposed to be made of such property by the Company and the Subsidiaries and (ii) Liens for the payment of federal,
state or other taxes, for which appropriate reserves have been made therefor in accordance with GAAP and, the payment of which is neither
delinquent nor subject to penalties. Any real property and facilities held under lease by the Company and the Subsidiaries are held by
them under valid, subsisting and enforceable leases with which the Company and the Subsidiaries are in compliance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(p)&nbsp;<U>Intellectual
Property</U>. The Company and the Subsidiaries have, or have rights to use, all patents, patent applications, trademarks, trademark applications,
service marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual property rights and similar rights
necessary or required for use in connection with their respective businesses as described in the SEC Reports and which the failure to
so have could have a Material Adverse Effect (collectively, the &ldquo;<U>Intellectual Property Rights</U>&rdquo;). Neither the Company
nor any Subsidiary has received a notice (written or otherwise) that any of, the Intellectual Property Rights has expired, terminated
or been abandoned, or is expected to expire or terminate or be abandoned, within two (2) years from the date of this Agreement except
where such action would not reasonably be expected to have a Material Adverse Effect. Neither the Company nor any Subsidiary has received,
since the date of the latest audited financial statements included within the SEC Reports, a written notice of a claim or otherwise has
any knowledge that the Intellectual Property Rights or any of the Company&rsquo;s products or planned products as described in the SEC
Reports violate or infringe upon the rights of any Person, except as could not have or reasonably be expected to not have a Material Adverse
Effect. To the knowledge of the Company, all such Intellectual Property Rights are enforceable and there is no existing infringement by
another Person of any of the Intellectual Property Rights. The Company and its Subsidiaries have taken reasonable security measures to
protect the secrecy, confidentiality and value of all of their intellectual properties, except where failure to do so could not, individually
or in the aggregate, reasonably be expected to have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(q)&nbsp;<U>Insurance</U>.
The Company and the Subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks and in such
amounts as are prudent and customary in the businesses in which the Company and the Subsidiaries are engaged, including, but not limited
to, directors and officers insurance coverage at least equal to the aggregate Subscription Amount. Neither the Company nor any Subsidiary
has any reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain
similar coverage from similar insurers as may be necessary to continue its business without a significant increase in cost.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(r)&nbsp;<U>Transactions
With Affiliates and Employees</U>. Except as set forth on <U>Schedule 3.1(r)</U>, none of the officers or directors of the Company or
any Subsidiary and, to the knowledge of the Company, none of the employees of the Company or any Subsidiary is presently a party to any
transaction with the Company or any Subsidiary (other than for services as employees, officers and directors), including any contract,
agreement or other arrangement providing for the furnishing of services to or by, providing for rental of real or personal property to
or from, providing for the borrowing of money from or lending of money to or otherwise requiring payments to or from any officer, director
or such employee or, to the knowledge of the Company, any entity in which any officer, director, or any such employee has a substantial
interest or is an officer, director, trustee, stockholder, member or partner, in each case in excess of $120,000 other than for (i) payment
of salary or consulting fees for services rendered, (ii) reimbursement for expenses incurred on behalf of the Company and (iii) other
employee benefits, including stock option agreements under any stock option plan of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(s)&nbsp;<U>Sarbanes-Oxley;
Internal Accounting Controls</U>. The Company and the Subsidiaries are in compliance with any and all applicable requirements of the Sarbanes-Oxley
Act of 2002 that are effective as of the date hereof, and any and all applicable rules and regulations promulgated by the Commission thereunder
that are effective as of the date hereof and as of the Closing Date. Except as set forth in the SEC Reports, the Company and the Subsidiaries
maintain a system of internal accounting controls sufficient to provide reasonable assurance that: (i) transactions are executed in accordance
with management&rsquo;s general or specific authorizations, (ii) transactions are recorded as necessary to permit preparation of financial
statements in conformity with GAAP and to maintain asset accountability, (iii) access to assets is permitted only in accordance with management&rsquo;s
general or specific authorization, and (iv) the recorded accountability for assets is compared with the existing assets at reasonable
intervals and appropriate action is taken with respect to any differences. The Company and the Subsidiaries have established disclosure
controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e) for the Company and the Subsidiaries and designed such
disclosure controls and procedures to ensure that information required to be disclosed by the Company in the reports it files or submits
under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Commission&rsquo;s rules
and forms. The Company&rsquo;s certifying officers have evaluated the effectiveness of the disclosure controls and procedures of the Company
and the Subsidiaries as of the end of the period covered by the most recently filed periodic report under the Exchange Act (such date,
the &ldquo;<U>Evaluation Date</U>&rdquo;). The Company presented in its most recently filed periodic report under the Exchange Act the
conclusions of the certifying officers about the effectiveness of the disclosure controls and procedures based on their evaluations as
of the Evaluation Date. Since the Evaluation Date, there have been no changes in the internal control over financial reporting (as such
term is defined in the Exchange Act) of the Company and its Subsidiaries that have materially affected, or is reasonably likely to materially
affect, the internal control over financial reporting of the Company and its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(t)&nbsp;<U>Certain
Fees</U>. Other than the compensation payable to the Placement Agent pursuant to the terms of the Placement Agency Agreement and as set
forth in the Prospectus relating to the placement of the Securities, no brokerage or finder&rsquo;s fees or commissions are or will be
payable by the Company or any Subsidiary to any broker, financial advisor or consultant, finder, placement agent, investment banker, bank
or other Person with respect to the transactions contemplated by the Transaction Documents (for the avoidance of doubt, the foregoing
shall not include any fees and/or commissions owed to the Depositary). Other than for Persons engaged by any Purchaser, if any, the Purchasers
shall have no obligation with respect to any fees or with respect to any claims made by or on behalf of other Persons for fees of a type
contemplated in this Section that may be due in connection with the transactions contemplated by the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(u)&nbsp;<U>Investment
Company</U>. The Company is not, and is not an Affiliate of, and immediately after receipt of payment for the Securities, will not be
or be an Affiliate of, an &ldquo;investment company&rdquo; within the meaning of the Investment Company Act of 1940, as amended. The Company
shall conduct its business in a manner so that it will not become an &ldquo;investment company&rdquo; subject to registration under the
Investment Company Act of 1940, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(v)&nbsp;<U>Registration
Rights</U>. Except as described in the Registration Statement and the Prospectus, no Person has any right to cause the Company or any
Subsidiary to effect the registration under the Securities Act of any securities of the Company or any Subsidiary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(w)&nbsp;<U>Listing
and Maintenance Requirements</U>. The shares of Common Stock are registered pursuant to Section 12(b) or 12(g) of the Exchange Act, and
the Company has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration of
the Common Stocks under the Exchange Act nor has the Company received any notification that the Commission is contemplating terminating
such registration. Except as set forth in the Registration Statement, the Company has not, in the 12 months preceding the date hereof,
received notice from any Trading Market on which the Common Stock is or has been listed or quoted to the effect that the Company is not
in compliance with the listing or maintenance requirements of such Trading Market. Except as set forth in the Registration Statement,
the Company is, and has no reason to believe that it will not in the foreseeable future continue to be, in compliance with all such listing
and maintenance requirements. The Common Stock is currently eligible for electronic transfer through The Depository Trust Company or another
established clearing corporation and the Company is current in payment of the fees to The Depository Trust Company (or such other established
clearing corporation) in connection with such electronic transfer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(x)&nbsp;<U>Application
of Takeover Protections</U>. The Company and the Board of Directors have taken all necessary action, if any, in order to render inapplicable
any control share acquisition, business combination, poison pill (including any distribution under a rights agreement) or other similar
anti-takeover provision under the Company&rsquo;s certificate of incorporation (or similar charter documents) or the laws of its state
of incorporation that is or could become applicable to the Purchasers as a result of the Purchasers and the Company fulfilling their obligations
or exercising their rights under the Transaction Documents, including without limitation as a result of the Company&rsquo;s issuance of
the Securities and the Purchasers&rsquo; ownership of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(y)&nbsp;<U>Disclosure</U>.
Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents, the Company confirms
that neither it nor any other Person acting on its behalf has provided any of the Purchasers or their agents or counsel with any information
that it believes constitutes or might constitute material, non-public information which is not otherwise disclosed in the Prospectus Supplement.
The Company understands and confirms that the Purchasers will rely on the foregoing representation in effecting transactions in securities
of the Company. All of the disclosure furnished by or on behalf of the Company to the Purchasers regarding the Company and its Subsidiaries,
their respective businesses and the transactions contemplated hereby, including the Disclosure Schedules to this Agreement, is true and
correct and does not contain any untrue statement of a material fact or omit to state any material fact necessary in order to make the
statements made therein, in the light of the circumstances under which they were made, not misleading. The press releases disseminated
by the Company during the twelve months preceding the date of this Agreement taken as a whole do not contain any untrue statement of a
material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in
light of the circumstances under which they were made and when made, not misleading. The Company acknowledges and agrees that no Purchaser
makes or has made any representations or warranties with respect to the transactions contemplated hereby other than those specifically
set forth in Section 3.2 hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(z)&nbsp;<U>No
Integrated Offering</U>. Assuming the accuracy of the Purchasers&rsquo; representations and warranties set forth in Section 3.2, neither
the Company, nor any of its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly, made any offers or sales
of any security or solicited any offers to buy any security, under circumstances that would cause this offering of the Securities to be
integrated with prior offerings by the Company for purposes of any applicable shareholder approval provisions of any Trading Market on
which any of the securities of the Company are listed or designated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(aa) <U>Solvency</U>.
Based on the consolidated financial condition of the Company as of the Closing Date, after giving effect to the receipt by the
Company of the proceeds from the sale of the Securities hereunder, (i) the fair saleable value of the Company&rsquo;s assets exceeds
the amount that will be required to be paid on or in respect of the Company&rsquo;s existing debts and other liabilities (including
known contingent liabilities) as they mature, (ii) the Company&rsquo;s assets do not constitute unreasonably small capital to carry
on its business as now conducted and as proposed to be conducted including its capital needs taking into account the particular
capital requirements of the business conducted by the Company, consolidated and projected capital requirements and capital
availability thereof, and (iii) the current cash flow of the Company, together with the proceeds the Company would receive, were it
to liquidate all of its assets, after taking into account all anticipated uses of the cash, would be sufficient to pay all amounts
on or in respect of its liabilities when such amounts are required to be paid. The Company does not intend to incur debts beyond its
ability to pay such debts as they mature (taking into account the timing and amounts of cash to be payable on or in respect of its
debt). The Company has no knowledge of any facts or circumstances which lead it to believe that it will file for reorganization or
liquidation under the bankruptcy or reorganization laws of any jurisdiction within one year from the Closing Date. <U>Schedule
3.1(aa)</U> sets forth as of the date hereof all outstanding secured and unsecured Indebtedness of the Company or any Subsidiary, or
for which the Company or any Subsidiary has commitments. For the purposes of this Agreement, &ldquo;<U>Indebtedness</U>&rdquo; means
(x) any liabilities for borrowed money or amounts owed in excess of $50,000 (other than trade accounts payable incurred in the
ordinary course of business), (y) all guaranties, endorsements and other contingent obligations in respect of indebtedness of
others, whether or not the same are or should be reflected in the Company&rsquo;s consolidated balance sheet (or the notes thereto),
except guaranties by endorsement of negotiable instruments for deposit or collection or similar transactions in the ordinary course
of business; and (z) the present value of any lease payments in excess of $50,000 due under leases required to be capitalized in
accordance with GAAP. Neither the Company nor any Subsidiary is in default with respect to any Indebtedness.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(bb) <U>Tax Status</U>.
Except for matters that would not, individually or in the aggregate, have or reasonably be expected to result in a Material Adverse Effect,
the Company and its Subsidiaries each (i) has made or filed all United States federal, state and local income and all foreign income and
franchise tax returns, reports and declarations required by any jurisdiction to which it is subject, (ii) has paid all taxes and other
governmental assessments and charges that are material in amount, shown or determined to be due on such returns, reports and declarations
and (iii) has set aside on its books provision reasonably adequate for the payment of all material taxes for periods subsequent to the
periods to which such returns, reports or declarations apply. There are no unpaid taxes in any material amount claimed to be due by the
taxing authority of any jurisdiction, and the officers of the Company or of any Subsidiary know of no basis for any such claim. The term
&ldquo;taxes&rdquo; mean all federal, state, local, foreign, and other net income, gross income, gross receipts, sales, use, ad valorem,
transfer, franchise, profits, license, lease, service, service use, withholding, payroll, employment, excise, severance, stamp, occupation,
premium, property, windfall profits, customs, duties or other taxes, fees, assessments, or charges of any kind whatsoever, together with
any interest and any penalties, additions to tax, or additional amounts with respect thereto. The term &ldquo;returns&rdquo; means all
returns, declarations, reports, statements, and other documents required to be filed in respect to taxes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(cc) <U>Foreign Corrupt
Practices</U>. Neither the Company nor any Subsidiary, nor to the knowledge of the Company or any Subsidiary, any agent or other person
acting on behalf of the Company or any Subsidiary, has (i) directly or indirectly, used any funds for unlawful contributions, gifts, entertainment
or other unlawful expenses related to foreign or domestic political activity, (ii) made any unlawful payment to foreign or domestic government
officials or employees or to any foreign or domestic political parties or campaigns from corporate funds, (iii) failed to disclose fully
any contribution made by the Company or any Subsidiary (or made by any person acting on its behalf of which the Company is aware) which
is in violation of law, or (iv) violated in any material respect any provision of FCPA. The Company has taken reasonable steps to ensure
that its accounting controls and procedures are sufficient to cause the Company to comply in all material respects with the FCPA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(dd) <U>Accountants</U>.
The Company&rsquo;s registered independent accounting firm is Enrome, LLP .To the knowledge and belief of the Company, such
accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with
respect to the financial statements to be included in the Company&rsquo;s Annual Report for the fiscal year ended December 31, 2022.
WWC, P.C. was the previous registered independent accounting firm of the Company. To the knowledge and belief of the Company, such
accounting firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with
respect to the financial statements to be included in the Company&rsquo;s Annual Report for the fiscal year ended December 31,
2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ee) <U>Acknowledgment
Regarding Purchasers&rsquo; Purchase of Securities</U>. The Company acknowledges and agrees that each of the Purchasers is acting solely
in the capacity of an arm&rsquo;s length purchaser with respect to the Transaction Documents and the transactions contemplated thereby.
The Company further acknowledges that no Purchaser is acting as a financial advisor or fiduciary of the Company (or in any similar capacity)
with respect to the Transaction Documents and the transactions contemplated thereby and any advice given by any Purchaser or any of their
respective representatives or agents in connection with the Transaction Documents and the transactions contemplated thereby is merely
incidental to the Purchasers&rsquo; purchase of the Securities. The Company further represents to each Purchaser that the Company&rsquo;s
decision to enter into this Agreement and the other Transaction Documents has been based solely on the independent evaluation of the transactions
contemplated hereby by the Company and its representatives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ff) <U>Acknowledgment
Regarding Purchaser&rsquo;s Trading Activity</U>. Anything in this Agreement or elsewhere herein to the contrary notwithstanding (except
for Sections 3.2(f) and 4.13 hereof), it is understood and acknowledged by the Company that: (i) none of the Purchasers has been asked
by the Company to agree, nor has any Purchaser agreed, to desist from purchasing or selling, long and/or short, securities of the Company,
or &ldquo;derivative&rdquo; securities based on securities issued by the Company or to hold the shares of Common Stock for any specified
term; (ii) past or future open market or other transactions by any Purchaser, specifically including, without limitation, Short Sales
or &ldquo;derivative&rdquo; transactions, before or after the closing of this or future, private, placement transactions, may negatively
impact the market price of the Company&rsquo;s publicly-traded securities; (iii) any Purchaser, and counter-parties in &ldquo;derivative&rdquo;
transactions to which any such Purchaser is a party, directly or indirectly, presently may have a &ldquo;short&rdquo; position in the
Common Stock, and (iv) each Purchaser shall not be deemed to have any affiliation with or control over any arm&rsquo;s length counter-party
in any &ldquo;derivative&rdquo; transaction. The Company further understands and acknowledges that (y) one or more Purchasers may engage
in hedging activities at various times during the period that the Securities are outstanding, including, without limitation, during the
periods that the value of the Pre-Funded Warrants are being determined, and (z) such hedging activities (if any) could reduce the value
of the existing shareholders&rsquo; equity interests in the Company at and after the time that the hedging activities are being conducted.
The Company acknowledges that such aforementioned hedging activities do not constitute a breach of any of the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(gg) <U>Regulation M
Compliance</U>. The Company has not, and to its knowledge no one acting on its behalf has, (i) taken, directly or indirectly, any
action designed to cause or to result in the stabilization or manipulation of the price of any security of the Company to facilitate
the sale or resale of any of the Securities, (ii) sold, bid for, purchased, or, paid any compensation for soliciting purchases of,
any of the Securities, or (iii) paid or agreed to pay to any Person any compensation for soliciting another to purchase any other
securities of the Company, other than, in the case of clauses (ii) and (iii), compensation paid to the Placement Agent in connection
with the placement of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(hh) <U>[</U><I>Reserved</I><U>]</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ii)&nbsp;<U>Share
Incentive Plans</U>. Each stock option granted by the Company under the Company&rsquo;s share incentive plans was granted (i) in accordance
with the terms of the Company&rsquo;s share incentive plans and (ii) with an exercise price at least equal to the fair market value of
the Common Stock on the date such stock option would be considered granted under GAAP and applicable law. No stock option granted under
the Company&rsquo;s share incentive plans has been backdated. The Company has not knowingly granted, and there is no and has been no Company
policy or practice to knowingly grant, stock options prior to, or otherwise knowingly coordinate the grant of stock options with, the
release or other public announcement of material information regarding the Company or its Subsidiaries or their financial results or prospects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(jj) <U>Office of Foreign
Assets Control</U>. Neither the Company nor any Subsidiary nor, to the Company&rsquo;s knowledge, any director, officer, agent, employee
or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets
Control of the U.S. Treasury Department (&ldquo;<U>OFAC</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(kk) <U>U.S. Real Property
Holding Corporation</U>. The Company is not and has never been a U.S. real property holding corporation within the meaning of Section
897 of the Internal Revenue Code of 1986, as amended, and the Company shall so certify upon Purchaser&rsquo;s request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ll) <U>Bank Holding Company
Act</U>. Neither the Company nor any of its Subsidiaries or Affiliates is subject to the Bank Holding Company Act of 1956, as amended
(the &ldquo;<U>BHCA</U>&rdquo;) and to regulation by the Board of Governors of the Federal Reserve System (the &ldquo;<U>Federal Reserve</U>&rdquo;).
Neither the Company nor any of its Subsidiaries or Affiliates owns or controls, directly or indirectly, five percent (5%) or more of the
outstanding shares of any class of voting securities or twenty-five percent or more of the total equity of a bank or any entity that is
subject to the BHCA and to regulation by the Federal Reserve. Neither the Company nor any of its Subsidiaries or Affiliates exercises
a controlling influence over the management or policies of a bank or any entity that is subject to the BHCA and to regulation by the Federal
Reserve.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(mm) <U>Money Laundering</U>.
The operations of the Company and its Subsidiaries are and have been conducted at all times in compliance with applicable financial record-keeping
and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, applicable money laundering statutes
and applicable rules and regulations thereunder (collectively, the &ldquo;<U>Money Laundering Laws</U>&rdquo;), and no Action or Proceeding
by or before any court or governmental agency, authority or body or any arbitrator involving the Company or any Subsidiary with respect
to the Money Laundering Laws is pending or, to the knowledge of the Company or any Subsidiary, threatened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.2&nbsp;<U>Representations
and Warranties of the Purchasers</U>. Each Purchaser, for itself and for no other Purchaser, hereby represents and warrants as of the
date hereof and as of the Closing Date to the Company as follows (unless as of a specific date therein, in which case they shall be accurate
as of such date):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;<U>Organization;
Authority</U>. Such Purchaser is either an individual or an entity duly incorporated or formed, validly existing and in good standing
under the laws of the jurisdiction of its incorporation or formation with full right, corporate, partnership limited liability company
or similar power and authority to enter into and to consummate the transactions contemplated by the Transaction Documents and otherwise
to carry out its obligations hereunder and thereunder. The execution and delivery of the Transaction Documents and performance by such
Purchaser of the transactions contemplated by the Transaction Documents have been duly authorized by all necessary corporate, partnership,
limited liability company or similar action, as applicable, on the part of such Purchaser. Each Transaction Document to which it is a
party has been duly executed by such Purchaser, and when delivered by such Purchaser in accordance with the terms hereof, will constitute
the valid and legally binding obligation of such Purchaser, enforceable against it in accordance with its terms, except: (i) as limited
by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application
affecting enforcement of creditors&rsquo; rights generally, (ii) as limited by laws relating to the availability of specific performance,
injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable
law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;<U>Understandings
or Arrangements</U>. Such Purchaser is acquiring the Securities as principal for its own account and has no direct or indirect arrangement
or understandings with any other persons to distribute or regarding the distribution of such Securities (this representation and warranty
not limiting such Purchaser&rsquo;s right to sell the Securities pursuant to the Registration Statement or otherwise in compliance with
applicable federal and state securities laws). Such Purchaser is acquiring the Securities hereunder in the ordinary course of its business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&nbsp;<U>Purchaser
Status</U>. At the time such Purchaser was offered the Securities, it was, and as of the date hereof it is, and on each date on which
it exercises any Pre-Funded Warrants, it will be either: (i) an &ldquo;accredited investor&rdquo; as defined in Rule 501(a)(1), (a)(2),
(a)(3), (a)(7) or (a)(8) under the Securities Act or (ii) a &ldquo;qualified institutional buyer&rdquo; as defined in Rule 144A(a) under
the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)&nbsp;<U>Experience
of Such Purchaser</U>. Such Purchaser, either alone or together with its representatives, has such knowledge, sophistication and experience
in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment in the Securities,
and has so evaluated the merits and risks of such investment. Such Purchaser is able to bear the economic risk of an investment in the
Securities and, at the present time, is able to afford a complete loss of such investment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)&nbsp;<U>Access
to Information</U>. Such Purchaser acknowledges that it has had the opportunity to review the Transaction Documents (including all exhibits
and schedules thereto) and the SEC Reports and has been afforded, (i) the opportunity to ask such questions as it has deemed necessary
of, and to receive answers from, representatives of the Company concerning the terms and conditions of the offering of the Securities
and the merits and risks of investing in the Securities; (ii) access to information about the Company and its financial condition, results
of operations, business, properties, management and prospects sufficient to enable it to evaluate its investment; and (iii) the opportunity
to obtain such additional information that the Company possesses or can acquire without unreasonable effort or expense that is necessary
to make an informed investment decision with respect to the investment. Such Purchaser acknowledges and agrees that neither the Placement
Agent nor any Affiliate of the Placement Agent has provided such Purchaser with any information or advice with respect to the Securities
nor is such information or advice necessary or desired. Neither the Placement Agent nor any Affiliate has made or makes any representation
as to the Company or the quality of the Securities and the Placement Agent and any Affiliate may have acquired non-public information
with respect to the Company which such Purchaser agrees need not be provided to it. In connection with the issuance of the Securities
to such Purchaser, neither the Placement Agent nor any of its Affiliates has acted as a financial advisor or fiduciary to such Purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f)&nbsp;<U>Certain
Transactions and Confidentiality</U>. Other than consummating the transactions contemplated hereunder, such Purchaser has not, nor has
any Person acting on behalf of or pursuant to any understanding with such Purchaser, directly or indirectly executed any purchases or
sales, including Short Sales, of the securities of the Company during the period commencing as of the time that such Purchaser first received
a term sheet (written or oral) from the Company or any other Person representing the Company setting forth the material pricing terms
of the transactions contemplated hereunder and ending immediately prior to the execution hereof. Notwithstanding the foregoing, in the
case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of such Purchaser&rsquo;s
assets and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers managing other portions
of such Purchaser&rsquo;s assets, the representation set forth above shall only apply with respect to the portion of assets managed by
the portfolio manager that made the investment decision to purchase the Securities covered by this Agreement. Other than to other Persons
party to this Agreement or to such Purchaser&rsquo;s representatives, including, without limitation, its officers, directors, partners,
legal and other advisors, employees, agents and Affiliates, such Purchaser has maintained the confidentiality of all disclosures made
to it in connection with this transaction (including the existence and terms of this transaction). Notwithstanding the foregoing, for
the avoidance of doubt, nothing contained herein shall constitute a representation or warranty, or preclude any actions, with respect
to locating or borrowing shares in order to effect Short Sales or similar transactions in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g)&nbsp;<U>Ownership
of Company Securities</U>. Except as disclosed in writing to the Company as of the date of this Agreement, no Purchaser, any of its Affiliates,
or any other Persons whose beneficial ownership of shares of Common Stock would be aggregated with the Purchaser&rsquo;s for purposes
of Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, including any &ldquo;group&rdquo; of which
the Purchaser is a member, directly or indirectly owns, beneficially or otherwise (including solely with respect to an economic interest),
any of the outstanding shares of Common Stock, or any other shares of capital stock, options, warrants, derivative securities, rights
or any other securities (including any securities convertible into, exchangeable for or that represent the right to receive securities)
of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company acknowledges and agrees that the representations
contained in this Section 3.2 shall not modify, amend or affect such Purchaser&rsquo;s right to rely on the Company&rsquo;s representations
and warranties contained in this Agreement or any representations and warranties contained in any other Transaction Document or any other
document or instrument executed and/or delivered in connection with this Agreement or the consummation of the transactions contemplated
hereby. Notwithstanding the foregoing, for the avoidance of doubt, nothing contained herein shall constitute a representation or warranty,
or preclude any actions, with respect to locating or borrowing shares in order to effect Short Sales or similar transactions in the future.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif">ARTICLE
IV</FONT><BR>
OTHER AGREEMENTS OF THE PARTIES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.1&nbsp;<U>Free
of Legends. The Offered Shares and Pre-Funded Warrants shall be issued free of legends.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.2&nbsp;<U>Furnishing
of Information</U>. Until the earliest of the time that no Purchaser owns Securities, the Company covenants to timely file (or obtain
extensions in respect thereof and file within the applicable grace period) all reports required to be filed by the Company after the date
hereof pursuant to the Exchange Act even if the Company is not then subject to the reporting requirements of the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.3&nbsp;<U>Integration</U>.
The Company shall not sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security (as defined in Section
2 of the Securities Act) that would be integrated with the offer or sale of the Securities for purposes of the rules and regulations of
any Trading Market such that it would require shareholder approval prior to the closing of such other transaction unless shareholder approval
is obtained before the closing of such subsequent transaction..</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.4&nbsp;<U>Securities
Laws Disclosure; Publicity</U>. The Company shall (a) by 9:00 a.m. (New York City time) on the date following the date hereof issue a
press release disclosing the material terms of the transactions contemplated hereby, and (b) file a Report on Form 8-K, including the
Transaction Documents as exhibits thereto, with the Commission within the time required by the Exchange Act. From and after the issuance
of such press release, the Company represents to the Purchasers that it shall have publicly disclosed all material, non-public information
delivered to any of the Purchasers by the Company or any of its Subsidiaries, or any of their respective officers, directors, employees
or agents in connection with the transactions contemplated by the Transaction Documents. In addition, effective upon the issuance of such
press release, the Company acknowledges and agrees that any and all confidentiality or similar obligations under any agreement, whether
written or oral, between the Company, any of its Subsidiaries or any of their respective officers, directors, agents, employees or Affiliates
on the one hand, and any of the Purchasers or any of their Affiliates on the other hand, shall terminate. The Company and each Purchaser
shall consult with each other in issuing any other press releases with respect to the transactions contemplated hereby, and neither the
Company nor any Purchaser shall issue any such press release nor otherwise make any such public statement without the prior consent of
the Company, with respect to any press release of any Purchaser, or without the prior consent of each Purchaser, with respect to any press
release of the Company, which consent shall not unreasonably be withheld or delayed, except if such disclosure is required by law, in
which case the disclosing party shall promptly provide the other party with prior notice of such public statement or communication. Notwithstanding
the foregoing, the Company shall not publicly disclose the name of any Purchaser, or include the name of any Purchaser in any filing with
the Commission or any regulatory agency or Trading Market, without the prior written consent of such Purchaser, except (a) as required
by federal securities law in connection with the filing of final Transaction Documents with the Commission and (b) to the extent such
disclosure is required by law or Trading Market or FINRA regulations, in which case the Company shall provide the Purchasers with prior
notice of such disclosure permitted under this clause (b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.5&nbsp;<U>Shareholder
Rights Plan</U>. No claim will be made or enforced by the Company or, with the consent of the Company, any other Person, that any Purchaser
is an &ldquo;<U>Acquiring Person</U>&rdquo; under any control share acquisition, business combination, poison pill (including any distribution
under a rights agreement) or similar anti-takeover plan or arrangement in effect or hereafter adopted by the Company, or that any Purchaser
could be deemed to trigger the provisions of any such plan or arrangement, by virtue of receiving Securities under the Transaction Documents
or under any other agreement between the Company and the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.6&nbsp;<U>Non-Public
Information</U>. Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents,
which shall be disclosed pursuant to Section 4.4, the Company covenants and agrees that neither it, nor any other Person acting on its
behalf will provide any Purchaser or its agents or counsel with any information that constitutes, or the Company reasonably believes constitutes,
material non-public information, unless prior thereto such Purchaser shall have consented to the receipt of such information and agreed
with the Company to keep such information confidential. The Company understands and confirms that each Purchaser shall be relying on the
foregoing covenant in effecting transactions in securities of the Company. To the extent that the Company delivers any material, non-public
information to a Purchaser without such Purchaser&rsquo;s consent, the Company hereby covenants and agrees that such Purchaser shall not
have any duty of confidentiality to the Company, any of its Subsidiaries, or any of their respective officers, directors, agents, employees
or Affiliates, or a duty to the Company, any of its Subsidiaries or any of their respective officers, directors, agents, employees or
Affiliates not to trade on the basis of, such material, non-public information, provided that the Purchaser shall remain subject to applicable
law. To the extent that any notice provided pursuant to any Transaction Document constitutes, or contains, material, non-public information
regarding the Company or any Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Report
on Form 6-K. The Company understands and confirms that each Purchaser shall be relying on the foregoing covenant in effecting transactions
in securities of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.7&nbsp;<U>Use
of Proceeds</U>. Except as set forth in the Prospectus Supplement and on <U>Schedule 4.7</U> attached hereto, the Company shall use the
net proceeds from the sale of the Securities hereunder for working capital purposes and general business purposes and shall not use such
proceeds: (a) for the satisfaction of any portion of the Company&rsquo;s Indebtedness (other than payment of trade payables in the ordinary
course of the Company&rsquo;s business and prior practices), (b) for the redemption of any shares of Common Stock or Common Stock Equivalents,
(c) for the settlement of any outstanding litigation or (d) in violation of FCPA or OFAC regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.8&nbsp;<U>Indemnification
of Purchasers</U>. Subject to the provisions of this Section 4.8, the Company will indemnify and hold each Purchaser and its directors,
officers, shareholders, members, partners, employees and agents (and any other Persons with a functionally equivalent role of a Person
holding such titles notwithstanding a lack of such title or any other title), each Person who controls such Purchaser (within the meaning
of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers, shareholders, agents, members, partners
or employees (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding a lack of such
title or any other title) of such controlling persons (each, a &ldquo;<U>Purchaser Party</U>&rdquo;) harmless from any and all losses,
liabilities, obligations, claims, contingencies, damages, costs and expenses, including all judgments, amounts paid in settlements, court
costs and reasonable attorneys&rsquo; fees and costs of investigation that any such Purchaser Party may suffer or incur as a result of
or relating to (a) any breach of any of the representations, warranties, covenants or agreements made by the Company in this Agreement
or in the other Transaction Documents or (b) any action instituted against the Purchaser Parties in any capacity, or any of them or their
respective Affiliates, by any stockholder of the Company who is not an Affiliate of such Purchaser Party, with respect to any of the transactions
contemplated by the Transaction Documents (unless such action is solely based upon a material breach of such Purchaser Party&rsquo;s representations,
warranties or covenants under the Transaction Documents or any agreements or understandings such Purchaser Party may have with any such
stockholder or any violations by such Purchaser Party of state or federal securities laws or any conduct by such Purchaser Party which
is finally judicially determined to constitute fraud, gross negligence or willful misconduct) or (c) in connection with any registration
statement of the Company providing for the resale by the Purchasers of the shares of Common Stock issuable upon exercise of the Pre-Funded
Warrants, respectively, the Company will indemnify each Purchaser Party, to the fullest extent permitted by applicable law, from and against
any and all losses, claims, damages, liabilities, costs (including, without limitation, reasonable attorneys&rsquo; fees) and expenses,
as incurred, arising out of or relating to (i) any untrue or alleged untrue statement of a material fact contained in such registration
statement, any prospectus or any form of prospectus or in any amendment or supplement thereto or in any preliminary prospectus, or arising
out of or relating to any omission or alleged omission of a material fact required to be stated therein or necessary to make the statements
therein (in the case of any prospectus or supplement thereto, in the light of the circumstances under which they were made) not misleading,
except to the extent, but only to the extent, that such untrue statements or omissions are based solely upon information regarding such
Purchaser Party furnished in writing to the Company by such Purchaser Party expressly for use therein, or (ii) any violation or alleged
violation by the Company of the Securities Act, the Exchange Act or any state securities law, or any rule or regulation thereunder in
connection therewith. If any action shall be brought against any Purchaser Party in respect of which indemnity may be sought pursuant
to this Agreement, such Purchaser Party shall promptly notify the Company in writing, and the Company shall have the right to assume the
defense thereof with counsel of its own choosing reasonably acceptable to the Purchaser Party. Any Purchaser Party shall have the right
to employ separate counsel in any such action and participate in the defense thereof, but the fees and expenses of such counsel shall
be at the expense of such Purchaser Party except to the extent that (i) the employment thereof has been specifically authorized by the
Company in writing, (ii) the Company has failed after a reasonable period of time to assume such defense and to employ counsel or (iii)
in such action there is, in the reasonable opinion of counsel, a material conflict on any material issue between the position of the Company
and the position of such Purchaser Party, in which case the Company shall be responsible for the reasonable fees and expenses of no more
than one such separate counsel. The Company will not be liable to any Purchaser Party under this Agreement (y) for any settlement by a
Purchaser Party effected without the Company&rsquo;s prior written consent, which shall not be unreasonably withheld or delayed; or (z)
to the extent, but only to the extent that a loss, claim, damage or liability is attributable to any Purchaser Party&rsquo;s breach of
any of the representations, warranties, covenants or agreements made by such Purchaser Party in this Agreement or in the other Transaction
Documents. The indemnification required by this Section 4.8 shall be made by periodic payments of the amount thereof during the course
of the investigation or defense, as and when bills are received or are incurred. The indemnity agreements contained herein shall be in
addition to any cause of action or similar right of any Purchaser Party against the Company or others and any liabilities the Company
may be subject to pursuant to law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.9&nbsp;<U>Reservation
of Common Stock</U>. As of the date hereof, the Company has reserved and the Company shall continue to reserve and keep available at all
times, free of preemptive rights, a sufficient number of shares of Common Stock for the purpose of enabling the Company to issue shares
of Common Stock pursuant to this Agreement and any exercise of the Pre-Funded Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.10&nbsp;<U>Listing
of Common Stock</U>. The Company hereby agrees to use best efforts to maintain the listing or quotation of the Common Stock on the Trading
Market on which it is currently listed and concurrently with the Closing, the Company shall apply to list or quote all of the Offered
Shares on such Trading Markets and promptly secure the listing of all of the Offered Shares on such Trading Markets. The Company further
agrees, if the Company applies to have the Common Stock traded on any other Trading Market, it will then include in such application all
of the Offered Shares and will take such other action as is necessary to cause all of the Offered Shares to be listed or quoted on such
other Trading Market as promptly as possible. The Company will then take all action reasonably necessary to continue the listing and trading
of its Common Stock on a Trading Market and will comply in all respects with the Company&rsquo;s reporting, filing and other obligations
under the bylaws or rules of the Trading Market. The Company agrees to maintain the eligibility of the Common Stock for electronic transfer
through the Depository Trust Company or another established clearing corporation, including, without limitation, by timely payment of
fees to the Depository Trust Company or such other established clearing corporation in connection with such electronic transfer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.11&nbsp;<U>[</U><I>Intentionally
Omitted</I><U>]</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.12&nbsp;<U>Equal
Treatment of Purchasers</U>. No consideration (including any modification of any Transaction Document) shall be offered or paid to any
Person to amend or consent to a waiver or modification of any provision of the Transaction Documents unless the same consideration is
also offered to all of the parties to such Transaction Document. For clarification purposes, this provision constitutes a separate right
granted to each Purchaser by the Company and negotiated separately by each Purchaser, and is intended for the Company to treat the Purchasers
as a class and shall not in any way be construed as the Purchasers acting in concert or as a group with respect to the purchase, disposition
or voting of the Common Stock or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.13&nbsp;<U>Certain
Transactions and Confidentiality</U>. Each Purchaser, severally and not jointly with the other Purchasers, covenants that neither it nor
any Affiliate acting on its behalf or pursuant to any understanding with it will execute any purchases or sales, including Short Sales
of any of the Company&rsquo;s securities during the period commencing with the execution of this Agreement and ending at such time that
the transactions contemplated by this Agreement are first publicly announced pursuant to the initial press release as described in Section
4.4. Each Purchaser, severally and not jointly with the other Purchasers, covenants that until such time as the transactions contemplated
by this Agreement are publicly disclosed by the Company pursuant to the initial press release as described in Section 4.4, such Purchaser
will maintain the confidentiality of the existence and terms of this transaction and the information included in the Disclosure Schedules.
Notwithstanding the foregoing, and notwithstanding anything contained in this Agreement to the contrary, the Company expressly acknowledges
and agrees that (i) no Purchaser makes any representation, warranty or covenant hereby that it will not engage in effecting transactions
in any securities of the Company after the time that the transactions contemplated by this Agreement are first publicly announced pursuant
to the initial press release as described in Section 4.4, (ii) no Purchaser shall be restricted or prohibited from effecting any transactions
in any securities of the Company in accordance with applicable securities laws from and after the time that the transactions contemplated
by this Agreement are first publicly announced pursuant to the initial press release as described in Section 4.4 and (iii) no Purchaser
shall have any duty of confidentiality or duty not to trade in the securities of the Company to the Company or its Subsidiaries after
the issuance of the initial press release as described in Section 4.4. Notwithstanding the foregoing, in the case of a Purchaser that
is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of such Purchaser&rsquo;s assets and
the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers managing other portions of
such Purchaser&rsquo;s assets, the covenant set forth above shall only apply with respect to the portion of assets managed by the portfolio
manager that made the investment decision to purchase the Securities covered by this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.14&nbsp;<U>Exercise
Procedures</U>. The applicable form of Notice of Exercise included in the Pre-Funded Warrants set forth the totality of the procedures
required of the Purchasers in order to exercise the Pre-Funded Warrants. No additional legal opinion, other information or instructions
shall be required of the Purchasers to exercise their Pre-Funded Warrants. Without limiting the preceding sentences, no ink-original Notice
of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise
form be required in order to exercise the Pre-Funded Warrants. The Company shall honor exercises of the Pre-Funded Warrants and shall
deliver shares of Common Stock in accordance with the terms, conditions and time periods set forth in the Transaction Documents.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif">ARTICLE
V</FONT><BR>
MISCELLANEOUS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.1&nbsp;<U>Termination</U>.
This Agreement may be terminated by any Purchaser, as to such Purchaser&rsquo;s obligations hereunder only and without any effect whatsoever
on the obligations between the Company and the other Purchasers, by written notice to the other parties, if the Closing has not been consummated
on or before the fifth (5<SUP>th</SUP>) Trading Day following the date hereof; <U>provided</U>, <U>however</U>, that no such termination
will affect the right of any party to sue for any breach by any other party (or parties).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.2&nbsp;<U>Fees
and Expenses</U>. At the Closing, the Company has agreed to reimburse the Placement Agent for all expenses (including, without limitation,
fees and disbursements of the Placement Agent&rsquo;s counsel and all travel and other out-of-pocket expenses) incurred by the Placement
Agent in connection with the transaction contemplated by the Transaction Documents, up to a maximum of $150,000, taken together and not
individually. Except as expressly set forth in the Transaction Documents to the contrary, each party shall pay the fees and expenses of
its advisers, counsel, accountants and other experts, if any, and all other expenses incurred by such party incident to the negotiation,
preparation, execution, delivery and performance of this Agreement. The Company shall pay all Depositary fees (including, without limitation,
any fees required for same-day processing of any instruction letter delivered by the Company), stamp taxes and other taxes and duties
levied in connection with the delivery of any Securities to the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.3&nbsp;<U>Entire
Agreement</U>. The Transaction Documents, together with the exhibits and schedules thereto, the Prospectus and the Prospectus Supplement,
contain the entire understanding of the parties with respect to the subject matter hereof and thereof and supersede all prior agreements
and understandings, oral or written, with respect to such matters, which the parties acknowledge have been merged into such documents,
exhibits and schedules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.4&nbsp;<U>Notices</U>.
Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing and shall
be deemed given and effective on the earliest of: (a) the time of transmission, if such notice or communication is delivered via facsimile
at the facsimile number or email attachment at the email address as set forth on the signature pages attached hereto at or prior to 5:30
p.m. (New York City time) on a Trading Day, (b) the next Trading Day after the time of transmission, if such notice or communication is
delivered via facsimile at the facsimile number or email attachment at the email address as set forth on the signature pages attached
hereto on a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading Day, (c) the second (2<SUP>nd</SUP>)
Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service or (d) upon actual receipt
by the party to whom such notice is required to be given. The address for such notices and communications shall be as set forth on the
signature pages attached hereto. To the extent that any notice provided pursuant to any Transaction Document constitutes, or contains,
material, non-public information regarding the Company or any Subsidiaries, the Company shall simultaneously file such notice with the
Commission pursuant to a Report on Form 6-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.5&nbsp;<U>Amendments;
Waivers</U>. No provision of this Agreement may be waived, modified, supplemented or amended except in a written instrument signed, in
the case of an amendment, by the Company and Purchasers which purchased at least 50.1% in interest of the Offered Shares and Pre-Funded
Warrants (on an as exercised basis) based on the initial Subscription Amounts hereunder or, in the case of a waiver, by the party against
whom enforcement of any such waived provision is sought, provided that if any amendment, modification or waiver disproportionately and
adversely impacts a Purchaser (or group of Purchasers), the consent of such disproportionately impacted Purchaser (or group of Purchasers)
shall also be required. No waiver of any default with respect to any provision, condition or requirement of this Agreement shall be deemed
to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other provision, condition or requirement
hereof, nor shall any delay or omission of any party to exercise any right hereunder in any manner impair the exercise of any such right.
Any proposed amendment or waiver that disproportionately, materially and adversely affects the rights and obligations of any Purchaser
relative to the comparable rights and obligations of the other Purchasers shall require the prior written consent of such adversely affected
Purchaser. Any amendment effected in accordance with this Section 5.5 shall be binding upon each Purchaser and holder of Securities and
the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.6&nbsp;<U>Headings</U>.
The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to limit or affect any
of the provisions hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.7&nbsp;<U>Successors
and Assigns</U>. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and permitted assigns.
The Company may not assign this Agreement or any rights or obligations hereunder without the prior written consent of each Purchaser (other
than by merger). Any Purchaser may assign any or all of its rights under this Agreement to any Person to whom such Purchaser assigns or
transfers any Securities, provided that such transferee agrees in writing to be bound, with respect to the transferred Securities, by
the provisions of the Transaction Documents that apply to the &ldquo;Purchasers.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.8&nbsp;<U>No
Third-Party Beneficiaries</U>. The Placement Agent shall be a third party beneficiary of the representations and warranties of the Company
in Section 3.1 and the representations and warranties of the Purchasers in Section 3.2. This Agreement is intended for the benefit of
the parties hereto and their respective successors and permitted assigns and is not for the benefit of, nor may any provision hereof be
enforced by, any other Person, except as otherwise set forth in Section 4.8 and this Section 5.8.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.9&nbsp;<U>Governing
Law</U>. All questions concerning the construction, validity, enforcement and interpretation of the Transaction Documents shall be governed
by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts
of law thereof. Each party agrees that all legal Proceedings concerning the interpretations, enforcement and defense of the transactions
contemplated by this Agreement and any other Transaction Documents (whether brought against a party hereto or its respective affiliates,
directors, officers, shareholders, partners, members, employees or agents) shall be commenced exclusively in the state and federal courts
sitting in the City of New York. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting
in the City of New York, Borough of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction
contemplated hereby or discussed herein (including with respect to the enforcement of any of the Transaction Documents), and hereby irrevocably
waives, and agrees not to assert in any Action or Proceeding, any claim that it is not personally subject to the jurisdiction of any such
court, that such Action or Proceeding is improper or is an inconvenient venue for such Proceeding. Each party hereby irrevocably waives
personal service of process and consents to process being served in any such Action or Proceeding by mailing a copy thereof via registered
or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this
Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein
shall be deemed to limit in any way any right to serve process in any other manner permitted by law. If any party shall commence an Action
or Proceeding to enforce any provisions of the Transaction Documents, then, in addition to the obligations of the Company under Section
4.7, the prevailing party in such Action or Proceeding shall be reimbursed by the non-prevailing party for its reasonable attorneys&rsquo;
fees and other costs and expenses incurred with the investigation, preparation and prosecution of such Action or Proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 30; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.10&nbsp;<U>Survival</U>.
The representations and warranties contained herein shall survive the Closing and the delivery of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.11&nbsp;<U>Execution</U>.
This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same agreement
and shall become effective when counterparts have been signed by each party and delivered to each other party, it being understood that
the parties need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission or by e-mail delivery
of a &ldquo;.pdf&rdquo; format data file, such signature shall create a valid and binding obligation of the party executing (or on whose
behalf such signature is executed) with the same force and effect as if such facsimile or &ldquo;.pdf&rdquo; signature page were an original
thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.12&nbsp;<U>Severability</U>.
If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal,
void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force
and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially reasonable efforts
to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision,
covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would have executed the remaining
terms, provisions, covenants and restrictions without including any of such that may be hereafter declared invalid, illegal, void or unenforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.13&nbsp;<U>Rescission
and Withdrawal Right</U>. Notwithstanding anything to the contrary contained in (and without limiting any similar provisions of) any of
the other Transaction Documents, whenever any Purchaser exercises a right, election, demand or option under a Transaction Document and
the Company does not timely perform its related obligations within the periods therein provided, then such Purchaser may rescind or withdraw,
in its sole discretion from time to time upon written notice to the Company, any relevant notice, demand or election in whole or in part
without prejudice to its future actions and rights; <U>provided</U>, <U>however</U>, that in the case of a rescission of an exercise of
a Pre-Funded Warrant, the applicable Purchaser shall be required to return any shares of Common Stock subject to any such rescinded exercise
notice concurrently with the return to such Purchaser of the aggregate exercise price paid to the Company for such shares and the restoration
of such Purchaser&rsquo;s right to acquire such shares pursuant to such Purchaser&rsquo;s Pre-Funded Warrant (including, issuance of a
replacement warrant certificate evidencing such restored right).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.14&nbsp;<U>Replacement
of Securities</U>. If any certificate or instrument evidencing any Securities is mutilated, lost, stolen or destroyed, the Company shall
issue or cause to be issued in exchange and substitution for and upon cancellation thereof (in the case of mutilation), or in lieu of
and substitution therefor, a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory to the Company of
such loss, theft or destruction. The applicant for a new certificate or instrument under such circumstances shall also pay any reasonable
third-party costs (including customary indemnity) associated with the issuance of such replacement Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 31; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.15&nbsp;<U>Remedies</U>.
In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages, each of the Purchasers
and the Company will be entitled to specific performance under the Transaction Documents. The parties agree that monetary damages may
not be adequate compensation for any loss incurred by reason of any breach of obligations contained in the Transaction Documents and hereby
agree to waive and not to assert in any Action for specific performance of any such obligation the defense that a remedy at law would
be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.16&nbsp;<U>Payment
Set Aside</U>. To the extent that the Company makes a payment or payments to any Purchaser pursuant to any Transaction Document or a Purchaser
enforces or exercises its rights thereunder, and such payment or payments or the proceeds of such enforcement or exercise or any part
thereof are subsequently invalidated, declared to be fraudulent or preferential, set aside, recovered from, disgorged by or are required
to be refunded, repaid or otherwise restored to the Company, a trustee, receiver or any other Person under any law (including, without
limitation, any bankruptcy law, state or federal law, common law or equitable cause of action), then to the extent of any such restoration
the obligation or part thereof originally intended to be satisfied shall be revived and continued in full force and effect as if such
payment had not been made or such enforcement or setoff had not occurred.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.17&nbsp;<U>Independent
Nature of Purchasers&rsquo; Obligations and Rights</U>. The obligations of each Purchaser under any Transaction Document are several and
not joint with the obligations of any other Purchaser, and no Purchaser shall be responsible in any way for the performance or non-performance
of the obligations of any other Purchaser under any Transaction Document. Nothing contained herein or in any other Transaction Document,
and no action taken by any Purchaser pursuant hereto or thereto, shall be deemed to constitute the Purchasers as a partnership, an association,
a joint venture or any other kind of entity, or create a presumption that the Purchasers are in any way acting in concert or as a group
with respect to such obligations or the transactions contemplated by the Transaction Documents. Each Purchaser shall be entitled to independently
protect and enforce its rights including, without limitation, the rights arising out of this Agreement or out of the other Transaction
Documents, and it shall not be necessary for any other Purchaser to be joined as an additional party in any Proceeding for such purpose.
Each Purchaser has been represented by its own separate legal counsel in its review and negotiation of the Transaction Documents. For
reasons of administrative convenience only, each Purchaser and its respective counsel have chosen to communicate with the Company through
Sullivan. Sullivan does not represent any of the Purchasers and only represents the Placement Agent. The Company has elected to provide
all Purchasers with the same terms and Transaction Documents for the convenience of the Company and not because it was required or requested
to do so by any of the Purchasers. It is expressly understood and agreed that each provision contained in this Agreement and in each other
Transaction Document is between the Company and a Purchaser, solely, and not between the Company and the Purchasers collectively and not
between and among the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.18&nbsp;<U>Liquidated
Damages</U>. The Company&rsquo;s obligations to pay any partial liquidated damages or other amounts owing under the Transaction Documents
is a continuing obligation of the Company and shall not terminate until all unpaid partial liquidated damages and other amounts have been
paid notwithstanding the fact that the instrument or security pursuant to which such partial liquidated damages or other amounts are due
and payable shall have been canceled.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<!-- Field: Page; Sequence: 32; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.19&nbsp;<U>Saturdays,
Sundays, Holidays, etc.</U> If the last or appointed day for the taking of any action or the expiration of any right required or granted
herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.20&nbsp;<U>Construction</U>.
The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to revise the Transaction Documents
and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against the drafting party shall
not be employed in the interpretation of the Transaction Documents or any amendments thereto. In addition, each and every reference to
share prices and shares of Common Stock in any Transaction Document shall be subject to adjustment for reverse and forward stock splits,
stock dividends, stock combinations and other similar transactions with respect to the Common Stock that occur after the date of this
Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.21&nbsp;<U>Sales
During Pre-Settlement Period</U>. Notwithstanding anything herein to the contrary, if at any time on or after the time of execution of
this Agreement by the Company and an applicable Purchaser, through, and including the time immediately prior to the Closing (the &ldquo;<U>Pre-Settlement
Period</U>&rdquo;), such Purchaser sells (excluding &ldquo;short sales&rdquo; as defined in Rule 200 of Regulation SHO) to any Person
all, or any portion, of any Shares to be issued hereunder to such Purchaser at the Closing (collectively, the &ldquo;<U>Pre-Settlement
Shares</U>&rdquo;), such Purchaser shall, automatically hereunder (without any additional required actions by such Purchaser or the Company),
be deemed to be unconditionally bound to purchase, and the Company shall be deemed unconditionally bound to sell, such Pre-Settlement
Shares to such Purchaser at the Closing; provided, that the Company shall not be required to deliver any Pre-Settlement Shares to such
Purchaser prior to the Company&rsquo;s receipt of the purchase price of such Pre-Settlement Shares hereunder; and provided further that
the Company hereby acknowledges and agrees that the forgoing shall not constitute a representation or covenant by such Purchaser as to
whether or not during the Pre-Settlement Period such Purchaser shall sell any Shares to any Person and that any such decision to sell
any Shares by such Purchaser shall be made, in the sole discretion of such Purchaser, at the time such Purchaser elects to effect any
such sale, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.22&nbsp;WAIVER
OF JURY TRIAL. IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY, THE PARTIES EACH KNOWINGLY
AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY, IRREVOCABLY AND EXPRESSLY WAIVES
FOREVER TRIAL BY JURY.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>Signature Pages Follow</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 33; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the parties
hereto have caused this Securities Purchase Agreement to be duly executed by their <FONT STYLE="font-size: 10pt">respective authorized
signatories as of the date first indicated above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding: 0.25pt; font-size: 10pt; width: 40%"><FONT STYLE="font-size: 10pt"><B>GD CULTURE GROUP LIMITED</B></FONT></TD>
    <TD STYLE="padding: 0.25pt; width: 5%">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt; font-size: 10pt; width: 55%"><FONT STYLE="font-size: 10pt"><U>Address for Notice:</U></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">Flat 1512, 15F, Lucky Centre,</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">No.165-171 Wan Chai Road</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">Wan Chai,&nbsp;Hong Kong</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding: 0pt; width: 4%; font-size: 10pt"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; padding: 0pt; width: 36%">&nbsp;</TD>
    <TD STYLE="padding: 0pt; width: 5%">&nbsp;</TD>
    <TD STYLE="padding: 0pt; width: 55%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding: 0pt">&nbsp;</TD>
    <TD STYLE="padding: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">Name: Xiaojian Wang</FONT></TD>
    <TD STYLE="padding: 0pt">&nbsp;</TD>
    <TD STYLE="padding: 0pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding: 0pt">&nbsp;</TD>
    <TD STYLE="padding: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">Title: Chief Executive Officer</FONT></TD>
    <TD STYLE="padding: 0pt">&nbsp;</TD>
    <TD STYLE="padding: 0pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="padding: 0pt">&nbsp;</TD>
    <TD STYLE="padding: 0pt">&nbsp;</TD>
    <TD STYLE="padding: 0pt; font-size: 10pt"><FONT STYLE="font-size: 10pt">Attention: Xiaojian Wang<BR>
Email: Xiaojian.gdc@gmail.com </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">With a copy to (which shall not constitute notice):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ortoli Rosenstadt LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">366 Madison Avenue, 3<SUP>rd </SUP>Floor, New York, NY 10017</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Attn: Jason Ye, Esq.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Email: jye@orllp.legal</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SIGNATURE PAGE FOR PURCHASER FOLLOWS]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 34 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>PURCHASER SIGNATURE PAGES TO GD CULTURE GROUP
LIMITED<BR>
RD SECURITIES PURCHASE AGREEMENT</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the undersigned
have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated
above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Purchaser: __________________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Signature of Authorized Signatory of Purchaser</I>:
___________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Authorized Signatory: _________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Title of Authorized Signatory: __________________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Email Address of Authorized Signatory:___________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Facsimile Number of Authorized Signatory: ________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Address for Notice to Purchaser:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Address for Delivery of Pre-Funded Warrants to Purchaser (if not same
as address for notice):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 40%; font-size: 10pt">Subscription Amount:</TD>
    <TD STYLE="width: 60%; font-size: 10pt">________________________</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">Shares:</TD>
    <TD STYLE="font-size: 10pt">________________________</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;Beneficial Ownership Blocker:</TD>
    <TD STYLE="font-size: 10pt">________________________</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">Pre-Funded Warrants:</TD>
    <TD STYLE="font-size: 10pt">________________________</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;Beneficial Ownership Blocker:</TD>
    <TD STYLE="font-size: 10pt">________________________</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">Employer Identification Number:</TD>
    <TD STYLE="font-size: 10pt">________________________</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#9744;&nbsp;&nbsp;Notwithstanding anything contained in
this Agreement to the contrary, by checking this box (i) the obligations of the above-signed to purchase the securities set forth in
this Agreement to be purchased from the Company by the above-signed, and the obligations of the Company to sell such securities to the
above-signed, shall be unconditional and all conditions to Closing shall be disregarded, (ii) the Closing shall occur no later than the
second (2<SUP>nd</SUP>) Trading Day following the date of this Agreement and (iii) any condition to Closing contemplated by this Agreement
(but prior to being disregarded by clause (i) above) that required delivery by the Company or the above-signed of any agreement, instrument,
certificate or the like or purchase price (as applicable) shall no longer be a condition and shall instead be an unconditional obligation
of the Company or the above-signed (as applicable) to deliver such agreement, instrument, certificate or the like or purchase price (as
applicable) to such other party on the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 35 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">EXHIBIT A</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">TO SECURITIES PURCHASE
AGREEMENT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>Form of Pre-Funded Warrant</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>Attached</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>7
<FILENAME>ea177982ex10-3_gdculture.htm
<DESCRIPTION>FORM OF PIPE SECURITIES PURCHASE AGREEMENT BETWEEN THE COMPANY AND CERTAIN PURCHASERS, DATED MAY 1, 2023
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: right"><FONT STYLE="text-transform: capitalize">Exhibit 10.3</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">SECURITIES PURCHASE
AGREEMENT</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Securities Purchase Agreement
(this &ldquo;<U>Agreement</U>&rdquo;) is dated as of May 1, 2023, between GD Culture Group Limited, a Nevada corporation (the &ldquo;<U>Company</U>&rdquo;),
and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a &ldquo;<U>Purchaser</U>&rdquo;
and collectively the &ldquo;<U>Purchasers</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="background-color: white">WHEREAS,
subject to the terms and conditions set forth in this Agreement and pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended
(the &ldquo;</FONT><U>Securities Act</U><FONT STYLE="background-color: white">&rdquo;), and Rule 506 promulgated thereunder, the Company
desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company, securities
of the Company as more fully described in this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NOW, THEREFORE, IN CONSIDERATION
of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt and adequacy of which are
hereby acknowledged, the Company and each Purchaser agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif">ARTICLE
I</FONT><BR>
DEFINITIONS</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.1   <U>Definitions</U>.
In addition to the terms defined elsewhere in this Agreement, for all purposes of this Agreement, the following terms have the meanings
set forth in this Section 1.1:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Acquiring
Person</U>&rdquo; shall have the meaning ascribed to such term in Section 4.4.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Action</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(j).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Affiliate</U>&rdquo;
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person as such terms are used in and construed under Rule 405 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Applicable
Laws</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1 (n).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Authorizations</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1 (n).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Board
of Directors</U>&rdquo; means the board of directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Business
Day</U>&rdquo; means any day except any Saturday, any Sunday, any day which is a federal legal holiday in the United States or any day
on which the Federal Reserve Bank of New York are authorized or required by law or other governmental action to close; provided, however,
for clarification, commercial banks shall not be deemed to be authorized or required by law to remain closed due to &ldquo;stay at home&rdquo;,
&ldquo;shelter-in-place&rdquo;, &ldquo;non-essential employee&rdquo; or any other similar orders or restrictions or the closure of any
physical branch locations at the direction of any governmental authority so long as the electronic funds transfer systems (including for
wire transfers) of commercial banks in The City of New York are generally open for use by customers on such day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Closing</U>&rdquo;
means the closing of the purchase and sale of the Securities pursuant to Section 2.1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Closing
Date</U>&rdquo; means the Trading Day on which all of the Transaction Documents have been executed and delivered by the applicable parties
thereto, and all conditions precedent to (i) the Purchasers&rsquo; obligations to pay the Subscription Amount and (ii) the Company&rsquo;s
obligations to deliver the Securities, in each case, have been satisfied or waived.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Commission</U>&rdquo;
means the United States Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common
Stock</U>&rdquo; means the shares of common stock, par value $0.0001, of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common
Stock Equivalents</U>&rdquo; means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time shares of Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument
that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, shares of
Common Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Common
Warrants</U>&rdquo; means, collectively, the Common Stock purchase warrants delivered to the Purchasers at the Closing in in accordance
with Section 2.2(a) hereof, which Common Warrants shall be exercisable immediately upon issuance and have a term expiring five (5) years
from the issuance date, in the form of <U>Exhibit A</U> attached hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Company
U.S. Counsel</U>&rdquo; means Ortoli Rosenstadt LLP with offices at 366 Madison Avenue, 3rd Floor, New York, NY 10017.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Company
PRC Counsel</U>&rdquo; means [__], with offices located at [&#9679;].</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Disclosure
Schedules</U>&rdquo; means the Disclosure Schedules of the Company delivered concurrently herewith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Effective
Date</U>&rdquo; means the earliest of the date that (a) the initial Registration Statement registering for resale all Warrant Shares has
been declared effective by the Commission, (b) all of the Warrant Shares have been sold pursuant to Rule 144 or may be sold pursuant to
Rule 144, provided the Company is in compliance with the current public information requirements under Rule 144 and without volume or
manner-of-sale restrictions, (c) following the one year anniversary of the Closing Date provided that a holder of Warrant Shares is not
an Affiliate of the Company, or (d) all of the Warrant Shares may be sold pursuant to an exemption from registration under Section 4(a)(1)
of the Securities Act without volume or manner-of-sale restrictions and Company Counsel has delivered to such holders a standing written
unqualified opinion that resales may then be made by such holders of the Warrant Shares pursuant to such exemption which opinion shall
be in form and substance reasonably acceptable to such holders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Evaluation
Date</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(s).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Exchange
Act</U>&rdquo; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>FCPA</U>&rdquo;
means the Foreign Corrupt Practices Act of 1977, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>GAAP</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(h).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Indebtedness</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(bb).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Intellectual
Property Rights</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(p).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Legend
Removal Date</U>&rdquo; shall have the meaning ascribed to it such term in Section 4.1(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Liens</U>&rdquo;
means a lien, charge, pledge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Material
Adverse Effect</U>&rdquo; shall have the meaning assigned to such term in Section 3.1(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Per Warrant
Purchase Price</U>&rdquo; equals $[&#9679;], subject to adjustment for reverse and forward share splits, share dividends, share combinations
and other similar transactions with respect to the Common Stock that occur after the date of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Person</U>&rdquo;
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company,
joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Placement
Agent</U>&rdquo; means Univest Securities LLC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Placement
Agency Agreement</U>&rdquo; means the Placement Agency Agreement by and between the Company and the Placement Agent dated the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Proceeding</U>&rdquo;
means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding,
such as a deposition), whether commenced or threatened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Purchaser
Party</U>&rdquo; shall have the meaning ascribed to such term in Section 4.8.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>RD Purchase
Agreement</U>&rdquo; means the securities purchase agreement as of the date hereof for the issue and sale of approximately $[&#9679;]
million of shares of Common Stock and pre-funded warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Registration
Statement</U>&rdquo; means a registration statement covering the resale by the Purchasers of the Warrant Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Required
Approvals</U>&rdquo; shall have the meaning ascribed to such term in Section 3.1(e).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Rule 144</U>&rdquo;
means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time,
or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Rule 424</U>&rdquo;
means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time,
or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>SEC Reports</U>&rdquo;
shall have the meaning ascribed to such term in Section 3.1(h).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Securities</U><FONT STYLE="background-color: white">&rdquo;
means the Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Securities
Act</U>&rdquo; means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Short
Sales</U>&rdquo; means all &ldquo;short sales&rdquo; as defined in Rule 200 of Regulation SHO under the Exchange Act (but shall not be
deemed to include locating and/or borrowing shares of Common Stock).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Subscription
Amount</U>&rdquo; means, as to each Purchaser, the aggregate amount to be paid for the Warrants purchased hereunder as specified below
such Purchaser&rsquo;s name on the signature page of this Agreement and next to the heading &ldquo;Subscription Amount,&rdquo; in United
States dollars and in immediately available funds.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Subsidiary</U>&rdquo;
means any subsidiary of the Company as set forth on <U>Schedule 3.1(a)</U>, and shall, where applicable, also include any direct or indirect
subsidiary of the Company formed or acquired after the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading
Day</U>&rdquo; means a day on which the principal Trading Market is open for trading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Trading
Market</U>&rdquo; means any of the following markets or exchanges on which the shares of Common Stock are listed or quoted for trading
on the date in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the
New York Stock Exchange (or any successors to any of the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Transaction
Documents</U>&rdquo; means this Agreement, and the Placement Agency Agreement, all exhibits and schedules hereto and thereto, the Warrants,
and any other documents or agreements executed in connection with the transactions contemplated hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Transfer
Agent</U>&rdquo; means Continental Stock Transfer &amp; Trust Company , and any successor transfer agent of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>VWAP</U>&rdquo;
means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common Stock is then listed or
quoted on a Trading Market, the daily volume weighted average price of the Common Stock for such date (or the nearest preceding date)
on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30
a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average
price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not
then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on the Pink Open Market (or a
similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of Common Stock so
reported, or (d) in all other cases, the fair market value of each share of Common Stock as determined by an independent appraiser selected
in good faith by the holders of a majority in interest of the Warrants then outstanding and reasonably acceptable to the Company, the
fees and expenses of which shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Warrants</U>&rdquo;
means, collectively, the Common Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&ldquo;<U>Warrant
Shares</U>&rdquo; means the shares of Common Stock issuable upon exercise of the Common Warrants and which are being registered pursuant
to the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif">ARTICLE
II</FONT><BR>
PURCHASE AND SALE</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.1   <U>Closing</U>.
On the Closing Date, upon the terms and subject to the conditions set forth herein, substantially concurrent with the execution and delivery
of this Agreement by the parties hereto, the Company agrees to sell, and the Purchasers, severally and not jointly, agree to purchase,
(i) the number of Securities set forth under the heading &ldquo;Subscription Amount&rdquo; on the Purchaser&rsquo;s signature page hereto,
at the Per Warrant Purchase Price. Each Purchaser shall deliver to the Company, via wire transfer, immediately available funds equal to
such Purchaser&rsquo;s Subscription Amount as set forth on the signature page hereto executed by such Purchaser. The Company shall deliver
to each Purchaser its respective Offered Shares and Warrants, as applicable, as determined pursuant to Section 2.2(a), and the Company
and each Purchaser shall deliver the other items set forth in Section 2.2 deliverable at the Closing. Upon satisfaction of the covenants
and conditions set forth in Sections 2.2 and 2.3, the Closing shall occur at the offices of Placement Agent&rsquo;s counsel or at such
other location as the parties shall mutually agree or virtually in accordance with the provisions of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.2   <U>Deliveries</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)   On
or prior to the Closing Date, the Company shall deliver or cause to be delivered to each Purchaser and the Placement Agent the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(i)   this
Agreement duly executed by the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(ii)   legal
opinions of Company U.S. Counsel and Company PRC Counsel, each in a form reasonably satisfactory to the Placement Agent and the Purchasers;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iii)   a
cold comfort letter, addressed to the Placement Agent from each of Enrome, LLP and WWC, P.C, the registered independent accountants of
the Company, in a form and substance reasonably satisfactory in all material respects to the Placement Agent;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iv)   the
Company shall have provided each Purchaser with the Company&rsquo;s wire instructions, on Company letterhead and executed by the Chief
Executive Officer or Chief Financial Officer;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(v)   a
copy of the irrevocable instructions to the Depositary instructing the Depositary to deliver on an expedited basis via The Depository
Trust Company Deposit or Withdrawal at Custodian System (&ldquo;<U>DWAC</U>&rdquo;) shares of Common Stock equal to such Purchaser&rsquo;s
Subscription Amount divided by the Per Warrant Purchase Price, registered in the name of such Purchaser; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(vi)   for
each Purchaser of Common Warrants pursuant to Section 2.1,a Common Warrant registered in the name of such Purchaser to purchase up to
a number of shares of Common Stock equal to the number stated on the Purchaser&rsquo;s signature page hereto, each with an exercise price
equal to $[&#9679;], subject to adjustment therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)   On
or prior to the Closing Date, each Purchaser shall deliver or cause to be delivered to the Company, the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(i)   this
Agreement duly executed by such Purchaser; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(ii)   such
Purchaser&rsquo;s Subscription Amount by wire transfer to the account specified by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.3   <U>Closing
Conditions</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)   The
obligations of the Company hereunder in connection with the Closing are subject to the following conditions being met:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(i)   the
accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect,
in all respects) on the Closing Date of the representations and warranties of the Purchasers contained herein (unless as of a specific
date therein in which case they shall be accurate as of such date);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(ii)   all
obligations, covenants and agreements of each Purchaser required to be performed at or prior to the Closing Date shall have been performed;
and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iii)   the
delivery by each Purchaser of the items set forth in Section 2.2(b) of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)   The
respective obligations of the Purchasers hereunder in connection with the Closing are subject to the following conditions being met:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(i)   the
accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect,
in all respects) when made and on the Closing Date of the representations and warranties of the Company contained herein (unless as of
a specific date therein in which case they shall be accurate as of such date);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(ii)   all
obligations, covenants and agreements of the Company required to be performed at or prior to the Closing Date shall have been performed;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iii)   the
delivery by the Company of the items set forth in Section 2.2(a) of this Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">(iv)   there
shall have been no Material Adverse Effect with respect to the Company since the date hereof; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.75in">(v)   from
the date hereof to the Closing Date, trading in the Common Stock and the Company&rsquo;s securities shall not have been suspended by the
Commission or any principal Trading Market, and, at any time prior to the Closing Date, trading in securities generally as reported by
Bloomberg L.P. shall not have been suspended or limited, or minimum prices shall not have been established on securities whose trades
are reported by such service, or on any Trading Market, nor shall a banking moratorium have been declared either by the United States
or New York State authorities nor shall there have occurred any material outbreak or escalation of hostilities or other national or international
calamity of such magnitude in its effect on, or any material adverse change in, any financial market which, in each case, in the reasonable
judgment of such Purchaser, makes it impracticable or inadvisable to purchase the Securities at the Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif">ARTICLE
III</FONT><BR>
REPRESENTATIONS AND WARRANTIES</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.1   <U>Representations
and Warranties of the Company</U>. Except as set forth in the Disclosure Schedules, which Disclosure Schedules shall be deemed a part
hereof and shall qualify any representation or otherwise made herein to the extent of the disclosure contained in the corresponding section
of the Disclosure Schedules, the Company hereby makes the following representations and warranties to each Purchaser:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)   <U>Subsidiaries</U>.
All of the direct and indirect Subsidiaries of the Company are set forth on <U>Schedule 3.1(a)</U>. The Company owns or controls, directly
or indirectly, the percentage of the capital stock or other equity interests disclosed in <U>Schedule 3.1(a)</U> of each Subsidiary of
the Company free and clear of any Liens, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly
issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)   <U>Organization
and Qualification</U>. The Company and each of the Subsidiaries is an entity duly incorporated or otherwise organized, validly existing
and in good standing under the laws of the jurisdiction of its incorporation or organization, with the requisite power and authority to
own and use its properties and assets and to carry on its business as currently conducted. Neither the Company nor any Subsidiary is in
violation or default of any of the provisions of its respective certificate or articles of incorporation, bylaws or other organizational
or charter documents. Each of the Company and the Subsidiaries is duly qualified to conduct business and is in good standing as a foreign
corporation or other entity in each jurisdiction in which the nature of the business conducted or property owned by it makes such qualification
necessary, except where the failure to be so qualified or in good standing, as the case may be, could not have or reasonably be expected
to result in: (i) a material adverse effect on the legality, validity or enforceability of any Transaction Document, (ii) a material adverse
effect on the results of operations, assets, business, prospects or condition (financial or otherwise) of the Company and the Subsidiaries,
taken as a whole, or (iii) a material adverse effect on the Company&rsquo;s ability to perform in any material respect on a timely basis
its obligations under any Transaction Document (any of (i), (ii) or (iii), a &ldquo;<U>Material Adverse Effect</U>&rdquo;) and no Proceeding
has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking to revoke, limit or curtail such power and authority
or qualification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)   <U>Authorization;
Enforcement</U>. The Company has the requisite corporate power and authority to enter into and to consummate the transactions contemplated
by this Agreement and each of the other Transaction Documents and otherwise to carry out its obligations hereunder and thereunder. The
execution and delivery of this Agreement and each of the other Transaction Documents by the Company and the consummation by it of the
transactions contemplated hereby and thereby have been duly authorized by all necessary action on the part of the Company and no further
action is required by the Company, the Board of Directors, a committee of the Board of Directors or the Company&rsquo;s shareholders in
connection herewith or therewith other than in connection with the Required Approvals. This Agreement and each other Transaction Document
to which it is a party has been (or upon delivery will have been) duly executed by the Company and, when delivered in accordance with
the terms hereof and thereof, will constitute the valid and binding obligation of the Company enforceable against the Company in accordance
with its terms, except (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium
and other laws of general application affecting enforcement of creditors&rsquo; rights generally, (ii) as limited by laws relating to
the availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution
provisions may be limited by applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)   <U>No
Conflicts</U>. The execution, delivery and performance by the Company of this Agreement and the other Transaction Documents to which it
is a party, the issuance and sale of the Securities and the consummation by it of the transactions contemplated hereby and thereby do
not and will not (i) conflict with or violate any provision of the Company&rsquo;s or any Subsidiary&rsquo;s certificate or articles of
incorporation, bylaws or other organizational or charter documents, or (ii) conflict with, or constitute a default (or an event that with
notice or lapse of time or both would become a default) under, result in the creation of any Lien upon any of the properties or assets
of the Company or any Subsidiary, or give to others any rights of termination, amendment, anti-dilution or similar adjustments, acceleration
or cancellation (with or without notice, lapse of time or both) of, any agreement, credit facility, Indebtedness or other instrument (evidencing
a Company or Subsidiary Indebtedness or otherwise) or other understanding to which the Company or any Subsidiary is a party or by which
any property or asset of the Company or any Subsidiary is bound or affected, or (iii) subject to the Required Approvals, conflict with
or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or governmental
authority to which the Company or a Subsidiary is subject (including federal and state securities laws and regulations), or by which any
property or asset of the Company or a Subsidiary is bound or affected; except in the case of each of clauses (ii) and (iii), such as could
not have or reasonably be expected to result in a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)   <U>Filings,
Consents and Approvals</U>. The Company is not required to obtain any consent, waiver, authorization or order of, give any notice to,
or make any filing or registration with, any court or other federal, state, local or other governmental authority or other Person in connection
with the execution, delivery and performance by the Company of the Transaction Documents, other than: (i) the filings required pursuant
to Section 4.4 of this Agreement, (ii) the filing with the Commission pursuant to the Warrants, (iii) the filing and approval of the application(s)
to each applicable Trading Market for the listing of the Warrants for trading thereon in the time and manner required thereby and (iv)
the filing of a Form D with the Commission and such other filings as are required to be made under applicable state securities laws (collectively,
the &ldquo;<U>Required Approvals</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f)   <U>Issuance
of the Securities</U>. The Securities are duly authorized and, when issued and paid for in accordance with the applicable Transaction
Documents, will be duly and validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company. The Company
has reserved from its duly authorized capital stock the maximum number of shares of Common Stock, including shares of Common Stock issuable
upon exercise of the Warrants issuable pursuant to this Agreement. The shares of Common Stock issuable upon exercise of the Warrants,
<FONT STYLE="background-color: white">when issued in accordance with the terms of </FONT>the Transaction Documents<FONT STYLE="background-color: white">,
will be validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company other than restrictions on transfer
provided for in the Transaction Documents. The Company has reserved from its duly authorized capital stock the maximum number of shares
of Common Stock issuable pursuant to this Agreement and the Warrants. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g)   <U>Capitalization</U>.
The capitalization of the Company as of the date hereof is as set forth on <U>Schedule 3.1(g)</U>, which <U>Schedule 3.1(g)</U> shall
also include the number of shares of Common Stock owned beneficially, and of record, by Affiliates of the Company as of the date hereof.
No Person has any right of first refusal, preemptive right, right of participation, or any similar right to participate in the transactions
contemplated by the Transaction Documents. None of the Securities will be subject to the preemptive rights of any holders of any security
of the Company or similar contractual rights granted by the Company. Except as disclosed in Schedule 3.1(g), there are no outstanding
options, warrants, scrip rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities, rights or
obligations convertible into or exercisable or exchangeable for, or giving any Person any right to subscribe for or acquire, any shares
of Common Stock or the capital stock of any Subsidiary, or contracts, commitments, understandings or arrangements by which the Company
or any Subsidiary is or may become bound to issue additional shares of Common Stock or Common Stock Equivalents or capital stock of any
Subsidiary. The issuance and sale of the Securities will not obligate the Company or any Subsidiary to issue shares of Common Stock or
other securities to any Person (other than the Purchasers). Except as disclosed on <U>Schedule 3.1(g),</U> there are no outstanding securities
or instruments of the Company or any Subsidiary with any provision that adjusts the exercise, conversion, exchange or reset price of such
security or instrument upon an issuance of securities by the Company or any Subsidiary. There are no outstanding securities or instruments
of the Company or any Subsidiary that contain any redemption or similar provisions, and there are no contracts, commitments, understandings
or arrangements by which the Company or any Subsidiary is or may become bound to redeem a security of the Company or such Subsidiary.
The Company does not have any stock appreciation rights or &ldquo;phantom stock&rdquo; plans or agreements or any similar plan or agreement.
All of the outstanding shares of capital stock of the Company are duly authorized, validly issued, fully paid and nonassessable, have
been issued in compliance with all federal and state securities laws, and none of such outstanding shares was issued in violation of any
preemptive rights or similar rights to subscribe for or purchase securities. No further approval or authorization of any stockholder,
the Board of Directors or others is required for the issuance and sale of the Securities. There are no shareholders agreements, voting
agreements or other similar agreements with respect to the Company&rsquo;s capital stock to which the Company is a party or, to the knowledge
of the Company, between or among any of the Company&rsquo;s shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h)   <U>SEC
Reports; Financial Statements</U>. The Company has filed all reports, schedules, forms, statements and other documents required to be
filed by the Company under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, for the three
years preceding the date hereof (or such shorter period as the Company was required by law or regulation to file such material) (the foregoing
materials, including the exhibits thereto and documents incorporated by reference therein, being collectively referred to herein as the
&ldquo;<U>SEC Reports</U>&rdquo;). For the twelve months preceding the date hereof, the Company has filed the SEC Reports on a timely
basis (including any valid extension of such time of filing provided under Rule 12b-25 or under coronavirus-related relief by the SEC)
and has filed any such SEC Reports prior to the expiration of any such extension. As of their respective dates, the SEC Reports complied
in all material respects with the requirements of the Securities Act and the Exchange Act, as applicable, and none of the SEC Reports,
when filed, contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary
in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. The Company is
not and has never been an issuer subject to Rule 144(i) under the Securities Act. The financial statements of the Company included in
the SEC Reports comply in all material respects with applicable accounting requirements and the rules and regulations of the Commission
with respect thereto as in effect at the time of filing. Such financial statements have been prepared in accordance with United States
generally accepted accounting principles applied on a consistent basis during the periods involved (&ldquo;<U>GAAP</U>&rdquo;), except
as may be otherwise specified in such financial statements or the notes thereto and except that unaudited financial statements may not
contain all footnotes required by GAAP, and fairly present in all material respects the financial position of the Company and its consolidated
Subsidiaries as of and for the dates thereof and the results of operations and cash flows for the periods then ended, subject, in the
case of unaudited statements, to normal, immaterial, year-end audit adjustments. The selected financial data set forth under the caption
&ldquo;Selected Financial Data&rdquo; in the SEC Reports fairly present, on the basis stated in such SEC Reports, the information included
therein. The agreements and documents described in the Registration Statement and the SEC Reports conform in all material aspects to the
descriptions thereof contained therein and there are no agreements or other documents required by the Securities Act and the rules and
regulations thereunder to be described in the SEC Reports or to be filed with the Commission as exhibits to the Registration Statement,
that have not been so described or filed. Each agreement or other instrument (however characterized or described) to which the Company
is a party or by which it is or may be bound or affected and (i) that is referred to in the Registration Statement or the SEC Reports,
or (ii) is material to the Company&rsquo;s business, has been duly authorized and validly executed by the Company, is in full force and
effect in all material respects and is enforceable against the Company and, to the Company&rsquo;s knowledge, the other parties thereto,
in accordance with its terms, except (x) as such enforceability may be limited by bankruptcy, insolvency, reorganization or similar laws
affecting creditors&rsquo; rights generally, (y) as enforceability of any indemnification or contribution provision may be limited under
the federal and state securities laws, and (z) that the remedy of specific performance and injunctive and other forms of equitable relief
may be subject to the equitable defenses and to the discretion of the court before which any proceeding therefore may be brought. None
of such agreements or instruments has been assigned by the Company, and neither the Company nor, to the best of the Company&rsquo;s knowledge,
any other party is in default thereunder and, to the best of the Company&rsquo;s knowledge, no event has occurred that, with the lapse
of time or the giving of notice, or both, would constitute a default thereunder. To the best of the Company&rsquo;s knowledge, performance
by the Company of the material provisions of such agreements or instruments will not result in a violation of any existing applicable
law, rule, regulation, judgment, order or decree of any governmental agency or court, domestic or foreign, having jurisdiction over the
Company or any of its assets or businesses, including, without limitation, those relating to environmental laws and regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i)   <U>Material
Changes; Undisclosed Events, Liabilities or Developments</U>. Since the date of the latest audited financial statements included within
the SEC Reports, except as set forth on <U>Schedule 3.1(i)</U>, (i) there has been no event, occurrence or development that has had or
that could reasonably be expected to result in a Material Adverse Effect, (ii) the Company has not incurred any liabilities (contingent
or otherwise) other than (A) trade payables and accrued expenses incurred in the ordinary course of business consistent with past practice
and (B) liabilities not required to be reflected in the Company&rsquo;s financial statements pursuant to GAAP or disclosed in filings
made with the Commission, (iii) the Company has not altered its method of accounting, (iv) the Company has not declared or made any dividend
or distribution of cash or other property to its shareholders or purchased, redeemed or made any agreements to purchase or redeem any
shares of its capital stock and (v) the Company has not issued any equity securities to any officer, director or Affiliate, except pursuant
to existing stock incentive plans, the issuance of Common Stock Equivalents as disclosed in the SEC Reports. The Company does not have
pending before the Commission any request for confidential treatment of information. Except for the issuance of the Securities contemplated
by this Agreement or as set forth on <U>Schedule 3.1(i)</U>, no event, liability, fact, circumstance, occurrence or development has occurred
or exists or is reasonably expected to occur or exist with respect to the Company or its Subsidiaries or their respective businesses,
prospects, properties, operations, assets or financial condition that would be required to be disclosed by the Company under applicable
securities laws at the time this representation is made or deemed made that has not been publicly disclosed at least one (1) Trading Day
prior to the date that this representation is made. Unless otherwise disclosed in an SEC Report filed prior to the date hereof, the Company
has not: (i) issued any securities or incurred any liability or obligation, direct or contingent, for borrowed money; or (ii) declared
or paid any dividend or made any other distribution on or in respect to its capital stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(j)   <U>Litigation</U>.
Except as set forth on <U>Schedule 3.1(j)</U>, there is no action, suit, inquiry, notice of violation, proceeding or investigation pending
or, to the knowledge of the Company, threatened against or affecting the Company, any Subsidiary or any of their respective properties
before or by any court, arbitrator, governmental or administrative agency or regulatory authority (federal, state, county, local or foreign)
(collectively, an &ldquo;<U>Action</U>&rdquo;). None of the Actions set forth on <U>Schedule 3.1(j)</U>, (i) adversely affects or challenges
the legality, validity or enforceability of any of the Transaction Documents or the Securities or (ii) could, if there were an unfavorable
decision, have or reasonably be expected to result in a Material Adverse Effect. Neither the Company nor any Subsidiary, nor any director
or officer thereof, is or has been the subject of any Action involving a claim of violation of or liability under federal or state securities
laws or a claim of breach of fiduciary duty. There has not been, and to the knowledge of the Company, there is not pending or threatened,
any investigation by the Commission involving the Company or any current or former director or officer of the Company. There are no Actions
required to be disclosed in the SEC Reports that have not been disclosed. The Commission has not issued any stop order or other order
suspending the effectiveness of any registration statement filed by the Company or any Subsidiary under the Exchange Act or the Securities
Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(k)   <U>Labor
Relations</U>. No labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees of the Company,
which could reasonably be expected to result in a Material Adverse Effect. None of the Company&rsquo;s or its Subsidiaries&rsquo; employees
is a member of a union that relates to such employee&rsquo;s relationship with the Company or such Subsidiary, and neither the Company
nor any of its Subsidiaries is a party to a collective bargaining agreement, and the Company and its Subsidiaries believe that their relationships
with their employees are good. To the knowledge of the Company, no executive officer of the Company or any Subsidiary, is, or is now expected
to be, in violation of any material term of any employment contract, confidentiality, disclosure or proprietary information agreement
or non-competition agreement, or any other contract or agreement or any restrictive covenant in favor of any third party, and the continued
employment of each such executive officer does not subject the Company or any of its Subsidiaries to any liability with respect to any
of the foregoing matters. The Company and its Subsidiaries are in compliance with all U.S. federal, state, local and foreign laws and
regulations relating to employment and employment practices, terms and conditions of employment and wages and hours, except where the
failure to be in compliance could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(l)   <U>Compliance</U>.
Neither the Company nor any Subsidiary: (i) is in default under or in violation of (and no event has occurred that has not been waived
that, with notice or lapse of time or both, would result in a default by the Company or any Subsidiary under), nor has the Company or
any Subsidiary received notice of a claim that it is in default under or that it is in violation of, any indenture, loan or credit agreement
or any other agreement or instrument to which it is a party or by which it or any of its properties is bound (whether or not such default
or violation has been waived), (ii) is in violation of any judgment, decree or order of any court, arbitrator or other governmental authority
or (iii) is or has been in violation of any statute, rule, ordinance or regulation of any governmental authority, including without limitation
all foreign, federal, state and local laws relating to taxes, environmental protection, occupational health and safety, product quality
and safety and employment and labor matters, except in each case as could not have or reasonably be expected to result in a Material Adverse
Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(m)   <U>Environmental
Laws</U>. The Company and its Subsidiaries (i) are in compliance with all federal, state, local and foreign laws relating to pollution
or protection of human health or the environment (including ambient air, surface water, groundwater, land surface or subsurface strata),
including laws relating to emissions, discharges, releases or threatened releases of chemicals, pollutants, contaminants, or toxic or
hazardous substances or wastes (collectively, &ldquo;<U>Hazardous Materials</U>&rdquo;) into the environment, or otherwise relating to
the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials, as well as
all authorizations, codes, decrees, demands, or demand letters, injunctions, judgments, licenses, notices or notice letters, orders, permits,
plans or regulations, issued, entered, promulgated or approved thereunder (&ldquo;<U>Environmental Laws</U>&rdquo;); (ii) have received
all permits licenses or other approvals required of them under applicable Environmental Laws to conduct their respective businesses; and
(iii) are in compliance with all terms and conditions of any such permit, license or approval where in each clause (i), (ii) and (iii),
the failure to so comply could be reasonably expected to have, individually or in the aggregate, a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(n)   <U>Regulatory
Permits</U>. The Company and the Subsidiaries possess all certificates, licenses, authorizations approvals, clearances, consents, registration
and permits issued by the appropriate federal, state, local or foreign regulatory authorities applicable to the Company (&ldquo;<U>Applicable
Laws</U>&rdquo;) necessary to conduct their respective businesses as described in the SEC Reports, except where the failure to possess
such permits could not reasonably be expected to result in a Material Adverse Effect (each, an &ldquo;<U>Authorization</U>&rdquo;), and
neither the Company nor any Subsidiary has received any notice of proceedings relating to the revocation or modification of any Authorization
or the noncompliance with any ordinance, law, rule or regulation applicable to the Company. The disclosures in the Registration Statement
concerning the effects of federal, state, local and all foreign regulation on the Company&rsquo;s business as currently contemplated are
correct in all material respects. The Company is and has been in material compliance with any term of any such Authorizations, except
for any violations which would not reasonably be expected to have a Material Adverse Effect. The Company has not received notice of any
claim, action, suit, proceeding, hearing, enforcement, investigation, arbitration or other action from any governmental authority or body
or third party alleging that any product, operation or activity is in violation of any Applicable Laws or Authorizations or has any knowledge
that any such entity or third party is considering any such claim, litigation, arbitration, action, suit, investigation or proceeding,
nor, to the Company&rsquo;s knowledge, has there been any material noncompliance with or violation of any Applicable Laws by the Company
that could reasonably be expected to require the issuance of any such communication or result in an investigation, corrective action,
or enforcement action by any governmental body or entity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(o)   <U>Title
to Assets</U>. The Company and the Subsidiaries have good and marketable title in fee simple to all real property owned by them and good
and marketable title in all personal property owned by them that is material to the business of the Company and the Subsidiaries, in each
case free and clear of all Liens, except for (i) Liens as do not materially affect the value of such property and do not materially interfere
with the use made and proposed to be made of such property by the Company and the Subsidiaries and (ii) Liens for the payment of federal,
state or other taxes, for which appropriate reserves have been made therefor in accordance with GAAP and, the payment of which is neither
delinquent nor subject to penalties. Any real property and facilities held under lease by the Company and the Subsidiaries are held by
them under valid, subsisting and enforceable leases with which the Company and the Subsidiaries are in compliance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(p)   <U>Intellectual
Property</U>. The Company and the Subsidiaries have, or have rights to use, all patents, patent applications, trademarks, trademark applications,
service marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual property rights and similar rights
necessary or required for use in connection with their respective businesses as described in the SEC Reports and which the failure to
so have could have a Material Adverse Effect (collectively, the &ldquo;<U>Intellectual Property Rights</U>&rdquo;). Neither the Company
nor any Subsidiary has received a notice (written or otherwise) that any of, the Intellectual Property Rights has expired, terminated
or been abandoned, or is expected to expire or terminate or be abandoned, within two (2) years from the date of this Agreement except
where such action would not reasonably be expected to have a Material Adverse Effect. Neither the Company nor any Subsidiary has received,
since the date of the latest audited financial statements included within the SEC Reports, a written notice of a claim or otherwise has
any knowledge that the Intellectual Property Rights or any of the Company&rsquo;s products or planned products as described in the SEC
Reports violate or infringe upon the rights of any Person, except as could not have or reasonably be expected to not have a Material Adverse
Effect. To the knowledge of the Company, all such Intellectual Property Rights are enforceable and there is no existing infringement by
another Person of any of the Intellectual Property Rights. The Company and its Subsidiaries have taken reasonable security measures to
protect the secrecy, confidentiality and value of all of their intellectual properties, except where failure to do so could not, individually
or in the aggregate, reasonably be expected to have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(q)   <U>Insurance</U>.
The Company and the Subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks and in such
amounts as are prudent and customary in the businesses in which the Company and the Subsidiaries are engaged, including, but not limited
to, directors and officers insurance coverage at least equal to the aggregate Subscription Amount. Neither the Company nor any Subsidiary
has any reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain
similar coverage from similar insurers as may be necessary to continue its business without a significant increase in cost.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(r)   <U>Transactions
With Affiliates and Employees</U>. Except as set forth on <U>Schedule 3.1(r)</U>, none of the officers or directors of the Company or
any Subsidiary and, to the knowledge of the Company, none of the employees of the Company or any Subsidiary is presently a party to any
transaction with the Company or any Subsidiary (other than for services as employees, officers and directors), including any contract,
agreement or other arrangement providing for the furnishing of services to or by, providing for rental of real or personal property to
or from, providing for the borrowing of money from or lending of money to or otherwise requiring payments to or from any officer, director
or such employee or, to the knowledge of the Company, any entity in which any officer, director, or any such employee has a substantial
interest or is an officer, director, trustee, stockholder, member or partner, in each case in excess of $120,000 other than for (i) payment
of salary or consulting fees for services rendered, (ii) reimbursement for expenses incurred on behalf of the Company and (iii) other
employee benefits, including stock option agreements under any stock option plan of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(s)   <U>Sarbanes-Oxley;
Internal Accounting Controls</U>. The Company and the Subsidiaries are in compliance with any and all applicable requirements of the Sarbanes-Oxley
Act of 2002 that are effective as of the date hereof, and any and all applicable rules and regulations promulgated by the Commission thereunder
that are effective as of the date hereof and as of the Closing Date. Except as set forth in the SEC Reports, the Company and the Subsidiaries
maintain a system of internal accounting controls sufficient to provide reasonable assurance that: (i) transactions are executed in accordance
with management&rsquo;s general or specific authorizations, (ii) transactions are recorded as necessary to permit preparation of financial
statements in conformity with GAAP and to maintain asset accountability, (iii) access to assets is permitted only in accordance with management&rsquo;s
general or specific authorization, and (iv) the recorded accountability for assets is compared with the existing assets at reasonable
intervals and appropriate action is taken with respect to any differences. The Company and the Subsidiaries have established disclosure
controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e) for the Company and the Subsidiaries and designed such
disclosure controls and procedures to ensure that information required to be disclosed by the Company in the reports it files or submits
under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Commission&rsquo;s rules
and forms. The Company&rsquo;s certifying officers have evaluated the effectiveness of the disclosure controls and procedures of the Company
and the Subsidiaries as of the end of the period covered by the most recently filed periodic report under the Exchange Act (such date,
the &ldquo;<U>Evaluation Date</U>&rdquo;). The Company presented in its most recently filed periodic report under the Exchange Act the
conclusions of the certifying officers about the effectiveness of the disclosure controls and procedures based on their evaluations as
of the Evaluation Date. Since the Evaluation Date, there have been no changes in the internal control over financial reporting (as such
term is defined in the Exchange Act) of the Company and its Subsidiaries that have materially affected, or is reasonably likely to materially
affect, the internal control over financial reporting of the Company and its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(t)   <U>Certain
Fees</U>. Other than the compensation payable to the Placement Agent pursuant to the terms of the Placement Agency Agreement, no brokerage
or finder&rsquo;s fees or commissions are or will be payable by the Company or any Subsidiary to any broker, financial advisor or consultant,
finder, placement agent, investment banker, bank or other Person with respect to the transactions contemplated by the Transaction Documents
(for the avoidance of doubt, the foregoing shall not include any fees and/or commissions owed to the Depositary). Other than for Persons
engaged by any Purchaser, if any, the Purchasers shall have no obligation with respect to any fees or with respect to any claims made
by or on behalf of other Persons for fees of a type contemplated in this Section that may be due in connection with the transactions contemplated
by the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(u)   Private
Placement. Assuming the accuracy of the Purchaser&rsquo;s representations and warranties set forth in Section 3.2, no registration under
the Securities Act is required for the offer and sale of the Securities by the Company to the Purchasers as contemplated hereby. The issuance
and sale of the Securities hereunder does not contravene the rules and regulations of the Trading Market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(v)   <U>Investment
Company</U>. The Company is not, and is not an Affiliate of, and immediately after receipt of payment for the Securities, will not be
or be an Affiliate of, an &ldquo;investment company&rdquo; within the meaning of the Investment Company Act of 1940, as amended. The Company
shall conduct its business in a manner so that it will not become an &ldquo;investment company&rdquo; subject to registration under the
Investment Company Act of 1940, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(w)   <U>Registration
Rights</U>. Other than each of the Purchasers pursuant to the Warrants, no Person has any right to cause the Company or any Subsidiary
to effect the registration under the Securities Act of any securities of the Company or any Subsidiary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(x)   <U>Listing
and Maintenance Requirements</U>. The shares of Common Stock are registered pursuant to Section 12(b) or 12(g) of the Exchange Act, and
the Company has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration of
the Common Stocks under the Exchange Act nor has the Company received any notification that the Commission is contemplating terminating
such registration. Except as set forth in the Registration Statement, the Company has not, in the 12 months preceding the date hereof,
received notice from any Trading Market on which the Common Stock is or has been listed or quoted to the effect that the Company is not
in compliance with the listing or maintenance requirements of such Trading Market. Except as set forth in the Registration Statement,
the Company is, and has no reason to believe that it will not in the foreseeable future continue to be, in compliance with all such listing
and maintenance requirements. The Common Stock is currently eligible for electronic transfer through The Depository Trust Company or another
established clearing corporation and the Company is current in payment of the fees to The Depository Trust Company (or such other established
clearing corporation) in connection with such electronic transfer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(y)   <U>Application
of Takeover Protections</U>. The Company and the Board of Directors have taken all necessary action, if any, in order to render inapplicable
any control share acquisition, business combination, poison pill (including any distribution under a rights agreement) or other similar
anti-takeover provision under the Company&rsquo;s certificate of incorporation (or similar charter documents) or the laws of its state
of incorporation that is or could become applicable to the Purchasers as a result of the Purchasers and the Company fulfilling their obligations
or exercising their rights under the Transaction Documents, including without limitation as a result of the Company&rsquo;s issuance of
the Securities and the Purchasers&rsquo; ownership of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(z)   <U>Disclosure</U>.
Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents, the Company confirms
that neither it nor any other Person acting on its behalf has provided any of the Purchasers or their agents or counsel with any information
that it believes constitutes or might constitute material, non-public information which is not otherwise disclosed in the Disclosure Schedules.
The Company understands and confirms that the Purchasers will rely on the foregoing representation in effecting transactions in securities
of the Company. All of the disclosure furnished by or on behalf of the Company to the Purchasers regarding the Company and its Subsidiaries,
their respective businesses and the transactions contemplated hereby, including the Disclosure Schedules to this Agreement, is true and
correct and does not contain any untrue statement of a material fact or omit to state any material fact necessary in order to make the
statements made therein, in the light of the circumstances under which they were made, not misleading. The press releases disseminated
by the Company during the twelve months preceding the date of this Agreement taken as a whole do not contain any untrue statement of a
material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in
light of the circumstances under which they were made and when made, not misleading. The Company acknowledges and agrees that no Purchaser
makes or has made any representations or warranties with respect to the transactions contemplated hereby other than those specifically
set forth in Section 3.2 hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(aa) <U>No Integrated Offering</U>.
Assuming the accuracy of the Purchasers&rsquo; representations and warranties set forth in Section 3.2, neither the Company, nor any of
its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly, made any offers or sales of any security or
solicited any offers to buy any security, under circumstances that would cause this offering of the Securities to be integrated with prior
offerings by the Company for purposes of (i) the Securities Act which would require the registration of any such securities under the
Securities Act, or (ii) any applicable shareholder approval provisions of any Trading Market on which any of the securities of the Company
are listed or designated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(bb) <U>Solvency</U>. Based
on the consolidated financial condition of the Company as of the Closing Date, after giving effect to the receipt by the Company of the
proceeds from the sale of the Securities hereunder, (i) the fair saleable value of the Company&rsquo;s assets exceeds the amount that
will be required to be paid on or in respect of the Company&rsquo;s existing debts and other liabilities (including known contingent liabilities)
as they mature, (ii) the Company&rsquo;s assets do not constitute unreasonably small capital to carry on its business as now conducted
and as proposed to be conducted including its capital needs taking into account the particular capital requirements of the business conducted
by the Company, consolidated and projected capital requirements and capital availability thereof, and (iii) the current cash flow of the
Company, together with the proceeds the Company would receive, were it to liquidate all of its assets, after taking into account all anticipated
uses of the cash, would be sufficient to pay all amounts on or in respect of its liabilities when such amounts are required to be paid.
The Company does not intend to incur debts beyond its ability to pay such debts as they mature (taking into account the timing and amounts
of cash to be payable on or in respect of its debt). The Company has no knowledge of any facts or circumstances which lead it to believe
that it will file for reorganization or liquidation under the bankruptcy or reorganization laws of any jurisdiction within one year from
the Closing Date. <U>Schedule 3.1(bb)</U> sets forth as of the date hereof all outstanding secured and unsecured Indebtedness of the Company
or any Subsidiary, or for which the Company or any Subsidiary has commitments. For the purposes of this Agreement, &ldquo;<U>Indebtedness</U>&rdquo;
means (x) any liabilities for borrowed money or amounts owed in excess of $50,000 (other than trade accounts payable incurred in the ordinary
course of business), (y) all guaranties, endorsements and other contingent obligations in respect of indebtedness of others, whether or
not the same are or should be reflected in the Company&rsquo;s consolidated balance sheet (or the notes thereto), except guaranties by
endorsement of negotiable instruments for deposit or collection or similar transactions in the ordinary course of business; and (z) the
present value of any lease payments in excess of $50,000 due under leases required to be capitalized in accordance with GAAP. Neither
the Company nor any Subsidiary is in default with respect to any Indebtedness.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(cc) <U>Tax Status</U>.
Except for matters that would not, individually or in the aggregate, have or reasonably be expected to result in a Material Adverse Effect,
the Company and its Subsidiaries each (i) has made or filed all United States federal, state and local income and all foreign income and
franchise tax returns, reports and declarations required by any jurisdiction to which it is subject, (ii) has paid all taxes and other
governmental assessments and charges that are material in amount, shown or determined to be due on such returns, reports and declarations
and (iii) has set aside on its books provision reasonably adequate for the payment of all material taxes for periods subsequent to the
periods to which such returns, reports or declarations apply. There are no unpaid taxes in any material amount claimed to be due by the
taxing authority of any jurisdiction, and the officers of the Company or of any Subsidiary know of no basis for any such claim. The term
&ldquo;taxes&rdquo; mean all federal, state, local, foreign, and other net income, gross income, gross receipts, sales, use, ad valorem,
transfer, franchise, profits, license, lease, service, service use, withholding, payroll, employment, excise, severance, stamp, occupation,
premium, property, windfall profits, customs, duties or other taxes, fees, assessments, or charges of any kind whatsoever, together with
any interest and any penalties, additions to tax, or additional amounts with respect thereto. The term &ldquo;returns&rdquo; means all
returns, declarations, reports, statements, and other documents required to be filed in respect to taxes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(dd) <U>No General Solicitation</U>.
Neither the Company nor any Person acting on behalf of the Company has offered or sold any of the Securities by any form of general solicitation
or general advertising. The Company has offered the Securities for sale only to the Purchasers and certain other &ldquo;accredited investors&rdquo;
within the meaning of Rule 501 under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ee) <U>Foreign Corrupt
Practices</U>. Neither the Company nor any Subsidiary, nor to the knowledge of the Company or any Subsidiary, any agent or other person
acting on behalf of the Company or any Subsidiary, has (i) directly or indirectly, used any funds for unlawful contributions, gifts, entertainment
or other unlawful expenses related to foreign or domestic political activity, (ii) made any unlawful payment to foreign or domestic government
officials or employees or to any foreign or domestic political parties or campaigns from corporate funds, (iii) failed to disclose fully
any contribution made by the Company or any Subsidiary (or made by any person acting on its behalf of which the Company is aware) which
is in violation of law, or (iv) violated in any material respect any provision of FCPA. The Company has taken reasonable steps to ensure
that its accounting controls and procedures are sufficient to cause the Company to comply in all material respects with the FCPA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ff) <U>Accountants</U>.
The Company&rsquo;s registered independent accounting firm is Enrome, LLP .To the knowledge and belief of the Company, such accounting
firm (i) is a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the
financial statements to be included in the Company&rsquo;s Annual Report for the fiscal year ended December 31, 2022. WWC, P.C. was the
previous registered independent accounting firm of the Company. To the knowledge and belief of the Company, such accounting firm (i) is
a registered public accounting firm as required by the Exchange Act and (ii) shall express its opinion with respect to the financial statements
to be included in the Company&rsquo;s Annual Report for the fiscal year ended December 31, 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(gg) No Disagreements with
Accountants and Lawyers. There are no disagreements of any kind presently existing, or reasonably anticipated by the Company to arise,
between the Company and the accountants and lawyers formerly or presently engaged by the Company and the Company is current with respect
to any fees owed to its accountants and lawyers which could affect the Company&rsquo;s ability to perform any of its obligations under
any of the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(hh) <U>Acknowledgment
Regarding Purchasers&rsquo; Purchase of Securities</U>. The Company acknowledges and agrees that each of the Purchasers is acting solely
in the capacity of an arm&rsquo;s length purchaser with respect to the Transaction Documents and the transactions contemplated thereby.
The Company further acknowledges that no Purchaser is acting as a financial advisor or fiduciary of the Company (or in any similar capacity)
with respect to the Transaction Documents and the transactions contemplated thereby and any advice given by any Purchaser or any of their
respective representatives or agents in connection with the Transaction Documents and the transactions contemplated thereby is merely
incidental to the Purchasers&rsquo; purchase of the Securities. The Company further represents to each Purchaser that the Company&rsquo;s
decision to enter into this Agreement and the other Transaction Documents has been based solely on the independent evaluation of the transactions
contemplated hereby by the Company and its representatives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ii)   <U>Acknowledgment
Regarding Purchaser&rsquo;s Trading Activity</U>. Anything in this Agreement or elsewhere herein to the contrary notwithstanding (except
for Sections 3.2(f) and 4.13 hereof), it is understood and acknowledged by the Company that: (i) none of the Purchasers has been asked
by the Company to agree, nor has any Purchaser agreed, to desist from purchasing or selling, long and/or short, securities of the Company,
or &ldquo;derivative&rdquo; securities based on securities issued by the Company or to hold the shares of Common Stock for any specified
term; (ii) past or future open market or other transactions by any Purchaser, specifically including, without limitation, Short Sales
or &ldquo;derivative&rdquo; transactions, before or after the closing of this or future, private, placement transactions, may negatively
impact the market price of the Company&rsquo;s publicly-traded securities; (iii) any Purchaser, and counter-parties in &ldquo;derivative&rdquo;
transactions to which any such Purchaser is a party, directly or indirectly, presently may have a &ldquo;short&rdquo; position in the
Common Stock, and (iv) each Purchaser shall not be deemed to have any affiliation with or control over any arm&rsquo;s length counter-party
in any &ldquo;derivative&rdquo; transaction. The Company further understands and acknowledges that (y) one or more Purchasers may engage
in hedging activities at various times during the period that the Securities are outstanding, including, without limitation, during the
periods that the value of the Warrants are being determined, and (z) such hedging activities (if any) could reduce the value of the existing
shareholders&rsquo; equity interests in the Company at and after the time that the hedging activities are being conducted. The Company
acknowledges that such aforementioned hedging activities do not constitute a breach of any of the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(jj) <U>Regulation M Compliance</U>.
The Company has not, and to its knowledge no one acting on its behalf has, (i) taken, directly or indirectly, any action designed to cause
or to result in the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of any
of the Securities, (ii) sold, bid for, purchased, or, paid any compensation for soliciting purchases of, any of the Securities, or (iii)
paid or agreed to pay to any Person any compensation for soliciting another to purchase any other securities of the Company, other than,
in the case of clauses (ii) and (iii), compensation paid to the Placement Agent in connection with the placement of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(kk) <U>[Reserved]</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ll) <U>Share Incentive
Plans</U>. Each stock option granted by the Company under the Company&rsquo;s share incentive plans was granted (i) in accordance with
the terms of the Company&rsquo;s share incentive plans and (ii) with an exercise price at least equal to the fair market value of the
Common Stock on the date such stock option would be considered granted under GAAP and applicable law. No stock option granted under the
Company&rsquo;s share incentive plans has been backdated. The Company has not knowingly granted, and there is no and has been no Company
policy or practice to knowingly grant, stock options prior to, or otherwise knowingly coordinate the grant of stock options with, the
release or other public announcement of material information regarding the Company or its Subsidiaries or their financial results or prospects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(mm) <U>Office of Foreign
Assets Control</U>. Neither the Company nor any Subsidiary nor, to the Company&rsquo;s knowledge, any director, officer, agent, employee
or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the Office of Foreign Assets
Control of the U.S. Treasury Department (&ldquo;<U>OFAC</U>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(nn) <U>U.S. Real Property
Holding Corporation</U>. The Company is not and has never been a U.S. real property holding corporation within the meaning of Section
897 of the Internal Revenue Code of 1986, as amended, and the Company shall so certify upon Purchaser&rsquo;s request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(oo)   <U>Bank
Holding Company Act</U>. Neither the Company nor any of its Subsidiaries or Affiliates is subject to the Bank Holding Company Act of 1956,
as amended (the &ldquo;<U>BHCA</U>&rdquo;) and to regulation by the Board of Governors of the Federal Reserve System (the &ldquo;<U>Federal
Reserve</U>&rdquo;). Neither the Company nor any of its Subsidiaries or Affiliates owns or controls, directly or indirectly, five percent
(5%) or more of the outstanding shares of any class of voting securities or twenty-five percent or more of the total equity of a bank
or any entity that is subject to the BHCA and to regulation by the Federal Reserve. Neither the Company nor any of its Subsidiaries or
Affiliates exercises a controlling influence over the management or policies of a bank or any entity that is subject to the BHCA and to
regulation by the Federal Reserve.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(pp) <U>Money Laundering</U>.
The operations of the Company and its Subsidiaries are and have been conducted at all times in compliance with applicable financial record-keeping
and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, applicable money laundering statutes
and applicable rules and regulations thereunder (collectively, the &ldquo;<U>Money Laundering Laws</U>&rdquo;), and no Action or Proceeding
by or before any court or governmental agency, authority or body or any arbitrator involving the Company or any Subsidiary with respect
to the Money Laundering Laws is pending or, to the knowledge of the Company or any Subsidiary, threatened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(qq) <U>No Disqualification
Events</U>. With respect to the Securities to be offered and sold hereunder in reliance on Rule 506 under the Securities Act, none of
the Company, any of its predecessors, any affiliated issuer, any director, executive officer, other officer of the Company participating
in the offering hereunder, any beneficial owner of 20% or more of the Company&rsquo;s outstanding voting equity securities, calculated
on the basis of voting power, nor any promoter (as that term is defined under Rule 405 of the Securities Act) connected with the Company
in any capacity at the same of sale (each, an &ldquo;Issuer Covered Person and, together, &ldquo;Issuer Covered Persons&rdquo;) is subject
to any of the &ldquo;Bad Actor&rdquo; disqualifications described in Rule 506(d)(1)(i) to (viii) under the Securities Act (a &ldquo;Disqualification
Event&rdquo;), except for a Disqualification Event covered by Rule 506(d)(2) or (d)(3). The Company has exercised reasonable care to determine
whether any Issuer Covered Person is subject to a Disqualification Event. The Company has complied, to the extent applicable, with its
disclosure obligations under Rule 506(e), and has furnished to the Purchasers a copy of any disclosures provided thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(rr) <U>Other Covered Persons</U>.
Other than the Placement Agent, the Company is not aware of any person (other than any Issuer Covered Person) that has been or will be
paid (directly or indirectly) remuneration for solicitation of purchasers in connection with the sale of any Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ss) <U>Notice of Disqualification
Events</U>. The Company will notify the Purchasers and the Placement Agent in writing, prior to the Closing Date of (i) any Disqualification
Event relating to any Issuer Covered Person and (ii) any event that would, with the passage of time, become a Disqualification Event relating
to any Issuer Covered Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.2   <U>Representations
and Warranties of the Purchasers</U>. Each Purchaser, for itself and for no other Purchaser, hereby represents and warrants as of the
date hereof and as of the Closing Date to the Company as follows (unless as of a specific date therein, in which case they shall be accurate
as of such date):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)   <U>Organization;
Authority</U>. Such Purchaser is either an individual or an entity duly incorporated or formed, validly existing and in good standing
under the laws of the jurisdiction of its incorporation or formation with full right, corporate, partnership limited liability company
or similar power and authority to enter into and to consummate the transactions contemplated by the Transaction Documents and otherwise
to carry out its obligations hereunder and thereunder. The execution and delivery of the Transaction Documents and performance by such
Purchaser of the transactions contemplated by the Transaction Documents have been duly authorized by all necessary corporate, partnership,
limited liability company or similar action, as applicable, on the part of such Purchaser. Each Transaction Document to which it is a
party has been duly executed by such Purchaser, and when delivered by such Purchaser in accordance with the terms hereof, will constitute
the valid and legally binding obligation of such Purchaser, enforceable against it in accordance with its terms, except: (i) as limited
by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application
affecting enforcement of creditors&rsquo; rights generally, (ii) as limited by laws relating to the availability of specific performance,
injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable
law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)   <U>Own
Account</U>. Such Purchaser understands that the Securities are &ldquo;restricted securities&rdquo; and have not been registered under
the Securities Act or any applicable state securities law and is acquiring the Securities as principal for its own account and not with
a few to or for distributing or reselling such Securities or any part thereof in violation of the Securities Act or any applicable state
securities law, has no present intention of distribution any of such Securities in violation of the Securities Act or any applicable state
securities law and has no direct or indirect arrangement or understandings with any other persons to distribute or regarding the distribution
of such Securities in violation of the Securities Act or any applicable state securities law (this representation and warranty not limiting
such Purchaser&rsquo;s right to sell the Securities pursuant to the Registration Statement or otherwise in compliance with applicable
federal and state securities laws). Such Purchaser is acquiring the Securities hereunder in the ordinary course of its business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)   <U>Purchaser
Status</U>. At the time such Purchaser was offered the Securities, it was, and as of the date hereof it is, and on each date on which
it exercises any Warrants, it will be either: (i) an &ldquo;accredited investor&rdquo; as defined in Rule 501(a)(1), (a)(2), (a)(3), (a)(7)
or (a)(8) under the Securities Act or (ii) a &ldquo;qualified institutional buyer&rdquo; as defined in Rule 144A(a) under the Securities
Act. Such Purchaser hereby represents that neither such Purchaser not any of its Rule 506(d) Related Parties (as defined below) is a &ldquo;bad
actor&rdquo; within the meaning of Rule 506(d) promulgated under the Securities Act. For purpose of this Agreement, &ldquo;Rule 506(d)
Related Party&rdquo; shall mean a person or entity covered by the &ldquo;Bad Actor disqualification&rdquo; provision of Rule 506(d) of
the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)   <U>Experience
of Such Purchaser</U>. Such Purchaser, either alone or together with its representatives, has such knowledge, sophistication and experience
in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment in the Securities,
and has so evaluated the merits and risks of such investment. Such Purchaser is able to bear the economic risk of an investment in the
Securities and, at the present time, is able to afford a complete loss of such investment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">General Solicitation. Such
Purchaser is not, to such Purchaser&rsquo;s knowledge, purchasing the Securities as a result of any advertisement, article, notice or
other communication regarding the Securities published in any newspaper, magazine or similar media or broadcast over television or radio
or presented at any seminar or, to the knowledge of such Purchaser, any other general solicitation or general advertisement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)   <U>Access
to Information</U>. Such Purchaser acknowledges that it has had the opportunity to review the Transaction Documents (including all exhibits
and schedules thereto) and the SEC Reports and has been afforded, (i) the opportunity to ask such questions as it has deemed necessary
of, and to receive answers from, representatives of the Company concerning the terms and conditions of the offering of the Securities
and the merits and risks of investing in the Securities; (ii) access to information about the Company and its financial condition, results
of operations, business, properties, management and prospects sufficient to enable it to evaluate its investment; and (iii) the opportunity
to obtain such additional information that the Company possesses or can acquire without unreasonable effort or expense that is necessary
to make an informed investment decision with respect to the investment. Such Purchaser acknowledges and agrees that neither the Placement
Agent nor any Affiliate of the Placement Agent has provided such Purchaser with any information or advice with respect to the Securities
nor is such information or advice necessary or desired. Neither the Placement Agent nor any Affiliate has made or makes any representation
as to the Company or the quality of the Securities and the Placement Agent and any Affiliate may have acquired non-public information
with respect to the Company which such Purchaser agrees need not be provided to it. In connection with the issuance of the Securities
to such Purchaser, neither the Placement Agent nor any of its Affiliates has acted as a financial advisor or fiduciary to such Purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f)   <U>Certain
Transactions and Confidentiality</U>. Other than consummating the transactions contemplated hereunder, such Purchaser has not, nor has
any Person acting on behalf of or pursuant to any understanding with such Purchaser, directly or indirectly executed any purchases or
sales, including Short Sales, of the securities of the Company during the period commencing as of the time that such Purchaser first received
a term sheet (written or oral) from the Company or any other Person representing the Company setting forth the material pricing terms
of the transactions contemplated hereunder and ending immediately prior to the execution hereof. Notwithstanding the foregoing, in the
case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of such Purchaser&rsquo;s
assets and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers managing other portions
of such Purchaser&rsquo;s assets, the representation set forth above shall only apply with respect to the portion of assets managed by
the portfolio manager that made the investment decision to purchase the Securities covered by this Agreement. Other than to other Persons
party to this Agreement or to such Purchaser&rsquo;s representatives, including, without limitation, its officers, directors, partners,
legal and other advisors, employees, agents and Affiliates, such Purchaser has maintained the confidentiality of all disclosures made
to it in connection with this transaction (including the existence and terms of this transaction). Notwithstanding the foregoing, for
the avoidance of doubt, nothing contained herein shall constitute a representation or warranty, or preclude any actions, with respect
to locating or borrowing shares in order to effect Short Sales or similar transactions in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g)   <U>Ownership
of Company Securities</U>. Except as disclosed in writing to the Company as of the date of this Agreement, no Purchaser, any of its Affiliates,
or any other Persons whose beneficial ownership of shares of Common Stock would be aggregated with the Purchaser&rsquo;s for purposes
of Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, including any &ldquo;group&rdquo; of which
the Purchaser is a member, directly or indirectly owns, beneficially or otherwise (including solely with respect to an economic interest),
any of the outstanding shares of Common Stock, or any other shares of capital stock, options, warrants, derivative securities, rights
or any other securities (including any securities convertible into, exchangeable for or that represent the right to receive securities)
of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company acknowledges and agrees that the representations
contained in this Section 3.2 shall not modify, amend or affect such Purchaser&rsquo;s right to rely on the Company&rsquo;s representations
and warranties contained in this Agreement or any representations and warranties contained in any other Transaction Document or any other
document or instrument executed and/or delivered in connection with this Agreement or the consummation of the transactions contemplated
hereby. Notwithstanding the foregoing, for the avoidance of doubt, nothing contained herein shall constitute a representation or warranty,
or preclude any actions, with respect to locating or borrowing shares in order to effect Short Sales or similar transactions in the future.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif">ARTICLE
IV</FONT><BR>
OTHER AGREEMENTS OF THE PARTIES</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.1   <U>Transfer
Restrictions</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)   The
Securities may only be disposed of in compliance with state and federal securities laws. In connection with any transfer of Securities
other than pursuant to an effective registration statement or Rule 144, to the Company or to an Affiliate of a Purchaser or in connection
with a pledge as contemplated in Section 4.1(b), the Company may require the transferor thereof to provide to the Company an opinion of
counsel selected by the transferor and reasonably acceptable to the Company, the form and substance of which opinion shall be reasonably
satisfactory to the Company, to the effect that such transfer does not require registration of such transferred Securities under the Securities
Act. As a condition of transfer, any such transferee shall agree in writing to be bound by the terms of this Agreement and the Warrants
and shall have the rights and obligations of a Purchaser under this Agreement and the Warrants.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(b) The Purchasers
agree to the imprinting, so long as is required by this Section 4.1, of a legend on any of the Securities in substantially the following
form:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">NEITHER THIS SECURITY NOR THE SECURITIES
INTO WHICH THIS SECURITY IS EXERCISABLE HAS BEEN] REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION
OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE &ldquo;SECURITIES ACT&rdquo;),
AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT
TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE
WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION
WITH A BONA FIDE MARGIN ACCOUNT WITH A REGISTERED BROKER-DEALER OR OTHER LOAN WITH A FINANCIAL INSTITUTION THAT IS AN &ldquo;ACCREDITED
INVESTOR&rdquo; AS DEFINED IN RULE 501(a) UNDER THE SECURITIES ACT OR OTHER LOAN SECURED BY SUCH SECURITIES.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">The Company acknowledges
and agrees that a Purchaser may from time to time pledge pursuant to a bona fide margin agreement with a registered broker-dealer or grant
a security interest in some or all of the Securities to a financial institution that is an &ldquo;accredited investor&rdquo; as defined
in Rule 501(a) under the Securities Act and, if required under the terms of such arrangement, such Purchaser may transfer pledged or secured
Securities to the pledgees or secured parties. Such a pledge or transfer would not be subject to approval of the Company and no legal
opinion of legal counsel of the pledgee, secured party or pledgor shall be required in connection therewith. Further, no notice shall
be required of such pledge. At the appropriate Purchaser&rsquo;s expense, the Company will execute and deliver such reasonable documentation
as a pledgee or secured party of Securities may reasonably request in connection with a pledge or transfer of the Securities, including,
if the Securities are subject to registration pursuant to the Warrants, the preparation and filing of any required prospectus supplement
under Rule 424(b)(3) under the Securities Act or other applicable provision of the Securities Act to appropriately amend the list of selling
shareholders thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(c) Certificates
evidencing Warrant Shares shall not contain any legend (including the legend set forth in Section 4.1(b) hereof), (i) while a registration
statement (including the Registration Statement) covering the resale of such security is effective under the Securities Act, (ii) following
any sale of such Offered Shares or Warrant Shares pursuant to Rule 144 and the Company is then in compliance with the current public information
required under Rule 144 (assuming cashless exercise of the Warrants), (iii) if such Offered Shares or Warrant Shares are eligible for
sale or may be sold under Rule 144 (assuming cashless exercise of the Warrants) without volume or manner-of-sale restrictions, or (iv)
if such legend is not required under applicable requirements of the Securities Act (including judicial interpretations and pronouncements
issued by the staff of the Commission). The Company shall, following request by a Purchaser, if the applicable Securities are then eligible
for legend removal, cause its counsel to issue a legal opinion to the Transfer Agent or the Purchaser if required by the Transfer Agent
to effect the removal of the legend hereunder. If all or any portion of a Warrant is exercised at a time when there is an effective registration
statement to cover the resale of the Warrant Shares, if Warrant Shares may be sold under Rule 144 and the Company is then in compliance
with the current public information required under Rule 144 (assuming cashless exercise of the Warrants), or if the Warrant Shares may
be sold under Rule 144 without the requirement for the Company to be in compliance with the current public information required under
Rule 144 as to such Offered Shares or Warrant Shares or if such legend is not otherwise required under applicable requirements of the
Securities Act (including judicial interpretations and pronouncements issued by the staff of the Commission), then such Offered Shares
or Warrant Shares shall be issued free of all legends. The Company agrees that following the Effective Date or at such time as such legend
is no longer required under this Section 4.1(c), it will, no later than the earlier of (i) two (2) Trading Days and (ii) the number of
Trading Days comprising the Standard Settlement Period (as defined below) following the delivery by a Purchaser to the Company or the
Transfer Agent of a certificate representing Offered Shares or Warrant Shares, as the case may be, issued with a restrictive legend (such
date, the &ldquo;<U>Legend Removal Date</U>&rdquo;), deliver or cause to be delivered to such Purchaser a certificate representing such
shares that is free from all restrictive and other legends. The Company may not make any notation on its records or give instructions
to the Transfer Agent that enlarge the restrictions on transfer set forth in this Section 4. Certificates for Securities subject to legend
removal hereunder shall be transmitted by the Transfer Agent to the Purchaser by crediting the account of the Purchaser&rsquo;s prime
broker with the Depository Trust Company System as directed by such Purchaser. As used herein, &ldquo;Standard Settlement Period&rdquo;
means the standard settlement period, expressed in a number of Trading Days, on the Company&rsquo;s primary Trading Market with respect
to the shares of Common Stock as in effect on the date of delivery of a certificate representing Offered Shares or Warrants Shares, as
the case may be, issued with a restrictive legend.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(d) In addition
to such Purchaser&rsquo;s other available remedies, the Company shall pay to a Purchaser, in cash, (i) as partial liquidated damages and
not as a penalty, for each $1,000 of the Warrant Shares (based on the VWAP of the shares of Common Stock on the date such Securities are
submitted to the Transfer Agent) delivered for removal of the restrictive legend and subject to Section 4.1(c), $10 per Trading Day (increasing
to $20 per Trading Day five (5) Trading Days after such damages have begun to accrue) for each Trading Day after the Legend Removal Date
until such certificate is delivered without a legend and (ii) if the Company fails to (a) issue and deliver (or cause to be delivered)
to a Purchaser by the Legend Removal Date a certificate representing the Securities so delivered to the Company by such Purchaser that
is free from all restrictive and other legends and (b) if after the Legend Removal Date such Purchaser purchases (in an open market transaction
or otherwise) shares of Common Stock to deliver in satisfaction of a sale by such Purchaser of all or any portion of the number of shares
of Common Stock, or a sale of a number of shares of Common Stock equal to all or any portion of the number of shares of Common Stock that
such Purchaser anticipated receiving from the Company without any restrictive legend, then, an amount equal to the excess of such Purchaser&rsquo;s
total purchase price (including brokerage commissions and other out-of-pocket expenses, if any) for the shares of Common Stock so purchased
(including brokerage commissions and other out-of-pocket expenses, if any) (the &ldquo;<U>Buy-In Price</U>&rdquo;) over the product of
(A) such number of Offered Shares or Warrant Shares that the Company was required to deliver to such Purchaser by the Legend Removal Date
multiplied by (B) the lowest closing sale price of the shares of Common Stock on any Trading Day during the period commencing on the date
of the delivery by such Purchaser to the Company of the applicable Offered Shares or Warrant Shares (as the case may be) and ending on
the date of such delivery and payment under this clause (ii).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(e) Each Purchaser,
severally and not jointly with the other Purchasers, agrees with the Company that such Purchaser will sell any Securities pursuant to
either the registration requirements of the Securities Act, including any applicable prospectus delivery requirements, or an exemption
therefrom, and that if Securities are sold pursuant to a Registration Statement, they will be sold in compliance with the plan of distribution
set forth therein, and acknowledges that the removal of the restrictive legend from certificates representing Securities as set forth
in this Section 4.1 is predicated upon the Company&rsquo;s reliance upon this understanding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.2   <U>Furnishing
of Information; Public Information</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)   Until
the earliest of the time that (i) no Purchaser owns Securities or (ii) the Warrants have expired, the Company covenants to timely file
(or obtain extensions in respect thereof and file within the applicable grace period) all reports required to be filed by the Company
after the date hereof pursuant to the Exchange Act even if the Company is not then subject to the reporting requirements of the Exchange
Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)   At
any time during the period commencing from the six (6) month anniversary of the date hereof and ending at such time that all of the Securities
(assuming cashless exercise for the Warrants) may be sold without the requirement for the Company to be in compliance with Rule 144(c)(1)
and otherwise without restriction or limitation pursuant to Rule 144, if the Company (i) shall fail for any reason to satisfy the current
public information requirement under Rule 144(c) or (ii) has ever been an issuer described in Rule 144(i)(1)(i) or becomes such an issuer
in the future, and the Company shall fail to satisfy any condition set forth in Rule 144(i)(2) (a &ldquo;Public Information Failure&rdquo;)
then, in addition to such Purchaser&rsquo;s other available remedies, the Company shall pay to a Purchaser, in cash, as partial liquidated
damages and not as a penalty, by reason of any such delay in or reduction of its ability to sell the Securities, an amount in cash equal
to two percent (2.0%) of the aggregate Subscription Amount of such Purchaser&rsquo;s Securities on the day of a Public Information Failure
and on every thirtieth (30th) day (pro-rated for periods totaling less than thirty days) thereafter until the earlier of (a) the date
such Public Information Failure is cured and (b) such time that such public information is no longer required for the Purchasers to transfer
the Warrant Shares pursuant to Rule 144. The payments to which a Purchaser shall be entitled pursuant to this Section 4.2(b) are referred
to herein as &ldquo;Public Information Failure Payments.&rdquo; Public Information Failure Payments shall be paid on the earlier of (i)
the last day of the calendar month during which such Public Information Failure Payments are incurred and (ii) the third (3rd) Business
Day after the event or failure giving rise to the Public Information Failure Payments is cured. In the event the Company fails to make
Public Information Failure Payments in a timely manner, such Public Information Failure Payments shall bear interest at the rate of 1.5%
per month (prorated for partial months) until paid in full. Nothing herein shall limit such Purchaser&rsquo;s right to pursue actual damages
for the Public Information Failure, and such Purchaser shall have the right to pursue all remedies available to it at law or in equity
including, without limitation, a decree of specific performance and/or injunctive relief.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.3   <U>Integration</U>.
The Company shall not sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security (as defined in Section
2 of the Securities Act) that would be integrated with the offer or sale of the Securities in a manner that would require the registration
under the Securities Act of the Sale of Securities or that would be integrated with the offer or sale of the Securities for purposes of
the rules and regulations of any Trading Market such that it would require shareholder approval prior to the closing of such other transaction
unless shareholder approval is obtained before the closing of such subsequent transaction..</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.4   <U>Securities
Laws Disclosure; Publicity</U>. The Company shall (a) by 9:00 a.m. (New York City time) on the date following the date hereof issue a
press release disclosing the material terms of the transactions contemplated hereby, and (b) file a Report on Form 8-K, including the
Transaction Documents as exhibits thereto, with the Commission within the time required by the Exchange Act. From and after the issuance
of such press release, the Company represents to the Purchasers that it shall have publicly disclosed all material, non-public information
delivered to any of the Purchasers by the Company or any of its Subsidiaries, or any of their respective officers, directors, employees
or agents in connection with the transactions contemplated by the Transaction Documents, including, without limitation, the Placement
Agent. In addition, effective upon the issuance of such press release, the Company acknowledges and agrees that any and all confidentiality
or similar obligations under any agreement, whether written or oral, between the Company, any of its Subsidiaries or any of their respective
officers, directors, agents (including the Placement Agent), employees or Affiliates on the one hand, and any of the Purchasers or any
of their Affiliates on the other hand, shall terminate. The Company and each Purchaser shall consult with each other in issuing any other
press releases with respect to the transactions contemplated hereby, and neither the Company nor any Purchaser shall issue any such press
release nor otherwise make any such public statement without the prior consent of the Company, with respect to any press release of any
Purchaser, or without the prior consent of each Purchaser, with respect to any press release of the Company, which consent shall not unreasonably
be withheld or delayed, except if such disclosure is required by law, in which case the disclosing party shall promptly provide the other
party with prior notice of such public statement or communication. Notwithstanding the foregoing, the Company shall not publicly disclose
the name of any Purchaser, or include the name of any Purchaser in any filing with the Commission or any regulatory agency or Trading
Market, without the prior written consent of such Purchaser, except (a) as required by federal securities law in connection with (i) any
registration statement contemplated by this Agreement or the Warrants and (ii) the filing of final Transaction Documents with the Commission
and (b) to the extent such disclosure is required by law or Trading Market or FINRA regulations, in which case the Company shall provide
the Purchasers with prior notice of such disclosure permitted under this clause (b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.5   <U>Shareholder
Rights Plan</U>. No claim will be made or enforced by the Company or, with the consent of the Company, any other Person, that any Purchaser
is an &ldquo;<U>Acquiring Person</U>&rdquo; under any control share acquisition, business combination, poison pill (including any distribution
under a rights agreement) or similar anti-takeover plan or arrangement in effect or hereafter adopted by the Company, or that any Purchaser
could be deemed to trigger the provisions of any such plan or arrangement, by virtue of receiving Securities under the Transaction Documents
or under any other agreement between the Company and the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.6   <U>Non-Public
Information</U>. Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents,
which shall be disclosed pursuant to Section 4.4, the Company covenants and agrees that neither it, nor any other Person acting on its
behalf will provide any Purchaser or its agents or counsel with any information that constitutes, or the Company reasonably believes constitutes,
material non-public information, unless prior thereto such Purchaser shall have consented to the receipt of such information and agreed
with the Company to keep such information confidential. The Company understands and confirms that each Purchaser shall be relying on the
foregoing covenant in effecting transactions in securities of the Company. To the extent that the Company delivers any material, non-public
information to a Purchaser without such Purchaser&rsquo;s consent, the Company hereby covenants and agrees that such Purchaser shall not
have any duty of confidentiality to the Company, any of its Subsidiaries, or any of their respective officers, directors, agents, employees
or Affiliates, or a duty to the Company, any of its Subsidiaries or any of their respective officers, directors, agents, employees or
Affiliates not to trade on the basis of, such material, non-public information, provided that the Purchaser shall remain subject to applicable
law. To the extent that any notice provided pursuant to any Transaction Document constitutes, or contains, material, non-public information
regarding the Company or any Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a Report
on Form 8-K. The Company understands and confirms that each Purchaser shall be relying on the foregoing covenant in effecting transactions
in securities of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.7   <U>Use
of Proceeds</U>. Except as set forth on <U>Schedule 4.7</U> attached hereto, the Company shall use the net proceeds from the sale of the
Securities hereunder for working capital purposes and general business purposes and shall not use such proceeds: (a) for the satisfaction
of any portion of the Company&rsquo;s Indebtedness (other than payment of trade payables in the ordinary course of the Company&rsquo;s
business and prior practices), (b) for the redemption of any shares of Common Stock or Common Stock Equivalents, (c) for the settlement
of any outstanding litigation or (d) in violation of FCPA or OFAC regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.8   <U>Indemnification
of Purchasers</U>. Subject to the provisions of this Section 4.8, the Company will indemnify and hold each Purchaser and its directors,
officers, shareholders, members, partners, employees and agents (and any other Persons with a functionally equivalent role of a Person
holding such titles notwithstanding a lack of such title or any other title), each Person who controls such Purchaser (within the meaning
of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers, shareholders, agents, members, partners
or employees (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding a lack of such
title or any other title) of such controlling persons (each, a &ldquo;<U>Purchaser Party</U>&rdquo;) harmless from any and all losses,
liabilities, obligations, claims, contingencies, damages, costs and expenses, including all judgments, amounts paid in settlements, court
costs and reasonable attorneys&rsquo; fees and costs of investigation that any such Purchaser Party may suffer or incur as a result of
or relating to (a) any breach of any of the representations, warranties, covenants or agreements made by the Company in this Agreement
or in the other Transaction Documents, (b) any action instituted against the Purchaser Parties in any capacity, or any of them or their
respective Affiliates, by any stockholder of the Company who is not an Affiliate of such Purchaser Party, with respect to any of the transactions
contemplated by the Transaction Documents (unless such action is solely based upon a material breach of such Purchaser Party&rsquo;s representations,
warranties or covenants under the Transaction Documents or any agreements or understandings such Purchaser Party may have with any such
stockholder or any violations by such Purchaser Party of state or federal securities laws or any conduct by such Purchaser Party which
is finally judicially determined to constitute fraud, gross negligence or willful misconduct) or (c) in connection with any registration
statement of the Company providing for the resale by the Purchasers of the shares of Common Stock issuable upon exercise of the Warrants,
respectively, the Company will indemnify each Purchaser Party, to the fullest extent permitted by applicable law, from and against any
and all losses, claims, damages, liabilities, costs (including, without limitation, reasonable attorneys&rsquo; fees) and expenses, as
incurred, arising out of or relating to (i) any untrue or alleged untrue statement of a material fact contained in such registration statement,
any prospectus or any form of prospectus or in any amendment or supplement thereto or in any preliminary prospectus, or arising out of
or relating to any omission or alleged omission of a material fact required to be stated therein or necessary to make the statements therein
(in the case of any prospectus or supplement thereto, in the light of the circumstances under which they were made) not misleading, except
to the extent, but only to the extent, that such untrue statements or omissions are based solely upon information regarding such Purchaser
Party furnished in writing to the Company by such Purchaser Party expressly for use therein, or (ii) any violation or alleged violation
by the Company of the Securities Act, the Exchange Act or any state securities law, or any rule or regulation thereunder in connection
therewith. If any action shall be brought against any Purchaser Party in respect of which indemnity may be sought pursuant to this Agreement,
such Purchaser Party shall promptly notify the Company in writing, and the Company shall have the right to assume the defense thereof
with counsel of its own choosing reasonably acceptable to the Purchaser Party. Any Purchaser Party shall have the right to employ separate
counsel in any such action and participate in the defense thereof, but the fees and expenses of such counsel shall be at the expense of
such Purchaser Party except to the extent that (i) the employment thereof has been specifically authorized by the Company in writing,
(ii) the Company has failed after a reasonable period of time to assume such defense and to employ counsel or (iii) in such action there
is, in the reasonable opinion of counsel, a material conflict on any material issue between the position of the Company and the position
of such Purchaser Party, in which case the Company shall be responsible for the reasonable fees and expenses of no more than one such
separate counsel. The Company will not be liable to any Purchaser Party under this Agreement (y) for any settlement by a Purchaser Party
effected without the Company&rsquo;s prior written consent, which shall not be unreasonably withheld or delayed; or (z) to the extent,
but only to the extent that a loss, claim, damage or liability is attributable to any Purchaser Party&rsquo;s breach of any of the representations,
warranties, covenants or agreements made by such Purchaser Party in this Agreement or in the other Transaction Documents. The indemnification
required by this Section 4.8 shall be made by periodic payments of the amount thereof during the course of the investigation or defense,
as and when bills are received or are incurred. The indemnity agreements contained herein shall be in addition to any cause of action
or similar right of any Purchaser Party against the Company or others and any liabilities the Company may be subject to pursuant to law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.9   <U>Reservation
of Common Stock</U>. As of the date hereof, the Company has reserved and the Company shall continue to reserve and keep available at all
times, free of preemptive rights, a sufficient number of shares of Common Stock for the purpose of enabling the Company to issue shares
of Common Stock pursuant to this Agreement and any exercise of the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.10   <U>Listing
of Common Stock</U>. The Company hereby agrees to use best efforts to maintain the listing or quotation of the Common Stock on the Trading
Market on which it is currently listed. The Company will then take all action reasonably necessary to continue the listing and trading
of its Common Stock on a Trading Market and will comply in all respects with the Company&rsquo;s reporting, filing and other obligations
under the bylaws or rules of the Trading Market. The Company agrees to maintain the eligibility of the Common Stock for electronic transfer
through the Depository Trust Company or another established clearing corporation, including, without limitation, by timely payment of
fees to the Depository Trust Company or such other established clearing corporation in connection with such electronic transfer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.11 <I><U>[Intentionally
omitted.]</U>.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.12   <U>Equal
Treatment of Purchasers</U>. No consideration (including any modification of any Transaction Document) shall be offered or paid to any
Person to amend or consent to a waiver or modification of any provision of the Transaction Documents unless the same consideration is
also offered to all of the parties to such Transaction Document. For clarification purposes, this provision constitutes a separate right
granted to each Purchaser by the Company and negotiated separately by each Purchaser, and is intended for the Company to treat the Purchasers
as a class and shall not in any way be construed as the Purchasers acting in concert or as a group with respect to the purchase, disposition
or voting of the Common Stock or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.13   <U>Certain
Transactions and Confidentiality</U>. Each Purchaser, severally and not jointly with the other Purchasers, covenants that neither it nor
any Affiliate acting on its behalf or pursuant to any understanding with it will execute any purchases or sales, including Short Sales
of any of the Company&rsquo;s securities during the period commencing with the execution of this Agreement and ending at such time that
the transactions contemplated by this Agreement are first publicly announced pursuant to the initial press release as described in Section
4.4. Each Purchaser, severally and not jointly with the other Purchasers, covenants that until such time as the transactions contemplated
by this Agreement are publicly disclosed by the Company pursuant to the initial press release as described in Section 4.4, such Purchaser
will maintain the confidentiality of the existence and terms of this transaction and the information included in the Disclosure Schedules.
Notwithstanding the foregoing, and notwithstanding anything contained in this Agreement to the contrary, the Company expressly acknowledges
and agrees that (i) no Purchaser makes any representation, warranty or covenant hereby that it will not engage in effecting transactions
in any securities of the Company after the time that the transactions contemplated by this Agreement are first publicly announced pursuant
to the initial press release as described in Section 4.4, (ii) no Purchaser shall be restricted or prohibited from effecting any transactions
in any securities of the Company in accordance with applicable securities laws from and after the time that the transactions contemplated
by this Agreement are first publicly announced pursuant to the initial press release as described in Section 4.4 and (iii) no Purchaser
shall have any duty of confidentiality or duty not to trade in the securities of the Company to the Company or its Subsidiaries after
the issuance of the initial press release as described in Section 4.4. Notwithstanding the foregoing, in the case of a Purchaser that
is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of such Purchaser&rsquo;s assets and
the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers managing other portions of
such Purchaser&rsquo;s assets, the covenant set forth above shall only apply with respect to the portion of assets managed by the portfolio
manager that made the investment decision to purchase the Securities covered by this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.14   <U>Form
D; Blue Sky Filings</U>. The Company agrees to timely file a Form D with respect to the Securities as required under Regulation D and
to provide a copy thereof, promptly upon request of any Purchaser. The Company shall take such action as the Company shall reasonably
determine is necessary in order to obtain an exemption for, or to qualify the Securities for, sale to the Purchasers at the Closing under
applicable securities or &ldquo;Blue Sky&rdquo; laws of the states of the United States, and shall provide evidence of such actions promptly
upon request of any Purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.15   <U>Capital
Changes</U>. Until the date that is 180 days from the Closing Date, the Company shall not undertake a reverse or forward share split or
reclassification of the shares of Common Stock without the prior written consent of the Purchasers which purchased at least 60% in interest
of the Securities based on the initial Subscription Amounts hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.16   <U>Acknowledgment
of Dilution</U>. The Company acknowledges that the issuance of the Securities may result in dilution of the outstanding shares of Common
Stock, which dilution may be substantial under certain market conditions. The Company further acknowledges that its obligations under
the Transaction Documents, including, without limitation, its obligation to issue the Warrant Shares pursuant to the Transaction Documents,
are unconditional and absolute and not subject to any right of set off, counterclaim, delay or reduction, regardless of the effect of
any such dilution or any claim the Company may have against any Purchaser and regardless of the dilutive effect that such issuance may
have on the ownership of the other shareholders of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.17   <U>Exercise
Procedures</U>. The applicable form of Notice of Exercise included in the Warrants set forth the totality of the procedures required of
the Purchasers in order to exercise the Warrants. Without limiting the preceding sentences, no ink-original Notice of Exercise shall be
required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise form be required in
order to exercise the Warrants. The Company shall honor exercises of the Warrants and shall deliver shares of Common Stock in accordance
with the terms, conditions and time periods set forth in the Transaction Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.18   <U>Reservations
Shares of Common Stock</U>. As of the date hereof, the Company has reserved and the Company shall continue to reserve and keep available
at all times, free of preemptive rights, a sufficient number of shares of Common Stock for the purpose of enabling the Company to issue
shares of Common Stock pursuant to this Agreement and shares of Common Stock pursuant to any exercise of the Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif">ARTICLE
V</FONT><BR>
MISCELLANEOUS</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.1   <U>Termination</U>.
This Agreement may be terminated by any Purchaser, as to such Purchaser&rsquo;s obligations hereunder only and without any effect whatsoever
on the obligations between the Company and the other Purchasers, by written notice to the other parties, if the Closing has not been consummated
on or before the fifth (5<SUP>th</SUP>) Trading Day following the date hereof; <U>provided</U>, <U>however</U>, that no such termination
will affect the right of any party to sue for any breach by any other party (or parties).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.2   <U>Fees
and Expenses</U>. At the Closing, the Company has agreed to reimburse the Placement Agent for all expenses (including, without limitation,
fees and disbursements of the Placement Agent&rsquo;s counsel and all travel and other out-of-pocket expenses) incurred by the Placement
Agent in connection with the transaction contemplated by the Transaction Documents, up to a maximum of $150,000, taken together and not
individually. Except as expressly set forth in the Transaction Documents to the contrary, each party shall pay the fees and expenses of
its advisers, counsel, accountants and other experts, if any, and all other expenses incurred by such party incident to the negotiation,
preparation, execution, delivery and performance of this Agreement. The Company shall pay all Depositary fees (including, without limitation,
any fees required for same-day processing of any instruction letter delivered by the Company), stamp taxes and other taxes and duties
levied in connection with the delivery of any Securities to the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.3   <U>Entire
Agreement</U>. The Transaction Documents, together with the exhibits and schedules thereto, contain the entire understanding of the parties
with respect to the subject matter hereof and thereof and supersede all prior agreements and understandings, oral or written, with respect
to such matters, which the parties acknowledge have been merged into such documents, exhibits and schedules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.4   <U>Notices</U>.
Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing and shall
be deemed given and effective on the earliest of: (a) the time of transmission, if such notice or communication is delivered via facsimile
at the facsimile number or email attachment at the email address as set forth on the signature pages attached hereto at or prior to 5:30
p.m. (New York City time) on a Trading Day, (b) the next Trading Day after the time of transmission, if such notice or communication is
delivered via facsimile at the facsimile number or email attachment at the email address as set forth on the signature pages attached
hereto on a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading Day, (c) the second (2<SUP>nd</SUP>)
Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service or (d) upon actual receipt
by the party to whom such notice is required to be given. The address for such notices and communications shall be as set forth on the
signature pages attached hereto. To the extent that any notice provided pursuant to any Transaction Document constitutes, or contains,
material, non-public information regarding the Company or any Subsidiaries, the Company shall simultaneously file such notice with the
Commission pursuant to a Report on Form 8-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.5   <U>Amendments;
Waivers</U>. No provision of this Agreement may be waived, modified, supplemented or amended except in a written instrument signed, in
the case of an amendment, by the Company and Purchasers which purchased at least 50.1% in interest of the Warrants (on an as exercised
basis) based on the initial Subscription Amounts hereunder or, in the case of a waiver, by the party against whom enforcement of any such
waived provision is sought, provided that if any amendment, modification or waiver disproportionately and adversely impacts a Purchaser
(or group of Purchasers), the consent of such disproportionately impacted Purchaser (or group of Purchasers) shall also be required. No
waiver of any default with respect to any provision, condition or requirement of this Agreement shall be deemed to be a continuing waiver
in the future or a waiver of any subsequent default or a waiver of any other provision, condition or requirement hereof, nor shall any
delay or omission of any party to exercise any right hereunder in any manner impair the exercise of any such right. Any proposed amendment
or waiver that disproportionately, materially and adversely affects the rights and obligations of any Purchaser relative to the comparable
rights and obligations of the other Purchasers shall require the prior written consent of such adversely affected Purchaser. Any amendment
effected in accordance with this Section 5.5 shall be binding upon each Purchaser and holder of Securities and the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.6   <U>Headings</U>.
The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to limit or affect any
of the provisions hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.7   <U>Successors
and Assigns</U>. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and permitted assigns.
The Company may not assign this Agreement or any rights or obligations hereunder without the prior written consent of each Purchaser (other
than by merger). Any Purchaser may assign any or all of its rights under this Agreement to any Person to whom such Purchaser assigns or
transfers any Securities, provided that such transferee agrees in writing to be bound, with respect to the transferred Securities, by
the provisions of the Transaction Documents that apply to the &ldquo;Purchasers.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.8   <U>No
Third-Party Beneficiaries</U>. The Placement Agent shall be a third party beneficiary of the representations and warranties of the Company
in Section 3.1 and the representations and warranties of the Purchasers in Section 3.2. This Agreement is intended for the benefit of
the parties hereto and their respective successors and permitted assigns and is not for the benefit of, nor may any provision hereof be
enforced by, any other Person, except as otherwise set forth in Section 4.8 and this Section 5.8.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.9   <U>Governing
Law</U>. All questions concerning the construction, validity, enforcement and interpretation of the Transaction Documents shall be governed
by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts
of law thereof. Each party agrees that all legal Proceedings concerning the interpretations, enforcement and defense of the transactions
contemplated by this Agreement and any other Transaction Documents (whether brought against a party hereto or its respective affiliates,
directors, officers, shareholders, partners, members, employees or agents) shall be commenced exclusively in the state and federal courts
sitting in the City of New York. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting
in the City of New York, Borough of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction
contemplated hereby or discussed herein (including with respect to the enforcement of any of the Transaction Documents), and hereby irrevocably
waives, and agrees not to assert in any Action or Proceeding, any claim that it is not personally subject to the jurisdiction of any such
court, that such Action or Proceeding is improper or is an inconvenient venue for such Proceeding. Each party hereby irrevocably waives
personal service of process and consents to process being served in any such Action or Proceeding by mailing a copy thereof via registered
or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this
Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein
shall be deemed to limit in any way any right to serve process in any other manner permitted by law. If any party shall commence an Action
or Proceeding to enforce any provisions of the Transaction Documents, then, in addition to the obligations of the Company under Section
4.7, the prevailing party in such Action or Proceeding shall be reimbursed by the non-prevailing party for its reasonable attorneys&rsquo;
fees and other costs and expenses incurred with the investigation, preparation and prosecution of such Action or Proceeding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.10   <U>Survival</U>.
The representations and warranties contained herein shall survive the Closing and the delivery of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.11   <U>Execution</U>.
This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same agreement
and shall become effective when counterparts have been signed by each party and delivered to each other party, it being understood that
the parties need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission or by e-mail delivery
of a &ldquo;.pdf&rdquo; format data file, such signature shall create a valid and binding obligation of the party executing (or on whose
behalf such signature is executed) with the same force and effect as if such facsimile or &ldquo;.pdf&rdquo; signature page were an original
thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.12   <U>Severability</U>.
If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal,
void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force
and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially reasonable efforts
to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision,
covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would have executed the remaining
terms, provisions, covenants and restrictions without including any of such that may be hereafter declared invalid, illegal, void or unenforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.13   <U>Rescission
and Withdrawal Right</U>. Notwithstanding anything to the contrary contained in (and without limiting any similar provisions of) any of
the other Transaction Documents, whenever any Purchaser exercises a right, election, demand or option under a Transaction Document and
the Company does not timely perform its related obligations within the periods therein provided, then such Purchaser may rescind or withdraw,
in its sole discretion from time to time upon written notice to the Company, any relevant notice, demand or election in whole or in part
without prejudice to its future actions and rights; <U>provided</U>, <U>however</U>, that in the case of a rescission of an exercise of
a Warrant, the applicable Purchaser shall be required to return any shares of Common Stock subject to any such rescinded exercise notice
concurrently with the return to such Purchaser of the aggregate exercise price paid to the Company for such shares and the restoration
of such Purchaser&rsquo;s right to acquire such shares pursuant to such Purchaser&rsquo;s Pre-Funded Warrant (including, issuance of a
replacement warrant certificate evidencing such restored right).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.14   <U>Replacement
of Securities</U>. If any certificate or instrument evidencing any Securities is mutilated, lost, stolen or destroyed, the Company shall
issue or cause to be issued in exchange and substitution for and upon cancellation thereof (in the case of mutilation), or in lieu of
and substitution therefor, a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory to the Company of
such loss, theft or destruction. The applicant for a new certificate or instrument under such circumstances shall also pay any reasonable
third-party costs (including customary indemnity) associated with the issuance of such replacement Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.15   <U>Remedies</U>.
In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages, each of the Purchasers
and the Company will be entitled to specific performance under the Transaction Documents. The parties agree that monetary damages may
not be adequate compensation for any loss incurred by reason of any breach of obligations contained in the Transaction Documents and hereby
agree to waive and not to assert in any Action for specific performance of any such obligation the defense that a remedy at law would
be adequate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.16   <U>Payment
Set Aside</U>. To the extent that the Company makes a payment or payments to any Purchaser pursuant to any Transaction Document or a Purchaser
enforces or exercises its rights thereunder, and such payment or payments or the proceeds of such enforcement or exercise or any part
thereof are subsequently invalidated, declared to be fraudulent or preferential, set aside, recovered from, disgorged by or are required
to be refunded, repaid or otherwise restored to the Company, a trustee, receiver or any other Person under any law (including, without
limitation, any bankruptcy law, state or federal law, common law or equitable cause of action), then to the extent of any such restoration
the obligation or part thereof originally intended to be satisfied shall be revived and continued in full force and effect as if such
payment had not been made or such enforcement or setoff had not occurred.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.17   <U>Independent
Nature of Purchasers&rsquo; Obligations and Rights</U>. The obligations of each Purchaser under any Transaction Document are several and
not joint with the obligations of any other Purchaser, and no Purchaser shall be responsible in any way for the performance or non-performance
of the obligations of any other Purchaser under any Transaction Document. Nothing contained herein or in any other Transaction Document,
and no action taken by any Purchaser pursuant hereto or thereto, shall be deemed to constitute the Purchasers as a partnership, an association,
a joint venture or any other kind of entity, or create a presumption that the Purchasers are in any way acting in concert or as a group
with respect to such obligations or the transactions contemplated by the Transaction Documents. Each Purchaser shall be entitled to independently
protect and enforce its rights including, without limitation, the rights arising out of this Agreement or out of the other Transaction
Documents, and it shall not be necessary for any other Purchaser to be joined as an additional party in any Proceeding for such purpose.
Each Purchaser has been represented by its own separate legal counsel in its review and negotiation of the Transaction Documents. For
reasons of administrative convenience only, each Purchaser and its respective counsel have chosen to communicate with the Company through
Sullivan. Sullivan does not represent any of the Purchasers and only represents the Placement Agent. The Company has elected to provide
all Purchasers with the same terms and Transaction Documents for the convenience of the Company and not because it was required or requested
to do so by any of the Purchasers. It is expressly understood and agreed that each provision contained in this Agreement and in each other
Transaction Document is between the Company and a Purchaser, solely, and not between the Company and the Purchasers collectively and not
between and among the Purchasers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.18   <U>Liquidated
Damages</U>. The Company&rsquo;s obligations to pay any partial liquidated damages or other amounts owing under the Transaction Documents
is a continuing obligation of the Company and shall not terminate until all unpaid partial liquidated damages and other amounts have been
paid notwithstanding the fact that the instrument or security pursuant to which such partial liquidated damages or other amounts are due
and payable shall have been canceled.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.19   <U>Saturdays,
Sundays, Holidays, etc.</U> If the last or appointed day for the taking of any action or the expiration of any right required or granted
herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.20   <U>Construction</U>.
The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to revise the Transaction Documents
and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against the drafting party shall
not be employed in the interpretation of the Transaction Documents or any amendments thereto. In addition, each and every reference to
share prices and shares of Common Stock in any Transaction Document shall be subject to adjustment for reverse and forward stock splits,
stock dividends, stock combinations and other similar transactions with respect to the Common Stock that occur after the date of this
Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.21   <U>Sales
During Pre-Settlement Period</U>. Notwithstanding anything herein to the contrary, if at any time on or after the time of execution of
this Agreement by the Company and an applicable Purchaser, through, and including the time immediately prior to the Closing (the &ldquo;<U>Pre-Settlement
Period</U>&rdquo;), such Purchaser sells (excluding &ldquo;short sales&rdquo; as defined in Rule 200 of Regulation SHO) to any Person
all, or any portion, of any Shares to be issued hereunder to such Purchaser at the Closing (collectively, the &ldquo;<U>Pre-Settlement
Shares</U>&rdquo;), such Purchaser shall, automatically hereunder (without any additional required actions by such Purchaser or the Company),
be deemed to be unconditionally bound to purchase, and the Company shall be deemed unconditionally bound to sell, such Pre-Settlement
Shares to such Purchaser at the Closing; provided, that the Company shall not be required to deliver any Pre-Settlement Shares to such
Purchaser prior to the Company&rsquo;s receipt of the purchase price of such Pre-Settlement Shares hereunder; and provided further that
the Company hereby acknowledges and agrees that the forgoing shall not constitute a representation or covenant by such Purchaser as to
whether or not during the Pre-Settlement Period such Purchaser shall sell any Shares to any Person and that any such decision to sell
any Shares by such Purchaser shall be made, in the sole discretion of such Purchaser, at the time such Purchaser elects to effect any
such sale, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.22   WAIVER
OF JURY TRIAL. IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY, THE PARTIES EACH KNOWINGLY
AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY, IRREVOCABLY AND EXPRESSLY WAIVES
FOREVER TRIAL BY JURY.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>Signature Pages Follow</I>]</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the parties
hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first
indicated above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>GD CULTURE GROUP LIMITED</B></FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Address for Notice:</U></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding: 0.25pt">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">Flat 1512, 15F, Lucky Centre,</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">No.165-171 Wan Chai Road</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">Wan Chai,&nbsp;Hong Kong</P></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 4%; padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="width: 36%; padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="width: 20%; padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="width: 40%; padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: Xiaojian Wang</FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: Chief Executive Officer</FONT></TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt">&nbsp;</TD>
    <TD STYLE="padding-top: 0.25pt; padding-right: 0.25pt; padding-left: 0.25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention: Xiaojian Wang<BR>
Email: Xiaojian.gdc@gmail.com </FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">With a copy to (which shall not constitute notice):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ortoli Rosenstadt LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">366 Madison Avenue, 3<SUP>rd </SUP>Floor, New York, NY 10017</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Attn: Jason Ye, Esq.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Email: jye@orllp.legal</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SIGNATURE PAGE FOR PURCHASER FOLLOWS]</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 30 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[PURCHASER SIGNATURE PAGES TO GD CULTURE GROUP
LIMITED<BR>
SECURITIES PURCHASE AGREEMENT]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the undersigned
have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated
above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Purchaser: _________________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Signature of Authorized Signatory of Purchaser</I>:
__________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Name of Authorized Signatory: _______________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Title of Authorized Signatory: ________________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Email Address of Authorized Signatory:________________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Facsimile Number of Authorized Signatory: _____________________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Address for Notice to Purchaser:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Address for Delivery of the Warrants to Purchaser (if not same as address
for notice):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">DWAC for Offered Shares:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Subscription Amount: $_________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Common Warrants: _________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">EIN Number: ____________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#9744; <FONT STYLE="font-family: Wingdings; font-size: 10pt"> </FONT>Notwithstanding
anything contained in this Agreement to the contrary, by checking this box (i) the obligations of the above-signed to purchase the
securities set forth in this Agreement to be purchased from the Company by the above-signed, and the obligations of the Company to
sell such securities to the above-signed, shall be unconditional and all conditions to Closing shall be disregarded, (ii) the
Closing shall occur no later than the second (2<SUP>nd</SUP>) Trading Day following the date of this Agreement and (iii) any
condition to Closing contemplated by this Agreement (but prior to being disregarded by clause (i) above) that required delivery by
the Company or the above-signed of any agreement, instrument, certificate or the like or purchase price (as applicable) shall no
longer be a condition and shall instead be an unconditional obligation of the Company or the above-signed (as applicable) to deliver
such agreement, instrument, certificate or the like or purchase price (as applicable) to such other party on the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 31 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">EXHIBIT A</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">TO SECURITIES PURCHASE
AGREEMENT</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>Form of Common Warrant</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>Attached</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I></I></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>8
<FILENAME>ea177982ex99-1_gdculture.htm
<DESCRIPTION>CLOSING PRESS RELEASE DATED MAY 4, 2023
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>GD Culture Group Limited Announces Closing of
$9.55 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules and Private Placement </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">NEW YORK, May 4, 2023, (GLOBE NEWSIRE)-- <FONT STYLE="background-color: white">GD
Culture Group Limited (&ldquo;GDC&rdquo; or the &ldquo;Company&rdquo;, formerly known as&nbsp;JM Global Holding Company, TMSR Holding
Company Limited and Code Chain New Continent Limited), a holding company currently conducting business through Shanghai Highlight Media
Co., Ltd. (&ldquo;Highlight Media&rdquo;) today announced the closing of its previously announced registered direct offering and concurrent
private placement in an aggregate of (i) 310,168 shares of the Company&rsquo;s common stock, par value $0.0001 per share, and pre-funded
warrants to purchase up to 844,351 shares of the Company&rsquo;s common stock at a purchase price of $8.269 per share with respect to
the registered direct offering, and (ii) warrants to purchase up to 1,154,519 shares of the Company&rsquo;s common stock at an exercise
price of $8.27 per share with respect to the private placement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">The aggregate
gross proceeds to the Company of both transactions were approximately $9.55 million.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Univest Securities, LLC acted as the sole placement
agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The registered direct offering was made pursuant
to a shelf registration statement on Form S-3 (File No. 333-254366) previously filed and declared effective by the U.S. Securities and
Exchange Commission (&ldquo;SEC&rdquo;) on March 26, 2021. A final prospectus supplement and accompanying prospectus describing the terms
of the proposed offering were filed with the SEC and are available on the SEC&rsquo;s website located at http://www.sec.gov. Electronic copies
of the final prospectus supplement and the accompanying prospectus may be obtained, by contacting Univest Securities, LLC at info@univest.us,
or by calling +1 (212) 343-8888.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The offer and sale of the warrants in the private
placement were made in a transaction not involving a public offering and were not registered under the Securities Act of 1933, as amended
(the &ldquo;Securities Act&rdquo;), or applicable state securities laws. Accordingly, the warrants and the underlying shares of common stock
may not be reoffered or resold in the United States except pursuant to an effective registration statement or an applicable exemption
from the registration requirements of the Securities Act and such applicable state securities laws. The securities were offered only to
accredited investors. The Company agreed to file one or more registration statements with the SEC covering the resale of the shares of
common stock issuable upon exercise of the warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This press release does not constitute an offer
to sell or the solicitation of an offer to buy, nor will there be any sales of such securities in any jurisdiction in which such offer,
solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction. Copies of
the prospectus supplement relating to the registered direct offering, together with the accompanying base prospectus, can be obtained
at the SEC&rsquo;s website at www.sec.gov.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>About GD Culture Group Limited.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">GD Culture
Group Limited (&ldquo;GDC&rdquo; or the &ldquo;Company&rdquo;, formerly known as&nbsp;JM Global Holding Company, TMSR Holding Company
Limited and Code Chain New Continent Limited) is a holding company currently conducting business through Shanghai Highlight Media Co.,
Ltd. (&ldquo;Highlight Media&rdquo;). Highlight Media, founded in 2016, is an integrated marketing service agency, focusing on serving
businesses in China in connection with brand management, image building, public relations, social media management and event planning.
For more information, please visit the Company&rsquo;s website at: visit http://en.ccnctech.com/. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Forward-Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This announcement contains forward-looking statements
within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All statements other than statements
of historical fact in this announcement are forward-looking statements. These forward-looking statements involve known and unknown risks
and uncertainties and are based on current expectations and projections about future events and financial trends that the Company believes
may affect its financial condition, results of operations, business strategy and financial needs. Investors can identify these forward-looking
statements by words or phrases such as &ldquo;may,&rdquo; &ldquo;will,&rdquo; &ldquo;expect,&rdquo; &ldquo;anticipate,&rdquo; &ldquo;aim,&rdquo;
&ldquo;estimate,&rdquo; &ldquo;intend,&rdquo; &ldquo;plan,&rdquo; &ldquo;believe,&rdquo; &ldquo;potential,&rdquo; &ldquo;continue,&rdquo; &ldquo;is/are
likely to&rdquo; or other similar expressions. The Company undertakes no obligation to update forward-looking statements to reflect subsequent
occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that
the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out
to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For investor and media inquiries, please contact:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Ascent Investor Relations LLC</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Tina Xiao</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Phone: +1-917-609-0333 (U.S.)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Email: tina.xiao@ascent-ir.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>ex5-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex5-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !' E<# 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M:?M$?$3PE\=?!OBOXC?$RX^#L7B'1/%^FR:5X?\ %_Q0TV6\\>V_P$UV^O\
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MK\"/VW/BY^T-\3]6^!/[:GPT\0?$WX=^%K[X82_&[7?!_P"UC^RYK&GPZ/\
MV?H?PI\+>'_$VG:II<$-S<V^IQ3V&CZMI/B2WEL(/$-OIXFO;ZY[?QM\*/V*
MI/\ @LW^U=I'[7NNIX)^&GB7X%^ ?BOX-U#XB?%KQK\//[6^(&N6_@2_U7['
MXHA\4Z+?7D,%O_PD-EIWA+^U)=$TX:;-I.C:5&=+@MX*P_!&&EAH8JKCL?7I
M5^'\3FU'ZAEGMJDL7AZF4PK8.GA:E:CC:LL(LSC*K">'IK$1C&OAL14PK4Q5
MN**ZKRP]/"X2E4IYQ1R^I]:QWLX1P]:&83I8F=>%*IAJ<<0\#)4Y1K3=%MTJ
M]&%=.)_5[-?65O/!:SWEK#<W1(M;>:XACGN2.H@B=UDF([B-6QWJ2XN;>SAD
MN;NXAM;>( RSW$L<$,8+!09)965$!9E4%F +$ <D"OXK/^"C?C7]G/XL7'[=
MGBSX4>"M$T'XF_ CXFZ;I^K?';XT?M$^.;+XZ:]XVF\0Z3HD/A']EGX*Z9J$
M6G:?X&T"VTZ\B%_J?V6VBT".[U06+:NUO>1?4OQX^)OPV_:)^.__  2<\)_M
M1_%Z#6_V(_&W[-JZCXXUR3XAW.E_#3QU^TQX>\(S6.O^'_B?XST;4[.S.M:1
MXAM_#]AJ]EJNK02:7=ZEJ$%S+ISWVI2H+@"K[# 8B>,Q5..(HX^KC*$LL<\7
M1^HY+A\[C3PE"CB:L,56QF'Q,:>$H5:]*O*4)U*D(QC.A2'Q=3]MC*,</0G*
MC4PE/#U8XWEP]7ZUF=;*Y3Q%6I0IRH4L-6HN>(JPI5*2C*,(2DW&K4_:+]G?
M]N:^^,_[5O[;?[/7B+P5X?\ !7AC]D:[\'I;_$ ^*IKD^)].\2:?JNHW^IZW
M97VEZ?I_ARUTFWTWSGF35+^!K=WGFE@CCR?L3X.?&+X?_'SX<^'OBS\+-<7Q
M+X!\6'6'\->(([>>U@UJST77M4\.S:G917217#:==WVDW4VFW,D48O+%K>\C
M013I7\IG[/?PY^"WBK7O^"]'PX^!\Z>)O@]IOPF\/W'PWB\!>.-=UVVOK;PM
MH?Q"U[2[+2_%5CK5[K'B/0H_$FFS6LUC/J^I:=K>G6\NB7/]H:1)Y#_>W_!"
M7PS^QG;? OX4^,_AUXL\.:A^UMXD^$7B.U^+OANQ^)VOZUKVG:%I_P 0PEQ<
M:A\,[GQ#=Z)X3M5F7PHL.H67AW2Q="YB-K<3I>7)EOB+A?+,'@LQQ^%6849X
M)<.4(86G@:DX1>.X;P^9XC$YASUYU<"\1B)5'4E*]'"UE]7C&;K1]C.3Y]CL
M1BL'A*[P=2.*><U95YXJ,9-87.ZV!HT,'RTHT\5[&C&"A&-JF(IOVS<53E[3
M^@NBOG%/$FEZ'^T3XM&N^(+'2+!_AIX<^SIJVKPV%DUR=8NBY@2\N(K<W!C7
M+F,>:8Q\Q*BHO!7B_0-/^+?QI.K^*M(LK2YF\"S:2-2UVTM[6>"7PZTCRZ8M
MU=I"\4ADB>1[0%',D3L6+J3^3+,J7/"$N2+ECL1@I<U:DO9^PISFJLDY1:53
MDY8QERZO24K6/N_82LVKNU*%56A)\W/))Q5D[N-[MJ_HCZ3HKX2TWPIXP\8?
M$OX@W7A<O9W&A_&"VEE\82^+=3@;1M'MH+.[O]"M_"\7F6>IV^I6[G#R^7&#
M/Y141JS#[MJ\#C)XQ5I/#SHPIU94Z<Y2YH5E"I7IR<&XP=XRH^]92A[\5&<G
M&:BJM)4N5<ZDY14FDK.-XPDD]7NI:7L]&VDFKE%%%=QB%%%% !1110 4444
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MX)\3_#^W^(>B^,+6*UCF-UX:O;2ZM_"J:O;F2T'C^5/!I<:PRPGUG0/A_P#
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M5;5K^TC"::A%QE&,HM045&\9*<6UR1=VG[R4E9I-<3XK^&GPY\=WNB:EXX\
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M*SZF/Q1_Z\M[VU4)6U[7Z==NI[#1117I& 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!S,>EW:^,KO6BJ?
M8)O#.G:6C^8/,-W;ZKJEW*IBQD((;J$B3.&8LH&5-<YXF\+:OK/C/PGK-FT$
M=AH6^:]:XN'MA+OE<".V.EBVU:XN47YA;:AJ#>'61RT^FW5R R%%83P].<'"
L7-RNLJ[M*SYU.-1*]OAYH1TL[JZOKI:FT[JUU%PVZ--??9L])HHHK<@__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>10
<FILENAME>gdc-20230501.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 86o5s7xRiXhun8uDb31cWaqOuaPty5BxaZkxsmx0HYmqXyQiYCW/1SA9NIO20aYN -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:GDC="http://ccnctech.com/20230501" elementFormDefault="qualified" targetNamespace="http://ccnctech.com/20230501">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://ccnctech.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="gdc-20230501_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="gdc-20230501_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
    <import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
    <import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
    <import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
    <import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>11
<FILENAME>gdc-20230501_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>12
<FILENAME>gdc-20230501_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://ccnctech.com/role/Cover" xlink:href="gdc-20230501.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://ccnctech.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm139854633386032">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>May 01, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May  01,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-37513<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">GD Culture Group Limited<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001641398<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">47-3709051<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">NV<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">c/o GD Culture Group Limited<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Flat 1512, 15F, Lucky Centre,<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine3', window );">Entity Address, Address Line Three</a></td>
<td class="text">No.165-171 Wan Chai Road<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Wan Chai<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">HK<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">00000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">+852<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">95791074<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">GDC<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 3 such as an Office Park</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>ea177982-8k_gdculture_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="gdc-20230501.xsd" xlink:type="simple"/>
    <context id="From2023-05-01to2023-05-01">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001641398</identifier>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2023-05-01</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2023-05-01to2023-05-01">0001641398</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2023-05-01to2023-05-01">false</dei:AmendmentFlag>
    <dei:EntityAddressPostalZipCode contextRef="From2023-05-01to2023-05-01">00000</dei:EntityAddressPostalZipCode>
    <dei:DocumentType contextRef="From2023-05-01to2023-05-01">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2023-05-01to2023-05-01">2023-05-01</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2023-05-01to2023-05-01">GD Culture Group Limited</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2023-05-01to2023-05-01">NV</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2023-05-01to2023-05-01">001-37513</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2023-05-01to2023-05-01">47-3709051</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2023-05-01to2023-05-01">c/o GD Culture Group Limited</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2023-05-01to2023-05-01">Flat 1512, 15F, Lucky Centre,</dei:EntityAddressAddressLine2>
    <dei:EntityAddressAddressLine3 contextRef="From2023-05-01to2023-05-01">No.165-171 Wan Chai Road</dei:EntityAddressAddressLine3>
    <dei:EntityAddressCityOrTown contextRef="From2023-05-01to2023-05-01">Wan Chai</dei:EntityAddressCityOrTown>
    <dei:EntityAddressCountry contextRef="From2023-05-01to2023-05-01">HK</dei:EntityAddressCountry>
    <dei:CityAreaCode contextRef="From2023-05-01to2023-05-01">+852</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2023-05-01to2023-05-01">95791074</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2023-05-01to2023-05-01">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2023-05-01to2023-05-01">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2023-05-01to2023-05-01">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2023-05-01to2023-05-01">false</dei:PreCommencementIssuerTenderOffer>
    <dei:EntityEmergingGrowthCompany contextRef="From2023-05-01to2023-05-01">false</dei:EntityEmergingGrowthCompany>
    <dei:Security12bTitle contextRef="From2023-05-01to2023-05-01">Common Stock, par value $0.0001</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2023-05-01to2023-05-01">GDC</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2023-05-01to2023-05-01">NASDAQ</dei:SecurityExchangeName>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>15
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
M"  IB:16-VYA77<$  #<$0  &    'AL+W=O<FMS:&5E=',O<VAE970Q+GAM
M;)V8;7/B-A#'OXK&[73:*8DM\YP",X0\7.:2' WT,M-.7PA;@":VY)/E$+Y]
M5P9LVC-KIKP VWC__FFU_J_LP4;IMW3-N2$?<233H;,V)KERW318\YBEERKA
M$OY9*ATS [MZY::)YBS,@^+(]3VOX\9,2&<TR(]-]6B@,A,)R:>:I%D<,[V]
MYI':#!WJ' Z\B-7:V /N:)"P%9]Q\T<RU;#G%BJAB+E,A9)$\^70&=.K:[]C
M _(SO@J^28^VB1W*0JDWN_,0#AW/$O&(!\9*,/AYYQ,>158).+[M19WBFC;P
M>/N@?I</'@:S8"F?J.A5A&8]='H."?F299%Y49M/?#^@MM4+5)3FWV2S.[?5
M<DB0I4;%^V @B(7<_;*/?2*. IK^B0!_'^#GW+L+Y90WS+#10*L-T?9L4+,;
M^5#S:( 3TL[*S&CX5T"<&4W4.]<#UX"4/> &^[#K79A_(NR);8E'&\3W_.:_
MHUT *"C\@L+/Y9H8!?EKO$B-AGGZNPIHI]"J5K#%>Y4F+.!#!ZHSY?J=.Z.?
M?J =[S>$KUGP-3'UT8T*,BA%0^;;A%?!X>&]B\\(1*N :*$J8R (<XJ[B*VJ
M*/#X)8M2CG"T"X[V><F8<BU42&YE2*#V*O."*]DJRLNHKHXZ!5H'%;R51I@M
MN1,1)\]9O*@N;5S#\^A%L]NF&$^WX.F>P_/"5\)6-N3LF<65B<)U[F_(!&PF
MTYS<:Y4EY%'$PO 00>P5B+US$"<PH9I%Y$&&_(-\YMLJ2%S)@\QU6K39[R%8
M_0*K?P[6G'V0AQ#8Q%($+/?QT_.**[:Z,*U>WVM3!(]ZI6]ZYP ^R$#I1.F<
MK4%F!FX$HC29J P2"GE58>5\UZ@_?\4@C\R=G@,Y#D/PQ+1QV(#RD9Q\D=5D
MN&3@*O(_RI&6K8"B3HXSSS>JDAF7!+\TA+:IWX#ONP9YS(*W?<GS!@9=]@>*
M.SP.O=:\.M6XZ+.ZI)WV!>U2\LHDF:R9("^*H6DNFPG%N\%_B2=V#PIWKC:R
MDA67.P!B;&6#H7A?^(YM=S-58N%*G[#&2\NV0L_J*P705*4&S/)/D9R^P>NZ
M#'PPMK+%4+PWY!,WAA7Y:11<X-=>V\=(RDY"\0;PJ )(RG2M)-9]:T3Z[6Z?
M>MT61E0V$8I[_JL6QG"H3!7'F=QWD+22"A>J6SOY9=_P<6>?J4@$P@BY(D_0
M*[1@4>5J%U>IY2E;A(_[^53SBP#2PV7 =TM<6&7"8OS+<ED]?S5ZM61'SP2X
M:W]']I"F&9#5 N*RM8"EZ?NX/\^%@76F6A+J_[SXA<QXD$&]5=I4C9*M3UC:
MS(P*WAHD89J\LRCCY$?OTJZJ,-K2\'W<H>>:A;;J9MMXH:IK#A>XOYE@(*6[
M^[@G'_)$;C^"-9,K?G)17"/T/)[=C'_'F$J#]\\R^-N8ZY5-$BQK-F9M?2-A
MLGI&<<&35>8>/:O;]QY/S%XQ)1%?@I!WV84QZ]VKA-V.44G^^+Y0QJ@XWUQS
M!G> /0'^7RIE#COVC4#Q0F?T#U!+ P04    "  IB:16GZ ;\+$"  #B#
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M#ZP+V.Q _G@>F*FX3YI"5S%NV G&D3S'$)C%^(QF&5*=##[Q_F"G)$WS/(X
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MTZ(=I7\=Q_:0T^FO8R*T>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X 4$L#!!0
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MBBJ6<%H@XLD@;6E6?;!/3K3G>1<W]T6NS>,)KM\,<'AT_@%02P,$%     @
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MX3]>?P%02P$"% ,4    "  IB:16!T%-8H$   "Q    $
M@ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( "F)I%;L9\3T[P
M "L"   1              "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4
M Q0    ( "F)I%:97)PC$ 8  )PG   3              "  <T!  !X;"]T
M:&5M92]T:&5M93$N>&UL4$L! A0#%     @ *8FD5C=N85UW!   W!$  !@
M             ("!#@@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4
M Q0    ( "F)I%:?H!OPL0(  .(,   -              "  ;L,  !X;"]S
M='EL97,N>&UL4$L! A0#%     @ *8FD5I>*NQS     $P(   L
M     ( !EP\  %]R96QS+RYR96QS4$L! A0#%     @ *8FD5JK$(A8S 0
M(@(   \              ( !@!   'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0
M   ( "F)I%8D'INBK0   /@!   :              "  > 1  !X;"]?<F5L
M<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( "F)I%9ED'F2&0$  ,\#
M   3              "  <42  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@
0   )  D /@(   \4      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="ea177982-8k_gdculture.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ccnctech.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: dei:EntityAddressPostalZipCode -  ea177982-8k_gdculture.htm 22</Log>
  </Logs>
  <InputFiles>
    <File doctype="8-K" original="ea177982-8k_gdculture.htm">ea177982-8k_gdculture.htm</File>
    <File>ea177982ex10-1_gdculture.htm</File>
    <File>ea177982ex10-2_gdculture.htm</File>
    <File>ea177982ex10-3_gdculture.htm</File>
    <File>ea177982ex4-1_gdculture.htm</File>
    <File>ea177982ex4-2_gdculture.htm</File>
    <File>ea177982ex5-1_gdculture.htm</File>
    <File>ea177982ex99-1_gdculture.htm</File>
    <File>gdc-20230501.xsd</File>
    <File>gdc-20230501_lab.xml</File>
    <File>gdc-20230501_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="24">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>21
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "ea177982-8k_gdculture.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 24
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "ea177982-8k_gdculture.htm"
     ]
    },
    "labelLink": {
     "local": [
      "gdc-20230501_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "gdc-20230501_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "gdc-20230501.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    }
   },
   "elementCount": 59,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2023": 3,
    "total": 3
   },
   "keyCustom": 0,
   "keyStandard": 24,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "GDC",
   "nsuri": "http://ccnctech.com/20230501",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "ea177982-8k_gdculture.htm",
      "contextRef": "From2023-05-01to2023-05-01",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://ccnctech.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "ea177982-8k_gdculture.htm",
      "contextRef": "From2023-05-01to2023-05-01",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://ccnctech.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r10": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r11": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r12": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r13": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r14": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r15": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r16": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r19": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r9": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>22
<FILENAME>0001213900-23-036462-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001213900-23-036462-xbrl.zip
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M]PI/CX;I=49U$%&+>MZC.>E'2D"6I:=_-Q2X5,8Z1>!A,NQR:\-[/"G_=A"
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M0%=%P($]![6+!(HLA<GF=D[E7 67*K8%]63Q![R0=PJF]BB0,PZ =+U\\"K
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MEM1,E:C<9(?2;@AWJ5@XU,5?J7 %D;P%U?)!]6TZ!=9-4'A:V:";&Z7-!5T
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MNE++DLE8]JK*O^+ ($F*^PI%\HP;4$;@!&:,@R6X/=8$CN1&9+QUL8BM^3B
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M2:_*E6TM84:NI,<E.%W:W!0O3.#W=EM! KS3?"S%6+=].N$ \&_F79V@"AU
M91*\&]KA/_$>V7K5?JY]9;2))%W1-!R=%EFEBFW0L[M.!7R>'3C_,8-P]E24
MIX21,&G*;K1A)0<0)<SIEECS-JG"FAXM%**#J7JT?5R<,^[TTP>SSO=6BSW=
M,K470%\LOI"+>@;6TM&[T[?&4G)">39^&L<LS,&214Y8,A6VNE:+ A6!EM,,
MK')+766F(M)A)0O@42NN@H<SH8^07H$;'([@130AV(#($\-<9W4:>=@'L1N_
MT!U'@C9CBD#ERSPOB3-#3(#2Q6\5 !-I[E((VXN\!!(XH,!$20J SOUEV)]
MV;X#G^C@P_[QWNGO_=[IX1LN)OKE^+UB4T> CTN122-"M(PMJU?Z3JAWJYJS
MS*-/4206G5 TV>#X1ER$W!4E@^=@>339.Y$:EBW\Q2)(QX1%=\&3KK*JF6L6
M_K-ZC]6Z[\UHK&,%K&[=VHYJ H9T4E9IUB90 M8I>.69),6<S(<"V I7ENH^
M)"H)GS<R62W/J%6.R\'%A^;B5Q[_H %;N0:61DRTJG83C2@NIV-3N*74Y8%
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ME;FV7#[:67@+CO0^X8XUX&;B(#PT'X\P"_[SYC^",+963[0;VBD06H*&M>C
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M\*W@%CTMT Z@MHP%^/)?NP#?6>27(LK#5^\.?D?>>_C+^=LW+_\_4$L#!!0
M   ( "F)I%:?TCE>(98  /(1 P <    96$Q-S<Y.#)E>#$P+3)?9V1C=6QT
M=7)E+FAT;>R]:W/;1K8N_)U5_ \X\^ZS2ZJ"%5MVDDF<-U6*+<^XCF/[V,[D
M3.W:=0HD00DQ"7  4 KGUY]U[5[=:%!RXB2:,>?#Q")!H-&7=7W6L[[YZ[OO
M7WP[G7SSU_.SI_#?#/_WS;OG[UZ<?_O-9_Q?^/8S^?J;[UX]_7OV]MW?7YS_
M_W]:-G7_=?;@_J;/WE7KLLM>EM?9FV9=U#E_D&=OR[9:_@E^"#]]'?YNUJP6
MM_CQXVQ=M!=5_76&E]Y_G/7ES_V]OBWJ;MFTZZ^S[693MO.B*^6K8E5=P-5M
M=7'9_^G;;YZ]>OE.'QS_M&[J\D_?GO]\6<VJ?CIY</_D])O/\ ?PZJ__B$'/
MR[HOVS]]^Y_UK-L\_H,'\?;\R0]OGK][?OXV>_W#FR=_/7M[/IV<_>7-^?GW
MYR_?C0WNEXY+'O[3MNNKY4X^K.I%B3>]?_)Y5=\T+;_ED]]=5AW<8[YMJ[Z"
M![S>MO-+F+GL[*(MRS5<.IT<]7C1?ZX6_]@VC[_YX5OWU3>?_?#M?[;T\7$&
MERR*OEQD19<UR^S[8I<]R+/3^Z</\VQ6]M=E66=_>9H]V:[Z;5MF?VF;[29[
M4:TK^$V>%?!J5\6BR.9-NVG:HJ^:.H,'E^:Y3YKUIJAW]JGY=%+4BZPLYI?9
M1H;>9A6^8K6L8#!P%[Q)!S-1T',WQ06\YF79EGV3'>$/\ZRJYZOMHJHOLJKO
MLFX[GY==U[1=AO<N.OQQAT/T0]%I:LU@>"CS9K4JYWUU5:YV63A^]Z/.OL+)
MI[7A KDU*^;O+V CU(M[,&]-^W5V?0G[X4_?_OC7\S?G9V]A>;OM[">8SPQ6
M"V<3#O":UV7>U(L*MPFL6-EG</+[2UC)C#:KVZ)T*>R,;EO4=).BSLKEDE<H
M:\N+JNMEMW4];%_Z#8P'=A$^SI\,D! P"MC8#[YZ"#L:-GD!URY@BP6[5*3L
M#]^:,P4_Q 6_W9N[G4W/ERV?+<JN:N%6?3.=5%VW+>F]NG*UPG>B[>]V5YZY
M(V$^Z\JKLBU6L"GQV[KILY^:JNY7N]S<W)VA;-DV:SL"O(%[(9@%^&HZT='!
M9*P;.%O++=X?;C=OJQG,S& U3F[00O^>6_[EJQ_A5KBCG[UZ<YYGSU]F3UZ]
M?/O\Z?F;LW?/7[V<3GA"L_6VWQ8KV-E790W;M<,]WA=5G9I*7F78]5D#/VVS
MBZ99T$=7Q6I;S%8E_K@#22B[&^_?EO.RVO"9*!;E/[;%?(>+"5L/-DO1PI*B
M8)S!BL[?U\WUJEQ<H'"V.W&XM[("QX2;8 FRK[GNOOY-]'N@Q..)OGF!?]MG
M!V<;'WAO6:RKU>[KFPS(LS?OGC]Y ?;'<ST:W[V!\3\]?_;\Y7/<'&\_K;/R
MX.2!//R';Y^6RZIF$8_R\P0FJ89]RU(_5 @+O!2.2;GJRFO<PZD#@X<%)" *
MN4W3J1P+K\%;\C9&<X!O?EF JJ#S618U? RZ8*AQWJ)*@6'!"XSN_P^>./Y_
MG)D_;O%^V1B\L3C_Q[9J8=:FD]=@^32UL7VR[A+7(YY?$"6B0&"-P1J[I'7
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M2P:6=DW'3$:7WKGY=/);'(CLEYX'BA!^U .1_:+S ,MTRP/!.NYH$>P)68H
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MC<1S4D,A8'^LGI"MY(91B 01HBJLL"7^.8?4$!(-LEX(T4/>#)HQKIN'@_/
MKOUIN[C0ZJ$P.Y'#K=[#*U5]5JTW+59<<,J5W@C&(7U&;#EBE(B[95NENT*
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M'1JG''\1&)II<7G[?9R<5DHDPF]Z&A85 S2"N)D@1#D8L*W[=BM&F"8O#/
M.4+)@L=,.2+8>@VNA9=$EAY=)D9B16Z)3Q["%>2!X)#=8W56B*B_SV"3K+CE
MUF-/01NRCT5K3P=T((W<BKK=9.XB80YWD_ >?IFNB\[:/LD=\)LMY71RF[7$
MX. O6\GH K],M&P+Y@?$]>)#[1=,%]?5HZPPEN>@HE4+EAX3SRJ4Q 560-LA
M#@G=@3Q:[M 7QIFW"Z@.DCJN>T4V^) 7E92VH'1^AHOQ]M[#@;L]=N&HG&!
M6(]MK4N>"!O-#A<T51Q87(!(N<#ICWOE&B^(R]\[+$D8V'H-.G;J/BZVK=-"
M_76Y EUQ].#T. .CK[_L;$V:^64^0+K_1=*;SSWS:?;\Y+N3!S@N/W=GM+,5
MPA&^\8)2EG#\&=2D7FD0HLAOE3YP>G/@'="M>0F=>^M_Y\\<FW')0T?M/_P^
M#E?(B^8019_>9'E*,H4?(:&JRI2[X)CNR8D^N'](BDI2],']0U;T[@8\+GS
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MK?*E ?G!266@'=[>R/:^-FU1.95K&/C@=-#V=A#M1XZIL/C*9?N4-OM[*H5
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MOK-J85_$:FCU"D]=H3E/TB&V&ZYG0UHW"WA:SJA_)J\B0^ FX()M #ZDODV
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MOS+T2,:@U-X5S U+"-I.K&!71 7J:H8F%WVZ:2I$U6WP!:,DL"V*5:Z)0@O
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M)SM#N9:OSY9=]:.PLH#O%]3G*N=F>)1RU&W?YU4$ >]  TX8&:@(1=-28HC
MDA*>A6./OO1VF=TZ(?,3<*)F7K@:2;1#_%=5,S'+3+TKGKQU#=A=R;JZE9HO
M-;.VE',(4HC^BMEG./*:.QD74E^*K%5\@L P9Z!)$!8D/CG=@.T@;EHIAN;*
MZ/D&\3J.X5#9_K-"I!2SR7#Z I<S.KHIJJ5;SCQ?9)MEJT)&=B*LE^P4Q\YP
MUG2L9 AA;>9LR<(FV*T4[%'>7A68=N^H>JFFWK:M!:B3>N2NW!<719=&B#*\
MTQUWCK?%;!H20-.G >I=MN#>\I@A'9YR:WHQJ@49T$=A@80DZU,F[3[MCDBZ
ML7'G:B $]@> 6<F:)5F=/]O;,CHJ<X1[@V-+$8L2]7/&<&T9 V:)WV//<%.9
M'2!])EQIJF6TY+WG-@;HAMXLY]ZQ07T)7,G$-*=\;D:#@:_ Z2.1('_ &$K6
M-\:=O<ZW"JO38.OD0DH ),<.<[-<6V@*R1D(Q401%-.$W.?][XR.P@_QQ(CV
M<'?5Q\Z7*74G@;V/*XGKL"+((;%D[+T&EJ5,]J&_%+8&CJ]D2KJ]KI;LU6$_
M\YU[U/6VZ;:@,X$]]A2;LIX/]9(2V!0ZS?"H,-L>%#=<F8DF"H#TP/XF8[GL
M<)JRUSIQV+RDWP Y&>Q_/!%,A,3W+ 1K+VO80X45!$6K")."8]BY25B.\)[H
ME/QP!/Y4(Z,#6VXI_VKR_+V@,-'CVI/5/,DC1[@O\9G@=MTS51/!N$A$G_"6
M, -^-CHZY0NI;=-"\7PM7,-+-B=_!V1<0FH@VD.5DV- BYO52H*)PW"BHR/R
M7?90RJU^P#PY1L[,Y+U"X 7HIDVZ-\/ JY=!:P..SL?!109 U/>=7B?(I-S$
M[0X^S0*!!P/.LA-X=;KUDY]NK4<8Y:&<R3\%[PO]URI,$D6 *!VP0HS5P75>
MP*VZ1K ,>:-H?$0R7 Y;S=]6V%D;QGI!QG2%N"D9M0$MVC9WLK'_6%+547Y(
M)JR"CA4DHET&!*Z;5"]^5_\A2A AG$43)K2;5^*:>>&I#QSKX'F22&3A7Q 4
M-SNY^,K0,2"Z','@./JY+6P\;+*SPIUC(Y0#X L4^L@6[#1@D!WC7FOYOU/^
M))(8<V#Z HEC;MA;L!KDKT:7$)RX1FO_*D-6'OP>S&AT1)N,EXUFY+06TA<:
MUT$;5BIQ&W:?T.@2)=(V)!Y=A<(?]6;=SJC4$\S5&\3EP_*K4 _WX1';JEV5
M>_VB#,RWFP09[D#NN2 Y3&JL8P/"%$I4-X8+-ZER$BR*/E7GJ%B3F.+#$3@<
MI^^X] J1\+ASN+"?"%7P!IGM$@L90Q<3[42-[E0U%EC%P U99-0F CG^JG0"
M+A$\E[8NIAO6)XU*+YVLS.S-CL-"[IMXG(MX?%U1'<$"MH(!\U@@.HF0^NM,
M#5K]&4:S"'ILY2XI8;@*>N*4K:3.T4>?LCUFN\&FN^3*'7C>';$RA_T@D%%T
M;1<2!L7[/)--2I0'LTF92\A7"*W#3QQC[QFF'A%HT++$'*D/,"V3F&6IRGEG
M_JE8!,HF,V<3,RA^DM]P\5W6"MN%;2 8560P:X'QPP@V==B!#;DETVJ:@_ S
MPTU8)T^],<5GA:VQ9;?4S<NR([3'U5> <R+KQH4Q'-%U]Y56=H5L!2B+MHG[
M'@A#P]<)MDJVE!I#*3Q]6SR8@Y&I]K"Z='TU(HKWV2Q?YMJ!ETKK@$"7XEP8
M*W%HOW'>MC2^:6AQ<1PW\PCXS(K!W)T5;$V>P0Y.@5K)NG9GSV7*;-?D6,$+
MPH1</W9KC!\D.HJ8?3HFG97S%;B;N7._K2I0432>7D*)M#7FOQQ@5]Q&AYMB
MOS3ZB<25XL,2^^]D?/9UFS0D=#HB3WQ98AQ!3'MPI5)J!Y::5F#X1:);C9-[
M@<4L<28H7+QQ& FIO0^-TPXW-5EJ5]APN<0QT/L3F [Q[>WLAJ[8=[-/%OF<
M17LYY_)<FXY!+*+3V&R2VK-)"(=MK[.YZV2>J<:C%SMK/#8OZA6"J\W*@PKQ
ME,W6K&&'##/<W1Z9Q#ID8%X#-OH]D^+[Q%/^=HBG<#SE;X=XRJ=*Q^-<M-&7
MY/Q"+R/HI(WS<@1MJ$./C6#"V\3A:HH)$<*%:12P"S/485/G)C"AC3F5+*6L
M-' 4@50=@A+%Y+CL?2[)5NJ9JRWX,.M3 <]GJ2!L.F4>G1+"HW>Y!H+!N)3<
M[V^!KU4=JUXLSO8W:.AY7!%/C2>!'=[D=.?S\-L;X#!K=O#3XZ=][5\L1C]*
M@) SU(W8(XZRO#>OBY5,A*!+,<;MN)EXD%-CVW5Z(2B$_I)C93W\=@O'SUZ%
M4H4;J6XX"]C<,J@R-'8$I@2S':SD@O6A+]&S_2*Z PSAY'PONN,9UU9T$N(I
M,4@<>7Z)<1U@'$"=\YSZ/=Z36(OWC]COZH_!?Q;"?\[$X'1V1MC;EUF/-3[A
MB+KN1^_(,HDEKO_E %AK2+"1]EKBVIKJ]V!,C?OR9U*3N"+^S-*GKJ2Q!!L8
MCQ)L,-&3,G@Z. N6T7)\ [._ZAMM_8V.K^[JP]0;'&V5_4+)Q7>ASZ2)UW#O
M@)0?'44QY=TE=M#S(7L)2DUI<;\*NMXT'-NOV;,EAH'S9X\F?$#R/0?Y]'Y?
M3%%0,+G\JZG$>J"-'40]!!790SQQ\]S=@<'U]>,Q'Y/FZ%['CWJ85)R+R;6(
M2#YVB^X_!I>\$BXI#1I%BY($QTN?,^C4JUX+5\V -)4;17-G;]<KZ>W*UFO\
M5\ZP!0/;MGBE-(6[0*\D-2$O\T4Q*]C93>YT['6#-Q4=;\G) B4S-?_=9UFP
M(6!UB J'5.Q\4/@P=Z&J\\6F0?W0I!+2(ZE_DE# L9A$O1(<3[;)AA0\=X_E
M3ELQ7D^*(WFWIUS@@?OWNBIC?E;E)QT/3'?NC3I ;.L<G#*/M(UY\'0YY+R'
M"2$XF 8@\,)%))-/WP[R3SN$D4I]!XKILK+)HH@B+'D3MT[E)(2B: 8G(IJ!
M\KZ43 J,[[GZ1=+\@;1@X@@#>9VU386]$VQD).5XOFYFZO:J#M%K8 =NT.?)
M.(5HR]0J?K0&0YNT<L,!K-=EAR>KR%NE.4]OL514Z5_,9LL0:Q1-N9=,&W&X
MZLF1^\WM3AIZ%-F/BYM]E;L0<<\'1C97WRE(AMA6'<SLB,+V5"C5$)"U$"?X
MT"6OPW^?POI!,N;2'32V1H9+Y!FP5-HG'.%B!G*L^1W^3K>&P8EK@P"CWTN;
M6CGJL9' ^#%?33^)7Y0HBTV)BP[=%_-UR1]7]W./'_;7*#" -DS"C?;(L=ZH
M.4M*5BIWH"%^I\3.1C<*"=?-C9'&E*TDP9PTEN!/#%_P^]?58+HSIN.^:Q_"
M3^X1FN!%2[V&U(#,B7F&\08?M73M,_Q<]KMI?(GNNFIQ]_O 3<.YYBO$.G);
MWF?DFR#-7K0"?6!>Y8U/OB/.PZ68:VRU5[#.X!BCVJIK(( 6%#]Z5EO"@" K
MNVU].[(1'PF>"(LP]BP<" 1]W]A+/U"]QI6/CCA+S-D#L,]@_'E[ #7N.UW\
MJ0[OT3\C2[K-&O.A;NP#U?*>]*Y_;2D#* Z:0&/\-'77Y;;P)\\J@K@FXDDR
M$L&SB3CJP=F#&W?N<9!=XRD'#K&2O.F FH3M:A30_[:C>MN'=4.;)!;L"2)G
M#G;C?5G=+O/Y5=YE**"&YNTMD@YN*DB(*QLMW95)=,^\.?M$1;X\1$4X*O+E
M(2KRJ=+Q^%K+"4^?CX[.J:B^>68 WUW;PTA<!&U.L%CSN:#LT,MHXKB:3XP2
M-!*<Z"24^OR1C@-Z=,1C=A0H7UIB-.&3F?><G*H>!W^T?KX8\/6C)P0U4B>/
M/L,L)9?:IWR_O09&/#K:YEG=F":]7;_"6/61YKJBG)@UG$8UU[H G?IM%N9X
M@FR5"(\$SW%JN&BMV>>X\R09DX\?Z/^J(MFAOS1V?:S97A?3@M5<:N!&.;9N
M@X,2GRGJA-B&32! N#L@0UA9=SX_)<<BA<*\L-&1]_$#W21"-H%S'\,1O)6W
M^?(&>_>6[?6.O>S4!SO*H@/WW[ I^J#D$"*^R5K =SD5DVJ9-5N*MI6S8A8:
M,W'>0B:L<[12'CV>/GC\&9X-_Q%V#72KFZ+>- _(TL[GFDDHU E3FW!FI+D,
MFHUOYQV@<.2_K(LZU%7P>3?GX^1$39ZBMB5"N&%22FT'9^U..@S'4;?"@JHZ
MA$;:ZT9UV_,9U; S'_0,HSN:MB,UU>-\C\&:R3U+X."5FS#V$R'%B-*;B?98
M-^T^TXE:"82\T#..X'*S:5<X!@O/4J@5)VR8DKL%XM=:JFN,?!-%#?>(VY]H
M_8=3M.!RH_*',;.4[(Y5T2RYZV0WANQS_I!42G+?D)8N-B3J@=[OQ?3X]"E&
M28=8'W_!5]J8%77,"G%6SBG?.TH].P#;V&#PP2/!SN9B?4-,2C;U1A..37J0
MF9%$)27.['1<Y5Q44B8E/8+R$5[=8S#_8/>CZS;H7""/LGB"=Q?(Q0#>4.=L
MI%2_1IM$O:9KQDP(X_[8* %1QHD/S>%HA+&Q',"5W&!J]=QVVOCNY.2M996:
MT0ULQ*40^Y(+#U".(#V#ZQ9F"Q26AT) <J?(+; ILPVW$HF.@=^F)O+.?8!&
M8E6U/*J58+@&9@'8-AV-4<9LV-$&**!4:E 2<]]C32&19$G*+9>P!,6) H=<
M>B.-F*+*<$^%L0HV#CME#>SBLKKUS>[UO%ID6P1?Y'I%*%- <!V.S_EM])M'
MIE6).1%+:MPJZT\35"$>Y%30@RF7)L]3HH/2'-YL#JPGB[:S!7N/([;:SU;?
M]>K:"WA7'1C"S.Q5#T\KU7(5IE]AH4IGEJ&S,5Q2TH=4:3)#(6Y"S3-H-<:
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MT0H5_A5C,'"Z1KIRSB![4GQZ-NZ#%!8S0=#/>A?K:@.;SI%:\A)R.G7 *FV
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MC[,Z$I$M'1'K$XWE<I;%T0N)/KP3J!S':9L.=&7==XP;84Z)P&Q(I:; -XT
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M8M";5#;YTF?_F"BYS*9H5>HWIGLEM^TET\>TM/1=KQ':F'L4!8%W7TH+.L-
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MXIA[DF=AG16EBW8_GH4>CK9;K^1:R'"5,; B2L>C+(5U4<8P(,B$CF+[:SJ
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M<V-US&H+0H0='4#8A0I&Y=%55G+)7]7H5*6Y*W:7F_W-Q#&@115#GN94URG
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M_N35<_'^;![/JAYHI>(,QXZ.?LUN\U4ON92D(H1HU&DGQ1&*K#PU5DA\CDU
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ML%+WG!>5PZ2.J\&='+S(^.B0F*<]0111_[+#1(@AX 2IMD-^">Y@CVR#LQ8
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M"EI*OV=W>,\>X9Z-UI(JFII9FL/[C4U6G(_P$AQ3!N,']-R= IF3<69HC9;
ML?B*+;83$6*GM0Y,"]>XMUZ4Z<3@T(DC.PT5K@3, $@/5#/_6L(*"ANYA3S
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M?&E?!]*3MJ6\2))/XH#&9"&Y:-I>9Z_*DSGG[80OH5DA=MI&OP>T4"JEC*+
MY@*I&/HQ;:HN5Y7 VKB<^I"P,MWNR@ 7U;+!;,JGH;(+/IFE[B)JEUVX\%.C
MT,;5K/17EDAXN"N#EH=MKEEOC433UI-B$ [V#0=_N!RD]RVC2U\R6G-ZL:@E
M?O]:)K "D([1L R&Q&"3#EVD5$OM3MZI@;=@O9BDI84/ $U^"7]6S'B2&@74
M"% K.(FY**<]2< DQ^"/A60S6?Y5&[=='1!':2GWP!NY?6,CJI=M4DIHIKP]
MY--%<D&+=!EWZ.0[V083E^D\<9E'=I(CW  6(M*7&W35(77LAQLI0QH.A/&\
M97TY#ZQ'^Z'X!QT\JYQ-+RETL%*N[$B?=UU+++EJ5 ^0K! =P6TA-X?YL,R9
MB^0B?#;%"' AJ"(_2_^U3*>4Z3U-YLF)*/%D^!'2 2CS259?L%@U"7#=GS;C
MC8V-#KFJLNU"L>GM[MJE _0G@G2G"'25!8 1]Z?-#3+7M#S#- A< +$%__2X
M?8D%$SU-@17:LK"?S@CWAE:UHT;[9GKW%:LDN1GMRQAASV<CP".$7>"W"6AS
M54A7@;ULA%3@C6U%!RQ?4^NR4#1-)07?^/76T3'N^I,RF:-;,RO00JFB1@4.
MCEYI4Y%3+A1XS7JT53%2()LUL1+#_8*_&TVBLM=7_OH%78^YR5@1:Q$)^XX>
M9T,U=0R0"W.,,#4\3DU9VPXS(&J;*P[*.X6JD[;=I76A%<AN/:G0CUL3\ 5P
M:]4H$ F*5\)<ZN^?;W#D8CCH=&;)K#O3K4,IXKE*'A9S,>.2U:&QFD1\F5A3
MQ3GX)B#0GN(\>SUJ*Z?IRHZZ?W7G<FM.L(6#[2C5,GQ$*]C96SS_W!9FF&-W
M_HTO.L5",-]61==U:II6Q8[)"/O<-4W=FOIP\.DU3><IK_NUBYJ:%GFGG7VG
M[?ZK)6X]^9:C%>9H/?E/SM'J<8GUL>M-;HH>-U6Z[BH5 F<5#NJ22SH\5ON-
M+"15S-NNFN;"A9:Z'-O\:2S]$7,\4<)V.* T*5]-W4Q]$AS\"9VC,I9-.[[,
MX.HV%9(H]R\>&3R2\@EI731/Q@8)72)8NFY%)7Z]S+VGKB&)T4\L5FL#4R06
M(U,_G4D:Q#M$3ZD(!@#G1KYGFR&FJIZ^E(#]'!RK6/80574"GAT.#FEQ%'<V
MS45$479>U0X'J7A1+S<>NQ.7"3^#CO6K&(ZY?@:=HJX0GE%+J0B'#)&&'7*S
M^8U/-YN-,GI"*JM".9]AU<_\HN.JFKP2CRUNINWEQ<-] O9X#2N-$!U /7Q&
M=F%)WUS#+I$6(N][)&G9]EX]:IKX#4"=&V:WGFS04%U4E0$,Y)*,B[,PYI3H
MC-,FP- J)3BV$69E<HM/5;MT%:0Y*-J8DU@6'QL"<HTQ&0A$3X*U1 @!.M>0
MJR,+2-N(1O"H>"K/TG*N?.(.!"%$825CR$I[C!  XU0S^T"*$:/OON&L[W8,
M-AW92<YF/:JY;%=0.<C"EB!XIPP8S!K.'OE5NT.53 @]2ABX6# @/56XM[F%
ME>V8U@<]Q&,+;[_V^ZB#?D@.Q.IH].]0U2R>P!.'ZUW9\4?=^055H>)36,5L
MII6K?!)S0)<&SA%89)%=P//6-D>78"V02:A)<YXH;NMU^W6@=I"OTT$8U9P,
M+/!<:X]E'DP0Q!QPRUT9/()1!4?C!XE42H0B@-^ 5\PLK"G.T1:^B-M^^VH%
M8^C$(=-)IM-MW)$7R($]]Q,/ETLAWOLL\80394X+L!3,E':F K4)+AX.FHYW
M.9K,E'9IO]NUJ^E4P#@*W,$KCY*C?9J$""HU272,U\\Q_8H]V!2/"OH/><W/
MK88R@M>CUP14F< 8)K9Q19FR![D))@DSH_R!*-PZ*FWH3YOLIT6A7Q#8BCV4
MVOXE!"=#A'(S#2H G+;-;4%RY?4@ <7/ZF _BGFT^(\FM8&3BFW[$<I@(XDB
MO-1=C$JH=PR\T91&3<BF1 O-X8"=U>V2>^O="3=QB1'KW./,45<:%Y$FF8$>
MD(OVD8M;VY)47D6HC> %8C8HHR*(H(E2[[W><QOZ)I[/BJHBIZ'.%.&W(#QC
M9Z&X \GI:W38&J\X8/82$M@T=(>TUCX9X']I ()^3B N90^M!E,&'I^@*PDG
MS5'1"?II"5^9(O+Y]!$-^!NE99U1-PO8,K,^?VO@JIUY)8JWG-O@P:[HJ&%1
MXDE):*6$L$B3SD1?UA=T^TJKTEG?P9N_+EGI0+C9;F$(2W8T*=,%ZZ/OBFCF
M;^F1GYB=B+=XP$IDVQ7WV21VMZ%%V+J>;_U(&EL.Z-:.ORK'KJ4LL91W^AK9
ML!ISP$FQMO[4YSP@V9\9 2N7\Q.E$GM_-0Y%*#)H= ). PO"ODP;+\R=\.X:
M45Q4%D*S]@T.\ +10Y8+N[]RX T!<N@DU7^0._3I-W=HZ Y]^LT=>H?<H6?*
MM[1#[6@J4">.D]\E4K\GZ;;B,% Y89VU? (2[,YPZ7 3ZC(VBX%M$4[T9E]!
MG?RN6YQ,R.&'$DNR?CO4()VFUA'<BBTHI@AG]V(NCWA5^G <N6K_9NBH>9JH
M%+*&NY3U' Y.)@R/C/_%+J46(8^[[S7SO%Y@0J4-$^("Q/C%:7&.H$GT&96+
MQ 78+6@2?-,1^.=HJI]M(K/Q\<3N^3=2@<_1:G<.:O;MJD);GRD\X98DZMS8
MHB@BG4U@D<P%LM@!$#>@D$/W1!-;$@DGZA:W?O -6 6S A&-R9KTD54XN)=S
M^#_B0Z?BE0)M=SX&=<V@DFHY,V!(SX>1&YBGTY4AK4CCL#==L!N!QMBK$!JY
M'0D0RUPE6H5.>@7B;)$CE+7:0#^UH=M&-H?/WJ$2W-!91\GV3IFE>A!@BX<$
MD4.@P%4E2#4]X+D4^H5Q9Q+;QQ19;B(@9@*8*6 ;I!6N_B03M&S=)59T>[+.
MI#+#%5R,.N9&S1!1+RJ+'$R#U;&0^ZR!ZV#!#IAV%,H!*FPC!GD[]YH<\>@5
M8<015"\I-U82!P6YO(PL=BMIC+C]\MQ8-PNHX2AY*A>-ROK1Z6*RW555P*6V
MT7^ K__,AWBH16[#W';;ZHWO0=V718]+>0600&D=V8:HMC$9,)^MD>]=3>02
M7"6]XNY(4>#ECNVZ R'<><5^=G'UR/R=L\<=\:']C=UC;7=MFW*Q$O,G2*Q=
MJXL3[JM$#@(+8]8@O>NHBUH1 V"Y( FC,E;4.8HSV9+HA!I@AT.'JH!*,.Y]
MELIY;CUN. "[BO#)<X/'&+8@.Y>&8YUICV*$8O\HP>1P;K9I<X+>(:*3EGRP
M)=I\@A5I:[PN,B.=?K=5UV4Z9J2K \:3T$Y_1,&36=C98P/B<[)$T8GN>REL
M^_=[[][/;P"-?X9V-38"9T>GGG:M,]^<FZ^9%=3C:&C.L5,G08'I%XY3%3N(
MX$+;Z.4R5WL^><LH8! JME>#5)%FRZVD;HYE22D@D]+59'!_#VP#S].%%7'3
MO7R2^IQ5710Y<A_,&3=;TXWFT#D1?-7K/KUZTJ6KX_=:<XW@EZXE<NG>?FJE
M]%&L5#A"*6;<3R"77HOA9/W&[>T_B1+E\@:1/$A =-7R<A2 D*J;42+JR9<Z
M9)!DQ4FQK%QYA[H-2P,Y:"6>X$\F=-1-9^Q$PTVKM?QFG5;# ?K=VA1&C5)"
MS-/NE(9.*9XDV03A$%=W-F'95DB7EJ"[[:?TDXO1H.!]I;(B6PB_S4B?5'-K
MYZ:S(_0]M(_MB\DNIO@?1HI6OUS4^6X^K%T5&:IP*#H0^-BF1Q+'5FBP$14:
MZ,6PZBWR$C%P&J"IM,]\_-S)>,0+C26V  0QKTXHP,B\-V+(AL5FNN?I&GD/
MA%Q8QM;:GAW<'9[EN$)7$/<C+EZS7H<^&=:8GW<IL#*#ZQ!-TVH"-F='\-0N
M'#4&DI0@,G+[6JFH:*:44;8/_IL@K 4F^0.4C6Z2L#&5LE,YA41ZG<2\@J;A
M"1UJVJ0IYX6.0,* 9ZCT7\C)0>D:I)9.@!+)A!,-VR=PD(G#P2Z]"HF+0K!Z
MB:'R);F/<,\8V/#<1I;R7]1*NW+_MM ;#JXN&*[51+-#!6L)ZS1WDW.)AEX;
MTB !W4I'[ T7=@-EKN+F.L-PQ&[FH&W@..::V59X4,,X<'%(.N%C+\>0"2,V
MB 1T&K5O$1]SE8MDZK/++^;D"!BZ-&[H);#2A/IR%4M8*7);A0Y)JJG=:=[8
M""RW;ZG;"5E8[T*!,SI^NQ128M8P].9I*M6,>)]].AIY)9&CE=O:53FF>J[H
M(B>[;7"H[(*38ML=V:Z7<!%"3_!N0X3ZI&K9 JO8IA5(5%NLQX"E5>_6PG#"
M?9JA1L0/[6N+N116)U^J=$55:O,;*(\MT?@9Y)F^SL8Y5Q XXE=4J5ZKQ:DN
MPW*$?+K^_?=_MC2X=$'U# ,LZ16+H,,$5S%@KF9DZ<2/F"_E/=AT_<:T[:5P
MT' &D?Q]%6.WHU F%*EA,5$XY'#0.6::4Z,4BAG8_+4;68>>O<!ROG\=5N*#
MGIJL+R)P"6TLND2!JC2FOL%$4)>\6(^V<K4DHG-=MA+.7SHV"E+!-V;[;A,D
MWS0LUK3Y/F%OLB"#EAEI53V4LF;@][I<"KITBEE=<V[;25$=<<WZ+%%;*P8W
MI; 2*&#1LUY?B";@?;"=]*,$K[*D10QGM-9P!MJ.\BQ6;&C+6")1'(Q:J51D
M!+B3$F&#,+-N.+B,^F*2>E.!RQ'GB._I^C CU1="%#"F#'J5L Z3-EV5EC8I
M":B]P*U/U5TMIZ.W3'AM_.>JPU1I+A-Q&)ODKFFR*L8/9<C^K"%ZO(^!2Y/)
MM<B]Z7I\AY?JL-C0)H-5IEZG83\;;/%]WCI;UZ.CL$1W.% 35%L_#B2)0+H&
MW@&*_76<24@/UF.(10/A<U8PFA8VQFL<CG<++N<34D*>?4L)"5-"GOTGIX3<
M%EY8?QOL)ZX-]HXIJ9!_RV6-59\+D.KVHVJJ*[:41>RFE D[96OV:)&EW>53
M83MK.,ZHYUOH7U 2D)O@+ @R1)"%IO*D(/)%YQ0ZC="IX\4AGDOJ,[;-)J6^
MF?7HG<&2,UNXOU1:O+(I;"8Q+' PUAH=T#%7$G7UV//A0!NPP&=?75T;Q2T0
M2/2K5\LQTZ4![]"C7H):0"YMS" J+]5&NQX)SYP4\S&<U%50[H'U%-+9$RTS
MPXN&>$O $:.K6$ RMVJ.]8V?,#EJ8'(VXG2<BKM]3C+,U:#B3NO+ZT^!)3N:
M/DR218JY*4T+LO%$LH(#-UC=3N7T25PNZ9/J^Y(@_]7GN<)[HQ91*)RB*UD.
M:QQ9(J4#U>]E*6_CBVYZC3PIX>)L6=(Y I<@F;B&>_)=?V*K31K_S)A=OU<:
M\XHM$'P>&NBEK%'+LVT;"6Z"9@T\%\7U?=:ZFU'(R!Q@ ]62%>4IVS\J7Y@2
M]WHA&Q'>W\V1\*6\^=-AA'-(CR"GIA8%@Y>FX5]6V2959T,V=I<J>1H(3\K/
MZYS5<-!>0 I!N&G3Q%H@&B*EV'''XL.!P9;F8;A+;QQ?]+- B?9T](0'[*.>
M\,L^&F2<30^D>\] B[_B2?GRT?X]@:M4#0L/2C#&#Y,ZB7;U.<R:P2ZWV/(-
M")N(12UK**S$MAVI@6]*LH'GMAE%2T<(.)OD/ZH!P&X&_H/&MI3EXM$SX;;
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M*H@1;D'EQ2E[GK+FMW3U3\D,>V-5SJ1R,9'0*>/],>&<.M&GNT5-$TR3 3J
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M=2\V5URJ803\\1D$?1N9]"VHO48/OUC%&H+0 EDQX2U/X/C6R?B4'.-B_7Q
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M?\,3&;<75AW+U%% )>K80BBW^GPTI[EX[NB4DXXB?-[2>NF($ WOFA+S(WQ
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MD@F?'=(F'M$].#B"#:1!88Q=H+$S('@[G:W/=%]'Z;Q*B\_,-/0D@!.\P0/
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MSY$YX41O^TIG:W["O>'MN"\4,@AY(][6(1IV_UK"M0>.!3=-\TN\OGF1P8N
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MS<CI;O/I:3LD>="9=AYP=\^^CX1\?.MKLH+,T6..NM"Y. 9%9O(\8O%8-TS
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MK(Q\X=/]0SB=^DG HZ=G\LAI;P\/0NT@C,G12QKWRXB=?3X#=&7\!"N"[RB
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M2[8:&P1(8F3P4OS.V@(*<"SKZJU-+I?(^42/+8<;[%2D66[=0XK[U8B4V%F
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M6*PMCJEI6&/XT+0WVY""D9\F96 79I+6:ULG; OS&CB ABTG7UH5HYGIA&1
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MPL*S%ZJ54, HF5[,'-K8.P&-O9,7CKTH&5_(%!+;<FZX.Z+N1H)/2'@E6;0
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M4$L! A0#%     @ *8FD5DQ6J>'$20  R[$! !P              ( !XAH
M &5A,3<W.3@R97@Q,"TQ7V=D8W5L='5R92YH=&U02P$"% ,4    "  IB:16
MG](Y7B&6  #R$0, '               @ '@9   96$Q-S<Y.#)E>#$P+3)?
M9V1C=6QT=7)E+FAT;5!+ 0(4 Q0    ( "F)I%9V:"H^YJ,   ]6 P <
M          "  3O[  !E83$W-SDX,F5X,3 M,U]G9&-U;'1U<F4N:'1M4$L!
M A0#%     @ *8FD5A' FXZC0   7D$! !L              ( !6Y\! &5A
M,3<W.3@R97@T+3%?9V1C=6QT=7)E+FAT;5!+ 0(4 Q0    ( "F)I%8EVPL#
MZ%L  %?R 0 ;              "  3?@ 0!E83$W-SDX,F5X-"TR7V=D8W5L
M='5R92YH=&U02P$"% ,4    "  IB:16(G7,_,$+  #N,@  &P
M    @ %8/ ( 96$Q-S<Y.#)E>#4M,5]G9&-U;'1U<F4N:'1M4$L! A0#%
M  @ *8FD5H'T.G_%"0  VB,  !P              ( !4D@" &5A,3<W.3@R
M97@Y.2TQ7V=D8W5L='5R92YH=&U02P$"% ,4    "  IB:16 #:6V"<#  "H
M"P  $               @ %14@( 9V1C+3(P,C,P-3 Q+GAS9%!+ 0(4 Q0
M   ( "F)I%8M&F%+_@H  ("&   4              "  :95 @!G9&,M,C R
M,S U,#%?;&%B+GAM;%!+ 0(4 Q0    ( "F)I%9W+'&B50<  -17   4
M          "  =9@ @!G9&,M,C R,S U,#%?<')E+GAM;%!+!08     "P +
+  P#  !=: (    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
